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ABSTRACT 
In response to DNA damage, a signaling cascade is activated within cells that promotes cell cycle 
arrest in order to provide adequate time for DNA repair to occur. Replication Factor A (RFA) is an 
essential, heterotrimeric complex that acts as a primary sensor of DNA damage, localizes to sites of and 
binds to broken DNA, and serves as a platform for several DNA damage repair proteins. RFA-coated 
ssDNA leads to activation of the sensor kinase Mec1. Activation of Mec1 leads directly to phosphorylation 
of the checkpoint regulator Rad53, which in turn activates several downstream effectors that halt cell 
growth and promote DNA repair. 
In response to a permanent, irreparable DNA lesion yeast cells undergo Rad53-dependent 
checkpoint arrest for approximately 12 hours. After this prolonged arrest, cell cycle restart occurs 
sometime between 12-15 hours, promoting mitosis despite the presence of an unrepaired lesion. This 
aberrant checkpoint exit is known as checkpoint adaptation. Checkpoint adaptation deficiency, or the 
inability to override the established Rad53-dependent checkpoint, can be conferred through deletion of 
non-essential but important genes involved in DNA damage repair (e.g., ku70D, rdh54D). The molecular 
mechanism(s) by which checkpoint adaptation occurs remains poorly understood; however, a single point 
mutation (K45E) in the Rfa1 subunit of the RFA complex is capable of rescuing adaptation deficiencies. 
During the DNA damage response, the RFA complex is known to be post-translationally modified 
through phosphorylation, ubiquitination, and sumoylation. Despite robust characterization of these 
modifications to RFA, the physiological role of phosphorylation within the N-terminal (NT) domain of the 
second subunit of the RFA complex, Rfa2, remains elusive. My studies using phospho-mimetic Rfa2 
mutants demonstrates that phosphorylation of the NT is: 1) dispensable for activation of the Rad53-
dependent checkpoint, 2) is readily detected during the temporal window within which checkpoint 
adaptation occurs and 3) promotes checkpoint adaptation in all adaptation-deficient mutations tested. 
Furthermore, analysis of Rfa2 phospho-mutants in sensor kinase deletions mec1D and tel1D reveal 
phosphorylation of the Rfa2 NT may directly impede Mec1 activity, thereby inhibiting maintenance of the 
Rad53-dependent checkpoint and providing a mechanism by which cells can escape an established DNA 
damage-dependent checkpoint. 
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CHAPTER 1: INTRODUCTION 
1.1. Introduction to the DNA damage response 
The transfer of unadulterated genetic material from cell-to-cell (mitosis) or parent-to-offspring 
(meiosis) is dependent on the ability of each cell to maintain the integrity of its own genome prior to these 
processes. Fortunately, each cell comes equipped with signaling pathways and proteins, many of which 
are highly conserved, responsible for the detection and processing of DNA lesions that might otherwise 
compromise the integrity of an organism’s genome. Once a DNA lesion has been detected, an 
intracellular program known as the DNA damage response (DDR) is initiated, where lesion processing 
and repair (LPR) triggers the activation and establishment of the DNA damage-dependent checkpoint 
(DDC). While the primary purpose of the LPR is to facilitate faithful repair of the DNA lesion, the DDC 
provides the DNA repair machinery adequate time to process any and all lesions detected by halting 
cellular growth with the goal of preventing aberrant chromosomal division and genomic instability (Ciccia 
et al. 2010). 
At the center of all DNA metabolism is the essential, conserved, heterotrimeric complex 
Replication Protein A (RPA). Replication Protein A’s primary biochemical function is to bind any single-
stranded DNA (ssDNA) detected in the cell (Blackwell et al. 1994). Originally identified as being essential 
for in vitro DNA replication of SV40 viral DNA (Wold et al. 1988), RPA also functions as a genuine 
guardian of the genome by playing an indispensable role in mediating LPR in every phase of the cell 
cycle (Wold 1997). As the first line of defense against potentially mutagenic lesions, RPA is required for 
generating the initial scaffold that promotes error-free DNA repair through a process known as 
homologous recombination (HR) (Zou et al. 2003). During both LPR and the DDC, RPA’s activity appears 
to be mediated through post-translational modification of the heterotrimeric complex. These modifications 
are thought to control repair by regulating the interactions between RPA and its partners (Marechal et al. 
2015). Recent work, and work within this thesis suggest that post-translational modification, particularly 
phosphorylation, of RPA also temporally regulates the DDC and mitotic exit in response to irreparable 
DNA lesions. 
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1.2. Replication Protein A – guardian of the genome 
Replication Protein A (RPA) is a highly conserved heterotrimeric protein complex that plays 
essential roles in DNA replication, repair and homologous recombination. The RPA complex is comprised 
of the Rpa1, Rpa2, and Rpa3 proteins (Figure 1.1A and 1.1B), and in budding yeast, RPA is known as 
Replication Factor A (RFA) containing the analogous subunits Rfa1, Rfa2, and Rfa3. As guardian of the 
genome, RPA binds and protects any single-stranded DNA (ssDNA) intermediates that arise during DNA 
replication, DNA repair, and homologous recombination to prevent nucleolytic digestion of ssDNA or the 
formation of repair- or replication-impeding secondary structures (e.g., hairpins) (Yuzhakov et al. 1999, 
Kowalczykowski 2000). RPA plays dynamic and indispensable roles in the coordination and assembly of 
replication machinery, such as the DNA polymerase Δ holoenzyme and DNA polymerase α-primase 
(Dornreiter et al. 1992, Yuzhakov et al. 1999), the initial signaling platform utilized in during DDR in 
activating the DDC (Zou et al. 2003), and even in the maintenance of telomeres (Smith et al. 2000, 
Schramke et al. 2004, Grudic et al. 2007, Luciano et al. 2012). 
1.2.A. Basic biochemical properties of RPA 
The heterotrimeric RPA complex has been demonstrated to bind ssDNA in a sequence non-
specific manner with 5’®3’ polarity and very high (sub-nanomolar) affinity (Kim et al. 1994, Bochkarev et 
al. 1997, Arunkumar et al. 2003). Rpa1 (616 amino acids (aa), 70 kDa) is the largest subunit of the RPA 
complex and contains the modular domain architecture and flexible arrangement, when compared with 
the other RPA subunits (Figure 1.1B). An oligonucleotide binding (OB)-fold amino-terminal (N-terminal) 
domain, known as DBD-F (DNA binding domain F), is linked to the rest of the core Rpa1 peptide through 
a flexible linker region. The core Rpa1 protein consists of OB-fold domains A, B, and C (DBD-A, DBD-B, 
and DBD-C), where DBD-A and DBD-B promote the strongest ssDNA interactions for the RPA complex 
(Kim et al. 1992, Kim et al. 1994). DBD-C of Rpa1 is also capable of binding ssDNA, and is primarily 
required for trimerization of the RPA complex with Rpa2 and Rpa3 through conserved alpha helical 
bundles that exist at the C-terminal regions within DBD-C of Rpa1, DBD-D of Rpa2, and DBD-E of Rpa3 
(Bochkareva et al. 2002). Rpa2 (270 aa, 32 kDa) is comprised of a short, unstructured 40 amino acid 
phosphorylation domain within its N-terminus that leads into a high affinity oligonucleotide binding fold 
(DBD-D) and terminates with a specialized winged-helix domain (WHD) composed of a winged helix-loop-
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helix motif (Mer et al. 2000). Rpa3 (121 aa, 14 kDa), the smallest of the RPA subunits, is composed of an 
oligonucleotide binding fold (DBD-E) that appears to have very low affinity for DNA (similar to DBD-F), 
and its major role appears to be stabilization of the heterotrimeric complex (Iftode et al. 1999, Bochkareva 
et al. 2002). 
  
Figure 1.1. RPA Schematics and Crystal Structure of RPA-ssDNA Complex from U. maydis. 
A. Pictorial representation of the RPA heterotrimer as utilized throughout this thesis. B. Schematic 
diagram of the three individual RPA subunits Rpa1, Rpa2, and Rpa3. Rpa1 is comprised of DBD-F, DBD-
A, DBD-B, DBD-C and is 616 amino acids (aa) long. Rpa2 is 270 aa long and made up of an N-terminal 
phosphorylation domain (PD), DBD-D, and the winged-helix domain (WHD). C and D. Representation of 
RPA bound to ssDNA from structural data isolated from U. maydis RPA. PDB: 4GOP. 
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Replication Protein A complex binding to ssDNA is thought to proceed through a two-step binding 
mode process. First, RPA binds ssDNA in 8-10 nucleotide (nt) increments, representative of DBD-A and 
DBD-B interaction with ssDNA (Bochkarev et al. 1997, Arunkumar et al. 2003). This first binding mode is 
thought to be a short binding mode that affords RPA the ability to transition to its long binding mode that 
occludes 23-30 nucleotides of ssDNA through the additive binding of DBD-C and DBD-D (Bastin-
Shanower et al. 2001). Interestingly, DBD-A and DBD-B of Rpa1 have been demonstrated to have nearly 
100-fold higher affinity for ssDNA than that of the remaining RPA DBDs in vitro (Arunkumar et al. 2003). 
Moreover, mutation of aromatic residues within DBD-A (rpa1-aroA; F238/F269A) and DBD-B (rpa1-aroB; 
W361/F382A) confer significant defects in DNA replication leading to damage sensitive cells that 
accumulate in S- and G2-phases (Haring et al. 2008). Binding of the RPA complex to ssDNA has been 
shown via structural studies to transition from an elongated structure in the short 8-10 nt binding mode, to 
a condensed, almost horseshoe-like structure in the condensed, long 23-30 nt binding mode (Figure 1.1C 
and 1.1D) (Bochkareva et al. 2002, Fan et al. 2012). 
1.2.B. RPA domains required for LPR- and DDC-specific interactions 
While the core DBDs are required for RPA’s primary ssDNA binding activity, other regions of the 
RPA complex have been demonstrated to be required for RPA’s activity during LPR and establishment of 
the DDC. The most well studied and arguably most important domain of RPA involved DNA repair is 
DBD-F of Rpa1. While possessing an OB-fold structure, DBD-F does not contribute to binding of RPA to 
ssDNA or DNA replication, as RPA mutants lacking DBD-F (rpa1-ΔFL) or containing the rpa1-t11 (R45E 
and Y52F) mutation are proficient for both RPA localization to repair foci and DNA replication following 
endogenous Rpa1 knockdown (Haring et al. 2010). While it is unclear in human cells whether this leads 
to inviability of the cells, deletion of DBD-F in yeast results in inviability (Philipova et al. 1996). In human 
cells, deletion of DBD-F has been demonstrated to lead to an aberrant cell cycle distribution post-
exposure to DNA damaging agents, indicating a checkpoint deficiency, despite the mutant RPA complex 
being able to localize to DSB sites, similar to that observed for rpa1-t11 (Haring et al. 2008). It is unclear 
whether cells are able to establish a proper DDC with rpa1-t11 or rpa1-ΔFL, or if they initiate checkpoint 
establishment and then, through an unknown mechanism, bypass the established checkpoint. Because 
deletion of DBD-F in budding yeast results in inviable cells, the most well characterized DBD-F mutation 
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Table 1.1. DNA repair proteins in budding yeast and their human homologs.  
Functional 
Class 
S. cerevisiae H. sapiens Function Source 






Binds ssDNA, platform for 










Endonuclease; ATPase Lisby and 
Rothstein 2004 
Clamps Rad24/Rfc2-5 Rad17/Rfc2-5 Clamp loader complex 









9-1-1 clamp, interacts 
with Effector kinases 
Lisby and 
Rothstein 2004 
Adaptors Mrc1 Claspin Rad53/Chk1 Chaperone Lisby and 
Rothstein 2004 
Adaptors Rad9 BRCA1 
MDC1 
53BP1 
Rad53/Chk1 Chaperone Lisby and 
Rothstein 2004 










Effector Kinase Rad53 Chk2 Cell cycle arrest Lisby and 
Rothstein 2004 
Effector Kinase Chk1 Chk1 Cell cycle arrest, 






Rad52 Rad52 RPA-Rad51 Exchange 
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Table 1.1. DNA repair proteins in budding yeast and their human homologs (continued). 
Functional 
Class 
S. cerevisiae H. sapiens Function Source 
Recombination 
Protein 
Rad51 Rad51 Displaces RPA with 
Rad52; binds ssDNA, 






















Sae2 CtiP Component of 
MRXS/MRN-CtiP. 















Dna2 Dna2 Nuclease/Helicase; 



















Slx4 Slx4 Holliday junction 
resolution Endonuclease 




Dpb11 TopBP1 Mec1/ATR activation; 
interacts with 9-1-1 
Clamp; scaffold assembly 
at DSB 
Leung et al. 
2014 
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in DNA metabolism and cell cycle regulation is rfa1-t11 (K45E) (Umezu et al. 1998). The rfa1-t11 mutation 
confers hypersensitivity to DNA damaging agents (Chen et al. 1998, Umezu et al. 1998) and has been 
reported to have an inability to load Rad24-RFC onto damage-like substrates in vitro (Majka et al. 2006). 
However, it remains unclear as to whether a physical interaction between Rad24 and rfa1-t11 is 
abrogated or whether RFA containing rfa1-t11 interacts with the DNA properly to facilitate the proper 
loading of Rad24. Moreover, the rpa1-t11 (R41E and Y42F) mutation in human cells has been 
demonstrated to disrupt or impede interactions that are critical for checkpoint establishment, including 
ATR/ATRIP (Ball et al. 2005, Nakada et al. 2005), Rad17-RFC loading (Zou et al. 2003, Majka et al. 
2006), Rad9 (component of the Rad9-Rad1-Hus1 ’9-1-1’ PCNA-like clamp; Zou et al. 2003, Xu et al. 
2008) , as well as the MRN complex (Mre11-Rad50-Nbs1, essential complex for DSB processing; 
Robison et al. 2004, Robison et al. 2005, Olson et al. 2007) . DBD-F has also been reported to interact 
with TopBP1, a scaffolding protein required for activation of ATR (Kumagai et al. 2006, Mordes et al. 
2008, Navadgi-Patil et al. 2008, Germann et al. 2011). Table 1.1 lists all the known homologs between 
yeast and human proteins involved in the DDR. 
In yeast, rfa1-t11 has been demonstrated to promote checkpoint adaptation, or the ability of cells 
to enter into mitosis despite the continued presence of DNA lesions, in cells containing adaptation-
deficient mutations (Lee et al. 2001, Pellicioli et al. 2001, Lee et al. 2003, Ghospurkar et al. 2015). The 
interaction between Ddc2 (Mec1 chaperone/interacting partner) and RFA has been reported to be 
impeded by rfa1-t11, suggesting that Mec1 cannot become fully activated in rfa1-t11 cells (Zou et al. 
2003, Grandin et al. 2007, Deshpande et al. 2017); however, rfa1-t11 cells can still activate the Rad53-
dependent checkpoint suggesting a defect in checkpoint maintenance rather than checkpoint 
establishment. 
DBD-F is not the only domain thought to be essential for protein-protein interactions during the 
DDR. Rpa2 contains a C-terminal winged helix-loop-helix motif known as the winged-helix domain (WHD) 
(Mer et al. 2000). In human cells, the WHD has been demonstrated to interact with a number of proteins 
essential for proper genome maintenance such as Rad52 (strand-annealing protein required for 
homologous recombination; Park et al. 1996, Sung 1997, Gasior et al. 1998, Shinohara et al 1998 New et 
al. 2002, Sugiyama et al. 2006, Sleeth et al. 2007) , XPA (protein required for nucleotide excision repair; 
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Li et al. 1995, Stigger et al. 1998, Wang et al. 2000) , Ung2 (uracil-DNA glycosylase, prevents uracil 
incorporation into the genome during nucleotide excision repair; Mer et al. 2000, Hagen et al. 2008, Ali et 
al. 2010, Torseth et al. 2012, Herate et al. 2016) , SMARCAL1, and TIPIN (replication fork protection and 
replication restart; Ali et al. 2010, Kemp et al. 2010, Betous et al. 2013, Feldkamp et al. 2014, Witosch et 
al. 2014, Xie et al. 2014, Poole et al. 2015). In budding yeast, cells containing WHD truncations are 
hypersensitive to DNA damaging agents and exhibit hyper-recombination phenotypes that lead to 
excessive mutation of the genome (Santocanale et al. 1995, Maniar et al. 1997). RPA has also been 
demonstrated to interact with the XPF-ERCC1 endonuclease in order to initiate the processing of inter-
strand crosslinks present in DNA (Abdullah et al. 2017). 
Another domain that has been well characterized during the DDR is the N-terminal (NT) 
phosphorylation domain (PD) of Rpa2. This domain is unstructured and has not yet been demonstrated to 
become more ordered upon post-translational modification. Phospho-mimetic mutation of the Rpa2 NT 
has been demonstrated to weaken Rpa1 DBD-Fs interaction with the MRN complex in vitro, specifically 
with Mre11 and Nbs1, whereas an unphosphorylatable mutation of the same phospho-sites did not 
impede RPA-MRN complex interaction or localization to breaks but did increase persistence of the 
complex at the DSB site (Oakley et al. 2009). However, this data is somewhat conflicting to another report 
demonstrating that hyper-phosphorylated Rpa2 (and by extension, the RPA complex) co-localizes with 
phosphorylated Mre11 (and by extension the MRN complex) at stalled replication forks in vivo (Robison et 
al. 2004). Mechanistically, recruitment of MRN to break-sites has been shown to be dependent on the 
RPA complex, and disruptions in the MRN-RPA complex interactions lead to increased DNA replication 
after DSB induction with ionizing radiation (Olson et al. 2007). More recently, the Rpa2 NT has been 
shown to, upon DDR-dependent phosphorylation, influence the interaction with the ubiquitin ligase Prp19 
(Dubois et al. 2017). Ubiquitination of RPA, as described in section 1.3.B, has been shown to be a 
requirement of proper checkpoint activation. 
1.3. Post-translational modification of RPA and relevant mutant phenotypes 
In response to a variety of DNA metabolic processes, as well as during the cell cycle, RPA is 
known to be post-translationally modified, and this post-translational modification of RPA is thought to 
mediate its dynamic intracellular activities. Post-translational modifications (PTMs) allow for rapid 
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changes in protein function without the energetic cost of degrading and resynthesizing useable proteins. 
Examples of post-translational modification include ubiquitination (addition of ubiquitin, a small 8 kDa 
peptide), sumoylation (addition of small ubiquitin-like modifier, a small 12 kDa peptide), and 
methylation/acetylation (addition of small carbon chains, typically via N- or O- linkages on amino acid side 
chains). Each modification alters protein function in in different ways. For example, acetylation of the RPA 
complex is thought to promote DNA repair through the Nucleotide Excision Repair (NER) pathway (He et 
al. 2017, Zhao et al. 2017). This process is mediated by PCAF/GCN-5 acetylase complex and occurs on 
Rpa1 at K163 (ibid). RPA acetylation has also been deemed important during DNA repair, cells 
containing an rpa1-K163R mutation exhibit hypersensitivity to UV-induced DNA damage (ibid). However, 
Rpa1 K163 is also a known ubiquitin ligase target during the DDR program (ibid), and it is unknown 
whether preventing acetylation or ubiquitination of Rpa1 is more important during the DDR. Ubiquitination 
has been demonstrated to target proteins for degradation via the proteasome (Thrower et al. 2000) and is 
suggested to form a molecular ‘glue’ to keep proteins in close proximity with one another (Kim et al. 
2007). Sumoylation is thought to be important for nuclear transport of proteins (Rodriguez et al. 2001), 
transcriptional regulation (Kagey et al. 2003), and enhancement of protein stability (Desterro et al. 1998). 
Methylation and acetylation of amino acids on peptides can be used to neutralize side-group charges, 
impede phosphorylation of phospho-targets, and/or alter protein-protein interactions by disrupting docking 
contacts (Schubert et al. 2006). 
1.3.A. Sumoylation of RPA 
The RPA complex becomes robustly sumoylated and ubiquitinated during the DDR. Previous 
studies have reported that ubiquitination and sumoylation of RPA have been demonstrated to be 
important for proper LPR progression (Galanty et al. 2012, Yin et al. 2012, Marechal et al. 2014, Chung et 
al. 2015, Elia et al. 2015, Dubois et al. 2017), as well as proper establishment of the DDC (Marechal et al. 
2014, Wan et al. 2014, Dubois et al. 2017). However, the aforementioned studies were performed in 
ubiquitin- or sumo-ligase deletion/null mutations or using RNAi knockdown of the ligase itself, making it 
difficult to discern whether the defect lies with the inability to modify RPA or an inability to modify other 
LPR targets of these ligases. Moreover, these small protein additions are thought to function by recruiting 
and retaining the required DDR components at the lesion site to promote repair. In yeast cells, 
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sumoylation of RPA occurs on both Rfa1 and Rfa2 at and is achieved by Siz2, an E3 sumo ligase (Chung 
et al. 2015) and is regulated by the Slx5-Slx8 sumo-targeted ubiquitin ligase complex (Burgess et al. 
2007). In human cells, Rpa1 has been demonstrated to be sumoylated with sumo-2/3 at K449 and K577 
by a yet unidentified sumo ligase and is prevented by Senp6, a sumo protease (Dou et al. 2010, García-
Rodríguez et al. 2016). In human cells, a double mutation of K449 and K557 of Rpa1 leads to increased 
sensitivity to genotoxic agents, such as camptothecin, demonstrating that sumoylation of Rpa1 is 
essential for a proper DDR (Dou et al. 2010). Sumoylation of Rpa1 has been shown to be necessary for 
RPA-Rad51 exchange at DSBs, as deletion of Siz2 has been demonstrated to not only inhibit RPA 
sumoylation, but also impair RPA interaction with the strand-annealing protein Rad52 (Psakhye et al. 
2012). The interaction with RPA through Rad52 is thought to be critical in mediating the exchange 
between RPA and the Rad51 recombinase on ssDNA during homologous recombination (Psakhye et al. 
2012, Shima et al. 2013). Impediment of RPA desumoylation leads to the formation of DSBs during DNA 
replication and causes accumulation of cells in S- and G2/M phases (Dou et al. 2010). Sumoylation and 
desumoylation of RPA, in a controlled and coordinated fashion, is thus required for regulation of RPA’s 
activity during DNA replication, repair, and cell cycle progression. Similar to phosphorylation (discussed in 
section 1.4), permanent changes in a cell’s ability to readily modify RPA prevent cells from properly 
executing DNA replication, checkpoint activation, and mitotic exit. In both yeast and human cells, 
sumoylation of RPA, and other DDR machinery, has been implicated to be important for Mec1 and ATR 
activation, respectively (Galanty et al. 2009, Cremona et al. 2012, Cremona et al. 2012, Galanty et al. 
2012). It is unclear, however, whether sumoylation of RPA, or the lack of the E3 sumo ligases modifying 
targets outside of RPA are the direct drivers of these phenotypes. In human cells, depletion of Pias1 and 
Pias4 (sumo E3 ligases) lead to reduced ATR activation and reduced ATM-dependent phosphorylation of 
Rpa2 at S4/S8, indicating that sumoylation of RPA is required for proper checkpoint signaling (Galanty et 
al. 2009). Furthermore, depletion of Rnf4 (sumo-targeted ubiquitin E3 ligase) has been demonstrated to 
impair RPA turnover and impede Rad51 filament formation, inhibiting homologous recombination repair 
(Galanty et al. 2012). 
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1.3.B. Ubiquitination of RPA 
Ubiquitination of RPA occurs primarily via Rfwd3 and Prp19 (Gong et al. 2011, Liu et al. 2011, 
Marechal et al. 2014, Wan et al. 2014, Elia et al. 2015, Dubois et al. 2017, Feeney et al. 2017, Inano et al. 
2017). Rfwd3 and Prp19 are E3 ubiquitin ligases required for DNA repair. Rfwd3 has been demonstrated 
to have a constitutive interaction with RPA, whereas Prp19 interaction only occurs during the DDR 
following phosphorylation of the Rpa2 NT (Dubois et al. 2017). Prp19 has been demonstrated to 
ubiquitinate RPA bound to ssDNA and is required for efficient activation of Chk1 (Marechal et al. 2014). 
Preventing ubiquitination via Prp19 knockdown has been shown to lead to reduced Rpa2 
phosphorylation, as well as Chk1 activation, suggesting ubiquitination plays an important role in the 
recruitment and activation of ATR/ATRIP. ATR/ATRIP has been shown to preferentially interact with K63 
tetra-ubiquitin molecules which is the type of ubiquitination Prp19 has been demonstrated to stimulate on 
Rpa1 and Rpa2 (Marechal et al. 2014, Dubois et al. 2017). Preventing ubiquitination of RPA via 
knockdown or mutation of Prp19 or Rfwd3, or mutation of known RPA ubiquitin sites (specifically Rpa2: 
K37, K38 (Elia et al. 2015) has been shown to lead to a slight increase in γ-H2AX after hydroxyurea 
treatment, impaired checkpoint activation, and repair through homologous recombination leading to 
replication fork collapse and replication catastrophe, demonstrating a role for ubiquitination of RPA in the 
DDR (Marechal et al. 2014, Elia et al. 2015, Dubois et al. 2017). An interaction between RFA and the 
yeast homolog to human Prp19 (Prp19/Pso4) has not yet been demonstrated; however, yeast containing 
a pso4-1 mutation display sensitivity to ultraviolet radiation (UV) and exhibit deficiencies in mitotic 
recombination (Henriques et al. 1989, Grey et al. 1996). 
Ubiquitination of RPA is also reported to be driven by Rnf4, a sumo-targeted ubiquitin ligase 
(STUbL) that is thought to regulate and ubiquitinate sumoylated DDR proteins such as Mdc1 (Mediator of 
DNA damage checkpoint protein 1, Luo et al. 2012 ) CtIP (C-terminal binding protein 1 (CtBP1) 
interacting protein; Sartori et al. 2007, Himmels et al. 2016) (Galanty et al. 2009, Galanty et al. 2012, Luo 
et al. 2012, Yin et al. 2012). However, Rnf4 is only able to ubiquitinate proteins that have already received 
prior sumoylation modifications, and typically ubiquitinates the sumo groups that have been covalently 
attached to its targets (Galanty et al. 2012, Yin et al. 2012). Preventing ubiquitination of Mdc1 or CtIP 
leads to reduced resection of the DSB and inhibition of both the generation of RPA coated ssDNA and 
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homologous recombination (Galanty et al. 2009, Galanty et al. 2012, Luo et al. 2012, Yin et al. 2012). 
Replication Protein A, as described above, is sumoylated on K449 and K577, and mutation of these 
residues to the non-sumoylatable K449/K577R leads to reduced RPA turnover (degradation) and an 
increase in RPA occupancy on ssDNA generated at DSBs, analogous to results observed for Rnf4-
deficient cells (Galanty et al. 2012). The most common phenotype observed in preventing sumoylation or 
ubiquitination of RPA or other complexes during the DDR is reduced checkpoint activation through sensor 
kinases and deficiency in homologous recombination repair. However, it is unknown whether this is due 
to reduced RPA modification or reduced modification of the multitude of enzymes functioning during the 
DDR, as several components require small ubiquitin-like modifiers for proper function. However, if DNA 
repair proteins are held together through a variety of sumoylation and ubiquitination events that act to 
coordinate the repair process, then the aforementioned phenotypes are somewhat expected. 
1.4. Phosphorylation of the human RPA complex and related mutant phenotypes 
Phosphorylation of proteins is a rapid way cells use to alter protein function by the addition of an 
80 Dalton (Da) phosphate group to Serine/Threonine/Tyrosine (S/T/Y) side-chains. Phosphorylation of 
proteins can occur on multiple S/T/Y sites and can dynamically change protein function. Phosphorylation 
can be inhibitory to activity, as is the case with Dun1-mediated phosphorylation of Sml1 (causing 
degradation of Sml1) during the DDR (Gardner et al. 1999), or stimulatory to activity, as is the case with 
Mec1-mediated phosphorylation of Rad53 during establishment of the DDC in yeast (Sanchez et al. 1996, 
de la Torre-Ruiz et al. 1998, Gardner et al. 1999, Sanchez et al. 1999, Pellicioli et al. 2001, Sweeney et 
al. 2005, Clerici et al. 2014). Phosphorylation of RPA is also thought to mediate RPA’s activity throughout 
the DDR. While Rpa1 in humans has been shown via large-scale screens to be phosphorylated at T180, 
T191, and S384 (Matsuoka et al. 2007, Olsen et al. 2010), the most important and physiologically 
relevant phosphorylation events that occur to the RPA complex appear to occur within the NT 
phosphorylation domain of Rpa2, as alteration of phospho-acceptor sites produce synthetic phenotypes. 
Most of what is understood about Rpa2 phosphorylation comes from experiments performed in 
human cells. Cells containing the phospho-deficient rpa2-S4/S8A mutation display reduced 
phosphorylation of critical DDR factors Chk1, Mre11, and TopBP1 (Liu et al. 2012), as well as aberrant 
replication restart following etoposide-induced DNA damage (Ashley et al. 2014). Additionally, rpa2-
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S4/S8A mutants fail to phosphorylate T21 of the Rpa2 NT, suggesting a site-dependency or sequential 
phosphorylation mechanism may be responsible for achieving an optimal Rpa2 NT phospho-state 
(Oakley et al. 2009). Cells containing S23/S29A phospho-deficient mutations display increased γ-H2AX 
and apoptosis (Anantha et al. 2007), and reduced Rad51 loading in response to genotoxic insult (Anantha 
et al. 2008), suggesting phosphorylation of these residues may be important for the RPA-Rad51 
exchange during homologous recombination. Rpa2 mutations containing T21/S33A prevent DNA 
synthesis during recovery from HU-induced replication stress or DNA damage caused by UV-radiation 
(Olson et al. 2006, Vassin et al. 2009). Further highlighting the importance of Rpa2 phosphorylation in 
DNA repair after HU-induced replication stress, a severely phospho-deficient extensive Rpa2 mutation 
rpa2-Ala7 (S4/S8/S11/S12/S13/T21/S33A) generates phenotypes that display reduced Rad51 filament 
formation (Shi et al. 2010), analogous to, but more severe than, that observed in the S23/S29A mutation. 
Additionally, it was reported that the rpa2-Ala7, and rpa2-S23/29A mutations accumulate in either S- or 
G2- phases of the cell cycle, without any sort of DNA damage stimulus (Anantha et al. 2007, Anantha et 
al. 2008, Shi et al. 2010); however, the significance of this result is unclear, as it has been demonstrated 
that cell cycle distribution in untreated rpa2-Ala9 cells (where all nine S/T residues in the NT are mutated 
to A), does not appear to be greatly affected (unpublished results, SJH). Taken together, preventing 
phosphorylation of the Rpa2 NT during either cell cycle progression or the DDR program leads to 
reduced/impaired homologous recombination and aberrant replication restart. 
Phospho-mimetic mutation of Rpa2 has provided additional mechanistic insight into the regulatory 
role that the RPA complex plays during cell cycle regulation during the DDR. In yeast, the physical 
presence and subsequent phosphorylation of the Rfa2 NT has been implicated to play a role in telomere 
maintenance, as an NT deletion mutation of Rfa2 (rfa2-ΔN40) displayed severely shortened telomeres via 
decreased Est1 recruitment to telomeric DNA (Schramke et al. 2004). In human cells, cells containing 
rpa2-S8/S33D, rpa2-T21/S33D, or rpa2-S8/S23/S29/S33D mutations decreased viability and RPA foci 
formation at DSBs following camptothecin exposure indicating a defect in DNA repair efficiency and 
suggesting that the phospho-state of Rpa2 mediates RPA complex recruitment to DSB sites (Lee et al. 
2010). Rpa2 has been demonstrated to be dephosphorylated by the PP4 phosphatase complex (PP4R2, 
PP4C), and inhibition of PP4 components via transient knockdown has been shown to cause inefficient 
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Rad51 loading and a prolonged G2/M checkpoint, suggesting that PP4-mediated dephosphorylation is 
required for efficient progression of homologous recombination repair. Knockdown of another 
phosphatase complex PP2A/C (components of the PP2 phosphatase complex) has been shown to lead 
to increased RPA foci after HU exposure, suggesting that PP2-mediated dephosphorylation is required 
for efficient repair and resolution of HU-induced stalled replication forks (Feng et al. 2009). Consistently, 
the aforementioned Rpa2 mutations also display deficiencies in the ability to resolve HU-induced fork 
damage during replication stress. However, it is somewhat unclear as to whether mediation of the Rpa2 
phospho-state or broad inhibition of phosphatase activity is responsible for the aforementioned 
phenotypes, as each of the Rpa2 mutations mentioned above have been noted to lead to proper 
establishment of the damage-dependent checkpoint.  
Phospho-mimetic studies of the Rpa2 NT phospho-state using ectopically expressed rpa2 
mutations have revealed that phosphorylation of Rpa2 prevents RPA from participating in chromosomal 
DNA replication (Vassin et al. 2004, Olson et al. 2006), and leads to defects in DNA synthesis during HU-
induced replication stress causing apoptosis (Vassin et al. 2009) despite observed increases in RPA 
binding to ssDNA (Vassin et al. 2009). In vitro, phosphorylation of Rpa2 has been shown to recruit Palb2 
(partner and localizer of BRCA2), an interaction that is thought to mediate replication restart at and 
stabilize stalled replication forks, as use of phospho-mimetic Rpa2 or transient knockdown of PP4R2 
cause impaired or slowed replication fork movement during HU-induced replication stress and during 
recovery once hydroxyurea is removed (Murphy et al. 2014). Moreover, phosphorylation or phospho-
mimetic mutation of the Rpa2 NT has been demonstrated, through in vitro interaction assays, to impede 
interaction with the MRN complex (specifically Mre11 and Nbs1; Oakley et al. 2009) . However, much of 
the data generated using phospho-mimetic mutation of Rpa2 is conflicting in that constitutively mimicking 
phosphorylation leads to replication or repair deficient phenotypes that mirror those observed in cells 
containing unphosphorylatable Rpa2 mutations. Taken together, the above phenotypes for phospho-
mimetic or unphosphorylatable Rpa2 NT mutations highlight the critical nature of rapidly modulating the 
Rpa2 NT phospho-state in order to successfully mediate the processes of DNA replication and repair, as 
well as RPA’s dynamic activity as a sensor of DNA damage, essential replication factor, and cell cycle 
regulatory complex.  
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1.4.A. Phosphorylation of Rpa2 in other model systems 
Rpa2 in Xenopus laevis egg extracts and in the pathogenic yeast Candida albicans has been 
shown to be phosphorylated during mitotic entry, mitotic exit, and during the DDR. It is unclear which of 
the conserved kinases phosphorylates Rpa2 in Xenopus laevis, however it is thought that this 
phosphorylation is mediated by ATR and CDK (Recolin et al. 2012). Phosphorylation of Rpa2 in Candida 
albicans has been demonstrated to occur by both Mec1- and Cdc28-dependent mechanisms. In mutant 
cells where Mec1 expression is inhibited, or that containing the cdc28-as mutation that is inhibited by 
1NM-PP1 (ATP analog), display reduced Rpa2 phosphorylation during HU-induced replication stress as 
well as upon entry into mitosis (Gao et al. 2014). 
In Candida albicans, phosphorylation SQ/TQ sites within the Rfa2 NT (S18 and S30) by Mec1, 
and to a lesser extent phosphorylation of the Rfa2 NT by Cdc28, were implicated to be important during 
replication stress caused by hydroxyurea (HU) (Gao et al. 2014). Cells expressing a phospho-deficient 
rfa2-4A mutation (T11A, S18A, S29A, S30A) were reported to be more sensitive to HU-induced stress 
and in some instances were unable to deactivate the Rad53-dependent checkpoint when compared with 
rfa2-4D (T11D, S18D, S29D, S30D) mutant cells (ibid). In Xenopus extracts, Rpa2 phospho-mimetics 
(S26D, S31D, T35D) exhibit deficiency in checkpoint activation in response to aphidicolin treatment 
(leading to fork unwinding and replication stress), whereas phospho-deficient Rpa2 mutation could still 
faithfully activate Chk1 during S-phase (Recolin et al. 2012). As mentioned in section 1.4, the phospho-
mimetic Rfa2 mutations used mirror phenotypes of unphosphorylatable Rfa2 mutations suggesting that 
rapidly modulating the phospho-state of Rfa2 is essential for proper RPA complex function in all DNA 
metabolic processes. 
1.4.B. Phosphorylation of RFA in budding yeast 
In budding yeast, RFA has been demonstrated to be phosphorylated at S178 of Rfa1 (similar in 
position to Rpa1 T180, Matsuoka et al. 2007) and S122 of Rfa2 by the sensor kinase Mec1 (Kim et al. 
2003). The physiological role of phosphorylation at the known Mec1 sites (Rfa1-S178 and Rfa2-S122) is 
unclear due to the observation that these sites appear to be completely dispensable for the DDR in yeast 
(Ghospurkar et al. 2015). While this will be covered more in-depth in chapter 3, aspartate- or alanine- 
mutagenesis of S122 (Rfa2) and S178 (Rfa1) revealed that every possible combination of S178A/D and 
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S122A/D mutations were as proficient as wild-type cells in tolerating clastogen challenge. Furthermore, 
while S122 phosphorylation is a common marker for Mec1 activity, each rfa2-S122A/D mutation is capable 
of performing checkpoint arrest in an indistinguishable manner from WT cells suggesting that Mec1-
dependent phosphorylation of RPA at S122 is not required for proper checkpoint activation (see Chapter 
3). Additionally, the only identified phosphorylation events that occur in budding yeast on the Rfa2 NT 
occur during meiosis by Ime2 (Brush et al. 2001, Clifford et al. 2004, Bartrand et al. 2006) or in a set1Δ or 
mec3Δ mutant by Rad53 (Schramke et al. 2001). Phosphorylation of RFA also occurs during meiosis and 
will be discussed in section 1.5.C. 
1.5. Meiotic process and meiotic recombination 
Paramount to the propagation of any sexually reproducing species is the stable exchange of 
genetic information from parent to offspring through the process of meiosis. Broadly, the process of 
meiosis involves duplication of a diploid genome, followed by recombination between homologous 
chromatids, which is necessary to ensure proper chromosome segregation during the reductional division 
critical for the generation of viable haploid gametes. This differs from mitotic recombination in that mitotic 
recombination is primarily driven between sister chromatids. Replication Protein A, by virtue of its ssDNA-
binding role in DNA replication and the DDR, plays essential but somewhat poorly understood roles in the 
meiotic process. Not only does RPA interact with proteins that play a significant role during meiosis, but it 
is phosphorylated during the meiotic program by some of its interacting partners. Described in the 
following sections are the process of meiosis and its importance in proper chromosome segregation and 
the known extent and context of RPA’s meiotic protein interactions.  
The process of meiosis is essential for all sexually reproducing organisms, and leads to increased 
genetic variability among organisms (Martini et al. 2002). In order for meiosis to occur properly, five major 
cellular programs must be executed in a precise and step-wise manner (Figure 1.2) (Page et al. 2003). 
First, the genetic information of the diploid organism must be duplicated during premeiotic DNA synthesis. 
Second, as the cells enter prophase of meiosis I (MI), the formation of DSBs and pairing of homologous 
chromosomes occurs leading to meiotic recombination. Meiotic recombination must occur between paired 
homologous chromosomes (interhomologs) in order to guarantee proper chromosome segregation during 
meiotic divisions (Baker et al. 1976, Hollingsworth et al. 1990). Prophase I is typically broken up into five 
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stages, based on the physical state of the chromosomes: (1) leptotene – pairing and synaptonemal 
complex (SC) assembly occurs, (2) zygotene – synapsis of homologs mediated by the SC, (3) pachytene 
– homologous recombination between synapsed homologs, (4) diplotene – SC degradation and initial 
untethering of recombined homologs, and (5) diakinesis – complete untethering of recombined homologs. 
Third, recombined homologous chromosomes align during metaphase I, are attached to the kinetochore 
components during anaphase I, and are segregated in a reductional division during telophase I, resulting 
in separation of homologous chromosomes to opposite poles and halving of the genomic content (hence 
the name reductional division). Fourth, the daughter cells undergo an equational division known as MII, in 
which the sister chromatids of the recombined chromosomes are aligned and segregated (prophase II – 
telophase II), in order to segregate the recombined chromosomes into four haploid gametes (cytokinesis). 
Finally, the haploid gametes (spores) are packaged, which in budding yeast includes the development of 
a tough ascal coat that surrounds the four spores and protects them from harsh environmental conditions. 
During meiotic homologous recombination in yeast, nearly 200 DSBs are intentionally introduced 
to the paired chromosomes through the activity of an evolutionarily conserved type II topoisomerase 
known as Spo11 (Keeney et al. 1997). In yeast cells, Spo11 acts in concert with nine other meiotic DSB 
processing factors (Ski8/Rec103, Mre11-Rad50-Xrs2, Rec102-Rec104, Mer2, Rec114, Mei4; Keeney 
2008) to bind more frequently than average regions of the genome known as “meiotic recombination hot 
spots”, where Spo11 cleaves one or more of the four chromatids. Once DSBs are formed, resection of 
each of the ~180-200 DSBs is achieved through the 5’®3’ exonuclease activity of the Exo1 exonuclease 
in a manner similar to that observed during the mitotic DDR (discussed in 1.6.A; (Mimitou et al. 2008, 
Mimitou et al. 2010, Shim et al. 2010), followed by brief occupancy of the generated ssDNA by RPA 
(Ribeiro et al. 2016). Replication Protein A is then actively replaced with Dmc1, the meiosis-specific 
Rad51 protein required for interhomolog strand invasion (Bishop et al. 1992, Dresser et al. 1997, Hong et 
al. 2001, Martinez et al. 2016). Dmc1-coating of the ssDNA promotes strand invasion of the homologous 
chromosomes, as opposed to Rad51 filaments that promote strand invasion of the sister chromatid 
(Dresser et al. 1997, Arbel et al. 1999).  
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Figure 1.2. The Five Stages of Meiosis. 
A. Premeiotic DNA synthesis occurs on homologous chromosomes (red and blue). B. Entry into prophase 
I leads to pairing of homologous chromosomes and SC assembly during leptotene, followed by DSB 
formation by RIC (Spo11 et al). C. Synapsis, or fusion of the chromosomes, occurs during zygotene 
followed by meiotic recombination during pachytene. D. Degradation of the SC promotes initial 
segregation of synapted chromosomes during diplotene, and full separation of recombined chromosomes 
occurs during diakinesis, leading to two cells with haploid chromosomes after the MI reductional division 
(cytokinesis I) E. MII equational division further segregates sister chromatids into individual gametes 
(cytokinesis II) F. Haploid gametes are then packaged, which in yeast leads to the formation of the ascal 
coat surrounding the four haploid spores. 
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Once strand-invasion and homologous base pairing to form heteroduplex DNA are complete, 
DNA synthesis and second-strand capture occurs to repair the Spo11-generated DSBs and link the 
chromosomes together through the generation of double Holliday Junctions (dHJ) across each break 
(Bizard et al. 2014). The dHJs are then resolved through the employment of ‘resolvases’ or ‘dissolvases’ 
that untether the chromosomes from one another (Heyer et al. 2003, Heyer 2004, Bizard et al. 2014, 
Bocquet et al. 2014, Matos et al. 2014, Sarbajna et al. 2014, Wyatt et al. 2014, West et al. 2015), leading 
to the formation of crossover or noncrossover products that are segregated during the reductional 
division. Failure to properly induce Spo11-dependent DSBs, defects in strand invasion, or defects in dHJ 
resolution typically lead to incomplete or inviable meiotic products (Baudat et al. 2000). In human cells, it 
is presumed that defects in meiotic recombination lead to aberrant chromosome segregation events that 
lead to cellular disease and developmental defects (Ratcliffe 1981, Zaki et al. 2005, Templado et al. 2011, 
Adams et al. 2015). 
1.5.A. Meiotic recombination is essential for proper chromosomal segregation 
In order for meiotic recombination to be executed, homologous chromosomes must be aligned 
through the formation of the tripartite synaptonemal complex (SC), composed of two axial elements (on 
each homologous chromosome) and a central core element (Page 2003). While formation of the SC axial 
elements on each chromosome occurs during early leptotene, synapsis between chromosomes only 
occurs once a homology search has concluded successfully. The homology search occurs through DSB 
formation and strand invasion, and as such, cells defective for meiotic recombination are also defective 
for SC formation (ibid). Following the homology search, transverse filaments are formed during pachytene 
(Zickler et al. 1999, Fraune et al. 2012), resulting in fully paired homologous chromosomes. Furthermore, 
improper SC assembly inhibits proper crossover formation and can lead to inviable meiotic products and 
embryonic lethality (Page 2003, Kouznetsova et al. 2011). 
Much of what we know about the meiotic program, however, does not come from the study of 
human gametogenesis, but rather the study of yeast progressing through meiosis. Several of the 
components required to elicit programmed DSBs during meiosis, as well as the factors required to repair 
the lesions generated, have been demonstrated to be essential in preventing aberrant recombination 
phenotypes, and some have even been demonstrated to completely inhibit meiosis when deleted. For 
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example, spo11Δ yeast are unable to complete meiotic recombination due to a lack of adequate DSBs 
being formed to promote resection and recombination (Keeney et al. 1997, McKee et al. 1997, Baudat et 
al. 2000, Romanienko et al. 2000, Diaz et al. 2002), however, microscopic analysis of nuclear genome 
content in spo11Δ yeast revealed that these mutants are still able to complete meiotic divisions through 
MI and MII but are inviable. Moreover, deletion of the meiosis specific recombinase Dmc1 prevents 
proper meiotic progression due to a lack of recombination between interhomologs (Bishop et al. 1992, 
Diener et al. 1996, McKee et al. 1997, Shinohara et al. 1997, Xu et al. 1997, Thompson et al. 1999, 
Fukushima et al. 2000). Replication Protein A is also an essential protein for proper meiotic recombination 
(Soustelle et al. 2002). Cells containing the rfa1-t11 mutation have been demonstrated to exhibit a 
marked reduction in spore survival after meiosis, as well as a 10- to 100-fold reduction in total genome 
recombination (ibid). As described in section 1.5.C., RPA is known to be phosphorylated on Rpa2 by 
Ime2 on S27 (Clifford et al. 2004), as well as S122 by Mec1 (Brush et al. 2001, Bartrand et al. 2006) 
during early meiotic signaling and the initial resection events post-Spo11 catalyzed breaks, respectively. 
The physiological significance of Rpa2 phosphorylation by Ime2 remains unknown. 
1.5.B. RPA interactions with LPR and meiosis-specific factors during meiosis 
During meiotic DNA replication and recombination, as well as during the initial entry into meiosis, 
RPA has been demonstrated to interact with a number of meiosis-specific proteins. As described 
previously, RPA been shown to become phosphorylated by the meiosis-specific Cdc28 homolog Ime2, 
and the physiological function of this early phosphorylation remains unclear (Clifford et al. 2004). 
Replication Protein A has also been shown to interact with the meiosis specific proteins MeioB and 
Spata22 in mice (Luo et al. 2013, Souquet et al. 2013, Ribeiro et al. 2016). MeioB is a meiosis-specific 
homolog to Rpa1, containing 3’®5’ exonuclease and ssDNA-binding activity as well as structural domain 
similarity to Rpa1. Spata22 is a meiosis-specific protein that interacts with MeioB and RPA in order to 
promote recombination during meiosis I (ibid). 
During meiotic recombination, RPA also interacts with Rad51 and Dmc1, each of which are 
required for proper strand invasion during mitosis and meiosis, respectively (Golub et al. 1998, Murayama 
et al. 2013). Furthermore, RPA has been shown to interact with Rad52 during meiosis, promoting the 
assembly of Rad51 and the Rad55/Rad57 heterodimer at Rad52-RPA foci that are thought to lead to 
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exchange hand-off to Dmc1 (Shinohara et al. 1997, Sung 1997, Gasior et al. 1998). Further mediation of 
Dmc1-foci formation and protofilament assembly is thought to be driven by interaction with Mei5-Sae3 
heterodimer, RPA, and Dmc1 (Hayase et al. 2004, Tsubouchi et al. 2004, Ferrari et al. 2009). Taken 
together, the above interactions highlight an important role for RPA in meiosis in the governance and 
regulation of assembly of highly ordered and organized protein-DNA complexes that execute the meiotic 
program on nuclear substrates. 
1.5.C. Phosphorylation of RPA during meiosis 
Rfa2 is phosphorylated during the earliest stages of meiosis by the meiosis-specific Cdc28-
related cyclin-dependent kinase Ime2 at S27 located within N-terminal phosphorylation domain (Clifford et 
al. 2004). Unlike the above mentioned PTMs, phosphorylation of Rfa2 by Ime2 during meiosis can occur 
when RPA is not bound to ssDNA (ibid). The function of Rfa2 NT phosphorylation during meiosis remains 
unclear. During meiosis, Rfa2 has also been demonstrated to be phosphorylated at S122 by Mec1 in a 
similar manner to that observed in mitotic cells experiencing a double-strand break (DSB) (Brush et al. 
1996, Brush et al. 2001, Bartrand et al. 2004). Spo11-dependent meiotic break processing leads to RPA-
coated ssDNA in a similar fashion to that observed during the mitotic DDR and leads to additional 
phosphorylation of Rfa2 at S122 through transient activation of Mec1 (ibid). Previously, it was shown that 
mutation of S122 of Rfa2 does not affect the ability of cells to perform DNA repair in response to multiple 
different DNA damaging agents, demonstrating that Mec1-dependent phosphorylation of S122 is likely 
not required for repair through homologous recombination (Ghospurkar et al. 2015). Thus, while it has 
been reported that mutation of S122 seems to produce a modest impact on crossover frequency during 
meiosis compared to wild-type (WT) cells, this impact in crossover frequency did not impact the viability of 
these cells after meiosis had been completed suggesting that phosphorylation of RPA outside of the Rfa2 
NT doesn’t play a major role in regulating the meiotic program (Brush et al. 2001, Bartrand et al. 2006). 
1.6. The DNA damage response 
The DNA damage response (DDR) is a critical signaling pathway used by cells to prevent 
mutation of the genome. Without the DDR program, simple genotoxic stressors like UV-radiation (e.g.; 
exposure to sun light or tanning beds) would cause severe genomic instability that could lead to 
mutations that might otherwise lead to cellular diseases, like cancer, in humans. Replication Protein A 
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acts as a primary activator of the DDR program as the primary sensor of broken or single-stranded DNA 
in cells. As mentioned previously in section 1.1, Replication Protein A binds this broken DNA and 
establishes the initial scaffold used both in the repair process and for preventing entry into mitosis through 
establishment of the DNA damage checkpoint. Replication Protein A’s indispensable role in the DDR is 
underscored by the numerous RPA phenotypes that lead to aberrant LPR or improper DDC signaling. 
1.6.A. Initiation of the DNA damage response – lesion processing and repair 
To prevent cells from dividing with unstable genomic information, whether caused by errors in 
DNA replication or by genotoxic stressors caused by clastogens, a complex series of signals are elicited 
that activate the intracellular LPR, which broadly encompasses all of the proteins responsible for the 
physical repair of a DNA lesion. A pictorial overview of LPR leading to the establishment of the DDC are 
diagrammed in Figure 1.3 and Figure 1.4, respectively. The DDR program involves four general steps: (1) 
recognition of the DNA lesion, (2) establishment of the intracellular DNA damage checkpoint (DDC), (3) 
physical repair of the DSB, and (4) release of the DDC to facilitate cell cycle re-entry. 
In response to DNA double-strand breaks (DSBs) specifically, the DDR program starts with the 
recognition or detection of the DSB, followed by programmed resection of the DSB by the MRX (Mre11-
Rad50-Xrs2) complex (Trujillo et al. 2003, Lisby et al. 2004, Deshpande et al. 2014). ATPase activity 
within the Rad50 subunit of the MRX complex is thought to induce and regulate MRX endonuclease 
activity at break sites (ibid). ATP-bound Rad50, within the MRX complex, has been demonstrated to 
promote DNA end binding and end tethering, whereas ATP hydrolysis is required for Mre11 
endonuclease activity and the promotion of DNA resection at the DSB site (Deshpande et al. 2014). MRX 
endonuclease recruitment and activity at the DSB end not only leads to activation of the sensor kinase 
Tel1 (Nakada et al. 2003, Lee et al. 2005, Paull et al. 2005), but also provides access by the 
multifunctional Dna2 helicase/nuclease and the Sgs1-Top3-Rmi1 (STR) nuclease complex that unwind 
and digest DNA in a 5’ ®3’ directionality creating a 3’ overhang on the unprocessed strand (Shim et al. 
2010). The newly formed 3’ ssDNA overhang structure is then bound by the RPA complex, and extensive 
resection at the DSB allows for additional RPA molecules to be loaded onto the elongated 3’ ssDNA 
overhang. The formation of RPA-coated ssDNA is then recognized by the sensor kinase Mec1/Ddc2 (Zou 
et al. 2003). 
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Figure 1.3. Initiation of Lesion Processing and Repair in Saccharomyces cerevisiae. 
A. Induction of DNA damage, facilitated by a chemical clastogen or various types of radiation, leads to the 
formation of a double-strand break (DSB). B. The free ends of the DSB are rapidly bound by the Mre11-
Rad50-Xrs2 (MRX) complex. Localization of MRX to DSB ends leads to the activation of the Tel1 sensor 
kinase, which phosphorylates H2AX at S129, and stimulates Ino80-dependent chromatin remodeling 
around the DSB. C. Phosphorylation of Sae2 by Tel1 recruits it to MRX and stimulates MRX-S 
endonucleolytic processing of the break. This enables loading of the Sgs1-Top3-Rmi1 (STR) and Dna2 
nuclease-helicase complexes for 5’®3’ resection of the DSB, creating a 3’ overhang ssDNA structure. D. 
RPA rapidly coats 3’ ssDNA generated during STR-Dna2 resection. E. Mec1/Ddc2 sensor kinase is 
recruited to RPA-coated ssDNA platform, attenuates Tel1-MRX-S signaling at the DSB terminus, and 
halts resection. F. Mec1-dependent activation and recruitment of Rad9-Rad53 heterodimer to the DSB 
initiates the DNA damage checkpoint by causing release Mec1-phosphorylated Rad53 from Rad9. 
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Figure 1.4. Mec1/Tel1 sensor kinase signaling and Checkpoint Establishment. 
A. Activation of Mec1 and Tel1 lead to the establishment of the DDC in budding yeast by phospho-
activation of Rad9, Rad53, and Chk1. B. Phospho-activation of Rad9 leads to complex formation with 
inactive Rad53 hetero-dimers that undergo trans auto-phosphorylation. C. Rad9-Rad53 heterodimers co-
localize to the DSB via Rad9 association with γ-H2AX, leading to Mec1-dependent Rad53 hyper-
phosphorylation. Hyper-phosphorylation of Rad53 causes its dissociation from Rad9 and promotes cell 
cycle arrest signaling alongside Chk1. D. Schematic assembly of Rad9-Rad53 at the 5’ Junction of 
ssDNA platform generated by RPA/Mec1/Ddc2 E. Hyper-phosphorylated Rad53 activates Dun1, an 
effector kinase that phosphorylates and inhibits the activity of Sml1, a potent inhibitor of ribonucleotide 
reductase. Inhibition of Sml1 allows for conversion of rNTPs to dNTPs for DNA synthesis during repair. 
Rad53 also directly inhibits the kinase activity of Cdc5, by inhibiting Clb2/Cdc28 cyclin activity on Cdc5 
and preventing entry into mitosis. F. Activation of Chk1 (from C) promotes phosphorylation of Pds1. Pds1 
phosphorylation prevents its degradation by the APCCDC20 complex, preventing entry into anaphase and 
subsequently premature chromosome segregation. 
Tel1 activity at the DSB site that leads to the generation of the RPA-coated ssDNA platform, and 
the generation of the RPA-ssDNA platform is then able to recruit the Mec1 sensor kinase through an 
interaction between RPA and Ddc2 (Zou et al. 2003). Activation of Mec1 kinase activity is also dependent 
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on the recruitment of Dpb11 (Navadgi-Patil et al. 2008), Ddc1 (Majka et al. 2006, Navadgi-Patil et al. 
2009), and the Dna2 nuclease/helicase (Wanrooij et al. 2015, Wanrooij et al. 2016), discussed in 1.6.C. 
Mec1 and Tel1 activity at DSB sites has been demonstrated to activate a number of different effector 
molecules necessary for DNA repair, including phosphorylation of the histone variant H2AX at S129, the 
Ino80 chromatin remodeling complex (Gospodinov et al. 2011), the nuclease Sae2 (Baroni et al. 2004), 
and adaptor molecules Rad9 (Vialard 1998) or Mrc1 (Osborn et al. 2003, Grandin et al. 2005, Chen et al. 
2009, Berens et al. 2012), and the yeast master checkpoint regulators Rad53 and Chk1 (Cortez et al. 
2001, Nakada et al. 2003, Nakada et al. 2003, Nakada et al. 2004, Clerici et al. 2005, Lee 2005, Nakada 
2005, Javaheri et al. 2006, Namiki et al. 2006, Toh et al. 2006, Hammet et al. 2007). Activation of Rad53 
and Chk1 initiate the establishment of the DNA damage checkpoint (DDC) and will be discussed in-depth 
in sections 1.7.A and 1.7.B. Once activated, the DDC affords cells adequate time to process and repair 
the DSB, preserving the integrity of the genome. 
1.6.B. DNA damage repair through non-homologous end joining 
Not all repair processes are the same, and as such, do not always lead to the activation of the 
DDC in cells. One such mechanism cells employ to rapidly repair their genome is the error-prone Non-
Homologous End Joining (NHEJ) pathway (Figure 1.5). NHEJ is the preferred repair mechanism used by 
cells that encounter DNA damage in the G1 phase of the cell cycle, when end resection of broken ends is 
less active likely due to reduced CDK signaling, as well as the lack of a viable sister chromatid with which 
to perform homologous recombination (Chiruvella et al. 2013). Ku70/Ku80 heterodimers localize to the 
DSB site, along with the MRX complex and the DNA ligase IV complex (Dnl4/Lig4), forming the canonical 
NHEJ complex (Clerici et al. 2008). At this point, the DNA ligase IV complex can then stimulate the 
loading of DNA polymerase µ and λ to perform fill in synthesis of the damaged genetic material, leading to 
a fairly accurate repair of the DNA (Chiruvella et al. 2013). 
However, under conditions of prolonged occupancy of the MRX complex at the break, the Ku 
heterodimer is removed from the DSB site and alternative NHEJ, also known as microhomology-mediated 
end joining (MMEJ), is performed (Chiruvella et al. 2013). During MMEJ, mutagenic rearrangement of the 
DNA is possible due to small homologous overlaps less than 18 nucleotides in length (Sfeir et al. 2015) 
formed by the displacement of the Ku complex from the break site. If the homologous nucleotide repeats 
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that flank the DSB are greater than 30 nucleotides in length, then the complimentary 3’ overhangs are 
annealed through a process known as single-strand annealing (SSA) (Paques et al. 1999), which requires 
the strand-annealing protein Rad52. 
 
Figure 1.5. Non-Homologous End Joining. 
A. Ku70/Ku80 complex, along with MRX, localize to the DSB site. Lack of homologous template material 
or lack of S- or G2-phase cyclins enable stable Ku association at the DSB. B. MRX-KU is recognized by 
the DNA Ligase IV complex (Dnl4/Lig4), which localizes to the ends of the DSB and begins filling in 
nucleotide gaps generated by the DSB C. DNA Ligase IV complex stimulates DNA polymerase µ and λ 
loading and the polymerases complete DNA synthesis through the DSB D. Repaired DNA achieved 
through NHEJ, where replaced nucleotides are represented by green regions on the DNA. 
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In either of these three error-prone type repair mechanisms, fusion of the broken DNA ends 
causes permanent loss off the material not contained within the homologous overlap, can be regarded as 
highly mutagenic, and may contribute to genome instability as homologous template is not used for 
repair. However, when homologous recombination repair is unable to be performed, either due to lack of 
template or lack of essential repair components, NHEJ mechanisms must be used to preserve the greater 
whole of the genome within a cell. 
1.6.C. DNA damage repair through homologous recombination 
During the S- or G2-phases of the cell cycle, DSBs are typically processed through the 
homologous recombination (HR) due to the availability of the necessary homologous genetic material 
required for HR, kept within close proximity by the cohesion complex (Symington et al. 2014), as well as 
the protein machinery required to execute HR. A pictorial diagram of HR can be found in Figure 1.6 and 
Figure 1.7. Homologous recombination repair starts with the formation of the RPA-coated ssDNA 
platform, generated by resection, which is then recognized by Mec1/Ddc2, as depicted in Figure 1.3D-F 
(Zou et al. 2003). The RPA molecules proximal to the 5’ junction of the processed DNA interact with and 
load the Rad24-RFC2-5 clamp loader complex and facilitate loading of the Rad17-Mec3-Ddc1 clamp 
(Majka et al. 2006). Replication Protein A is then exchanged for Rad51, forming the presynaptic 
nucleofilament, a process that is dependent on Rad52 (Sung 1997, Gasior et al. 2001, Gaines et al. 
2015). Formation of the Rad51/Rad52 proto-filament allows for strand- pairing and invasion of 
homologous genetic material to prime repair synthesis, a process that is stabilized by the presence of 
RPA binding of the displaced loop (D-loop) of homologous, single-stranded DNA, similar in structure to a 
replication bubble (Sung 1997, Gasior et al. 2001, Eggler et al. 2002, Sneeden et al. 2013, Gaines et al. 
2015). 
Homologous template copying via DNA synthesis is stimulated by D-loop localized RPA and 
achieved via DNA polymerase α (alpha) and δ (delta) loading and activity (Eggler et al. 2002, Wang et al. 
2004, Sneeden et al. 2013). Completion of DNA synthesis leads to the formation of complex DNA 
structures known as Holliday Junctions (Holliday 2007). Processing of the Holliday junctions formed 
during repair uncouples the homologous genetic material, forming crossover or non-crossover products 
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that can be uncoupled through branch migration and/or decatenation, completing error-free repair of the 
DSB and preserving the integrity of the cellular genome (Bizard et al. 2014). 
 
Figure 1.6. Initiation of Homologous Recombination in Budding Yeast. 
A. Loading of the Rad24-RFC2-4 clamp loader complex (CLC) by RPA stimulates loading of the 9-1-1 
Clamp (Rad17-Mec3-Ddc1), allows for loading of the scaffold protein Dpb11 (via Rad9 and 9-1-1 complex 
dependent interactions) and subsequently Mec1 activation. B. Mec1 hyper-phosphorylates Rad53, 
causing its dissociation from Rad9 and leads to checkpoint establishment (Fig 1.2). C. RPA is exchanged 
for Rad51/Rad52 heterodimers, creating the Rad51 protofilament and establishing a cellular commitment 
to homologous recombination repair. 
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Figure 1.7. Process of Homologous Recombination. 
A. Rad51 proto-filament, alongside the strand-annealing protein Rad52, perform strand invasion of 
homologous template material used for repair. B. Invasion by the Rad51 protofilament leads to the 
formation of a loop of displaced ssDNA from the homologous template, known as the D-loop, which is 
bound by RPA. C. The RPA-bound D-loop serves as a recruitment platform for DNA polymerase a and D 
which perform DNA synthesis from the free 3’ hydroxyl group from each end of the DSB. D. Completion of 
DNA synthesis leads to the generation of the double Holliday structure joint molecule. E. Resolvases act 
on the DHJ joint molecule, restoring the DNA into fully repaired duplex DNA. 
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1.6.D. Other types of DNA repair (NER, BER, MMR, and BIR) 
Certain types of clastogens elicit differential chemical effects on the DNA they act upon. In some 
instances, NHEJ or HR are not required to or are unable to be utilized repair the break. These repair 
mechanisms consist of Nucleotide Excision Repair (NER), Base Excision Repair (BER), and Mismatch 
Repair (MMR). In NER, BER, or MMR, single or small numbers of nucleotides are excised from the 
genomic material through similar mechanisms. In each, the exonuclease Exo1 provides resection through 
the excised material and provides access to DNA ligase I (MMR) or III (NER/BER) to perform gap 
synthesis to restore the genetic material. In each of these cases, the repair is thought to be mostly error 
free, as the donor template for repair is the remaining, intact strand of the duplex (the one not being 
repaired). However, in some instances, each of these mechanisms can lead to permanent changes in the 
genome if the correct strand of DNA is not repaired. These processes are reviewed in depth in (Li 2008) 
and (Iyama et al. 2013) and are mostly beyond the scope of this thesis. 
Break-induced replication (BIR) is a final type of DNA repair that is utilized by cells when normal 
repair of the DNA through homologous recombination (HR) fails. Break-induced replication involves 
similar steps to HR repair in that the DSB must be resected and eventually coated by Rad51, as 
described in 1.6.C. However, unlike HR repair, BIR occurs when only one arm of the DSB can find 
homologous template. In this instance, BIR is used to synthesize new DNA from the homologous 
template and proceeds through the end of the template material (which is often the end of a 
chromosome). Break-induced replication is thought to be carried out through a D-loop migration 
mechanism, by which the D-loop becomes a pseudo-replication bubble (Sakofsky et al. 2017). This 
process is detailed and reviewed in Sakofsky and Malkova (Sakofsky et al. 2017). Replication Protein A’s 
role in the later steps of BIR remains unclear. 
1.7. DNA damage-dependent checkpoint (DDC) 
The DNA Damage Checkpoint (DDC) is a conserved process that is designed to prevent entry 
into mitosis during the DDR program, preserving genomic stability and reducing mutation frequency in 
cells that have experienced some form of genotoxic insult. As described below, entry into mitosis in yeast 
is a much simpler process than in more complex organisms like human cells which depend on the 
inhibition of multiple cyclins to prevent anaphase and mitotic entry/exit. Replication Protein A plays critical 
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roles in the DDR program and the establishment and maintenance of the DDC. Not only is RPA required 
for the initial events that lead to establishment of the DDC, but mutant forms of RPA have been shown to 
alleviate checkpoint signaling and/or promote aberrant or premature replication restart in cells. 
Understanding how RPA is regulated during the establishment, maintenance, and recovery from the DDC 
leading to mitotic entry may provide researchers with novel targets to inhibit mitotic entry in cells that grow 
uncontrollably (i.e. cancer cells), as developing therapeutics that directly improve checkpoint function may 
lead to a reduction in mutations caused by improper or incomplete lesion processing, and thus increase 
genomic fidelity. This is especially prevalent as current therapeutic practices in the treatment of cancer 
involve the use of broad spectrum DNA damaging agents with the rationale that cancer cells will be 
unable to tolerate the added genomic instability while normal cells will faithfully repair any lesions that are 
generated during chemotherapy. 
1.7.A. Establishment of the DDC in Saccharomyces cerevisiae 
In Saccharomyces cerevisiae, the DNA Damage Checkpoint (DDC) is established rapidly to 
prevent cells from entering mitosis with incomplete or damaged genetic information and affords the DNA 
repair machinery adequate time to repair the DNA to preserve genomic integrity. As discussed briefly in 
1.6.B, DSBs that are repaired in the G1 phase of the cell cycle, typically by NHEJ, often do not elicit a 
DDR from the cells, which prevents the establishment of a DDC. During the S- or G2-phases of the cell 
cycle; however, the establishment of the DDC is essential in preventing unwanted mutagenesis of the 
genome due to genotoxic insult. As described in section 1.1, initiation of the DDR program leads to 
establishment of the DDC through activation of the master checkpoint regulators in yeast, Rad53 and 
Chk1. 
In order to fully activate Rad53, a number of conditions must first be met. First, the DNA damage 
response must have proceeded far enough along to generate the RPA-ssDNA platform that is recognized 
by Mec1/Ddc2. Replication Protein A stimulates loading of the Rad24-RFC2-5 clamp loader complex, 
which leads to the loading of 9-1-1 clamp (Rad17-Mec3-Ddc1) (Majka et al. 2006, Majka et al. 2006, 
Navadgi-Patil et al. 2009, Navadgi-Patil et al. 2011). An additional scaffold protein, Dpb11, interacts with 
the 9-1-1 clamp, and helps facilitate activation of Mec1/Ddc2 kinase activity (Mordes et al. 2008, Navadgi-
Patil et al. 2008, Puddu et al. 2008, Navadgi-Patil et al. 2009, Navadgi-Patil et al. 2011). Mec1 is known 
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to phosphorylate a host of downstream effector molecules, most important of which for this thesis are 
Rad9 and Rad53 (de la Torre-Ruiz et al. 1998, Naiki et al. 2004, Sweeney et al. 2005, Bonilla et al. 2008, 
Clerici et al. 2014). Rad9 phosphorylation promotes its association to Rad53 and to damage-modified 
histones (H2AX S129 phosphorylation by Tel1/Mec1 (Downs et al. 2000, Burma et al. 2001, Ward et al. 
2001) and H3K79 methylation by the Dot1 methyltransferase (Huyen et al. 2004, Grenon et al. 2007, 
Lazzaro et al. 2008, Puddu et al. 2008). Rad9 association with inactive Rad53 dimers leads to trans auto-
phosphorylation of Rad53 and dissociates the heterodimers from one another (Gilbert et al. 2001). 
Localization of the Rad9-Rad53 dimer to DSB sites allows for Mec1-dependent hyper-phosphorylation of 
Rad53, causing it’s dissociation from the Rad9 adaptor and eliciting Rad53’s checkpoint arrest signaling 
activity. 
1.7.B. Checkpoint arrest in yeast prevents anaphase, entry into mitosis via Rad53/Chk1 activity 
Once fully activated, Rad53 activates Dun1 to promote the conversion of ribonucleotide 
triphosphates into deoxyribonucleotide triphosphates through the inhibition of Sml1. The increased dNTP 
pools are then used during DNA synthesis after the DSB is processed (Gardner et al. 1999). Rad53 
inhibits Cdc5 kinase activity by maintaining elevated levels of CDK activity in the cell (Sanchez et al. 
1999, Ira et al. 2004). Cdc5, an essential Polo-like kinase within the mitotic exit network (MEN) of kinases, 
facilitates entry into mitosis through the phospho-targeted destruction of a number of cyclins that Rad53 
upregulates during establishment and maintenance of the DDC (Charles et al. 1998, Shirayama et al. 
1998, Sanchez et al. 1999). Rad53’s activity on Clb2/Cdc28 inhibits Clb2/Cdc28 phosphorylation of the 
mitosis-promoting Cdc5 Polo-like kinase (Cdc5 is an active target of Clb2/Cdc28 phospho-activation; 
Schleker et al. 2010) (Sanchez et al. 1999). Mitotic exit also requires interaction between APCCDC20 and 
Pds1 targets Pds1 for degradation through ubiquitination and allows entry into anaphase (Cohen-Fix et al. 
1996, Cohen-Fix et al. 1997, Cohen-Fix et al. 1999, Agarwal et al. 2003). Rad53 also acts with Chk1 and 
phosphorylates Pds1, inhibiting Pds1 association with Cdc20 (Agarwal et al. 2003). Chk1 activity has 
been determined to be the predominant cause of phosphorylation on Pds1 in order to inhibit anaphase by 
preventing Pds1 ubiquitination, and prevents aberrant chromosome segregation through inhibition of 
spindle pole body dissolution (Cohen-Fix et al. 1996, Cohen-Fix et al. 1997, Cohen-Fix et al. 1999, 
Sanchez et al. 1999, Wang et al. 2001, Agarwal et al. 2003). In more complex organisms, activation of 
  33 
the master checkpoint regulators Chk1 and Chk2 (Chk1 and Rad53 respectively) not only leads to the 
inhibition of anaphase, but also leads to the inhibition of cyclin signaling that would continue to move the 
cell cycle forward. This is in contrast to yeast, as yeast primarily halt cell growth by preventing 
degradation of Pds1 and inhibition of Cdc5 signaling activity which directly inhibits entry into anaphase, 
chromosome segregation, and entry into mitosis (ibid). 
1.7.C. The currently undefined role for RPA phosphorylation during the DDC 
RPA’s role in the checkpoint response seems relatively straightforward at first glance. Replication 
Protein A is required for Mec1-dependent recognition of DSBs (Rouse et al. 2002, Rouse et al. 2002, Zou 
et al. 2003, Dubrana et al. 2007), loading of the Rad24-RFC2-5 clamp (Kim et al. 2001, Majka et al. 2006, 
Majka et al. 2006, Piya et al. 2015), as well as recruitment and stabilization of the DNA repair 
polymerases DNA pol α and DNA pol δ (Wang et al. 1999, Eggler et al. 2002, Wang et al. 2004, Sneeden 
et al. 2013). Previous research has suggested a more important role for RPA in mediating the DDC 
during DNA repair, as the rfa1-t11 mutation or phospho-mimetic mutation of the Rfa2 NT appear to 
promote aberrant checkpoint exit (Lee et al. 2001, Pellicioli et al. 2001, Ghospurkar et al. 2015). This 
aberrant checkpoint exit is known as checkpoint adaptation and occurs approximately 10-12 hours after 
the initial DDR in yeast (Sandell et al. 1993, Toczyski et al. 1997). During checkpoint adaptation, the 
primary signals keeping Rad53 hyper-phosphorylated are deactivated, leading to entry into mitosis 
despite the presence or persistent of lesions with the genetic material (Sanchez et al. 1999, Pellicioli et al. 
2001, Vidanes et al. 2010, Ferrari et al. 2013). In some instances, checkpoint adaptation can be inhibited 
by mutations of certain yeast genes. Some of these include the deletion or mutation of Cdc5 (kinase 
involved in mitotic exit; Toczyski et al. 1997) CKII (casein kinase II complex, ibid), Rdh54 (Swi2/Snf2 
chromatin remodeler; Lee et al. 2001, Ferrari et al. 2013) , Srs2 (helicase involved in recombination; Vaze 
et al. 2002) , Rtt107 and Slx4 (scaffolding proteins involved in reversal of Rad53 signaling by competing 
for Rad9 proximal to the DSB; Ohouo et al. 2010, Ohouo et al. 2013, Cussiol et al. 2015, Dibitetto et al. 
2016), Ku70 (essential for repair through NHEJ; Lee et al. 1998) , Mre11 and Rad50 (components of the 
MRX complex that initiate resection and checkpoint signaling through Tel1 sensor kinase; Lee et al. 1998, 
Grenon et al. 2001, Nakada et al. 2004, Paull and Lee 2005), Sae2 (nuclease component of MRXS, 
thought to be required for resection; Baroni et al. 2004, Gobbini et al. 2015, Dibitetto et al. 2016). 
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Currently, it has been demonstrated that a point mutation of the large subunit of RPA, rfa1-t11 
(K45E), checkpoint adaptation is promoted in the adaptation-deficient mutations rdh54Δ (Lee et al. 2001) 
or yku70Δ (Lee et al. 2001, Pellicioli et al. 2001), but not in cells containing the cdc5-ad mutation 
(Pellicioli et al. 2001). Furthermore, recent evidence has demonstrated that phospho-mimetic mutations 
or mutations that promote natural phosphorylation within the Rpa2 N-terminal (NT) phosphorylation 
domain are able to rescue the adaptation deficiency conferred by yku70Δ (Ghospurkar et al. 2015). 
Understanding the basic mechanisms and conditions by which RPA can promote checkpoint adaptation 
was a major focus of and impetus for this thesis. 
1.8. Description of Thesis 
The goal of this thesis was to better understand the function of the Rfa2 NT during DNA repair, 
checkpoint adaptation and meiosis, as well as the physiological consequences behind the observed, 
robust phosphorylation that occurs to Rfa2 during checkpoint adaptation. This thesis focuses on these 
problems. Chapter 2 addresses how, when, where, and why Rfa2 is phosphorylated during genotoxic 
stress. Chapter 3 addresses Rfa2 phosphorylation, specifically during checkpoint adaptation. Chapter 4 
addresses global rescue of resection- and adaptation- deficient phenotypes using Rfa2 phospho-mimetic 
proteins. Chapter 5 addresses the role of Rfa2 NT phosphorylation as it contributes to meiosis and the 
meiotic recombination events that are essential for proper chromosomal segregation. 
My work on the biochemical properties governing Rfa2 phosphorylation reveals that Rfa2 
phosphorylation during the DDR is not only difficult to detect, but also occurs in the absence of many of 
the primary kinases involved in the DDR program, as demonstrated in tel1Δ, dun1Δ, chk1Δ, mec1Δ, and 
rad53Δ mutations. Furthermore, Rfa2 phosphorylation during checkpoint adaptation occurs more robustly 
than that observed during mitotically growing cells challenged with clastogens, suggesting that prolonged 
or irreparable DNA lesions are the major trigger of this post-translational modification of Rfa2. Studies 
performed here on the role phosphorylation plays during recombination refute the long-standing 
hypothesis that Rfa2 NT phosphorylation is both required for, and preferentially drives, DNA repair 
directly. My work on Rpa2 in checkpoint adaptation suggest a paradigm shifting new role for Rpa2 
phosphorylation in cell cycle regulation, specifically that RPA is the primary coordinator of checkpoint 
entry, but that Rpa2 phosphorylation specifically is what is primarily coordinating checkpoint exit, 
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particularly in the face of persistent, irreparable DNA lesions. Moreover, Rfa2 NT phospho-mimetic or 
naturally phosphorylatable Rfa2 NT mutations preferentially drive checkpoint adaptation in resection-
deficient mutations. I also demonstrate Rpa2 NT mutations do not appear to greatly impact resection of 
DSBs in checkpoint adaptation, suggesting that the adaptation rescue observed in Saccharomyces 
cerevisiae is independent of the ability of cells to resect the generated DSB. The findings detailed in this 
thesis provide evidence that Rfa2 NT phosphorylation plays a more important role in the temporal 
regulation of the DNA damage-dependent checkpoint during DNA repair, rather than mediating the repair 
process. 
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CHAPTER 2: RFA2 PHOSPHORYLATION DURING LESION PROCESSING AND DNA REPAIR 
2.1. Abstract 
Replication Protein A (RPA) is an essential single-stranded DNA (ssDNA) binding complex found 
in all eukaryotic organisms. In human cells, the amino-terminus (NT) of the Rpa2 subunit is 
phosphorylated by checkpoint kinases in response to DNA lesions. Phosphorylation of a residue outside 
of the yeast Rfa2 NT has been previously characterized. Although the yeast Rfa2 NT is serine/threonine-
rich, similar to the human Rpa2 NT, phosphorylation within this domain had not been well-characterized. 
In this study, characterization of the yeast Rfa2 NT revealed that a “delayed” phosphorylation of this 
domain occurs in response to prolonged exposure to multiple clastogens. Mutation or removal of all 
serines/threonines within the Rfa2 NT eliminates the observed delayed phosphorylation event. 
Interestingly, cells containing either an NT phospho-mimetic form or an NT deletion form are sensitive to 
DNA damaging agents and display an early phosphorylation event. In both of these mutations, the major 
phospho-target is an SQ motif at serine 122 (a Mec1/Tel1 target site). However, Mec1 activity appears to 
be reduced in the Rfa2 NT phospho-mimetic mutation. Furthermore, delayed Rfa2 NT phosphorylation is 
not dependent on the Rfa1 NT (DBD-F), nor is it dependent on checkpoint kinases that initiate the DNA 
damage-dependent checkpoint. When human and other eukaryotic Rpa2 NT are fused to the Rfa2 
protein, they exhibit earlier phosphorylation events that correlate with the presence of S/TQ motifs, which 
the yeast Rfa2 NT lacks. The delayed Rfa2 NT phosphorylation suggests a novel role for Rfa2 
downstream of the initial DNA damage response. 
2.2. Introduction 
Critical for the prevention of mutations in the genetic blueprint of all eukaryotic organisms and all 
DNA metabolic processes is the heterotrimeric ssDNA-binding protein Replication Protein A (RPA). 
Composed of three subunits, called Rpa1 (70 kDa), Rpa2 (32 kDa), and Rpa3 (14 kDa), the RPA 
complex was originally isolated as a factor essential for in vitro SV40 DNA replication (REF). Since its 
discovery, RPA’s biochemical role has been characterized as a single-stranded DNA (ssDNA) binding 
complex that facilitates cellular genome duplication and the maintenance of all genetic material (Wold et 
al. 1988, Heyer et al. 1990, Brill et al. 1991, Seroussi et al. 1993, Ghospurkar et al. 2015). Although 
RPA’s primary biochemical role is ssDNA binding, RPA also plays diverse molecular roles, via post-
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translational modification, in coordinating DNA replication, repair/recombination, and cell cycle regulatory 
responses to DNA damage (Marechal et al. 2015). Thus far phosphorylation remains the most well-
characterized post-translational modification of the RPA complex. Rpa2 is phosphorylated at multiple 
serine and threonine residues within its N-terminus by several checkpoint kinases, including, but not 
limited to, ATR-ATRIP, ATM, CDK, and DNA-PK (Liu et al. 2012). 
While Rpa2 is readily phosphorylated in response to genotoxic stress, the intracellular 
consequences and physiological role of these phosphorylation events play have remained elusive. 
Previous research has demonstrated that S23 and S29 of Rfa2 are phosphorylated by CDK during 
normal mitotic cell cycle progression, as well as upon cellular exposure to ionizing radiation (Brill et al. 
1989, Din et al. 1990). Unsurprisingly, cells containing an Rpa2 S23/S29A double mutation accumulated 
in G2-phase following camptothecin treatment indicating a cell cycle defect (Anantha et al. 2007) and also 
display reduced hyper-phosphorylation of the Rpa2 NT (Liu et al. 2012), suggesting a role for Rpa2 NT 
phosphorylation in mediating proper cell cycle progression. Additionally, phospho-mimetic studies of T21 
and S33 suggest that phosphorylation of these residues may be required for inhibition of DNA replication 
during UV-induced DNA damage (Olson et al. 2006). 
Studies performed using a phospho-mimetic NT (rfa2-D) mutation has been demonstrated to 
show reduced RPA complex association with replication centers, but show no detectable change in RPA 
complex association to repair foci (Vassin et al. 2004). Phospho-mimetic NT Rpa2 mutations have also 
been demonstrated to disrupt interaction with the MRN complex, specifically through Mre11, in vitro 
(Oakley et al. 2009). Moreover, Rpa2 phosphorylation may play a critical role in normal checkpoint 
initiation and maintenance, as S4/S8A mutations are defective for Chk1, Mre11 and TopBP1 
phosphorylation (Liu et al. 2012) – all of which are required for normal checkpoint activation in human 
cells. More recently, Rpa2 NT phosphorylation has been proposed as a biomarker for human oral cancer 
progression and prognosis, with abundant Rpa2 hyper-phosphorylation at S4 and/or S8 as an indicator of 
poorer diagnostic outcomes (Rector et al. 2016). 
While Rpa2 phosphorylation has been well characterized in human cells, the same level of 
biochemical characterization and corroboration of Rpa2 mutation phenotypes is lacking in other model 
systems. In advanced model systems such as Xenopus laevis, Rpa2 phosphorylation occurs in an 
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ssDNA-dependent manner during S-phase by Cdk2, as well as during mitotic entry in a DNA-independent 
mechanism by Cdc2 (Fang et al. 1993). Upon exit from mitosis, Rpa2 becomes dephosphorylated, and is 
re-phosphorylated upon RPA association with the pre-initiation complex (Francon et al. 2004). 
Furthermore, control of Rpa2 phosphorylation has been demonstrated to be important for S-phase-
dependent checkpoint signaling, as phospho-mimetic Rpa2 mutations are deficient in promoting 
checkpoint activation at unwound replication forks (Recolin et al. 2012, Recolin et al. 2012). 
In plant model systems, like Arabidopsis thaliana (thale cress) or Oryza sativa (rice), there are 
multiple copies of RPA subunit genes, particularly Rpa1 and Rpa2, and it has been hypothesized that the 
different forms are necessary to perform distinct functions involving an RPA complex in the cell. For 
example, plants may have a replication-specific Rpa2, a DNA damage-specific Rpa2, and have been 
shown to form distinct RPA complexes with precise combinations of RPA subunits to perform explicit 
functions. Consistent with this hypothesis are observations that Rpa1 and Rpa2 paralogs form differential 
complexes in plants that regulate meiotic crossover, DNA replication, and DNA repair (Marwedel et al. 
2003, Chang et al. 2009, Li et al. 2013, Aklilu et al. 2014, Eschbach et al. 2014, Aklilu et al. 2016). Post-
translational modifications of plant RPA subunits have not been studied. Consistent with other organisms, 
mutations of Rpa2 in Arabidopsis lead to hyper-sensitivity to DNA damaging agents (Elmayan et al. 
2005). 
In Candida albicans, Rpa2 phosphorylation has been detected in response to genotoxic stress 
(Wang et al. 2013), with residues in the N-terminal phosphorylation domain (T11, S18, S29, S30) being 
important during the intracellular response to clastogens. Phosphorylation of the aforementioned NT 
residues on Rpa2 is has been shown to be achieved through Mec1- and Clb2-Cdc28-dependent 
phosphorylation (Gao et al. 2014), analogous to that observed in human cells. Furthermore, Rpa2 
obtained from unchallenged, mitotically growing cells has been demonstrated by mass spectrometry to be 
phosphorylated differentially from cells treated with the DNA replication inhibitor hydroxyurea (HU) (Wang 
et al. 2013). In contrast to human cells, however, C. albicans cells containing either phospho-mimetic 
(T11D, S18D, S29D, S30D) or unphosphorylatable (T11A, S18A, S29A, S30A) mutations exhibit an 
increased sensitivity to DNA damaging agents, and defects in checkpoint recovery, but not checkpoint 
activation (Gao et al. 2014). 
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During her thesis work, Padmaja L. Ghospurkar tested phosphorylation of various eukaryotic N-
termini fused to the Rfa2 core peptide (DBD-D and WHD) in response to phleomycin challenge (Figure 
2.1; Ghospurkar 2015). Some of the most striking differences in Rfa2 post-translational modification are 
observed when comparing Rfa2-NT mutations within plants. Oryza sativa, as well Arabidopsis thaliana, 
contain multiple copies of RFA2 within their respective genomes. Biochemical studies involving Rfa2 in O. 
sativa and A. thaliana are non-existent, most likely because antibodies to each of the individual Rfa2 
isoforms do not exist. Our yeast system provides a unique opportunity to study Rfa2 NT domain function 
in vivo. Unsurprisingly, not only do each of these Rfa2 forms support mitotic growth and properly activate 
a DNA damage-induced checkpoint, each appears to be modified differentially in a DNA damage-
dependent manner. Rfa2-OS1 shows significant modification of the fusion protein in both unstressed and 
stressed conditions, whereas Rfa2-OS2 shows minimal or barely detectable modification under genotoxic 
stress. Rfa2-ATa shows robust modification in both unstressed and stressed conditions, while Rfa2-ATb 
shows robust modification of Rfa2 only in a stressed condition. Taken together, her results have two 
major implications for studying Rfa2 phosphorylation in budding yeast. First, Rfa2 phosphorylation from 
other eukaryotic organisms can be studied rapidly and cost-effectively in a Saccharomyces cerevisiae 
model, especially for model organisms where antibodies to the individual Rfa2 proteins do not exist. 
Secondly, her data correlates well with the idea that ‘redundant’ copies of genes may not be redundant 
but in fact may have specific functions within the cell that are separate and regulated in different ways 
from their duplicate counterparts. Moreover, the presence of phospho-species observed in Figure 2.1 
may be due to the presence of SQ/TQ (serine-glutamine/threonine-glutamine) kinase consensus 
phosphorylation sites within each respective Rpa2 paralog. 
In the budding yeast Saccharomyces cerevisiae, there are two known target sites for 
phosphorylation in RFA, both of which have been reported to be phosphorylated by the checkpoint kinase 
Mec1. The first lies at S178 of Rfa1, within a flexible linker between the N-terminus (DBD-F) and the core 
ssDNA binding domain (DBD-A) (Brush et al. 2000). The second, reported to be a Mec1-dependent 
phosphorylation site, lies at S122 of Rfa2 (within the unstructured loop 3-4 region) (Brush et al. 1996, 
Brush et al. 2000, Mallory et al. 2003). Despite their relative ease of identification, there is no observed 
physiological role for these residues in mitosis (Ghospurkar et al. 2015), and only a minor role reported in 
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meiosis (Brush et al. 1996, Brush et al. 2000, Brush et al. 2001, Clifford et al. 2004). Similar to 
observations made in Candida, the budding yeast Rfa2 NT is dispensable for checkpoint activation and 
mitotic growth (Gao et al. 2014, Ghospurkar et al. 2015). 
 
Figure 2.1.  Phosphorylation of eukaryotic Rpa2 NT in budding yeast. 
Adapted from Padamaja L. Ghospurkar’s thesis (Ghospurkar 2015). Immunoblot depicting Rfa2 NT 
mutations using NT sequence from other eukaryotic organisms. Phosphorylation of eukaryotic Rpa2 NT 
occurs in response to phleomycin (PHL) treatment and differs between different paralogs of Rpa2 found 
within their respective organisms. Equivalent numbers of cells were harvested prior to phleomycin (PHL) 
exposure (0) or four hours post-PHL exposure (+). Species are indicated as follows: SC – 
Saccharomyces cerevisiae, HS – Homo sapiens, CA – Candida albicans, XL – Xenopus laevis, AT – 
Arabidopsis thaliana, OS – Oryza sativa, MM – Mus musculus.  
Previous studies have demonstrated that the Saccharomyces Rfa2 N-terminus is important in the 
DNA damage response (Ghospurkar et al. 2015) and that in some special cases (ie, set1D mutations; 
Schramke et al. 2001, and during meiosis; Brush et al. 2001), it can be post-translationally modified by 
phosphorylation. However, identification of mitotic phosphorylation of RFA had been limited to serine 
residues that lie outside the N-terminus. In a study of the physiological importance of the yeast Rfa2 NT, it 
was demonstrated that an rfa2 mutation (rfa2-DX) that contained aspartate substitutions of 
serines/threonines in the N-terminus lead to checkpoint adaptation (Ghospurkar et al. 2015); however, 
this effect occurred 12-16 hr after induction of DNA damage and 8-12 hr following checkpoint activation. 
This led us to test whether Rfa2 NT-dependent phosphorylation was occurring after prolonged exposure 
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to DNA damage. Delayed Rfa2 phosphorylation occurs, and is readily detected, after prolonged genotoxic 
challenge. This additional phosphorylation is dependent on the physical presence of the N-terminal 
phosphorylation domain, but not the N-terminus of the larger RPA subunit, Rpa1, as Rfa2 NT 
phosphorylation occurs in the damage-sensitive rfa1-t11 (K45E) point mutation. Furthermore, this delayed 
phosphorylation does not appear to be dependent on the activity of kinases known to play essential roles 
during the initiation of the DNA damage-dependent checkpoint, such as Mec1 or Tel1. 
2.3. Materials and Methods 
2.3.A. Strains and Plasmids 
Yeast strains and plasmids used in these studies are listed in Appendix A and Appendix B, 
respectively. All yeast strains used within this study are isogenic derivatives of JKM179 
(hoΔ MATα hmlΔ::ADE1 hmrΔ::ADE1 ade1-100 leu2-3,112 lys5 trp1::hisG′ ura3-52 ade3::GAL-HO; Lee 
et al. 1998) containing either rfa2Δ::kanMX (NMM104) or rfa1Δ::kanMX (NMM101). To generate NMM104 
(JKM179 rfa2D::kanMX) or NMM101 (JKM179 rfa1D::kanMX), PCR of the kanMX cassette was performed 
using pEG202K (Appendix B) as a template and appropriate primers to RFA1 or RFA2 (Appendix C) 
containing an additional 40 nucleotides (nt) of homologous sequence located immediately upstream and 
downstream of the coding region of RFA2 or RFA1. This PCR product was co-transformed with pJM132, 
a centromeric vector containing wild-type RFA1, RFA2, and RFA3 genes expressed from their native 
promoters (Maniar et al. 1997), into competent JKM179 cells to facilitate one-step gene replacement at 
the RFA2 or RFA1 locus. Chromosomal knockout of RFA2 or RFA1 was verified by PCR using 
appropriate primers (Appendix C), using a strategy similar to that for the generation of yeast gene 
deletions (Kelly et al. 2001). PCR products were also sequenced to verify genomic replacement. 
The generation of TEL1, CHK1, and DUN1 kinase deletions in the NMM104 background was 
done using PCR amplification of the natMX cassette from plasmid pFA6-natNT2 (Euroscarf; Janke et al 
2004) with primers (Appendix C) containing an additional 40 nt of homologous sequence immediately 
upstream and downstream of the coding regions of each gene and one-step gene replacement. tel1D, 
chk1D, and dun1D candidates were screened via diagnostic replica plating and by PCR using diagnostic 
primers (Figure 2.2) (Appendix C).  
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Figure 2.2.  One-step gene replacement and verification strategy. 
A schematic representation of the one-step gene replacement strategy used for the generation of deletion 
mutations used in this study (Top Panels). PCR product containing a resistance cassette (natMX, kanMX, 
hphNX) and at least 40 nt of homologous sequence upstream and downstream of YFG (your favorite 
gene), was generated as described in section 2.3.A. This PCR fragment was transformed into lithium 
acetate competent yeast cells and incubated for 5 hours. Following selection and genomic isolation, PCR 
amplification using appropriate primers (Appendix C) confirmed each gene deletion (bottom panel). 
Displayed is the mec1Δ mutation amplified against MEC1 cells. Three amplicons were examined. 
Amplicon 1 is produced from a forward primer outside the deletion site and a reverse primer starting 
within the natMX cassette. Amplicon 2 is produced from a forward primer within the natMX cassette and a 
reverse primer outside of the gene deletion. Amplicon 3 is the full-length product produced a forward 
external primer at the 5’ end of the chromosome sequence and a reverse external primer at the 3’ end of 
the chromosome sequence. 
The MEC1 kinase deletion strain utilized in this study was also generated by one-step gene 
replacement. However, before attempting deletion of MEC1, the SML1 gene was first deleted by PCR 
amplification of hphN from pFA6-hphN (Euroscarf; Janke et al 2004) using a similar method to that 
described above. Once verified, the sml1Δ::hphN NMM104 derivative strain was transformed with 
mec1Δ::natMX PCR product amplified using the appropriate primers as described above. mec1D sml1D 
candidates were screened via diagnostic replica plating and PCR using diagnostic primers (Appendix C). 
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2.3.B. DNA damage spot-plating assays 
Wild-type or mutant cells were grown overnight at 30°C in liquid YPD media (1% yeast extract, 
2% peptone, 2% dextrose) and were initially diluted to an OD600 of 1.0 in 1x PBS. Six 10-fold serial 
dilutions from each initial sample were then performed, and 5 uL of the initial dilution and serial dilutions 
for each strain were spotted onto the following media: YPD, YPD + 0.0075–0.06% methyl 
methanesulfonate (MMS), YPD + 0.2–25 mg/ml camptothecin (CPT), YPD + 40–360 mM hydroxyurea 
(HU), YPD + 0.2–25 mg/ml phleomycin (PHL). Plates were incubated for 2–4 days at 30°C, and growth 
differences between the mutant and wild-type cells were documented. 
2.3.C. In vitro site-directed mutagenesis 
To generate S122D/A mutations in Rfa2 NT mutation vectors, in vitro site-directed mutagenesis 
was performed using Q5 High-Fidelity polymerase (New England Biolabs) and primers O-284 (S122D) or 
O-285 (S122A) on the appropriate pRS315-RFA2-derived template. Following DpnI digestion, 
mutagenesis reactions were transformed into bacterial cells and plasmid DNA was harvested from viable 
transformants. Vectors generated by mutagenesis were then digested with diagnostic enzymes (BstEII or 
BamHI) and sequenced (Eton Biosciences). Vectors identified to have S122D or S122A mutations were 
then transformed into NMM104 via plasmid shuffle (described below). 
2.3.D. Plasmid shuffle to generate mutant RPA strains 
Centromeric rfa2 mutant plasmids (pRS315 derivatives; LEU2) (Appendix B) were transformed 
into NMM104 cells. Transformants were selected on synthetic complete media (0.5% ammonium sulfate, 
0.17% yeast nitrogen base w/o amino acids, 2% dextrose) lacking leucine, resulting in transformants that 
contained two plasmids. Cells were grown in liquid SD-Leu media overnight, selecting for rfa2 mutant 
vectors, and subsequently plated and recovered on media containing 1.0 ug/mL 5-fluoroorotic acid (5-
FOA). Use of 1.0 ug/mL 5-FOA is specific for JKM179 derivative strains. Recovered colonies were then 
picked to a YPD master plate and subsequently replica plated to synthetic complete media lacking uracil 
or leucine to verify loss of pJM132 (URA3). Cells that were uracil auxotrophs (ura3) and leucine 
prototrophs (LEU2) were then used in further studies. 
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2.3.E. DNA damage induction and collection of whole-cell lysate 
Induction of DNA damage in cells for biochemical assays was performed in liquid culture. Yeast 
cells were grown for 20 hours (hr) in liquid YPD (1% yeast extract, 2% peptone, 2% dextrose) to an OD600 
of 1.0. Each culture was then exposed to one of the following DNA-damaging agents: 0.03 or 0.06% v/v 
methyl methanesulfonate (MMS), 5 or 25 ug/mL camptothecin (CPT), 5 or 25 ug/mL phleomycin (PHL), 
80 or 360 mM hydroxyurea (HU). In order to harvest an equivalent number of cells from each culture, 25 
ODs of cells were harvested from each culture at 0, 2, 4, 6, 8, 10, 12, 16, and 24 hr post-exposure to 
each damaging agent. Harvested cells were treated with 0.3 M NaOH for 5 minutes at room temperature, 
pelleted at 10K RPM for 2 minutes (min), and aspirated to remove NaOH from the pellet. The pelleted 
cells were then resuspended in 500 uL of K-Buffer (0.06 M Tris-HCl, ph 6.8, 5% glycerol, 2% SDS, 4% b-
mercaptoethanol, 10 mM DTT; Kushnirov 2000), and each protein sample was boiled at 100°C for 3 min. 
A modified Lowry assay (RC-DC Assay Kit; Bio-Rad) was used to quantify protein concentration within 
each sample to ensure even protein loading during SDS-PAGE. 
2.3.F. Phosphatase treatment of whole cell lysates 
Whole cell lysate obtained as described above was quantified and 100 ug total whole cell lysate 
was precipated in 100% ice cold acetone and harvested via centrifugation at 15,000 RPM for 10 minutes. 
Following aspiration of the supernatant, the pellet was resuspended in 100 uL of Buffer A (BA) + Protease 
Inhibitor Cocktail (G-Biosciences). An aliquot of 40 uL (approximately 40 ug) of the Buffer A protein 
suspension was added to a new centrifuge tube, to which 5 uL of 10X PMP buffer (NEB) and 5 uL of 10 
mM MnCl2 was added. 400 units (2 uL) of Lambda Protein Phosphatase (NEB) was then added to each 
sample. Samples were incubated at 30°C for 2 hours to allow full dephosphorylation of lysate. 50 uL of 2x 
K-buffer was then added to each sample and boiled for 3 min at 100°C. 20 uL (approximately 5 ug total 
protein) of the boiled suspension was then used in SDS-PAGE. 
2.3.G. SDS-PAGE and Immunoblotting 
Whole-cell lysate containing 10 ug total protein from each sample was loaded into SDS-PAGE 
gels containing a 4% (37.5:1 mono:bis) stacking gel and 12% (150:1 mono:bis) or 15% (29:1 mono:bis) 
resolving gel. Electrophoresis was then performed at 10-30 mA constant current for 15 minutes, 20-60 
mA constant current for 2-4 hours allowing the 25 kDa band (PageRuler Plus Prestained Protein Ladder; 
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Thermo Scientific) to reach the base of the gel. Each gel was equilibrated in Towbin Transfer Buffer (10 
mM Tris-HCl, 100 mM glycine, 10% Methanol) for 15 min and transferred onto a 0.2-micron nitrocelllose 
membrane (Bio-Rad) at 40 mA constant current for 16 hours at 4°C. 
Once transfer was complete, nitrocellulose membranes were then stained with Ponceau S (0.5% 
w/v Ponceau S, 1% v/v acetic acid) for 10 min to visualize total protein content to determine equivalent 
loading within each lane. Once membranes were imaged, the Ponceau S stain was removed by washing 
with Western Wash Buffer (WWB) (0.3% Tween-20, 5 uM NaF, 0.05 uM Na3VO4) for 15 minutes. Blocking 
buffer (WWB, 1% w/v BSA) was then added and the blot was incubated for 2 hours at room temperature. 
Blocking buffer was removed, and Primary Antibody Buffer (PAB) (WWB, 0.5% w/v nonfat dry milk, 0.5% 
BSA) containing a 1:40,000 dilution of α-Rfa2 antibody (kindly provided by Dr. Steve Brill) was added to 
the blots. Following a 16 hr incubation at 4°C, the PAB was removed and washes were performed using 
WWB. Secondary Antibody Buffer (SAB) (WWB, 0.2% w/v nonfat dry milk), containing a 1:40,000 dilution 
of goat-α-rabbit-HRP (Abcam; ab97051, 1:40,000, Bethyl; A120-101P, 1:40,000) was then added to each 
blot and allowed to incubate for 2 hr at room temperature. The SAB was then removed and washes using 
WWB were performed. All blots were developed using a fluorescent substrate (ECL2 Plus; Thermo 
Scientific) and visualized on a STORM imager (GE Healthcare). 
2.3.H. Phospho-specific Immunoblotting of rfa2-h2NT 
SDS-PAGE and western blotting was performed as described above, with the following changes. 
Phospho-specific antibodies to the human Rpa2 epitopes of pS4/pS8 (Bethyl; A300-245A, 1:5,000, 40 ug 
total protein), pT21 (Abcam; ab109394, 1:40,000, 2 ug total protein), pS29 (kindly provided by Jim 
Borowiec, 1:10,000, 10 ug total protein), pS33 (Bethyl; A300-246A, 1:5,000, 20 ug total protein) were 
used to probe site specific phosphorylation changes. All the above primary antibodies were generated in 
rabbits, and as such, were detected using the same secondary antibodies described above. 
2.4. Results 
2.4.A. Examination of sequential phosphorylation and site-dependent phosphorylation 
mechanisms in Saccharomyces cerevisiae using rfa2-h2NT 
Previous research performed in human cells suggest the existence of a sequential 
phosphorylation mechanism as a means by which to propagate phosphorylation throughout the N-
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terminal domain (Anantha et al. 2008, Liu et al. 2012). This has led to the proposal of two sequential 
phosphorylation models by the Borowiec (Figure 2.3A) and Oakley (Figure 2.3B) lab groups. The 
Borowiec model suggests that phosphorylation at S33 is the priming event that leads to phosphorylation 
at S23/29, which facilitates phosphorylation T21, S11/12/13, S8, and/or S4. The Oakley model suggests 
that while phosphorylation can occur initially at several different residues on the N-terminus individually, 
one primed event is necessary to propagate phosphorylation throughout the rest of the phosphorylation 
domain. Using our Rfa2-h2NT fusion protein, we probed whether sequential phosphorylation of the 
human NT occurs in budding yeast (Figure 2.4). 
Using a genetic approach, we modified each of the serine/threonine residues within the 
phosphorylation domain of rfa2-h2NT to alanine to determine site-specific dependency of phosphorylation 
by monitoring adjacent sites. Cells challenged with phleomycin, containing single serine to alanine or 
threonine to alanine mutations of the yeast Rfa2 protein exhibited near-identical levels of Rfa2 hyper-
phosphorylation (Figure 2.5A). Using human-peptide phospho-specific antibodies to probe the serine or 
threonine to alanine mutations within rfa2-h2NT, we demonstrate that preventing of phosphorylation at 
one site does not impede phosphorylation at adjacent or distal sites (Figure 2.5B). Both results, taken 
together, suggest two things: 1) sequential, primed phosphorylation of the N-terminal domain is not a 
mechanism employed in yeast to fully hyper-phosphorylate the Rfa2-h2NT protein, and 2) 
phosphorylation at all other residues examined was observed for each of the Rfa2-h2AI single mutants 
tested. Further analysis of Rfa2-h2NT phosphorylation revealed that phosphorylation at T21 and S33 
were achieved by Mec1 (Figure 2.6). Phosphorylation at T21 became more intense in a rad53Δ strain, 
similar to wild-type Rfa2 NT phosphorylation observed in a rad53Δ mutation (Schramke et al. 2001).  
2.4.B. Analysis of Rfa2-h2NT mutant function in Saccharomyces cerevisiae 
During our study of the function of the human Rpa2 NT in budding yeast, we also analyzed the 
function of human phospho-mimetic NT mutations (Figure 2.7 and 2.8). We found that each of the human 
NT mutations (rfa2-h2NT, rfa2-h2DX, rfa2-h2AX, rfa2-h2ΔNX) promoted proper checkpoint activation in 
yeast, as measured by Rad53 phosphorylation via immunoblot. Furthermore, modification of the 
humanized Rfa2 NT was only observed in the rfa2-h2NT mutant (Figure 2.8; (Ghospurkar et al. 2015). 
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Moreover, we found that each of the respective rfa2-h2 mutations recapitulated known phenotypes for 
Rfa2 NT mutations via diagnostic spot assays (Figure 2.9). 
 
Figure 2.3.  Borowiec and Oakley models for sequential phosphorylation of the Rpa2 NT. 
A. Borowiec model of sequential phosphorylation adapted from (Anantha et al. 2009). Top panel displays 
known kinase activity at Rpa2 NT sites. Bottom panel is the Borowiec Model for sequential 
phosphorylation emanating from S33, and propagating phosphorylation to S29 and S33. This additional 
phosphorylation leads to T21 phosphorylation, which then promotes phosphorylation at S11, S12, S13 
and S4 and S8 B. The Oakley model (Liu et al. 2012) for sequential phosphorylation suggests that 
phosphorylation at any site is required for priming of phosphorylation at adjacent or distal sites (reprinted 
with permission from Oxford Academic Journals: Liu et al., Nucleic Acids Research, 2012). 
 
Figure 2.4.  Human-specific antibody recognition of damage dependent and mitotic rfa2-h2NT 
phosphorylation. 
Phosphorylation of rfa2-h2NT occurs in response to PHL treatment and in mitotically growing cells. MMS 
treatment (0.03%) is indicated by ‘+’, untreated cells ‘0’.  Western blotting with human Rpa2 phospho-
specific antibodies (right-side blots with specific antibody used denoted to the right of each blot) was 
performed. Blots on left half represent resolution of approximately equal amounts of total Rfa2 or Rfa2-
h2NT (not total protein). Phosphorylation at S4/S8 occurs in response to PHL treatment. Human 
phospho-specific antibodies do not recognize the yeast Rfa2 peptide natively. This blot was done by 
Shenqin Liu of the Oakley lab and published in Ghospurkar et al. 2015. 
Rfa2 antibody 
h2NT y2NT h2NT y2NT 
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Figure 2.5.  rfa2-h2AI mutations have no discernable effect on sequential phosphorylation of rfa2-
h2NT. 
A. Analysis of rfa2-h2AI mutations during phleomycin challenge displays near identical biochemical 
phenotypes for each individual mutation, suggesting that sequential phosphorylation of the rfa2-h2NT in 
budding yeast is not occurring. B. Human phospho-specific antibody probes of rfa2-AI mutations from A. 
further demonstrate that sequential phosphorylation of the rfa2-h2NT in budding yeast is not occurring or 
is not impacted by single-site mutations. Phospho-site-specific antibodies are denoted to the right of the 
immunoblots. 
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Figure 2.6.  Mec1 phosphorylates rfa2-h2NT at known damage-dependent sites (T21 and S33). 
Kinase deletion mutations in the JKM179 background (AWY strains) were subjected to PHL treatment, 
harvested, and analyzed using a human phospho-specific antibody to Rpa2-T21 phosphorylation. mec1Δ 
cells are unable to phosphorylate T21 and S33, suggesting Mec1 is the primary kinase phosphorylating 
the SQ/TQ kinase consensus sites on Rfa2-h2NT in budding yeast. 
2.4.C. Analysis of Rfa2 NT extensive mutations in kinase deletion mutant yeast 
Through our collaboration with the Andre Walther Lab at Cedar Crest College (Allentown, PA, 
USA), we obtained several JKM179 derivative strains containing chromosomal integrations of two Rfa2 
NT extensive mutations (rfa2-DX and rfa2-AX) to analyze. Overnight cultures tel1Δ, chk1Δ, dun1Δ, sml1Δ, 
mec1Δ, or rad53Δ containing either RFA2, rfa2-DX (Figures 2.10 and 2.12) or rfa2-AX (Figures 2.11 and 
2.13) were harvested and an OD600 was determined. Six 10-fold serial dilutions were performed starting at 
an OD600 = 1.0 and spotted on YPD media or YPD media containing MMS, PHL, CPT, or HU at various 
concentrations. In nearly every case examined the presence of the rfa2-DX mutation led to an increase 
the kinase deletion mutant sensitivity to genotoxic agents. Surprisingly, the rfa2-DX mutation supported 
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some resistance to phleomycin in tel1Δ, chk1Δ, dun1Δ mutants, and was more effective at promoting 
genotoxic resistance to phleomycin than the rfa2-AX mutation.  
Deletion of the MEC1 and RAD53 genes is only possible after deleting SML1 (suppressor of 
Mec1 lethal). Yeast mutants containing the sml1Δ, mec1Δ sml1Δ, or rad53Δ sml1Δ deletions were 
sensitive to genotoxic agents and became more sensitive to HU, MMS, and CPT. Similar to that observed 
for tel1Δ, chk1Δ, dun1Δ the mec1Δ sml1Δ, or rad53Δ sml1Δ double mutants containing rfa2-DX were 
tolerant to phleomycin-induced genotoxic stress, whereas the same double mutants containing rfa2-AX 
were as sensitive to each genotoxic agent as the double mutants containing RFA2.  
These results are inconsistent with previous observations that the rfa2-DX mutation broadly 
increases sensitivity to genotoxic agents. Moreover, recreating these strains in the JKM179 background 
using one-step gene replacement (Figures 2.12, 2.14, and 2.16) revealed that rfa2-DX does lead to 
increased genotoxic sensitivity in tel1Δ, chk1Δ, dun1Δ mutants in all clastogens tested. Similarly, the rfa2-
AX mutation (Figures 2.13, 2.15, 2.17) supports clastogen resistance in line with RFA2 in each of the 
deletion mutants tested, and tel1Δ, chk1Δ, dun1Δ deletion mutants do not tolerate genotoxic challenge 
better than the same deletion mutants containing RFA2 in any of the genotoxic conditions analyzed. 
2.4.D. Detection of Rfa2 modifications during prolonged genotoxic stress 
In a previous study, phosphorylation of the yeast Rfa2 NT was unobservable in response to 
genotoxic stress carried out for up to 4 hours. However, a chimeric Rfa2 containing the human Rpa2 N-
terminus is robustly phosphorylated in this region in response to genotoxic stress (Ghospurkar et al. 
2015). This indicated that a sequence attached to the NT region of Rfa2 was capable of being 
phosphorylated, but that the native yeast Rfa2 NT was not detectably modified within the 4-hour time 
course. Characterization of Rfa2 NT phospho-mutations in a yku70D background revealed that the 
phospho-mimetic form stimulated checkpoint adaptation approximately 12-15 hours after the generation 
irreparable DSB and nearly 8-10 hours after initial checkpoint establishment (Ghospurkar et al. 2015). As 
a result of these previous experiments, we aimed to determine if delayed Rfa2 phosphorylation might be 
occurring in response to prolonged clastogen exposure. When treated with phleomycin (PHL), a chemical 
analog of bleomycin, rfa2-h2NT cells show robust phosphorylation of N-terminus approximately 2 hours 
after exposure. Additional modification of the Rfa2-h2NT protein does not appear to change with 
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prolonged exposure to phleomycin (Figure 2.20). Although we can detect minimal modification of Rfa2 at 
2 hours, the intensity of this modification increases until maximum modification is observed at 12 hours. 
Furthermore, we are able to detect two slower migrating species of Rfa2 in wild-type cells when damaged 
with phleomycin. We suggest that one or more of these slower migrating species also contains 
phosphorylation occurring at S122, which has been demonstrated previously (Brush et al. 1996). 
 
Figure 2.7.  Alignment of Rfa2 NT ‘extensive’ mutations with Rfa2-h2 NT ‘extensive’ mutations. 
A schematic of Rfa2 depicting the region of the Rfa2 NT that was mutated in each strain (top panel) and 
an alignment of the residues changed in each respective mutation (bottom panel). Sequence schematics 
are a zoom-in of the Rfa2/Rpa2 phosphorylation domain (PD). S/T indicates serines or threonines within 
the PD. A or D substitutions below indicate alanine or aspartate mutations, respectively. 
 
Figure 2.8.  Additional phosphorylation of Rfa2-h2 NT mutations is not observed in ‘extensive’ NT 
mutations. 
Top Panel: Rfa2 phosphorylation is only observed in rfa2-h2NT extensive mutation, whereas rfa2-h2DX, 
rfa2-h2AX, and rfa2-h2ΔN33 produce biochemical phenotypes in-line with that observed for the Rfa2 NT 
extensive variants (Figure 2.14), suggesting phosphorylation occurs on the NT of Rfa2-h2NT. Bottom 
Panel: Rad53 phosphorylation in response to PHL treatment occurs indistinguishably from WT cells in 
each of the rfa2-h2 NT extensive mutations, indicating NT extensive mutations do not impair checkpoint 
activation in budding yeast. 
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Figure 2.9.  Rfa2-h2 NT mutations produce phenotypes in line with Rfa2 NT extensive mutations. 
Six 10-fold serial dilutions of cells containing extensive Rfa2 NT mutations were plated on YPD media or 
YPD media containing genotoxic agents at various concentrations against rfa2-h2 NT extensive 
mutations to assess their phenotype. Each rfa2-h2 NT extensive mutation recapitulates the phenotype of 
its yeast Rfa2 NT extensive counterpart. Each DX and ΔNX extensive mutation is damage sensitive, 
whereas h2NT or AX extensive mutations support clastogen resistance in-line with WT Rfa2. 
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Figure 2.10. Diagnostic spot assay of tel1Δ, chk1Δ, dun1Δ mutants containing the rfa2-DX 
mutation 
JKM179 derivative mutants containing tel1Δ, chk1Δ, dun1Δ mutations and RFA2 or the rfa2-DX mutation 
were grown overnight in YPD media. The following day, an OD600 reading was taken, and cells six 10-fold 
serial dilutions were performed, starting at an OD600 = 1.0. 200 uL of each dilution was added to a 96-well 
micro-titer plate and 5 uL of each sample was spotted on YPD media or YPD media containing genotoxic 
agents at various concentrations. The rfa2-DX mutation leads to an increase in sensitivity to the genotoxic 
agents MMS, CPT, and HU, but not PHL in each strain analyzed.   
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Figure 2.11. Diagnostic spot assay of tel1Δ, chk1Δ, dun1Δ mutants containing the rfa2-AX 
mutation. 
JKM179 derivative strains containing tel1Δ, chk1Δ, dun1Δ mutations and RFA2 or the rfa2-AX mutation 
were grown overnight in YPD media. The following day, an OD600 reading was taken, and cells six 10-fold 
serial dilutions were performed, starting at an OD600 = 1.0. 200 uL of each dilution was added to a 96-well 
micro-titer plate and 5 uL of each sample was spotted on YPD media or YPD media containing genotoxic 
agents at various concentrations. The rfa2-AX mutation supports clastogen resistance in each strain in-
line with wild-type Rfa2.   
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Figure 2.12. Diagnostic spot assay of tel1Δ mutations (rfa2-DX and rfa2-h2NT). 
tel1Δ Rfa2 NT mutations were harvested and an OD600 for the exponentially growing culture was 
determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered water. 
200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was then 
spotted onto the YPD plates and YPD plates containing genotoxic agents at indicated concentrations 
using a multi-channel pipetman. tel1Δ mutant cells containing the rfa2-DX or rfa2-h2NT mutations are 
hypersensitive to genotoxic agents.  
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Figure 2.13. Diagnostic spot assay of tel1Δ mutations (rfa2-AX and rfa2-ΔNX). 
tel1Δ Rfa2 NT mutations were harvested and an OD600 for the exponentially growing culture was 
determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered water. 
200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was then 
spotted onto the YPD plates and YPD plates containing genotoxic agents at indicated concentrations 
using a multi-channel pipetman. tel1Δ mutant cells containing the rfa2-AX support clastogen resistance in-
line with wild-type Rfa2. tel1Δ mutant cells containing the rfa2-ΔNX mutation are hypersensitive to 
genotoxic agents. 
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Figure 2.14. Diagnostic spot assay of dun1Δ Rfa2 NT extensive mutations (rfa2-DX and rfa2-h2NT). 
dun1Δ Rfa2 NT extensive mutations were harvested and an OD600 for the exponentially growing culture 
was determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered 
water. 200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was 
then spotted onto the plates using a multi-channel pipetman. dun1Δ mutant cells containing the rfa2-DX 
mutation are hyper-sensitive to genotoxic agents, whereas the Rfa2-h2NT mutant appears to support 
genotoxic resistance in line with WT Rfa2.  
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Figure 2.15. Diagnostic spot assay of dun1Δ Rfa2 NT extensive mutations (rfa2-AX and rfa2-ΔNX). 
dun1Δ Rfa2 NT extensive mutations were harvested and an OD600 for the exponentially growing culture 
was determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered 
water. 200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was 
then spotted onto the plates using a multi-channel pipetman. dun1Δ mutant cells containing the rfa2-AX 
mutation are no more sensitive to genotoxic agents than dun1Δ mutants containing Rfa2, whereas the 
rfa2-ΔNX mutation leads to hyper-sensitivity to genotoxic agents.   
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Figure 2.16. Diagnostic spot assay of chk1Δ Rfa2 NT extensive mutations (rfa2-DX and rfa2-h2NT). 
chk1Δ Rfa2 NT extensive mutations were harvested and an OD600 for the exponentially growing culture 
was determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered 
water. 200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was 
then spotted onto the plates using a multi-channel pipetman. chk1Δ mutant cells containing the rfa2-DX 
mutation are hyper-sensitive to genotoxic agents, whereas the Rfa2-h2NT mutant supports genotoxic 
resistance in line with WT Rfa2. 
  60 
 
Figure 2.17. Diagnostic spot assay of chk1Δ Rfa2 NT extensive mutations (rfa2-AX and rfa2-ΔNX). 
chk1Δ Rfa2 NT extensive mutations were harvested and an OD600 for the exponentially growing culture 
was determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered 
water. 200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was 
then spotted onto the plates using a multi-channel pipetman. chk1Δ mutant cells containing the rfa2-AX 
mutation are no more sensitive to genotoxic agents than chk1Δ mutants containing Rfa2, whereas the 
rfa2-ΔNX mutation leads to hyper-sensitivity to genotoxic agent
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Figure 2.18. Diagnostic spot assay of sml1Δ, mec1Δ, rad53Δ mutants containing the rfa2-DX 
mutation. 
JKM179 derivative strains containing sml1Δ, mec1Δ, rad53Δ mutations and RFA2 or the rfa2-DX mutation 
were grown overnight in YPD media. The following day, an OD600 reading was taken, and cells six 10-fold 
serial dilutions were performed, starting at an OD600 = 1.0. 200 uL of each dilution was added to a 96-well 
micro-titer plate and 5 uL of each sample was spotted on YPD media or YPD media containing genotoxic 
agents at various concentrations. The rfa2-DX mutation leads to increased sensitivity to genotoxic agents 
in all strains analyzed. Cells containing mec1Δ and rad53Δ mutations are hyper-sensitive to genotoxic 
agents irrespective of the Rfa2 form present.   
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Figure 2.19. Diagnostic spot assay of sml1Δ, mec1Δ, rad53Δ mutants containing the rfa2-AX 
mutation. 
JKM179 derivative strains containing sml1Δ, mec1Δ, rad53Δ mutations and RFA2 or the rfa2-AX mutation 
were grown overnight in YPD media. The following day, an OD600 reading was taken, and cells six 10-fold 
serial dilutions were performed, starting at an OD600 = 1.0. 200 uL of each dilution was added to a 96-well 
micro-titer plate and 5 uL of each sample was spotted on YPD media or YPD media containing genotoxic 
agents at various concentrations. The rfa2-AX mutation supports clastogen resistance in each strain in-
line with Rfa2. Cells containing mec1Δ and rad53Δ mutations are hyper-sensitive to genotoxic agents 
irrespective of the Rfa2 form present.   
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2.4.E. Delayed modification observed upon prolonged DNA damage is phosphorylation 
The detectable modification of Rfa2 is suggestive of a phosphorylation event. To test this 
phosphorylation, whole cell lysates obtained from damage-induced cells were subjected to lambda 
protein phosphatase (lPP) treatment (Figure 2.21). Two types of prolonged damage were examined: 
phleomycin treatment that induces multiple DSBs throughout the genome and a galactose-inducible HO-
endonuclease generates a single, irreparable DSB due to a lack of silent mating loci in the yeast strain 
NMM104. 
Figure 2.21 demonstrates that highest molecular weight species of Rfa2 present in response to 
global DSB induction is removed by lPP and is present when the lPP inhibitor sodium orthovanadate is 
added to the reaction. Additionally, generation of a single, persistent DSB is also sufficient to induce Rfa2 
phosphorylation by 12 hours, as this higher molecular weight species is observed and subsequently 
removed by lPP. To ensure that lPP activity was occurring, samples were examined containing Rfa2-
h2NT, which is known to be phosphorylated on the NT in response to DSB agents. The slower migrating 
species in these samples are removed by lPP. 
2.4.F. Delayed Rfa2 NT phosphorylation is localized to the NT domain and is not dependent on 
early S122 phosphorylation 
Using Rfa2 ‘extensive’ mutations from previous studies (Figure 2.7), we sought to understand 
whether the additional, delayed phosphorylation of Rfa2 was occurring within the N-terminal 
phosphorylation domain. To determine whether the NT is a phospo-target during genotoxic stress, an 
alanine-scanning approach was used. The unphosphorylatable Rfa2-AX mutant has all 11 
serines/threonines mutated to alanine. In this rfa2-AX cells, no detectable modification of the Rfa2 protein 
is observed via immunoblot (Figure 2.20) in response to prolonged exposure to phleomycin. This 
demonstrates that serines/threonines within the NT region are necessary for delayed phosphorylation of 
Rfa2. 
It has been demonstrated previously that Rfa2 becomes phosphorylated at serine 122 
approximately 2 hours after a DSB has been generated in cells (Bartrand et al. 2004). S122, however, 
does not appear to play a major role in the DNA damage response as S122 mutations display no 
discernable phenotype when challenged with a variety of DNA damaging agents (Figure 2.22)  
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Figure 2.20. Rfa2 NT phosphorylation is detectable in challenged with phleomycin. 
A. Immunoprobe using α-Rfa2 antibody. Phospho-modification of Rfa2 is observed in response to PHL 
treatment starting at approximately 4 hours and becomes maximized by 12 hours. Phosphorylation of 
rfa2-h2NT is observed at 2 hours post-PHL exposure and maintains a similar intensity throughout the 
observed time course. rfa2-AX does not appear to be modified under the same conditions. B. rfa2-DX and 
rfa2-ΔNX are still modified in response to PHL treatment, suggesting phosphorylation occurs outside of 
the NT phosphorylation domain on these mutant proteins.  
 
Figure 2.21. Rfa2 NT phosphorylation is removed by lambda protein phosphatase. 
Immunoprobe using α-Rfa2 antibody. Modification observed on Rfa2 during PHL treatment or in response 
to an HO-induced DSB at the MAT locus is phosphorylation. Incubation of 40 ug total protein from whole 
cell lysates with lambda protein phosphatase (λpp) in Buffer A eliminates the observed phospho-shift. 
This demonstrates that the observed modifications to Rfa2 and Rfa2-h2NT are phosphorylation. Lamda 
protein phosphatase inhibitor Sodium Orthovanadate (NaOv3) was used as a control for λpp activity. 
Samples containing λpp retain the observed modification, further indicating that this modification is 
phosphorylation. 
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Figure 2.22. Known Mec1-dependent phosphorylation sites have no discernable function in the 
Lesion and DNA repair program. 
Six 10-fold serial dilutions of cells containing combinations of rfa1-S178A/D and rfa2-S122A/D were plated 
on YPD media or YPD media containing genotoxic agents at various concentrations. Each combination 
produces phenotypes in-line with wild-type cells and support genotoxic stress much more effectively than 
rfa1-t11, demonstrating that phosphorylation at Rfa1 on S178 or Rfa2 on S122 appear to be dispensable 
for the lesion and repair program (LPR). 
(Ghospurkar et al. 2015). To determine if S122 regulates the delayed phosphorylation observed within the 
NT, we employed an aspartic acid/alanine-scanning approach to S122. We hypothesized that if S122 
phosphorylation is required for the delayed NT phosphorylation observed, mutating this residue to the 
phospho-mimetic S122D mutation would cause additional NT phosphorylation, and that mutating it to the 
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unphosphorylatable S122A mutation would prevent delayed Rfa2 NT phosphorylation. However, delayed 
phosphorylation of Rfa2 is still observed in both rfa2-S122D and rfa2-S122A in response to prolonged 
phleomycin challenge (Figure 2.23A). When compared with Rfa2 from wild-type cells, one of the two 
observed phospho-species is absent. We presume that the missing phospho-species is due to an inability 
of S122 to be modified. This demonstrates that the observed delayed Rfa2 NT phosphorylation is still 
achieved without prior, early modification of S122. 
2.4.G. Damage-sensitive Rfa2 NT extensive mutations are prominently phosphorylated at S122 
Two additional extensive NT mutations were also examined to characterize Rfa2 phosphorylation. 
The first being a phospho-mimetic extensive mutation, rfa2-DX, was created by mutating all of the 
serines/threonines to aspartates. The second is an NT deletion mutation in which amino acids 2-38 of the 
Rfa2 NT are deleted (rfa2-DNX). Previous studies have demonstrated that rfa2-DX or rfa2-DNX cells exhibit 
increased sensitivity to DNA damaging agent, but in these cells the mutant Rfa2 proteins are still 
phosphorylated in response to genotoxic stress (Ghospurkar et al. 2015). However, phosphorylation of 
these mutant proteins had been observed after MMS treatment for 4 hours (Ghospurkar et al. 2015). 
Consistent with previous data, early, damage-dependent modification of Rfa2-DX and Rfa2-ΔNX is also 
observed upon treatment with phleomycin (Figure 2.23B and C). Phosphorylation of Rfa2-DX and Rfa2-
ΔNX is minimally observed in untreated, exponentially growing cells – a result that is consistent with the 
fact that these NT mutations harbor a cellular growth defect, even when unchallenged by genotoxic stress 
(Ghospurkar et al. 2015). Similar to that observed for Rfa2-h2NT, Rfa2-DX and Rfa2-ΔNX show maximal 
phosphorylation between 2-4 hours. We propose that the phosphorylation observed on Rfa2-DX and 
Rfa2-ΔNX is occurring at S122. S122 has been demonstrated to be a Mec1 target site of SQ/TQ 
consensus on Rfa2 that becomes phosphorylated in response to DNA damage and mitotic growth (Brush 
et al. 1996). Because all the serines/threonines within the NT have been mutated to aspartic acids or 
removed entirely in these mutations, the observed phosphorylation of rfa2-DX and rfa2-ΔNX, therefore, 
cannot be occurring within the NT domain. 
Although we observe phosphorylation in rfa2-DX and rfa2-ΔNX cells, the ratio of phosphorylated 
Rfa2 to unmodified Rfa2 appears to differ between the two mutations, especially after 8 hours. In 
particular, the ratio of phosphorylated to unphosphorylated Rfa2 is much greater in the rfa2-ΔNX mutation 
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than in the rfa2-DX mutation. This is perhaps unsurprising as it has been demonstrated that these two 
mutations, despite both being sensitive to DNA damage, demonstrate different synthetic genetic 
interactions and ability to exit a checkpoint in response to persistent DNA damage (Ghospurkar et al. 
2015). To determine if S122 is the site being modified on these mutations, we mutated S122 to S122D or 
S122A. Independent of whether S122 is in the phospho-mimetic or unphosphorylatable state, no 
observable damage-dependent phosphorylation of Rfa2 is detected. 
2.4.H. Rfa2 NT mutations display differential effects on Mec1 activity 
Although both Mec1 and Tel1 have been shown to phosphorylate Rfa2, Mec1 is the primary 
kinase demonstrated to target Rfa2 at serine 122 in response to both mitotic and meiotic DNA damage 
(Brush et al. 1996, Brush et al. 2001, Clifford et al. 2004, Bartrand et al. 2006). In this study, we observed 
S122 phosphorylation in the Rfa2 NT mutations rfa2-DX and rfa2-ΔNX, in response to phleomycin-induced 
DSBs. To characterize whether Mec1 or Tel1 activity is differentially affected by the phospho-state of the 
Rfa2 NT, we examined Rfa2 S122 phosphorylation in rfa2 mec1D sml1D or rfa2 tel1D double mutations in 
response to phleomycin induced DSBs. Specifically, we focused on the rfa2-DX and rfa2-ΔNX mutants.  
We suspected that if Mec1 or Tel1 kinase activity is dependent on the phospho-state of the Rfa2 
NT, then eliminating either of these kinases, or the physical presence of the Rfa2 NT, would reduce the 
appearance of S122 phospho-species. Immunoblots of Rfa2-DX and Rfa2-ΔNX in mec1Δ or tel1D 
indicated that phosphorylation efficiency of S122 is affected differentially. Cells containing mec1Δ were 
able to phosphorylate Rfa2-DX or Rfa2-ΔNX, in response to phleomycin challenge, indistinguishably from 
MEC1 cells. Cells containing tel1D were able to readily phosphorylate rfa2-ΔNX indistinguishably from 
MEC1/TEL1 cells but were unable to phosphorylate Rfa2-DX to the same level observed in wild-type cells 
(Figure 2.24). In tel1D cells, Mec1 is still active and this may explain why phosphorylation is still observed 
on rfa2-ΔNX. The observation that rfa2-DX is not readily phosphorylated in tel1D indicates that the 
phospho-state of the Rfa2 NT may regulate Mec1 activity at DSBs. rfa2-DX has been previously 
demonstrated to promote checkpoint exit in response to a persistent DSB, and it is possible that this 
phenomenon is a direct result of a hyper-phosphorylated Rfa2 NT attenuating Mec1 activity at DSB sites. 
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2.4.I. Examination of Rfa2 phosphorylation in DNA damage response kinases deletions 
Previous data has suggested a role for Mec1/Ddc2 and Tel1 in phosphorylation of Rfa2 in 
response to DNA damage. In an effort to further elucidate what kinases might be acting upon Rfa2, we 
deleted TEL1, CHK1, and DUN1 individually and assayed the Rfa2 phospho-state upon 2 different types 
of clastogen challenge (Figure 2.19). To reduce potential discrepancy between S122 phosphorylation and 
NT phosphorylation, 12% (150:1 mono:bis) acrylamide gels were used that allow the S122 phospho-
species to run with the same mobility as unphopshorylated Rfa2. Phosphorylation of Rfa2 in response to 
global DSBs induced by phleomycin appears to produce only one observable phospho-species, whereas 
a single DSB induced by HO-endonuclease appears to produce two distinct phospho-species. Together, 
these results demonstrate that phosphorylation of the Rfa2 NT occurs in response to DSBs in yeast.  
2.4.J. Rfa2 NT phosphorylation is observed under various genotoxic conditions 
Rfa2 N-terminal phosphorylation does not readily occur in response to genotoxic challenge within 
a previously analyzed 4-hour exposure to genotoxic agents (Ghospurkar et al. 2015). We sought to assay 
whether Rfa2 hyper-phosphorylation would occur in response to prolonged genotoxic stress or in a dose-
dependent fashion, as had been previously reported, with genotoxic agents (MMS, PHL, and CPT). Each 
genotoxic agent used leads to the generation of ssDNA intermediates that RFA would be required to bind 
and protect. In WT cells, Rfa2 hyper phosphorylation is observed roughly 4-8 hours after clastogen 
exposure, specifically when cells are exposed to phleomycin (Figure 2.26 and 2.27), and to a lesser 
extent when cells are exposed to methyl methanesulfonate (MMS) or camptothecin (CPT). This 
phosphorylation appears to increase in a dose-dependent manner, as increasing the concentration of 
DNA damaging agent used lead to an increase in observed Rfa2 phosphorylation (Figure 2.27) Cells 
expressing the Rfa2-h2NT fusion protein challenged under the same genotoxic conditions yield hyper-
phosphorylated Rfa2-h2NT. Maximal phosphorylation of Rfa2-h2NT is observed by 4-8 hours in nearly 
every condition, likely due to the appearance of SQ/TQ consensus phospho-target sites within the NT. 
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Figure 2.23. Rfa2 phosphorylation is not detected in Rfa2 NT extensive mutations containing 
S122A/D. 
A. Immunoprobe using α-Rfa2 antibody. 10 ug total protein from whole cell lysates was used for 
immunoblotting. Early phosphorylation of Rfa2 is observed by 4 hours, with an additional, late phospho-
shift occurring by 8 hours. Rfa2 phosphorylation occurs in response to PHL treatment in rfa2-S122A/D 
mutations. The additional, late phospho-shift observed on Rfa2 is eliminated in Rfa2-S122D or Rfa2-
S122A, but each mutant protein is still detectably phosphorylated. B. The additional phospho-shift 
observed in rfa2-S122A/D mutations is eliminated when the Rfa2 NT is mutated to rfa2-DX. The additional 
phospho-shift observed in rfa2-DX occurs at S122 and is eliminated when S122 is mutated indicating that 
S122 is the early phosphorylation event that occurs in cells. C. rfa2-ΔNX, similar to rfa2-DX, is 
phosphorylated at S122 in response to PHL treatment, and this additional phospho-shift is eliminated 
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Figure 2.24. Rfa2-DX phosphorylation at S122 is impeded in tel1Δ. 
Immunoprobe using α-Rfa2 antibody and 10 ug total protein from whole cell lysates. Phospho-mimetic 
rfa2-DX is phosphorylated in response to PHL treatment in WT cells indistinguishably from rfa2-ΔNX. 
Phosphorylation at S122 appears to be impaired in cells containing tel1Δ rfa2-DX when compared to rfa2-
ΔNX, where a greater majority of the rfa2 isolated appears to be phospho-shifted, suggesting that Mec1 
activity is impaired in rfa2-DX cells.  
 
Figure 2.25. Rfa2 NT phosphorylation occurs independent of Tel1, Chk1, and Dun1. 
Immunoprobe using α-Rfa2 antibody and 10 ug total protein from whole cell lysates. Cells were grown to 
an OD600 of 1.0 and global genotoxic stress was induced using phleomycin. A single DSB was stimulated 
by adding galactose to a final concentration of 2% to induce HO-endonuclease expression. Phleomycin 
induced damage produces two distinct bands, whereas a single DSB created by HO-endonuclease leads 
to the formation of three distinct phospho-species. This demonstrates that phosphorylation of the Rfa2 NT 
occurs in response to global DSBs, but more extensively in response to a single irreparable lesion. 
Phosphorylation of Rfa2 in tel1Δ, chk1Δ, and dun1Δ mutations occurs indistinguishably from WT cells. 
Immunoblots were produced from 12% (150:1 mono:bis) acrylamide gels that allow the observed early 
phosphorylation of S122 to run with unmodified Rfa2, allowing for more focused analysis of Rfa2 
phospho-species generated during genotoxic stress. 
2.4.K. Rfa2 NT phosphorylation is readily detectable in an rfa1-t11 mutation 
Central to RFA complex function is RFA1 DBD-F’s ability to load the 9-1-1 Clamp loader complex 
(Rad24-RFC2-5 in yeast) to the 5’ proximal junction, as well as facilitate loading of the 9-1-1 clamp 
(Rad17-Mec3-Ddc1) by stabilizing the clamp loader-5’ junction interaction (Kumagai et al. 2006, Delacroix 
et al. 2007, Lee et al. 2007, Mordes et al. 2008, Navadgi-Patil et al. 2008, Puddu et al. 2008, Lee et al. 
2010, Liu et al. 2011). These protein interactions are thought to be mediated via the N-terminus of Rfa1, 
known as DBD-F, and previous research has demonstrated that many DDR-specific protein interactions 
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which are dependent on the physical presence of a functional DBD-F within Rfa1. A point mutation of 
Rfa1, known as rfa1-t11 (K45E), is known to ablate several of these protein interactions, leading to 
defective checkpoint signaling and severe genotoxic sensitivity (Zou et al. 2003, Zou et al. 2003, Lucca et 
al. 2004, Majka et al. 2006). Furthermore, rfa1-t11 has been demonstrated to promote checkpoint exit in 
the presence of a persistent DNA lesion (Lee et al. 2001), similar to that observed for rfa2-DX 
(Ghospurkar et al. 2015). We postulated that if DBD-F of Rfa1 was essential for Rfa2 NT phosphorylation 
that Rfa2 would not become phosphorylated in rfa1-t11 mutations. Figures 2.25, 2.26 and 2.27 
demonstrate that Rfa2 phosphorylation is not reduced in rfa1-t11 mutations, suggesting that the delayed 
phosphorylation event observed on Rfa2 is not dependent on protein-protein interactions driven through 
the NT of Rfa1. Moreover, since rfa2-DX and rfa1-t11 promote checkpoint adaptation, and 
phosphorylation of Rfa2 is still observed in rfa1-t11 mutants, it is conceivable that phosphorylation of the 
Rfa2 NT may be the direct cause of checkpoint adaptation in rfa1-t11 mutants in response to prolonged 
genotoxic stress. 
2.5. Discussion 
The RPA complex is indispensable for all DNA metabolic processes due to its function in binding 
to single-stranded DNA (ssDNA) with nanomolar affinity, allowing RPA to act as a sensor of non-duplex 
DNA intermediates, and providing an essential role in the regulation of DNA damage-dependent 
checkpoint function. Coordinately, the amino-terminus (NT) of Rpa2 is hyper-phosphorylated by 
checkpoint kinases in response to lesions in DNA. However, the function post-translational 
phosphorylation of Rpa2 plays in cells remains elusive. Moreover, the long-term, generational 
consequences of Rpa2 in human cells are limited as expression and knockdown studies only produce 
phenotypes that can be observed transiently. It is clear that Rpa2 NT phosphorylation plays a critical role 
in mediating particular aspects of checkpoint signaling, namely delayed replication restart and checkpoint 
establishment and maintenance. 
2.5.A. Rfa2 is phosphorylated via two temporally distinct mechanisms 
In this study, examination of post-translational phosphorylation of Rfa2 in Saccharomyces 
cerevisiae revealed that there are two distinct phosphorylation events that Rfa2 experiences in response 
to the generation of DNA lesions. First, upon the generation of ssDNA intermediates Rfa2 becomes 
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Figure 2.26. Rfa2 phosphorylation in response to low-levels of genotoxic stress. 
A. Immunoprobe using α-Rfa2 antibody and 20 ug total protein from whole cell lysates. Rfa2 
phosphorylation is readily detectable upon cellular exposure to low levels of PHL, CPT and MMS 
concentrations indicated at 8 hours in WT and rfa1-t11 cells and occurs by 4 hours in rfa2-h2NT. 
Phosphorylation of Rfa2, rfa2-h2NT, or Rfa2 isolated from rfa1-t11 cells is not hyper-phosphorylated in 
response to HU-induced replication stress. B. Rad53 immunoblots from strains in A. depicting Rad53 
activation occurring in MMS and PHL treated cells, but not CPT or HU treated cells, indistinguishably in 
each condition. Phospho-activation of Rad53 does not occur in response to low levels of genotoxic stress 
induced by CPT or HU but occurs robustly in response to PHL or MMS treatment.   
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Figure 2.27. Rfa2 phosphorylation in response to high-levels of genotoxic stress. 
A. Immunoprobe using α-Rfa2 antibody using 20 ug total protein from whole cell lysates. Rfa2 
phosphorylation in NMM104 cells and NMM101 rfa1-t11 cells in response to various clastogens at high 
doses. Rfa2 phosphorylation is observed in response to PHL, MMS, and CPT, but not HU. B. Immoblot of 
Rad53 activation in the aforementioned strains occurs indistinguishably in response to high doses of 
genotoxic agents used in A. Phospho-activation of Rad53 does not occur in response to genotoxic stress 
induced by CPT, but occurs robustly in response to PHL, MMS, or HU treatment.  
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phosphorylated at S122 by Mec1. In response to prolonged genotoxic challenge, Rfa2 undergoes a late 
phosphorylation event on the NT phosphorylation domain. This phosphorylation only occurs in response 
to prolonged challenge and is thus delayed and likely not a function of the initial DNA damage response. 
Furthermore, examination of mutant strains containing deletions of kinases known to be involved in the 
initial DNA damage response (Mec1/Tel1), or immediately downstream of the initial downstream response 
(Chk1/Dun1), reveals that delayed Rfa2 NT phosphorylation is still readily detected in a manner 
indistinguishable from wild-type cells. This demonstrates that there is an unidentified kinase acting upon 
Rfa2, promoting delayed phosphorylation of the NT.  
2.5.B. Rfa2 phosphorylation at S122 as a marker for Mec1/Tel1 activity 
In this study, we examined Rfa2 S122 phosphorylation in Rfa2 NT phospho-mutations rfa2-DX 
and rfa2-ΔNX, and in mec1D or tel1D mutants. Analysis of phosphorylation of Rfa2-DX or Rfa2-ΔNX reveals 
that S122 phosphorylation occurs readily and accumulates in response to prolonged genotoxic stress. 
However, phosphorylation of S122 may not serve any physiological function as phospho-mimetic Rfa2-
S122 mutations do not display any increased sensitivity to DNA damaging agents. Instead, 
phosphorylation of S122 may serve as a biomarker for Mec1/Tel1 kinase activity during checkpoint 
initiation and maintenance. 
Cells containing either rfa2-DX or rfa2-ΔNX mutations exhibit increased sensitivity to DNA 
damaging agents, however their sensitivities may be due to a role for Rfa2 NT function in checkpoint exit. 
In cells containing the rfa2-ΔNX mutation, checkpoint initiation occurs indistinguishably from wild-type 
cells; however, in the presence of a persistent lesion these mutants experience permanent checkpoint 
arrest. As phosphorylation of S122 accumulates on rfa2-ΔNX through the observed 24-hour window, we 
postulate that Mec1 and Tel1 activity is maintained in these mutants, promoting the observed permanent 
arrest. 
The rfa2-DX mutation is known to promote checkpoint exit in yeast experiencing a permanent 
arrest caused by an irreparable lesion, whereas rfa2-ΔNX promotes checkpoint maintenance/arrest under 
the same conditions. Concomitant with this idea is the observation that rfa2-DX appears to inhibit 
accumulation of phosphorylation at S122 in a tel1D mutation, where only Mec1 activity on Rfa2 is 
expected. Mec1 is known to activate the master checkpoint regulator Rad53 and promote checkpoint 
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establishment and maintenance until a detected genotoxic insult has been repaired. The rfa2-DX mutation 
causes cells that encounter a persistent DNA lesion to exit the checkpoint prematurely, an observation 
that correlates well with a reduced presence of hyper-phosphorylated Rad53. It is enticing to speculate, 
based on these combined results, that the phospho-state of the Rfa2 NT may downregulate Mec1 activity 
at the site of DNA lesions, promoting checkpoint exit through Rad53 deactivation. 
2.5.C. Delayed Rfa2 NT phosphorylation is not dependent on the Rfa1 NT (DBD-F) 
The NT of Rfa1, known as DBD-F, serves as host to several protein-protein interactions that have 
been identified to be essential to the repair on lesions in DNA. DBD-F is known to interact with Rad24, a 
component of the Rad24-RFC2-5 clamp-loader complex, the MRX complex, and perhaps most 
importantly the checkpoint kinase complex Mec1/Ddc2 (Marechal et al. 2015). In a point mutation of the 
Rfa1 NT, known as rfa1-t11 (K45E), these interactions are reduced or eliminated, leading to an increased 
genotoxic sensitivity and instability in rfa1-t11 cells. Furthermore, the rfa1-t11 mutation has been 
demonstrated to promote relief of a permanent checkpoint induced by an irreparable lesion through a 
process known as checkpoint adaptation. 
In this study we observed Rfa2 NT phosphorylation in response to prolonged genotoxic challenge 
or an irreparable DSB in cells containing the rfa1-t11 mutation that was indistinguishable from wild-type 
cells. This observation has two major implications. The first major implication is that DBD-F is not 
responsible for the recruitment of the kinase(s) that produce delayed Rfa2 NT phosphorylation. This likely 
excludes Mec1/Ddc2 as the most likely culprit for delayed Rfa2 NT phosphorylation, as rfa1-t11 
negatively impacts Mec1/Ddc2 activity at DSB sites. The second implication is that the checkpoint 
adaptation-proficient phenotype conferred by rfa1-t11 may be caused directly by delayed Rfa2 NT 
phosphorylation. Further study will be required in order to elucidate the exact mechanism by which rfa1-
t11 and rfa2-DX promote checkpoint adaptation. 
2.5.D. Yeast as a model system to study Rfa2 dynamics of other eukaryotic organisms and the 
physiological relevance of Rfa2 phosphorylation within those organisms 
Saccharomyces cerevisiae can afford researchers a unique opportunity to study Rfa2 function 
from their own model organisms in a rapid and controlled fashion. As described in section 2.4.A, budding 
yeast Rfa2 is phosphorylated during genotoxic stress by two temporally distinct mechanisms, whereas 
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the Rfa2-h2NT mutant is robustly phosphorylated in response to genotoxic stress on the NT. While this 
phosphorylation occurs at T21 and S33 by Mec1, it has been difficult to characterize which kinases 
promote phosphorylation of the Rfa2-h2NT mutant at other sites like S4 or S8, etc. Moreover, as 
described in Padmaja Ghospurkar’s thesis, yeast transformed with a variety of eukaryotic rfa2 NT 
mutations are both mitotically viable and produce independent phosphorylation patterns in response to 
clastogen challenge. However, individual paralogs from the same species may be used in different 
processes such as DNA replication or DNA repair. Analysis of Rpa2 paralogs in Arabidopsis and Oryza, 
for example, demonstrated that each paralog experiences distinct modification events during genotoxic 
stress suggesting that the paralogs Rpa2-OS1 and Rpa2-ATa may be required for DNA repair in these 
organisms. Moreover, and consistent with this hypothesis are observations that Rpa1 and Rpa2 paralogs 
form differential complexes in plants that regulate meiotic crossover, DNA replication and DNA repair 
(Marwedel et al. 2003, Chang et al. 2009, Li et al. 2013, Aklilu et al. 2014, Eschbach et al. 2014, Aklilu et 
al. 2016). Our results together, however, do not rule out the simplest possibility of Mec1 phosphorylating 
SQ/TQ consensus motifs where they exist on each domain. Further study will be required to determine 
which specific eukaryotic NT promote checkpoint adaptation in yeast, which residues are required to be 
phosphorylated to drive adaptation, and which kinases are modifying these other eukaryotic N-termini in 
an effort to correlate which paralog of Rpa2 regulates checkpoint exit in each respective organism. 
2.5.E. Implications for delayed Rfa2 NT phosphorylation 
In this study, delayed Rfa2 NT phosphorylation was observed in response to prolonged genotoxic 
challenge in several checkpoint kinase deletions (tel1D, chk1D, dun1D), as well as in cells containing rfa1-
t11 (K45E). Human Rpa2 is known to be phosphorylated by DNA-PK, as well as CDK. While yeast do not 
possess a readily identifiable homolog to DNA-PK, yeast does have a clear CDK homolog in Cdc28. 
Delayed Rfa2 NT phosphorylation appears to be maximized around 12 hours in cells experiencing 
prolonged genotoxic challenge, the same window by which checkpoint adaptation occurs in yeast. We 
hypothesize that whichever kinase is producing maximally phosphorylated Rfa2 in this temporal window 
is not involved in the DNA damage response to checkpoint initiation, but critical for checkpoint exit and 
resumption to normal mitotic growth. As demonstrated in Figure 2.15 single deletions of the initial DSB 
sensor kinase Tel1, or downstream effector kinases Dun1 and Chk1, produce Rfa2 that is phosphorylated 
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indistinguishably from WT cells. It is possible then that Cdc28, or Cdc5, as a cell cycle regulatory kinase 
that promotes mitotic exit then phosphorylates the Rfa2 NT to promote checkpoint adaptation in response 
to a persistent DNA lesion. It is also curious that the phospho-state of the Rfa2 NT appears regulate 
Mec1 activity at break sites. We postulate that whichever kinase is phosphorylating the Rfa2 NT does so 
to relieve Mec1-dependent checkpoint maintenance to promote checkpoint recovery after a lesion has 
been repaired. Further study will be required to determine which kinase is directly responsible for 
producing the delayed Rfa2 NT phosphorylation observed. 
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CHAPTER 3: RFA2 NT PHOSPHORYLATION DURING CHECKPOINT ADAPTATION PROMOTES 
MITOTIC EXIT IN THE PRESENCE OF AN IRREPARABLE LESION 
3.1. Abstract 
In response to DNA damage, cells enter a checkpoint to provide adequate time for a DNA lesion 
to be processed properly. Upon repair of the lesion, cells exit the checkpoint and re-enter the cell cycle. 
However, cells can also exit the checkpoint despite the continued presence of a DNA lesion – termed 
checkpoint adaptation. This mechanism provides a balance between permanent checkpoint arrest and 
the potential for a cell to grow and divide, despite the lesion. One of the factors that senses disrupted 
DNA structure through its ability to bind to single-stranded DNA and mediates the activation of checkpoint 
arrest through interactions with key checkpoint proteins is Replication Protein A (RPA). It has been 
demonstrated in yeast that both the 70 kDa (Rfa1) and 32 kDa (Rfa2) subunits of RPA are also involved 
in the decision to exit a checkpoint with a lesion. In this study, we show that the Rfa2 N-terminus (NT) is 
phosphorylated during checkpoint adaptation. Furthermore, Rfa2 mutants that contain a phospho-mimetic 
NT, naturally-occurring NT phosphorylation, or that stimulate Rfa2 hyper-phosphorylation all drive 
checkpoint adaptation in an otherwise adaptation-deficient mutant. Certain subregions of the Rfa2 NT are 
important in this checkpoint adaptation phenotype, while post-translational modifications of other 
residues, particularly lysines, within Rfa2 are dispensable for the DNA damage response and may 
actually regulate the extent of Rfa2 phosphorylation. 
3.2. Introduction 
When cells are subjected to genotoxic stress, a signaling cascade is activated to halt cell growth 
and provide time for DNA repair machinery to properly process broken DNA (Hartwell et al. 1989, Elledge 
1996, Toczyski et al. 1997). In budding yeast, this signaling occurs in a conserved process known as the 
DNA damage response (DDR) and activates the sensory kinases Tel1 and Mec1 which can then 
phosphorylate the transducer kinases Chk1 and Rad53 (Longhese et al. 1998, Rhind et al. 1998, Weinert 
1998, Sanchez et al. 1999, Lowndes et al. 2000, O'Connell et al. 2000). Rad53 is activated by both Tel1 
(in response to DNA double-strand breaks; DSBs) and by Mec1 (in response to single-stranded DNA 
intermediates) in a Rad9- or Mrc1- dependent manner (de la Torre-Ruiz et al. 1998, Alcasabas et al. 
2001). Once activated, Rad53 drives cell cycle arrest through the phosphorylation of many known and 
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unknown downstream targets (Cohen-Fix et al. 1997, Smolka et al. 2007, Barnum et al. 2014). Ideally, 
checkpoint arrest would stall cell cycle progression until all DNA lesions have been repaired. However, 
under conditions of prolonged checkpoint arrest due to an irreparable DNA break, cells eventually initiate 
a program to exit the checkpoint and promote cell division. This process has been termed checkpoint 
adaptation (Sandell et al. 1993, Toczyski et al. 1997). 
In Saccharomyces cerevisiae (budding yeast), checkpoint activation can be driven by a single, 
controlled DSB (Toczyski 2006). In otherwise wild-type (WT) yeast, homologous recombination involving 
the silent mating loci (HML and HMR) is employed to repair an HO-induced break at the MAT locus. 
However, in this scenario, a checkpoint response through Rad53 phosphorylation (activation) is not 
detectable (Pellicioli et al. 2001). Rad53 activation is only detected in cells where repair of the HO-
induced break is delayed due to engineered, ectopic homologous sequences that lie at some distance 
from the break or on another chromosome (Haber 2000, Pellicioli et al. 2001). When cells are engineered 
to completely lack homologous sequence to recombine with sequence surrounding an HO-induced DNA 
break, the DNA break persists indefinitely, and checkpoint activation (Rad53 phosphorylation) is readily 
observed. Despite the persistence of a break, Rad53 becomes inactivated (dephosphorylated) in WT 
cells, and these cells attempt to divide (i.e., they exit checkpoint arrest) (Toczyski et al. 1997, Lee et al. 
1998, Lee et al. 2001). This phenomenon of checkpoint adaptation as a last-resort mechanism allowing 
cell growth and division while also leading to an increase in DNA mutations appears to also occur in 
mammalian cells (Swift et al. 2014) and is a potential cause for mutagenesis-induced cellular disease, 
including uncontrolled cellular proliferation (Kubara et al. 2012, Swift et al. 2014, Lewis et al. 2016, 
Serrano et al. 2016). 
A number of factors involved directly in repair of DNA or in the regulation of the cell cycle in 
response to DNA damage have been identified to either increase or decrease a cell’s ability to exit a 
checkpoint in the face of a persistent lesion. Some factors that when deleted inhibit checkpoint adaptation 
include: Yku70/Hdf1 (involved in non-homologous end joining; NHEJ; Lee et al. 1998) , Rdh54/Tid1 
(involved in recombination repair of DSBs; Lee et al. 2001) , Sgs1-Dna2 (helicase/nuclease involved 
directly in 5’®3’ resection of DNA; Zhu et al. 2008, Cejka et al. 2010) , Slx4-Rtt107 (complex that 
competes with Rad9 for interaction with Dpb11 and γ-H2AX to mute Rad53 activation; Cussiol et al. 2016, 
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Dibitetto et al. 2016) , subunits of casein kinase II (CKII; Toczyski et al. 1997) , and the phosphatases 
Pph3-Psy2 and Ptc2 (involved in dephosphorylating Rad53 and Mec1; O'Neill et al. 2007, Kim et al. 2011, 
Jablonowski et al. 2015) . Furthermore, adaptation-deficient mutations of the polo-like kinase Cdc5 and 
the sensory kinase Mec1 have been identified (cdc5-ad and mec1-ad; Toczyski et al. 1997, Clerici et al. 
2014) . Factors that when deleted promote checkpoint adaptation include Mre11 and Rad50 (components 
of the MRX complex that recognizes DSB ends and promotes resection; Lee et al. 1998, Viscardi et al. 
2007, Niu et al. 2010, Shim et al. 2010) and Tel1 (sensor kinase that phosphorylates Rad53; Vialard 
1998, Nakada et al. 2003, Nakada et al. 2003, Clerici et al. 2014) . Although DNA resection ability is often 
positively correlated with checkpoint adaptation proficiency, and in some instances appears to influence 
Rad53 dephosphorylation and checkpoint exit (e.g., overexpression of EXO1; Mimitou and Symington 
2010) , this is not always the case; a deletion of MRE11 (resulting in reduced resection) also leads to 
checkpoint adaptation proficiency. It is of interest that Mre11-Rad50-Xrs2 assists in the recruitment of 
Tel1, and that deletion of three of these four genes not only promotes adaptation, but does so in some 
adaptation-deficient strains (Clerici et al. 2014). In addition, a mutation (rfa1-t11) in the 70 kDa subunit of 
yeast Replication Factor A (RFA; the eukaryotic single-stranded binding complex; Umezu et al. 1998) , 
promotes adaptation proficiency in otherwise adaptation-deficient yku70D or rdh54/tid1D cells; however, 
adaptation in cdc5-AD cells could not be rescued by the rfa1-t11 mutation (Lee et al. 2001, Pellicioli et al. 
2001). 
Rdh54 (Rad54 homolog) is an ATPase/translocase member of the Swi2-like family of proteins 
and is thought to function as a nucleosome remodeler during the initial DSB processing events that occur 
immediately upon activation of the DDR (Lee et al. 2001). During the lesion and repair program (LRP), 
Rdh54 has been demonstrated to be important for the dissociation of Rad51 from chromatin during 
homologous recombination, which required for DNA polymerase activity during repair synthesis (Santa 
Maria et al. 2013). Enzymes within the Swi2-like family have been reported to be critical for homologous 
recombination, mediating processes such as DNA supercoiling/unwinding, D-loop formation, and branch 
migration (New et al. 1998, Mazin et al. 2000, Petukhova et al. 2000, Van Komen et al. 2000). 
Interestingly, it has been demonstrated that Rdh54 is phosphorylated by Mec1 and Rad53, specifically 
during the DDR during meiosis (Dresser et al. 1997, Shinohara et al. 2000). Mutant cells containing an 
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ATPase-dead form of Rdh54 (rdh54-K318R) or a deletion of the RDH54 gene are adaptation-deficient – 
this is to say that these cells cannot facilitate coordinated dephosphorylation and inactivation of Rad53 in 
the presence of an irreparable lesion during G2/M to bypass the established checkpoint and restart the 
cell cycle (Lee et al. 2001). 
Replication Factor A is an essential, heterotrimeric, single-stranded DNA (ssDNA) binding 
complex that is actively recruited to resected DSBs and establishes the signaling platform utilized to 
recruit in checkpoint machinery, including Ddc2-Mec1 (Zou et al. 2003), the Rad24-RFC2-5 clamp loader 
(Majka et al. 2006, Piya et al. 2015), the Rad17-Mec3-Ddc1 clamp (Zou et al. 2003, Majka et al. 2006), in 
addition to recruitment of additional resection machinery including Sgs1 helicase and Dna2 nuclease 
(Marechal et al. 2015), (Marechal et al. 2015). RFA/RPA is a target for many post-translational 
modifications, including sumoylation, ubiquitination, and phosphorylation (Marechal et al. 2015), with 
phosphorylation of the N-terminus (NT) of the 32 kDa human RPA subunit, Rpa2, being the most well-
characterized (Vassin et al. 2009, Liu et al. 2012, Marechal et al. 2015). While human Rpa2 NT 
phosphorylation is readily observed following DNA damage, detectable phosphorylation and 
characterization of the yeast Rfa2 NT has been limited at best (Wilson et al. 2018). The only conditions 
where Rfa2 NT phosphorylation was previously detected is in a set1D or mec3D mutation (Schramke et 
al. 2001), during meiosis (Clifford et al. 2004), and upon prolonged DNA damage (Wilson et al. 2018). 
However, like rfa1-t11, an amino-terminal phospho-mimetic form of Rfa2 (Rfa2-DX) also promotes 
checkpoint adaptation in yku70D cells (Ghospurkar et al. 2015). Conversely, an unphosphorylatable form 
of Rfa2 (Rfa2-AX) not only prevents checkpoint adaptation in yku70D cells but it also appears to enhance 
the adaptation deficiency in these double-mutant cells (Ghospurkar et al. 2015). 
Correlative and causative studies have indicated that phosphorylation of yeast Rfa2 NT (and 
human Rpa2 NT) plays a role in the DNA damage response; however, exactly what role(s) and their 
significance remain unclear. In this study, the function of the Rfa2 NT was probed to determine its role in 
checkpoint exit, particularly when DNA damage persists. We put forth the idea that RFA is not only 
instrumental in checkpoint activation, but that it is a prime candidate for driving checkpoint exit as well. In 
this study, we demonstrate that observed Rfa2 hyper-phosphorylation occurs around the time in which 
checkpoint adaptation begins to occur. Furthermore, using three different rfa2 mutant constructs (two of 
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which are naturally phosphorylated in yeast cells), we demonstrate that phosphorylation (or mimicking 
phosphorylation) does indeed drive checkpoint adaptation in another adaptation-deficient mutation 
(rdh54D), suggesting that promotion of checkpoint exit in the face of persistent DNA damage by Rfa2 
phosphorylation may be a generally applicable phenomenon. Finally, characterization of subregions of 
the Rfa2 NT reveals that two subregions, previously identified to have DNA damage-sensitivity or display 
synthetic genetic interactions, have the greatest influence on checkpoint adaptation efficiency. 
3.3. Materials and Methods 
3.3.A. Strains and Plasmids 
Yeast strains and plasmids used in these studies are listed in Appendix A and B, respectively. All 
yeast strains used within this study are isogenic derivatives of JKM179 (hoD MATa hmlD::ADE1 
hmrD::ADE1 ade1-100 leu2-3,112 lys5 trp1::hisG ura3-52 ade3::GAL::HO; Lee et al. 1998)  containing 
rfa2Δ::kanMX (NMM104; Wilson et al. 2018). 
The generation of an RDH54 deletion in NMM104 was completed using PCR amplification 
(Figure 3.1) of the natMX cassette from plasmid pFA6-natNT2 (Euroscarf) with appropriate primers 
(Appendix C) containing an additional 40 nt of homologous sequence immediately upstream and 
downstream of the coding regions of each gene and one-step gene replacement. Deletion candidates 
were then screened via diagnostic replica plating and by PCR using diagnostic primers (Appendix C) 
using a strategy like that for the generation of yeast gene deletions (Kelly et al. 2001). 
3.3.B. Single DSB induction and collection of whole-cell lysate 
All induction of DNA damage in cells for biochemical assays was performed in liquid culture. 
Yeast cells were grown for 20 hours (hr) in liquid YPD (1% yeast extract, 2% peptone, 2% dextrose) to an 
OD600 of 1.0, and subsequently sub-cultured the next day into YPR (1% yeast extract, 2% peptone, 2% 
raffinose) and grown for 20 hours to an OD600 of 2.0. A single break at the MAT locus via HO 
endonuclease was induced by adding 20% galactose to the YPR cultures to a final concentration of 2%. 
To harvest an equivalent number of cells, 10 ODs of cells were harvested from each culture at 
time-points indicated in figures. Harvested cells were treated with 0.1 M NaOH for 10 minutes at room 
temperature, pelleted at 10K RPM for 2 minutes (min), and aspirated to remove NaOH from the pellet. 
The pelleted cells were then resuspended in 500 uL of K-Buffer (0.06 M Tris-HCl, ph 6.8, 5% glycerol, 2% 
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SDS, 4% b-mercaptoethanol, 10 mM DTT; Kushnirov 2000), and each protein sample was boiled at 
100°C for 3 min. A Lowry assay (RC-DC Assay Kit; Bio-Rad) was used to quantify protein concentration 
within each sample to ensure even protein loading during SDS-PAGE. 
 
Figure 3.1.  One-step gene replacement and verification strategy used in the creation of rdh54Δ. 
The one-step gene replacement and verification strategy used in the creation of rdh54Δ is identical that 
described in Chapter 2, Figure 2.2. Amplicon sizes for rdh54Δ are 1: 961 bp, 2: 388 bp, 3; 1981 bp as 
generated by Serial Cloner. Fragments were generated via PCR, as described, and analyzed on a 1% 
agarose gel. 
3.3.C. Checkpoint adaptation plating assays 
Cells for the checkpoint adaptation plating assays were grown in liquid culture as described 
above. A single break at the MAT locus via HO endonuclease was induced by adding 20% galactose to 
the YPR cultures to a final concentration of 2%. Cells were grown for 8 hours in YPR-Gal media to sync 
cells at the G2/M checkpoint. 
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To observe cellular adaptation, 0.05 OD600 of cells were plated onto YPRG (1% yeast extract, 2% 
peptone, 2% raffinose, 2% galactose) media and spread using glass beads. Cells were counted under 
20x optical zoom on an Olympus microscope, and then categorized based on observed counts. At 8 
hours cells were counted as 1 cell (single cell), 2 cell (bilobal big buds), 3 cell, 4 cell, and 5+ cell clusters. 
At 24 and 48 hours cells were counted as 1-2 cell, 3-4 cell, 5-6 cell, 7-8 cell, and 9+ cell clusters. Colonies 
that formed as a result of NHEJ events were not counted. Average adaptation was calculated by 
averaging three independent data sets. Clusters ≥3 cells were eliminated from 24 and 48-hour averages. 
3.3.D. SDS-PAGE and Immunoblotting 
K-Buffered Whole-cell lysate from each sample was loaded into SDS-PAGE gels containing a 4% 
stacking gel (37.5:1 mono:bis) and 12% (150:1 mono:bis) or 15% resolving gel (29:1 mono:bis). 60 ug 
total whole cell lysate was used in SDS-PAGE to observe Rad53, 20 ug total whole cell lysate was used 
to observe Rfa2. Electrophoresis was then performed at 30 mA constant current for 15 minutes, 60 mA 
constant current for 2 hours allowing the 25 kDa band (PageRuler Plus Prestained Protein Ladder; 
Thermo Scientific) to reach the base of the gel. Each gel was equilibrated in Towbin Transfer Buffer (10 
mM Tris-HCl, 100 mM glycine, 10% Methanol) for 15 min and transferred onto a 0.2-micron nitrocellulose 
membrane (Bio-Rad) at 40 mA constant current for 16 hours at 4°C. 
Once transfer was complete, nitrocellulose membranes were then stained with Ponceau S (0.5% 
w/v Ponceau S, 1% v/v acetic acid) for 10 min to visualize total protein content to determine equivalent 
loading within each lane. Once membranes were imaged, the Ponceau S stain was removed by washing 
with Western Wash Buffer (WWB) (0.3% Tween-20, 5 uM NaF, 0.05 uM Na3VO4) for 15 minutes. Blocking 
buffer (WWB, 1% w/v BSA) was then added and the blot was incubated for 2 hours at room temperature. 
Blocking buffer was removed, and Primary Antibody Buffer (PAB) (WWB, 0.5% w/v nonfat dry milk, 0.5% 
BSA) was added to the blots. 
To probe Rfa2 phosphorylation, a 1:40,000 dilution of α-Rfa2 antibody (kindly provided by Dr. 
Steve Brill) was used in PAB. To probe Rad53 phosphorylation, a 1:6000 dilution of α-Rad53 antibody 
(ab104232, AbCam) was used in PAB. 
Following a 16 hr incubation at 4°C the PAB was removed and washes were performed using 
WWB. Secondary Antibody Buffer (SAB) (WWB, 0.2% w/v nonfat dry milk), containing a 1:40,000 dilution 
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of goat-α-rabbit-HRP (Abcam; ab97051, 1:40,000, Bethyl; A120-101P, 1:40,000) was then added to each 
blot and allowed to incubate for 2 hr at room temperature. The SAB was then removed and washes using 
WWB were performed. All blots were developed using a fluorescent substrate (ECL2 Plus; Thermo 
Scientific) and visualized on a STORM imager (GE). 
3.4. Results 
3.4.A. rdh54Δ mutations recapitulate known damage sensitives that are exacerbated by the 
phospho-state of the Rfa2 NT 
Previous research demonstrated that rdh54Δ mutants are sensitive to genotoxic agents via 
diagnostic spot assays (Klein 1997). In order to ensure that the rdh54Δ mutation and rdh54Δ rfa2 NT 
extensive mutation combinations created in this study would recapitulate known phenotypes, we 
performed a diagnostic spot assay (Figures 3.2 and 3.3). The rdh54Δ mutant used in this study is 
sensitive to genotoxic stress produced by MMS, CPT, PHL, and HU. Moreover, as observed in other 
studies, combination of rdh54Δ with rfa2-DX or rfa2-ΔNX produces hyper-sensitive phenotypes at lower 
doses, whereas rfa2-AX does not support clastogen resistance in rdh54Δ cells, suggesting that the 
rdh54Δ phenotype is dominant to the phenotypes produced by the Rfa2 NT extensive mutations during 
mitotic DNA damage. 
Through our collaboration with the Andre Walther Lab at Cedar Crest College (Allentown, PA, 
USA), we obtained two adaptation-deficient mutations, cdc5-AD and rdh54Δ with chromosomal 
integrations of the rfa2-DX or rfa2-AX extensive mutations in each background. Initial analysis of the 
Rad53 phosphorylation state during checkpoint adaptation (Figure 3.4) revealed that the phospho-
mimetic rfa2-DX promotes more rapid dephosphorylation of Rad53 in both cdc5-AD and rdh54Δ cells, 
specifically around 12-16 hours post-HO induction. The rfa2-AX mutation promoted a more robust 
checkpoint in rdh54Δ and led to a stronger initial activation of Rad53 in cdc5-AD cells. Moreover, rdh54Δ 
rfa2-AX double mutant cells also displayed hyper-phosphorylated Rad53 throughout the observed 36-hour 
time course, indicating that these cells were deficient for checkpoint exit. This led us to further test the 
effect of the Rfa2 NT phospho-state in rdh54Δ, as these mutants appeared to have a more significant 
checkpoint adaptation deficiency than cdc5-AD cells. 
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Figure 3.2.  Diagnostic spot assay of rdh54Δ Rfa2 NT phospho-mimetic mutations at various 
clastogen concentrations. 
NMM104 cells containing rdh54Δ Rfa2 NT mutations were harvested and an OD600 for the exponentially 
growing culture was determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in 
sterile filtered water. 200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the 
dilution was then spotted onto the plates using a multi-channel pipetman. rdh54Δ mutant cells containing 
the rfa2-DX mutation are hyper-sensitive to genotoxic agents and the rfa2-h2NT mutation increases 
sensitivity to genotoxic agents. 
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Figure 3.3.  Diagnostic spot assay of rdh54Δ Rfa2 NT unphosphorylatable mutations at various 
clastogen concentrations. 
NMM104 cells containing rdh54Δ Rfa2 NT mutations were harvested and an OD600 for the exponentially 
growing culture was determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in 
sterile filtered water. 200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the 
dilution was then spotted onto the plates using a multi-channel pipetman. rdh54Δ mutant cells containing 
the rfa2-AX mutation are no more sensitive to genotoxic agents than rdh54Δ mutants containing Rfa2, 
whereas the rfa2-ΔNX mutation leads to hyper-sensitivity to genotoxic agents.  
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3.4.B. The native Replication Factor A2 amino-terminus is phosphorylated in response to a single, 
irreparable double-strand break. 
Although phosphorylation of the human Rpa2 N-terminus in response to DNA damage is overt 
and readily detectable, there has been little report of phosphorylation in the yeast Rfa2 NT. Previously, 
detectable DNA damage-dependent phosphorylation of S. cerevisiae Rfa2 during mitosis has only been 
characterized for serine 122 (S122; (Brush et al. 1996, Brush et al. 2000, Bartrand et al. 2004). However, 
as described in Chapter 2 my study using rfa2-S122A/D mutations demonstrates that this damage-
dependent phosphorylation is dispensable for DNA repair and checkpoint activation. Phosphorylation 
within the Rfa2 NT has only been detected in meiosis (prior to programmed DSB formation; (Clifford et al. 
2004) and in specific mutations (set1D and mec3D; (Schramke et al. 2001). To our knowledge, Rfa2 NT 
phosphorylation in otherwise WT cells in response to DNA damage had never been characterized prior to 
the evidence presented in Chapter 2 (Wilson et al. 2018). Previous attempts to measure Rfa2 NT 
phosphorylation had been unsuccessful (Ghospurkar et al. 2015); however, these studies had only 
assessed the Rfa2 phospho-state after 2-4 hr post DNA damage. It was demonstrated that the phospho-
state of the Rfa2 NT has bearing on the ability of a cell to adapt to a checkpoint, which occurs roughly 12-
15 hr post DNA damage. Therefore, it was reasonable to address whether detection of more overt Rfa2 
phosphorylation simply required a longer period following DNA damage induction. Protein isolation from 
WT cells over a 24 hr time course revealed that Rfa2 phosphorylation is detectable by around 8 hr post 
DSB induction and becomes nearly maximally phosphorylated by 12-16 hr following a DNA break (Figure 
3.5, top panel). This is similar to the time in which checkpoint adaptation typically occurs and is just prior 
to when Rad53 dephosphorylation is observed (Figure 3.5, bottom panel).  
This correlative evidence is consistent with the previous observation that mimicking 
phosphorylation drives checkpoint adaptation in the otherwise adaptation-deficient yku70/hdf1D strain 
(Ghospurkar et al. 2015). This delayed phosphorylation also occurs much later (8-12 hr vs. 2-4 hr) than 
the S122 phosphorylation reported previously ((Brush et al. 1996, Brush et al. 2000, Bartrand et al. 2004). 
The observed delayed phosphorylation in response to prolonged phleomycin treatment is dependent on 
the presence of S/T residues in the Rfa2 NT (Chapter 2, Figure 2.7), as no phospho-species are detected 
for rfa2-AX (similar to that observed for prolonged phleomycin treatment of cells (Chapter 2, Figure 2.10; 
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Wilson et al. 2018a) . Analysis of post-translational modification of Rfa2-AX under HO-induced damage 
conditions has not been studied. 
3.4.C. Checkpoint adaptation efficiency is dependent on the Rfa2 NT and its phospho-state. 
A previous study demonstrated that mimicking phosphorylation or preventing phosphorylation of 
the Rfa2 N-terminus positively and negatively affected checkpoint adaptation, respectively. However, the 
adaptation deficiency of a unphosphorylatable Rfa2 NT had only a minor (~10%) reduction in checkpoint 
adaptation efficiency (Figure 3.6; Ghospurkar et al. 2015) . Previous studies of a unphosphorylatable rfa2-
AX mutation vs. another unphosphorylatable rfa2-DNX mutation (which is also missing this domain) 
revealed that of these two only the NT deletion mutant had a discernable DNA damage sensitivity 
(Ghospurkar et al. 2015). Therefore, these function differently in the DNA damage response. With respect 
to checkpoint adaptation efficiency, the rfa2 NT deletion mutation displayed a much more severe 
adaptation deficiency (Figure 3.6, Table 3.1), indicating that both the presence of the domain and 
phosphorylatable S/T residues are required for full checkpoint adaptation. 
 
 
Figure 3.4.  Rfa2 phospho-mimetics impact checkpoint adaptation differentially. 
cdc5-AD (Left Panels) and rdh54Δ are established adaptation-deficient mutations that are rescued by 
rfa2-DX. Rescue is classified as the ability to dephosphorylate Rad53 and enter mitosis. rfa2-AX mutations 
promote extended checkpoint maintenance in each mutation, as observed by hyper-phosphorylated 
Rad53 throughout the time course. 
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Figure 3.5.  Hyper-phosphorylation of Rfa2 during checkpoint adaptation. 
Rfa2 hyper-phosphorylation and Rad53 dephosphorylation during checkpoint adaptation are correlatively 
linked. A. Immunoblots depicting phospho-shift of Rfa2 during checkpoint adaptation (Top Panel) and 
Rad53 phosphorylation and dephosphorylation during checkpoint adaptation (Bottom Panel). Maximal 
Rad53 phosphorylation is achieved by 4 hours post-HO induction, whereas optimal Rfa2 hyper-
phosphorylation is observed by 12-16 hours. HO induction was achieved by adding 2% galactose to the 
media. At indicated time points, 10 ODs of cells were harvested, and protein was isolated via K-Buffer 
extraction. For Rfa2 blots, 10 ug total protein was used. For Rad53 blots, 40 ug total protein was used. 
3.4.D. Rfa2 NT mutations that mimic NT phosphorylation or are naturally phosphorylated promote 
checkpoint adaptation in adaptation-deficient rdh54D cells. 
To examine rfa2 mutations in the presence of other gene mutation/deletion strains, especially in 
the JKM179 background (Lee et al. 1998), we utilized the NMM104 strain (JKM179 derivative with RFA2 
deleted containing pJM132, which can be used for plasmid shuffle of rfa2 mutant alleles). We ensured 
that NMM104 containing rfa2 NT mutant alleles expressed from the native RFA2 promoter on plasmid 
pRS315 (Sikorski et al. 1989) behaved similarly to integrated forms of these alleles by performing a 
comparative DNA damage assay. The results of plasmid-expressed vs. integrated copies of rfa2 NT 
mutations were indistinguishable (Figure 3.6). Both rfa2-DX and rfa2-DNX reveal DNA damage sensitivity, 
similar to that observed not only for the JKM179 strain background, but also for other strain backgrounds 
we have tested (Ghospurkar et al. 2015). 
Integrated copies of Rfa2 NT mutant alleles had been examined in a yku70D strain previously, 
with the rfa2-DX mutation restoring adaptation proficiency and the rfa2-AX mutation enhancing the 
observed adaptation deficiency (Ghospurkar et al. 2015). To determine if the effects of Rfa2 NT mutations 
on checkpoint adaptation were more widely applicable the rdh54D checkpoint adaptation-deficient 
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mutation was generated. We first sought to ensure that our NMM104-derived rdh54D mutation 
recapitulated its known adaptation-deficient phenotype via microscopy (Figure 3.7, Table 3.2). Wild-type 
NMM104 (expressing RFA2 from pRS315) adapts at approximately 87-90% by 24 hours, 95% by 48 
hours post-HO induction (Figure 3.7, Table 3.1), whereas the NMM104 rdh54D mutant (expressing RFA2 
from pRS315) in these assays adapts at approximately 33% by 24 hours, 38% by 48 hours (Figure 3.7, 
Table 3.2). This data is consistent with previous observations that the deletion of RDH54 confers 
significant adaptation deficiency in response to an unrepaired lesion (Lee et al. 2001). 
Microscopy also revealed that rdh54D mutants containing an N-terminally truncated form of Rfa2 
(Rfa2-DNX), or an unphosphorylatable NT form (Rfa2-AX), display further reduced total adaptation (Figure 
3.8. Table 3.2). However, in the presence of a hyper-phospho-mimetic NT form of Rfa2 (Rfa2-DX), 
adaptation in rdh45D mutants increased markedly to approximately 66% by 24 hours, 75% by 48 hours 
post-HO induction (Figure 3.8, Table 3.2). Consistent with the observed adaptation rescue or adaptation 
prevention, analysis of Rad53 phosphorylation (indicative of checkpoint activation) and 
dephosphorylation(indicative of checkpoint exit) revealed two features (Figure 3.9): 1) adaptation-deficient 
cells display a more pronounced activation of Rad53, as indicated by even slower mobility species 
observed for rdh54D, rdh54D rfa2-AX, and rdh54D rfa2-DNX mutants, and 2) rdh54D rfa2-DX mutant cells 
result in detection of dephosphorylated Rad53 by 16 hrs post-HO induction. If Rfa2 NT phosphorylation 
helps facilitate checkpoint adaptation, then it was possible that in adaptation-deficient cells that Rfa2 
phosphorylation would be reduced. Examination of Rfa2 phosphorylation in rdh54D cells revealed that 
Rfa2 is still detectably phosphorylated; however, this phosphorylation is consistently delayed and/or 
reduced (Figure 3.10). Furthermore, the mobility of the phospho-species is not as reduced as in WT 
adaptation-proficient cells (Figure 3.5), indicating more phosphorylation of Rfa2 in WT vs. rdh54D cells. 
As observed in WT cells, Rad53 dephosphorylation begins to occur within the temporal window within 
which we observed Rfa2 NT phosphorylation. A similar phenomenon was observed in rdh54Δ mutants 
where detectable Rfa2 phosphorylation at 16-20 hours also display reduced Rad53 phosphorylation at 
the same times. This suggests that Rfa2 phosphorylation is the direct cause of Rad53 dephosphorylation 
during adaptation. 
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Figure 3.6.  Comparison of Rfa2 NT extensive mutant integrations versus plasmid-borne 
expression 
JKM179 cells containing RFA2, rfa2-DX, rfa2-AX, or rfa2-ΔNX and NMM104 cells containing pRS315-
derivative Rfa2 NT extensive mutation vectors were grown overnight and harvested the next day. Six 10-
fold serial dilutions were performed starting at an OD600 = 1.0 and spotted on YPD media or YPD media 
containing genotoxic agents at indicated concentrations. After 2 days, plates were analyzed and 
photographed. Cells containing the rfa2-DX or rfa2-ΔNX mutations were sensitive to genotoxic agents 
irrespective of whether the mutation was conferred by chromosomal integration or through ectopic 
expression via pRS315. Cells containing rfa2-AX were no more sensitive to genotoxic stress than cells 
containing RFA2, consistent with previous observations.  
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Figure 3.7.  The N-terminus and its phospho-state affect checkpoint adaptation. 
NMM104 cells containing Rfa2 NT mutations were grown in YPR media for 16 hours to an OD600 = 1.0 
and 20% galactose was added to each culture to a final concentration of 2% to induce expression of HO 
endonuclease. Cells were then harvested from HO-induced culture at 8 hours, diluted, spread on YPRG 
plates using glass beads, and then analyzed microscopically and quantitated at 8, 24, and 48 hours post-
HO induction. Averages are from three independent replicate data sets. HO expression was induced in 
exponentially growing cells by adding 2% galactose to the media. rfa2-AX or rfa2-ΔNX display reduced 
average adaptation compared to RFA2 cells. rfa2-DX adapts indistinguishably from RFA2 cells. 
Table 3.1. Average Adaptation Percentages in NMM104 cells. 
Strain 
Percentage of clusters 
≥ 3 Cells at 8 hours 
Average Adaptation 
by 24 hours 
Average Adaptation 
by 48 hours 
WT 8% 82% 86% 
rfa2-DX 11% 79% 83% 
rfa2-AX 11% 59% 71% 
rfa2-ΔNX 10% 38% 45% 
Average adaptation was calculated by subtracting the total number of cells greater than or equal to three 
cells at 8 hours from total observed adaptation at 24 and 48 hours. Averages are from three independent 
experiments. 
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3.4.E. Phosphorylation at serine 122 of Rfa2 has little influence on the checkpoint adaptation 
function of RFA. 
It is clear that Rfa2 becomes phosphorylated in response to prolonged DNA damage, whether it 
be a single, irreparable DSB (this study) or prolonged exposure to a clastogen, such as phleomycin 
(Ghospurkar et al. 2015, Wilson et al. 2018). It has also been demonstrated that this phosphorylation 
occurs in addition to that at serine (S) 122 (Brush et al. 1996, Brush et al. 2000, Bartrand et al. 2004), and 
that mutation of this site has no detectable effect on the mitotic DNA damage response, as measured by 
DNA damage sensitivity assays (Ghospurkar et al. 2015). However, it did remain possible that post-
translational modification of S122 could influence checkpoint adaptation, especially given the observation 
that an rfa2-AX mutant displays very little DNA damage sensitivity, yet it shows reduced adaptation 
efficiency and further reduces the efficiency in already adaptation-deficient mutations. Examination of 
rfa2-S122A and rfa2-S122D mutations microscopically to measure adaptation efficiency revealed that 
neither of these mutations had a role in checkpoint adaptation in otherwise WT cells (Figure 3.11). When 
combined with an Rfa2 NT mutant (rfa2-DX) that rescues adaption in two adaptation-deficient mutations, 
the addition of the rfa2-S122 mutation had little effect (Figure 3.11B). When combined with the rfa2 NT 
deletion mutation (rfa2-DNx) that already displays a 50% reduction in checkpoint adaptation, the addition 
of an rfa2-S122 mutation only had an effect when S122 was unphosphorylatable (slight reduction of 9-
10% compared to rfa2-DNx alone; Figure 3.11C, Table 3.3).  
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Figure 3.8.  The phospho-state of the Rfa2 NT affects the ability of checkpoint adaptation to be 
rescued in the adaptation-deficient rdh54D mutation. 
Rfa2 NT phospho-state determines rescue of rdh54Δ cells during checkpoint adaptation. rdh54Δ cells 
containing Rfa2 NT mutations were grown to an OD600 = 1.0 in YPR media and 20% galactose was added 
to a final concentration of 2% to induce HO-endonuclease expression. Cells were then harvested from 
HO-induced culture and analyzed microscopically as described. rdh54Δ cells containing rfa2-AX or rfa2-
ΔNX display reduced average adaptation compared to rdh54Δ RFA2. rfa2-DX confers greatly increased 
adaptation proficiency to rdh54Δ cells. Averages are from three independent replicate data sets. 
Table 3.2. Average Adaptation Percentages observed in rdh54Δ cells containing Rfa2 NT 
mutations. 
Strain 
Percentage of clusters  
≥ 3 Cells at 8 hours 
Average Adaptation  
by 24 hours 
Average Adaptation  
by 48 hours 
WT 7% 83% 88% 
rdh54Δ Rfa2 8% 23% 32% 
rdh54Δ rfa2-DX 8% 55% 67% 
rdh54Δ rfa2-AX 7% 16% 19% 
rdh54Δ rfa2-ΔNX 7% 15% 18% 
Average adaptation was calculated by subtracting the total number of cells greater than or equal to three 
cells at 8 hours from total observed adaptation at 24 and 48 hours. Averages are from three independent 
experiments. 
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Figure 3.9.  Rad53 activation corresponds to the ability of the Rfa2 NT mutation to rescue 
checkpoint adaptation in the adaptation-deficient rdh54D mutation. 
Rad53 activation corresponds with Rfa2 NT mutation rescue in checkpoint adaptation-deficient rdh54Δ. 
Immunoblots depicting Rad53 phosphorylation and dephosphorylation during checkpoint adaptation in 
rdh54Δ cells containing Rfa2 NT mutations. Mutant cells were grown in YPR for 16 hours and HO-
endonuclease expression was induced by adding 20% galactose to the culture to a final concentration of 
2%. At indicated time points, 10 OD600 of cells were harvested and whole cell lysate was isolated via K-
buffer extraction. Following quantitation of protein concentration using an RC-DC kit, 40 ug total protein 
was used in SDS-PAGE.   
 
Figure 3.10. Hyper-phosphorylation of the Rfa2 NT occurs but is reduced in the adaptation-
deficient rdh54D mutation. 
Hyper-phosphorylation of the Rfa2 NT occurs, but is impaired in the adaptation-deficient rdh54Δ mutation. 
A. Immunoblots depicting Rfa2 NT hyper-phosphorylation (Top Panel) and Rad53 phosphorylation and 
dephosphorylation (Bottom Panel) during checkpoint adaptation in rdh54Δ cells containing Rfa2 NT 
mutations. As Rfa2 phosphorylation increases Rad53 phosphorylation is decreases, specifically between 
20-24 hours. Induction of HO, protein collection, and total protein used in immunoblots was performed as 
described. 
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3.4.F. A naturally phosphorylated Rfa2 NT mutation also drives checkpoint adaptation in 
otherwise adaptation-deficient rdh54D cells. 
A previous study demonstrated that the domain substitution of the yeast Rfa2 NT for the human 
Rpa2 NT (Rfa2-h2NT) resulted in the chimeric Rfa2 protein in yeast cell being phosphorylated on the N-
terminus in a similar fashion to that measured in human cells for human Rpa2 (Ghospurkar et al. 2015). 
Similarities include not only the residues modified and whether or not they are in a DNA damage-
dependent manner, but they also include the timing of the events. Within 2-4 hr, the chimeric Rfa2 
containing the human Rpa2 NT is maximally phosphorylated in this domain (Ghospurkar et al. 2015).We 
took advantage of this mutant, as it is naturally phosphorylated in its N-terminus in response to clastogen 
exposure (Ghospurkar et al. 2015). To determine if a single, irreparable DSB would also trigger its natural 
phosphorylation in yeast cells, we induced HO expression in NMM104 containing only the rfa2-h2NT 
allele. Examination of Rfa2 phosphorylation in these cells revealed strong phosphorylation of rfa2-h2NT 
by 4 hrs post-HO induction (Figure 3.12, top panel). An additional slower-mobility species was also 
observed at 20 hr post-HO induction. Phosphorylation observed for rfa2-h2NT in rdh54D cells was 
indistinguishable from that in RDH54 cells, suggesting that the rdh54D did not impact the ability for the 
human Rpa2 NT to be modified (Figure 3.12, top panel compared with bottom panel). This is different 
than the phosphorylation of WT Rfa2 in rdh54D cells, and perhaps reflects a difference in the enzymes 
that modify these two domains in yeast. 
Because rfa2-h2NT is readily phosphorylated in JKM179 derivatives, we addressed whether this 
modification of the N-terminus could drive checkpoint adaptation in otherwise adaptation-deficient rdh54D 
cells. Microscopic examination of rdh54D rfa2-h2NT cells following induction of HO endonuclease 
revealed that adaptation proficiency in rdh54D can be restored to approximately 70% by 24 hr, 80% by 48 
hr (compared to 34% by 24 hr and 38% by 48 hr observed for rdh54D cells; Figure 3.13, Table 3.4). This 
data suggests that naturally driven phosphorylation, and not just a phospho-mimetic mutation form, of the 
Rfa2 NT can override the prolonged checkpoint arrest that occurs in rdh54D cells. 
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Figure 3.11. A known phosphorylation target (S122) outside of the Rfa2 NT does not affect 
checkpoint adaptation. 
Hyper-phosphorylation of the Rfa2 NT occurs, but is impaired in the adaptation-deficient rdh54Δ mutation. 
A. Phospho-mimetic mutation of S122, a known Mec1 phospho-site, does not impact checkpoint 
adaptation frequency in otherwise wild-type cells. B. Phospho-mimetic mutation of S122, combined with 
rfa2-DX, does not change observed adaptation rescue conferred by rfa2-DX. C. Adaptation deficiency 
conferred by rfa2-ΔNX is unable to be overcome by phospho-mimetic mutation of S122. Averages 
presented are from three independent replicate data sets. Induction of HO and microscopic analysis was 
performed as described. Averages are from three independent replicate data sets. 
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Table 3.3. Mutation of a known, Mec1-phospho-target site on Rpa2 does not greatly impact 
adaptation proficiency or deficiency conferred by Rfa2 phospho-mutants. 
Strain Percentage of clusters ≥ 3 Cells at 8 hours 
Average Adaptation 
by 24 hours 
Average Adaptation 
by 48 hours 
rfa2-S122D 15% 73% 78% 
rfa2-S122A 16% 70% 76% 
rfa2-DX 13% 73% 75% 
rfa2-DX-S122D 10% 78% 79% 
rfa2-DX-S122A 12% 78% 79% 
rfa2-ΔNX 16% 41% 49% 
rfa2-ΔNX-S122D 20% 38% 48% 
rfa2-ΔNX-S122A 19% 28% 36% 
Average adaptation was calculated by subtracting the total number of cells greater than or equal to three 
cells at 8 hours from total observed adaptation at 24 and 48 hours. Averages are from three independent 
experiments. 
 
Figure 3.12. Natural hyper-phosphorylation of the Rfa2 NT occurs indistinguishably in both the 
adaptation-proficient RDH54 strain and the adaptation-deficient rdh54D mutation. 
Natural hyper-phosphorylation of the Rfa2 NT occurs indistinguishably in RDH54 and rdh54Δ cells. 
Immunoblots depicting rfa2-h2NT hyper-phosphorylation in RDH54 (Top Panel) and rdh54Δ cells (Bottom 
Panel). Optimal rfa2-h2NT hyper-phosphorylation is observed by 20 hours in each mutation, with 
significant hyper-phosphorylation occurring by 4 hours. Induction of HO, protein collection, and total 
protein used in immunoblots was performed as described. 
Biochemical monitoring of Rad53 reveals a coordinate decrease in phosphorylated (activated) 
Rad53 in rdh54D rfa2-h2NT cells (Figure 3.14), suggestive that phosphorylation of the Rfa2 NT in these 
cells is causative of Rad53 dephosphorylation resulting in restoration of checkpoint adaptation. The 
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adaptation proficiency conferred by Rfa2 NT phospho-mutations in rdh54D is reduced when compared to 
proficiency conferred by an Rfa1 mutation, rfa1-t11. rdh54D cells containing rfa1-t11 adapt at nearly 90% 
by 24 hours (Lee et al. 2001). 
3.4.G. Regions of the Rpa2 NT and their importance in checkpoint adaptation 
It is clear that a phospho-mimetic form (rfa2-DX), and now a naturally-phosphorylated NT form 
(rfa2-h2NT), can both drive checkpoint adaptation in rdh54D cells. It has been difficult to identify which 
residue(s) in the yeast Rfa2 NT are being modified, presumably due to overlap of modification of some of 
the residues. In an attempt to identify which residues might be targets during prolonged DNA damage, we 
used rfa2 NT mutations where clusters of 3-4 residues were mutated to aspartates (D) or alanines (A) 
(Figure 3.14); these mutations have been previously characterized with respect to DNA damage 
sensitivity and synthetic genetic interaction (Ghospurkar et al. 2015). In all cases tested previously, 
mutations of subregions 1 and 3 were responsible for all observed damage sensitivities and/or synthetic 
genetic interactions. 
 
Figure 3.13. Natural hyper-phosphorylation of the Rfa2 NT drives adaptation proficiency in the 
adaptation-deficient rdh54D mutation. 
rdh54Δ cells containing the rfa2-h2NT mutation were harvested from HO-induced culture and analyzed 
microscopically as described. rfa2-h2NT mutation confers modest increases in adaptation proficiency to 
rdh54Δ cells compared with rfa2-DX (Figure 3.6). 
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Table 3.4. Average Adaptation Percentages conferred by rfa2-h2NT in rdh54Δ cells. 
Strain 
Percentage of clusters 
≥ 3 Cells at 8 hours 
Average Adaptation 
by 24 hours 
Average Adaptation 
by 48 hours 
WT 7% 83% 88% 
rfa2-h2NT 9% 82% 84% 
rdh54Δ Rfa2 8% 23% 32% 
rdh54Δ rfa2-h2NT 7% 62% 74% 
Average adaptation was calculated by subtracting the total number of cells greater than or equal to three 
cells at 8 hours from total observed adaptation at 24 and 48 hours. Averages are from three independent 
experiments. 
 
Figure 3.14. Rad53 activation corresponds to the ability of the Rfa2 NT mutation to rescue 
checkpoint adaptation in the adaptation-deficient rdh54D mutation. 
rfa2-h2NT promotes Rad53 dephosphorylation indistinguishably in RDH54 and rdh54Δ cells. A. 
Immunoblots depicting Rad53 phosphorylation and dephosphorylation in rdh54Δ RFA2 cells (Top Panel), 
RDH54 rfa2-h2NT cells (Middle Panel) and rdh54Δ rfa2-h2NT cells. Optimal Rad53 activation occurs by 4 
hours in each mutation, however, RDH54 rfa2-h2NT and rdh54Δ rfa2-h2NT appear to promote more 
rapid inactivation of Rad53 by 12 and 16 hours, respectively. Induction of HO, protein collection, and total 
protein used in immunoblots was performed as described. 
To identify which region(s) might be important during checkpoint adaptation and potential targets 
for phosphorylation, we examined whether mimicking phosphorylation (rfa2-DM mutations) in each Rfa2 
NT could promote checkpoint adaptation. Mutations in subregion 1 (rfa2-DM1) or subregion 3 (rfa2-DM3) 
displayed the most efficient checkpoint adaptation in both RDH54 and rdh54D cells (Figure 3.16, Table 
3.5), whereas mutations in subregion 2 (rfa2-DM2) led to a slight reduction in adaptation efficiency in 
RDH54 cells compared to WT RFA2 or the other subregion mutations. Despite this, mimicking 
phosphorylation in any of the three subregions led to an increase in checkpoint adaptation efficiency in 
rdh54D mutations of 6-20% by 24 hr and 16-24% by 48 hr post-HO induction (Figure 3.16A). The level of 
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adaptation rescue in any of the the rfa2-DM mutations by 24 and 48 hr post-HO induction in an rdh54D 
strain is somewhat reduced from that observed for rfa2-DX (66% and 75%), indicating that mimicking 
phosphorylation in any of the subregions has a similar effect on checkpoint adaptation rescue as mutating 
all three subregions simultaneously (Figure 3.16). 
 
Figure 3.15. Schematic of Rfa2 NT subregion mutations. 
Schematic of rfa2 NT subregion mutations. rfa2-DM1 consists of S3/S11/S12/T14D, rfa2-DM2 consists of 
S21/S23/S27D, and rfa2-DM3 consists of S30/T32/T34/T38D. Analogous residues are mutated to alanine 
to achieve respective rfa2-AM mutations. 
Although phospho-mimetics of any of the three subregions can promote checkpoint adaptation, 
phospho-mimetics of subregions 1 and 3 consistently promote slightly higher adaptation efficiency, 
consistent with those subregions being identified previously as those that lead to damage-sensitive and/or 
synthetic genetic phenotypes when mutated. Our data is also consistent with data demonstrating 
phosphorylation of key residues within these subregions being essential for normal mitotic growth and 
mitotic exit following DNA damage (Anantha et al. 2007, Anantha et al. 2008). 
Conversely, preventing phosphorylation within those same subregions (rfa2-AM mutations) was also 
examined for its effect on promoting checkpoint adaptation. In RDH54 cells, a slight reduction in 
checkpoint adaptation efficiency is observed at both 24 hr and 48 hr post-HO induction for rfa2-AM1 (76% 
and 85%) and rfa2-AM3 (81% and 82%) compared to WT RFA2 cells (91% and 94%; Fig 10), suggesting 
that an inability to phosphorylate S/T residues in these subregions has the most influence on checkpoint 
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adaptation efficiency. rfa2-AM2 mutation adaption efficiency (89% by 24 hr and 91% by 48 hr) is nearly 
indistinguishably compared to WT RFA2 cells (Figure 3.16). In the rdh54D mutation, the rfa2-AM1 mutation 
shows a slight reduction (24% vs. 34% for rdh54D cells) in checkpoint adaptation by 24 hr, but by 48 hr, 
all three, with subregion mutations adapt (43%, 37%, and 40% for rfa2-AM1, rfa2-AM2, and rfa2-AM3, 
respectively) with a similar efficiency to rdh54D cells (38%). Interestingly, rfa2-AM1 cells appear to have a 
slower progression of adaptation, as 9% and 19% differences in adaptation efficiency are observed 
between 24 and 48 hr in the RDH54 or rdh54D background, respectively. The other subregion mutations 
do not display more than a 3% change from 24 to 48 hr. Again, mutation of subregions 1 and 3 led to the 
most discernible reduction of adaptation efficiency in RDH54 cells, suggesting these are the most 
important regions for checkpoint adaptation and potentially the most relevant targets for phosphorylation, 
promoting the strongest rescue of the rdh54D adaptation deficiency observed. 
3.5. Discussion 
3.5.A. Rfa2 NT phosphorylation mediates checkpoint and mitotic exit 
Prior to this study, it was previously demonstrated that mimicking phosphorylation of the Rfa2 NT 
promoted checkpoint adaptation in adaptation-deficient yku70Δ mutant cells (Ghospurkar et al. 2015). In 
this study, adaptation rescue was observed in rdh54Δ cells containing the phospho-mimetic rfa2-DX 
mutation. While it has been known that mutant forms of RPA can promote checkpoint adaptation (Lee et 
al. 2001, Ghospurkar et al. 2015), it is possible that the mechanism by which each RPA mutant promotes 
rescue does so in unique ways. Furthermore, RDH54 has been deemed essential in alleviating 
checkpoint arrest in response to a permanent DNA lesion, however, this study demonstrates that 
phospho-mimetic Rfa2 NT mutations are sufficient to promote adaptation rescue in this severely 
adaptation-deficient strain. Based on our findings, we suggest that RPA, as the primary sensor of ssDNA 
in eukaryotic cells and the phospho-state of the Rfa2 NT, must play a key role in the decision to exit the 
DNA damage-dependent checkpoint in response to irreparable lesions. 
The hypothesis that phosphorylation of RPA drives mitotic exit is not entirely novel. In fact, 
previous studies done in human U2-OS osteocarcinoma and HCT116 colorectal cancer cells have 
determined that the phospho-state of Rpa2 does play a role in mediating mitotic exit. Rpa2 NT 
phosphorylation during mitosis has been demonstrated to occur at S23 and S29 by cyclin B-Cdc2, or 
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Figure 3.16. Rfa2 NT subregion mutations and their effect on adaptation in RDH54 and rdh54D 
mutant cells. 
A. rfa2-DM mutations promote checkpoint adaptation in rdh54Δ cells, albeit with reduced effect when 
compared to rfa2-DX. Averages are from three independent replicate data sets. B. Checkpoint adaptation 
is generally inhibited in rdh54Δ rfa2-AM mutations, conferring minimal increases in adaptation proficiency 
when compared to that observed for rdh54Δ rfa2-AX cells. Averages are from three independent replicate 
data sets. 
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Table 3.5. Average Adaptation Percentages conferred by Rfa2 subregion mutations. 
Strain 
Percentage of clusters  
≥ 3 Cells at 8 hours 
Average Adaptation  
by 24 hours 
Average Adaptation  
by 48 hours 
rfa2-Am1 13% 63% 72% 
rfa2-Am2 12% 77% 78% 
rfa2-Am3 14% 67% 68% 
rfa2-Dm1 13% 80% 80% 
rfa2-Dm2 12% 72% 76% 
rfa2-Dm3 16% 75% 77% 
rdh54Δ 11% 23% 27% 
rdh54Δ + rfa2-Am1 13% 11% 30% 
rdh54Δ + rfa2-Am2 15% 19% 23% 
rdh54Δ + rfa2-Am3 16% 22% 24% 
rdh54Δ + rfa2-Dm1 14% 26% 43% 
rdh54Δ + rfa2-Dm2 15% 35% 39% 
rdh54Δ + rfa2-Dm3 13% 38% 48% 
Average adaptation was calculated by subtracting the total number of cells greater than or equal to three 
cells at 8 hours from total observed adaptation at 24 and 48 hours. Averages are from three independent 
experiments. 
CDK (Anantha et al. 2008) and is thought do drive mitotic exit in response to late G2/M encountered DNA 
damage. This mitotically-phosphorylated Rpa2 was also demonstrated to not be associated with 
chromatin-bound fractions, suggesting that phospho-Rpa2 may elicit a signaling program that is not DNA 
dependent during mitotic exit. Further implication of S23 and S29 phosphorylation driving mitotic exit can 
be found in the observation that rpa2-S23/S29A mutations accumulate in G2/M, indicating that cells 
unable to phosphorylate Rpa2 after the initial DNA damage response stall during mitotic entry (Anantha et 
al. 2008). Phosphorylation of the Rpa2 NT has been suggested to impede interaction with ATM and DNA-
PK (Oakley et al. 2003), as well as the MRN complex (Oakley et al. 2009). Moreover, in vitro data 
suggests that dephosphorylation of Rpa2 restores the ability of RPA to interact with the aforementioned 
DNA damage response proteins (Oakley et al. 2003). 
In a previous study, it was demonstrated that rfa2-h2NT in yeast cells is able to become 
phosphorylated in a damage-dependent manner at the S4, S8, S12, T21, S29, and S33 (Ghospurkar et 
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al. 2015) – phospho-sites that are also observed in human cells (Anantha et al. 2008, Marechal et al. 
2015). Similar to that observed for rdh54Δ rfa2-DX, rdh54Δ mutant cells containing rfa2-h2NT mutation 
also adapt at a much higher frequency than those that contain Rfa2 or unphosphorylatable forms of the 
Rfa2 NT (rfa2-AX or rfa2-ΔNX, Figure 3.9, Table 3.2 and Figure 3.14, Table 3.4). This demonstrates that, 
when the Rfa2 NT is in a more readily phosphorylatable state, the phospho-state of Rpa2/Rfa2 are likely 
key in the initial molecular decisions involved in mitotic exit. 
3.5.B. Certain subregions of the Rfa2 NT may be preferential phospho-targets during mitotic exit 
Certain subregions of the Rfa2 NT, when mutated to a phospho-mimetic state (rfa2-DM1 and rfa2-
DM3, Figure 3.17, Table 3.5), are also capable of promoting checkpoint adaptation in rdh54Δ cells, albeit 
reduced to that observed for rfa2-DX. This evidence suggests that phosphorylation or phospho-mimetic 
mutation of just a few residues within the Rfa2 NT are sufficient to promote adaptation-deficient rescue. 
Moreover, preventing phosphorylation in these regions through alanine mutagenesis (rfa2-AM1 and rfa2-
AM3, Figure 3.17, Table 3.5) also appear to impede checkpoint exit due to an irreparable lesion. This 
further implicates the Rfa2 NT phospho-state as a key regulator of the decision to enter mitosis when 
damaged DNA is present in cells. 
3.5.C. Ubiquitination and sumoylation of RPA is dispensable during the DDC 
Other post-translational modification of RPA has been implicated as being essential for regulating 
the DNA damage response (replication restart, resumption to normal mitotic growth) and resistance to 
clastogen challenge, namely sumoylation and ubiquitination (Dou et al. 2010, Elia et al. 2015, Marechal et 
al. 2015). However, as stated previously, these studies were performed in E3 sumo/ubiquitin ligase 
deletions or RNAi knockdowns, making it difficult to distinguish whether modification of the RPA complex, 
or other E3 ligase targets, are the dominant drivers of the observed checkpoint and repair deficiencies. 
Moreover, ubiquitination or sumoylation of Rfa2, in budding yeast, appears to be dispensable for DNA 
repair. Cells containing a ‘lysine-less’ Rfa2 mutation (Rfa2-RX) appear to have DNA damage sensitivities 
in line with unmodified cells (unpublished data, WAL; Wilson et al. 2018b)  suggesting that ubiquitin-
dependent modification of Rfa2 is dispensable for the DNA damage response. However, preventing 
ubiquitin-dependent modification of Rfa1 does lead to a synthetic defect in cells challenged with typical 
clastogens (data not shown). The observation of additional phospho-species in rfa2-RX mutants suggests 
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that ubiquitin-dependent modification of Rfa2 may control the extent of phosphorylation the Rfa2 NT is 
subjected to. We speculate that additional phosphorylation of an otherwise unmodified Rfa2 would 
promote checkpoint adaptation in rdh54Δ cells. Promoting additional phosphorylation of Rfa2, through 
elimination of ubiquitin-dependent modification, facilitates checkpoint exit in rdh54Δ cells (unpublished 
data, WAL; Wilson et al. 2018b). 
3.5.D. Phosphorylation of the Rfa2 NT rescues adaptation-deficient rdh54Δ 
Rescue of rdh54Δ checkpoint adaptation deficiency has been demonstrated to be possible with 
mutation of large subunit, Rfa1, of the RPA complex (rfa1-t11, Lee et al. 2001). However, it has been 
reported that this is likely due to reduced checkpoint signaling, or checkpoint dampening, caused by 
inefficient interaction between RFA and Rad24-RFC2-5 that impairs loading of the 9-1-1 clamp which 
would impede full Mec1 activation (Zou et al. 2003, Majka et al. 2006, Majka et al. 2006, Piya et al. 2015). 
Cells containing rfa1-t11 have been demonstrated to be hyper-sensitive to clastogens; however, Rfa2 NT 
mutations have variable sensitivity to clastogens (Ghospurkar et al. 2015). Cells containing rfa2-DX or 
rfa2-ΔNX  mutations exhibit clastogen sensitivities in line with rfa1-t11 (Ghospurkar et al. 2015); however, 
Rfa2-h2NT (Ghospurkar et al. 2015), Rfa2-RX (Wilson et al. 2018), Rfa2-AX (Ghospurkar et al. 2015) all 
appear to be resistant to DNA damaging agents to the same degree as unmodified cells. This 
demonstrates that phosphorylation of Rfa2 is not correlated with whether or not a cell will be sensitive to 
DNA damaging agents and suggests that phosphorylation of Rfa2 during DNA repair is dispensable and 
may also provide rationale as to why Rfa2 NT phosphorylation is difficult to detect in clastogen-
challenged mitotic cells. While Rfa2 NT phosphorylation may not influence the ability of cells to perform 
DNA repair, it may influence the ability of cells to overcome irreparable lesions that might otherwise lead 
to permanent arrest or apoptosis. 
Phosphorylation of the Rfa2 NT may become critical when cells have experienced a prolonged 
DNA damage response or in the face of an irreparable lesion. rdh54Δ cells containing 
unphosphorylatable Rfa2 NT mutations (Rfa2-AX or Rfa2-ΔNX) never recover from the irreparable lesion, 
suggesting that some modification of the Rfa2 NT is necessary to recover from a prolonged DNA 
damage-dependent checkpoint response. Moreover, naturally phosphorylatable Rfa2 mutations appear to 
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drive robust checkpoint adaptation in rdh54Δ, alluding to the requirement of Rfa2 NT phosphorylation in 
driving checkpoint exit in the presence of an irreparable lesion. 
Ultimately, cells need to commit to a molecular decision that either commit cells to permanent 
arrest and eventual death or leads to an aberrant mitotic division in the presence of DNA damage, in the 
hope that during subsequent rounds of DNA replication that that lesion can be repaired. In adaptation-
deficient cells, Rfa2 NT phosphorylation is observed between 4-8 hours post-HO induction (Figure 3.5, 
Figure 3.10 and Figure 3.12), suggesting that phosphorylation of the NT does not occur during the initial 
DNA damage response, but rather occurs much later. Our data also suggests that phosphorylation of the 
Rfa2 NT is at the forefront of this molecular decision-making process, rather than being essential for DNA 
repair or the initial DNA damage response. Moreover, while ablation of the established DNA damage-
dependent checkpoint may provide the cell with a last-ditch mechanism to survive, in the context of a 
more complex organism this may lead to significant genome instability that gives rise to mutations that, in 
human cells, lead to cellular disease such as cancer. Identifying the mechanism(s) of how Rfa2 NT 
phosphorylation facilitates the molecular commitment to override an established DNA damage-dependent 
checkpoint may yet reveal a novel signaling pathway, driven by RPA, which promotes checkpoint override 
and mitotic exit in the presence of genomic catastrophe. 
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CHAPTER 4: RFA2 N-TERMINAL PHOSPHORYLATION RESCUES CHECKPOINT ADAPTATION-
DEFICIENT YEAST 
4.1. Abstract 
Checkpoint adaptation is broadly classified as the ability of cells to subvert a DNA damage-
dependent checkpoint and enter mitosis despite the presence of DNA damage. While this may benefit the 
cell, as it provides additional rounds for mitotic division, it may be detrimental to an organism and 
uncontrolled cellular growth that is a hallmark of many cellular disease such as cancer. The Replication 
Protein A (RPA) complex has been demonstrated to interact with several critical repair and checkpoint 
factors during the DNA damage response. It has also been demonstrated in yeast that mutation or post-
translational modification of individual RPA subunits can promote checkpoint adaptation. In this study, we 
show that phospho-mimetic or naturally phosphorylatable Rfa2 NT mutations cause checkpoint exit in 
adaptation- and resection-deficient mutations. We demonstrate that Rfa2 is natively and robustly 
phosphorylated during checkpoint adaptation in response to a single, controlled DSB in all mutants 
tested, in a manner that is different from that observed during global genotoxic stress. Furthermore, we 
demonstrate that Rfa2 NT phosphorylation is essential for checkpoint exit in the presence of a persistent 
DNA lesion in mutants containing documented adaptation deficiencies. 
4.2. Introduction 
Aberrant checkpoint exit in the presence of DNA damage, also known as checkpoint adaptation 
(Sandell et al. 1993, Toczyski et al. 1997), is thought to be dependent on several critical repair and 
checkpoint factors. Previous studies in budding yeast have demonstrated that mutation or deletion of CKII 
(heterotetrameric kinase complex; Tocyzski et al. 1997), Sae2 (component of MRXS endonuclease; 
Clerici et al. 2006, Gobbini et al. 2015), the Rtt107/Slx4 scaffold complex (dampens active checkpoints by 
competing with Rad9 for Dpb11 and γ-H2AX binding preventing continual Rad53 hyper-phosphorylation; 
Dibitetto et al. 2016), PP4 phosphatase complex (Pph3/Psy2 phosphatases; O’Neill et al. 2007) or Ptc2 
(PP2C-like phosphatase required for checkpoint recovery; Leroy et al. 2003) lead to checkpoint 
adaptation deficiency and prevent aberrant mitotic exit in the presence of a persistent lesion. 
Typically, in order to maintain genomic integrity, a complex, conserved signaling network is 
activated to stall cell growth during DNA repair. These include the first-responder complexes RPA 
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(Replication Protein A; Marechal and Zou 2015), MRX (Mre11-Rad50-Xrs2; Gobbini et al. 2016), STR-
Dna2 (Sgs1-Top3-Rmi1-Dna2 Helicase/Nuclease complex; Cejka et al. 2010), sensor kinases Mec1 and 
Tel1 (Morrow et al. 1995, Sanchez et al. 1996, Gobbini et al. 2013), and effector kinases Rad53 and 
Chk1 (Sanchez et al. 1999, Agarwal et al. 2003). Rad53 and Chk1, once activated, work in concert to 
both inhibit Cdc5 and Clb2/Cdc28 mitotic entry signaling (Sanchez et al. 1999, Schleker et al. 2010) as 
well as to maintain Pds1 phosphorylation, preventing it’s degradation by the APCCDC20 complex and entry 
into anaphase (Cohen-Fix et al. 1996, Yamamoto 1996, Cohen-Fix et al. 1999, Gardner et al. 1999, 
Wang et al. 2001). 
Entry into anaphase and mitotic exit cannot be delayed indefinitely, however, and budding yeast 
provide a unique opportunity to readily study the processes of checkpoint establishment, recovery, and 
exit. Checkpoint establishment and activation can be facilitated through a single, controlled DSB at the 
MAT locus with HO endonuclease (Toczyski 2006). In unmodified yeast, homologous recombination is 
employed to repair the MAT locus, Rad53 never becomes phosphorylated (Pellicioli et al. 2001), and cell 
cycle progression resumes normally. In mutant cells, where the homologous MAT sequences HMR and 
HML have been deleted, checkpoint activation occurs and remarkably, 12-15 hours after the irreparable 
double-strand break (DSB) is formed, cell cycle restart occurs in a process known as checkpoint 
adaptation (Toczyski et al. 1997, Lee et al. 1998, Lee et al. 2001). Cell cycle restart in the face of a 
persistent lesion has been implicated in several, mutagenesis-induced cellular diseases, including cancer 
(Kubara et al. 2012, Swift et al. 2014, Lewis et al. 2016, Serrano et al. 2016). Checkpoint adaptation 
deficiency can be conferred to yeast cells through various deletions of non-essential genes thought to 
play important roles in their respective LPR and DDC pathways. In this study, we examined checkpoint 
adaptation deficiency and rescue, via genetic interaction with mutant RPA complexes, in rtt107D, sae2D, 
slx4D, cka1D, cka2, ckb1D, ckb2D, pph3D, ptc2D, and psy2D mutations. This is of significant interest, as 
prolonged checkpoint arrest in cells seems to promote a last-resort division mechanism that can lead to 
uncontrolled cellular proliferation (Serrano et al. 2016). 
It was hypothesized previously that extensive hyper-resection of an irreparable DSB would lead 
to checkpoint adaptation (Lee et al. 1998) through alternative repair pathways like single-strand annealing 
(SSA), where microhomology within the resected DNA tracts allows for stable enough association of the 
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damaged ends to promote repair-dependent synthesis and religation of the broken DNA fragments 
(Bhargava et al. 2016). Many proteins required for DSB resection when mutated or deleted, like Sae2 or 
Fun30, lead to a resection-dependent adaptation-deficiency (Clerici et al. 2005, Eapen et al. 2012, 
Gobbini et al. 2015), whereas others, like Mre11, lead to resection-proficient adaptation-deficiency (Lee et 
al. 1998) despite being able to establish the Rad53-dependent checkpoint indistinguishably from normal 
cells. Thus, the link between resection of DSB ends and the ability of a cell to override an established 
damage-dependent checkpoint is unclear. 
Understanding the regulatory networks involved in the DDR and DDC are essential to our 
understanding of how cells exit a checkpoint despite the presence of damaged genetic information. In 
human cells, RPA and the phospho-state of Rpa2 are thought to regulate mitotic exit (Anantha et al. 
2008), replication restart (Liu et al. 2012, Ashley et al. 2014), and even DNA repair pathway choice 
(Marechal et al. 2015). In budding yeast Rtt107 and Slx4, as a dimer, compete for Dpb11 and γ-H2AX 
binding with the Rad53 chaperone Rad9 in order to dampen the established checkpoint once repair starts 
(Ohouo et al. 2010, Ohouo et al. 2013, Dibitetto et al. 2016). Sae2 deletions lead to both resection 
deficiency and adaptation deficiency that can be overcome through Dna2-Exo1-dependent resection 
(Symington 2016). Casein kinase II (CKII) is a heterotetrameric kinase complex comprised Cka1, Cka2, 
Ckb1, and Ckb2. The ‘A’ subunits of CKII have been demonstrated to function as the catalytic units of the 
Ser/Thr kinase complex, while the CKB subunits have been demonstrated to regulate kinase complex 
activity (Ackermann et al. 2001). CKII is also thought to play a critical role in mediating cell cycle entry, as 
deletions of individual components of the tetrameric complex cka1Δ and cka2Δ, or deletion of both ckb1Δ 
and ckb2Δ, disrupt expression of several cell cycle regulatory proteins (Pyerin et al. 2005). Furthermore, 
downregulation of CKII genes via RNAi in human cells has been demonstrated to induce apoptosis in 
tumorigenic tissues, highlighting the importance of CKII activity in mediating both cellular growth and 
programmed cell death (Wang et al. 2005). Moreover, the Ckb1 and Ckb2 subunits of CKII have been 
demonstrated to interact in vitro and in vivo with the Ptc2 phosphatase (Guillemain et al. 2007), strongly 
suggesting that CK2 activation of the PP2C phosphatase complex is required to dephosphorylate and 
inactivate Rad53 during checkpoint recovery and mitotic exit. The multifunctional role each of these 
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complexes and their components play during the initial LPR, the establishment of the DDC, and relief of 
the DDC promoting mitotic exit are also of interest. 
Previous studies have demonstrated that Rfa2 N-terminal phosphorylation leads to checkpoint 
adaptation in adaptation-deficient mutations (Ghospurkar et al. 2015) Wilson et al. 2018b). In this study 
we broadly characterized the adaptation deficiencies of multiple resection-deficient and adaptation-
deficient mutations. We also monitored checkpoint adaptation proficiency through immunoblot analysis of 
the phospho-state of Rad53. We found that not only is the Rpa2 NT required for checkpoint exit, as 
demonstrated previously, but natural phosphorylation or phospho-mimetic forms of the Rpa2 NT actively 
promote checkpoint adaptation in phosphatase- and resection-deficient cells. We demonstrate that the 
Rpa2 NT becomes phosphorylated in a manner distinct from that observed under global genotoxic stress 
with the DSB-inducer phleomycin. We show that, despite the presence of a persistent DNA lesion, Rad53 
hyper-phosphorylation becomes reduced in cells containing Rpa2 phospho-mimetic mutations, and that 
this event induces additional rounds of cellular division. Taken together, the results from this study 
suggest a defined role for hyper-phosphorylation of the Rpa2 NT in regulating the DDC, which facilitates 
cell cycle restart as a last-resort survival mechanism, leading to aberrant cell growth and genomic 
instability. 
4.3. Materials and Methods 
4.3.A. Strains and Plasmids 
Yeast strains and plasmids used in these studies are listed in Appendix A and Appendix B, 
respectively. All yeast strains used within this study are isogenic derivatives of JKM179 (hoD MATa 
hmlD::ADE1 hmrD::ADE1 ade1-100 leu2-3,112 lys5 trp1::hisG ura3-52 ade3::GAL::HO; Lee et al. 1998) 
containing rfa2Δ::kanMX (NMM104, Wilson et al. 2018A). 
The generation of CKA1, CKA2, CKB1, CKB2, CHK1, DUN1 deletions in NMM104 was 
completed using PCR amplification of the natMX cassette from plasmid pFA6-NatNT2 (Euroscarf) with 
appropriate primers (Appendix C) containing an additional 40 nt of homologous sequence immediately 
upstream and downstream of the coding regions of each gene and one-step gene replacement. The 
same strategy was used to delete SLX4, RTT107, and SAE2 using PCR amplification of the hphNX 
cassette from plasmid pFA6-hphNX (Euroscarf) using appropriate primers (Appendix C). Deletion 
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candidates were then screened via diagnostic replica plating (section 4.3.B.) and by PCR using 
diagnostic primers (Appendix C) using a strategy like that for the generation of yeast gene deletions (Kelly 
et al. 2001). 
MEC1 kinase deletion strains utilized in this study were also generated by one-step gene 
replacement. However, before attempting deletion of the respective kinase gene, the SML1 gene was first 
deleted by single-step gene replacement using PCR amplicon of hphN from pFA6-hphN (Euroscarf) using 
a similar method to that described above. Once verified, the sml1Δ::hphN NMM104 derivative strain was 
transformed mec1Δ::natMX PCR amplicons as described above. mec1D sml1D candidates were 
screened via diagnostic replica plating and by PCR using diagnostic primers (Table S3). 
CKII rfa1-t11 mutations were generated via two-step gene replacement as follows. pRS315-rfa1-
t11-BsaHI was digested with MfeI to linearize the vector and target integration to the RFA1 locus. The 
digested plasmid was then transformed into JKM179 yku70D cells and transformants were selected for on 
synthetic complete media (0.5% ammonium sulfate, 0.34% yeast nitrogen base without amino acids) 
containing dextrose (2%) and lacking uracil (SD-Ura). The integrants were then grown overnight in liquid 
YPD (1% yeast extract, 2% peptone, 2% dextrose) and plated onto media containing 0.8 μg/mL 5-
fluoroorotic acid (SD+5-FOA). Genomic DNA from 5-FOA-resistant cells was isolated and PCR 
was performed using appropriate primers (Appendix C). This PCR product was then digested with BsaHI 
to determine correct integration of the rfa1-t11 mutant allele and was subsequently sequenced (Eton 
Bioscience) to verify proper integration of the mutation. rfa1-t11 damage sensitivity was also confirmed 
via diagnostic replica plating. 
4.3.B. Diagnostic replica plating used in analysis of deletion mutants 
Deletion of SLX4, SAE2, RTT107, CKII genes, MEC1, TEL1, CHK1, and DUN1 all lead to DNA 
damage sensitive phenotypes. Screening of transformants picked to a master plate prior to PCR was 
performed via diagnostic replica plating. YPD media with or without genotoxic agents and SD- media with 
strain specific amino-acid dropouts were used in replica plating. Damage-sensitive candidates, or yeast 
that grew poorly on YPD media containing 5 ug/mL PHL or CPT were then analyzed via PCR following 
genomic DNA isolation as described in section 4.3.A. 
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4.3.C. Single DSB induction and collection of whole-cell lysate 
All induction of DNA damage in cells for biochemical assays was performed in liquid culture. 
Yeast cells were grown for 20 hours (hr) in liquid YPD (1% yeast extract, 2% peptone, 2% dextrose) to an 
OD600 of 1.0, and subsequently sub-cultured the next day into YPR (1% yeast extract, 2% peptone, 2% 
raffinose) and grown for 20 hours to an OD600 of 2.0. A single break at the MAT locus via HO 
endonuclease was induced by adding 20% galactose to the YPR cultures to a final concentration of 2%. 
To harvest an equivalent number of cells, 10 ODs of cells were harvested from each culture at 
time-points indicated in figures. Harvested cells were treated with 0.1 M NaOH for 10 minutes at room 
temperature, pelleted at 10K RPM for 2 minutes (min), and aspirated to remove NaOH from the pellet. 
The pelleted cells were then resuspended in 500 uL of K-Buffer (0.06 M Tris-HCl, ph 6.8, 5% glycerol, 2% 
SDS, 4% b-mercaptoethanol, 10 mM DTT; Kushnirov 2000), and each protein sample was boiled at 
100°C for 3 min. A Lowry assay (Bio-Rad RC-DC Assay Kit) was used to quantify protein concentration 
within each sample to ensure even protein loading during SDS-PAGE. 
4.3.D. Checkpoint adaptation plating assays 
Cells for the checkpoint adaptation plating assays were grown in liquid culture as described 
above. A single break at the MAT locus via HO endonuclease was induced by adding 20% galactose to 
the YPR cultures to a final concentration of 2%. Cells were grown for 8 hours in YPR-Gal media to sync 
cells at the G2/M checkpoint. 
To observe cellular adaptation, 0.05 OD600 of cells were plated onto YPRG (1% yeast extract, 2% 
peptone, 2% raffinose, 2% galactose) media and spread using glass beads. Cells were counted under 
20x optical zoom on an Olympus microscope, and then categorized based on observed counts as 
described in Chapter 3, section 3.3.C. 
4.3.E. SDS-PAGE and Immunoblotting 
K-Buffered Whole-cell lysate from each sample was loaded into SDS-PAGE gels containing a 4% 
stacking gel (37.5:1 mono:bis) and 12% (150:1 mono:bis) or 15% resolving gel (29:1 mono:bis). 40-60 ug 
total whole cell lysate was used in SDS-PAGE to observe Rad53, 10-20 ug total whole cell lysate was 
used to observe Rfa2. Electrophoresis was then performed at 30 mA constant current for 15 minutes, 60 
mA constant current for 2 hours allowing the 25 kDa band (PageRuler Plus Prestained Protein Ladder; 
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Thermo Scientific) to reach the base of the gel. Each gel was equilibrated in Towbin Transfer Buffer (10 
mM Tris-HCl, 100 mM glycine, 10% Methanol) for 15 min and transferred onto a 0.2-micron nitrocellulose 
membrane (Bio-Rad) at 40 mA constant current for 16 hours at 4°C. 
Once transfer was complete, nitrocellulose membranes were then stained with Ponceau S (0.5% 
w/v Ponceau S, 1% v/v acetic acid) for 10 min to visualize total protein content to determine equivalent 
loading within each lane. Once membranes were imaged, the Ponceau S stain was removed by washing 
with Western Wash Buffer (WWB) (0.3% Tween-20, 5 uM NaF, 0.05 uM Na3VO4) for 15 minutes. Blocking 
buffer (WWB, 1% w/v BSA) was then added and the blot was incubated for 2 hours at room temperature. 
Blocking buffer was removed, and Primary Antibody Buffer (PAB) (WWB, 0.5% w/v nonfat dry milk, 0.5% 
BSA) was added to the blots. 
To probe Rfa2 phosphorylation, a 1:40,000 dilution of α-Rfa2 antibody (kindly provided by Dr. 
Steve Brill) was used in PAB. To probe Rad53 phosphorylation, a 1:6000 dilution of α-Rad53 antibody 
(ab104232, AbCam) was used in PAB. 
Following a 16 hr incubation at 4°C the PAB was removed and washes were performed using 
WWB. Secondary Antibody Buffer (SAB) (WWB, 0.2% w/v nonfat dry milk), containing a 1:40,000 dilution 
of goat-α-rabbit-HRP (Abcam; ab97051, 1:40,000, Bethyl; A120-101P, 1:40,000) was then added to each 
blot and allowed to incubate for 2 hr at room temperature. The SAB was then removed and washes using 
WWB were performed. All blots were developed using a fluorescent substrate (ECL2 Plus; Thermo 
Scientific) and visualized on a STORM imager (GE). 
4.3.F. Yeast genomic DNA isolation for qPCR resection assays 
Ten OD600 of cells were harvested prior to HO induction and every hour for four hours post-HO 
induction with galactose. Cells were pelleted at 2500 RPM and the media was aspirated away from the 
pellet. Pellets were then resuspended in 500 uL of YEX buffer (Yeast Extraction Buffer: 100 mM Tris-HCl, 
pH 8.0, 50 mM EDTA, 2% SDS), 500 uL of glass beads, and 500 uL of P:C:I (phenol:chloroform:isoamyl 
alcohol; 25:24:1) was added to each tube. Cells were bead-beat on maximum speed at 4⁰C for 30 
minutes. Tubes were then placed in a centrifuge at max speed for 10 minutes to separate the solubilized 
DNA (aqueous phase) away from cellular debris and phenol. The aqueous phase was then extracted 
twice in ice-cold 24:1 chloroform:isoamyl alcohol, and then precipitated using 3M NaAC and 2.5 volumes 
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of ice-cold 95% ethanol. Nucleic acids were harvested by centrifuging the reaction tubes at 4⁰C, max 
speed for 10 minutes. Ethanol was aspirated away, and the nucleic acid pellets were washed once with 
ice-cold 70% ethanol. Following another centrifugation and aspiration, nucleic acid pellets were dried for 
10 minutes in a vacuum centrifuge and resuspended in 100 uL of TE, pH = 8.0. 1 uL of RNase A was 
then added to each tube and the tubes were incubated at 37⁰C for 30 minutes to eliminate RNA. 3M 
NaAC and 2.5 volumes of ice-cold 95% ethanol was then added to the tubes to precipitate DNA, which 
was harvested and dried as described. Following the final drying step, DNA was resuspended in 100 uL 
of ddH2O, quantitated via spectroscopy, and 100 ng of DNA was used in each qPCR reaction, with 
appropriate primers (Appendix C).  
4.3.G. Analysis of resection via qPCR 
DNA isolated as described in section 4.3.F was 2 mg of DNA was digested with SspI enzyme at 
37°C for 2 hours. DNA was then diluted to 20ng/uL and 5 uL (100ng) of diluted DNA was used in qPCR 
as follows. EvaGreen SYBR qPCR master mix (abm), appropriate primers for each SspI restriction site at 
the MAT locus (Appendix C), and filter-sterile ddH2O were used to create a qPCR master mix. Primers 
were utilized at a final concentration of 300 nM each. 15 uL of each master mix was added to a 96-well 
qPCR plate. 5 uL (100ng) of dilute DNA sample was then added to each well, and qPCR was performed 
on an AB7500 system (Applied Biosystems).  
4.4. Results 
4.4.A. Adaptation proficiency conferred by Rfa2 NT extensive mutations is not dependent on DSB 
resection 
Previously, it was demonstrated that Rfa2 NT extensive mutations have significant impacts on the 
ability of cells to undergo checkpoint adaptation or enter mitosis with broken/damaged DNA (Chapter 3; 
Ghospurkar et al. 2015, Wilson et al. 2018b) . Characterization of ectopically expressed Rfa2 NT 
extensive mutations in otherwise unmodified cells during checkpoint adaptation reveals that, as observed 
previously, the rfa2-DX and rfa2-h2NT mutations promote checkpoint adaptation in-line with wild-type cells 
(Figure 4.1, Table 4.1). The rfa2-AX mutation leads to an approximate 10% decrease in adaptability of 
cells, whereas rfa2-ΔNX leads to a 40% reduction in cells aberrantly entering mitosis. Biochemical 
analysis of the phospho-state of Rad53 reveals that, in each of the Rfa2 NT extensive mutations, 
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checkpoint activation occurs indistinguishably from wild-type, however, rfa2-AX and rfa2-ΔNX mutations 
lead to an additional Rad53 phospho-species that persists through 12-16 hours post-DSB induction 
(Figure 4.2). 
Previous research has speculated that the process of resection, or controlled nucleolytic digestion 
of the 5’ strand proximal to the DSB, impacts the ability of cells to undergo checkpoint adaptation (Lee et 
al. 1998, Eapen et al. 2012). This hypothesis was largely driven by the observation that yku70Δ 
adaptation deficiency could be rescued by rfa1-t11 and led to extensive long-range resection 3-6 hours 
after a single DSB was introduced at the MAT locus in the rfa1-t11 yku70Δ double mutation (Lee et al. 
1998). However, recent research has demonstrated that promoting extensive or long-range resection 
through either deletion of RAD9 (Rad53 chaperone during G2/M; Dibitetto et al. 2016)  or via over-
expression of Exo1 exonuclease (Eapen et al. 2012, Clerici et al. 2014) can rescue adaptation-deficiency 
by inhibiting or promoting extensive resection of the DSB, respectively. Moreover, preventing extensive 
resection through over-expression of Rad9 successfully inhibits checkpoint adaptation in adaptation-
deficient mutants suggestive that the extent of which resection proceeds at a DSB may mediate the 
checkpoint adaptation process (Dibitetto et al. 2016). This led us to test whether resection of the HO-
induced DSB at the MAT locus was affected by Rfa2 NT extensive mutations (Figure 4.3 and 4.4). Using 
primers identical to that used in Dibitetto et al. (2016), we first performed a proof of concept PCR on 
undigested and SspI digested DNA to ensure that the products generated for the assay were able to be 
synthesized only if undigested DNA was present. We discovered that spurious amplification of R2, R3, 
and R7 (Figure 4.3, panel 2 and 3) occurred in the absence of any template DNA. Ultimately, we decided 
to commit to using primers for the R1, R4, and R6 resection products as they exist at 1.7, 5.9, and 8.9 
kbp distal to the MAT locus, on the right arm of chromosome III (Figure 4.4A). By selecting different range 
positions on the chromosome, we assessed that we would be able to measure both short-range (1-5 kbp) 
and long-range resection (5 kbp+) with high confidence. 
Using the qPCR strategy described in Figure 4.4A, we were able to determine that both short-
range and long-range resection of the MAT locus is not significantly impacted by Rfa2 NT extensive 
mutations. Analysis of short-range resection reveals that each mutant rfa2 form, as well as rfa1-t11 have 
a minor defect (~10% reduction) in fold-enrichment of product at R1, or 1.7 kbp distal MAT. Long-range 
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resection appears to be most greatly impacted by rfa1-t11, a mutation that was previously reported to 
generate hyper-resection phenotypes, or rfa2-AX. Resection in rfa2-DX, rfa2-h2NT, or rfa2-ΔNX was 
reduced when compared to wild-type at 1.7, 5.9, and 8.9 kbp from the DSB site. Taken together, these 
data suggest that: 1) resection of the DSB is not the primary determinant for checkpoint adaptation and 2) 
that phosphorylation and the physical presence of the Rfa2 NT may only play a minor role during DSB 
resection. 
 
Figure 4.1.  Rfa2 NT phosphorylation is required for checkpoint adaptation in wild-type cells. 
Microscopic analysis of checkpoint adaptation in NMM104 (JKM179 rfa2Δ::KanMX) cells. Broadly, rfa2 
NT phospho-mimetic or naturally phosphorylatable mutations promote adaptation rescue, whereas an 
unphosphorylatable NT leads to a reduction in adaptation and an NT truncation severely impedes 
adaptation. Cells were harvested at 8 hours from culture induced to express HO endonuclease using 
galactose to a final concentration of 2%. 0.05 OD600 of cells were spread on YPRG plates using 
microbeads and analyzed at 8, 24, and 48 hours post-HO induction. Averages are from three 
independent experiments. 
Table 4.1. Average Adaptation Percentages in NMM104 cells. 
Strain Percent of clusters  ≥3 Cells at 8 Hours 
Average Percent  
Adaptation by 24 hours 
Average Percent  
Adaptation by 48 hours 
WT 8% 82% 86% 
rfa2-DX 11% 79% 83% 
rfa2-AX 9% 59% 71% 
rfa2-ΔNX 10% 38% 45% 
rfa2-h2NT 15% 77% 79% 
Average adaptation was calculated by subtracting the total number of cells greater than or equal to three 
cells at 8 hours from total observed adaptation at 24 and 48 hours. Averages are from three independent 
experiments. 
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Figure 4.2.  Rad53 phospho-state is correlated with checkpoint adaptation. 
Rad53 immunoblots from NMM104 cells containing Rfa2 NT extensive mutations. Rad53 hyper-activation 
is not impaired in Rfa2 NT extensive mutations but becomes more rapidly inactivated with the rfa2-DX or 
rfa2-h2NT mutations, or more hyper-activated with the rfa2-AX or rfa2-ΔNX mutations at 6 hours and 
proceeding through 16 hours. 10 OD600 of cells were harvested at indicated time points and treated as 
described. 40 ug of whole cell lysate was used in SDS-PAGE. 
4.4.B. The Rfa2 NT is required for checkpoint adaptation 
Previous studies have shown that deletion of the DNA damage sensor kinase Tel1 leads to 
adaptation proficiency, and tel1Δ rescues adaptation deficiency caused by mec1-ad mutation, or dna2Δ, 
sgs1Δ, and yku70Δ (Clerici et al. 2014). In our adaptation assays, tel1Δ adapts slightly better than WT 
cells (Figure 4.5, Table 4.2) and tel1Δ Rfa2 NT extensive mutations adapt with a similar frequency to Tel1 
proficient strains. However, tel1Δ is unable to rescue the adaptation defect conferred by rfa2-ΔNX, 
suggesting that the physical presence of the Rfa2 NT is the most minimal requirement for checkpoint 
adaptation in budding yeast. Moreover, the tel1Δ mutation is both sensitive to DNA damaging agents, and 
all of the tested Rfa2 NT extensive mutations appear to enhance the observed sensitivity to genotoxic 
agents (Figures 4.6 and 4.7).  
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Figure 4.3.  Proof of concept for resection qPCR assay. 
Genomic DNA was harvested from 10 OD600 of exponentially growing cells and treated with or without 
SspI enzyme and then utilized in standard PCR as described in 4.3. PCR was also performed on primers 
without DNA revealing amplicons R1, R4, and R7 were dependent on, SspI-undigested DNA. Spurious 
amplification was observed in reactions using primers specific to R2, R3, and R6 in the absence of DNA 
template and in the presence of both digested and undigested DNA. 
4.4.C. Rfa2 NT extensive mutations promote rescue of adaptation-deficient rtt107Δ and slx4Δ 
As described previously, Rtt107 and Slx4 form a functional complex during lesion processing and 
repair (LPR) that has been shown to compete for binding of the BRCT-domain containing scaffold Dpb11 
(a known activator of Mec1 kinase activity at break sites) with the Rad53 chaperone Rad9 (Ohouo et al. 
2013). Preventing Rad9-Rad53 complex binding with Dpb11 is thought to lead to an attenuation or 
‘winding down’ of the checkpoint signal and lead to mitotic exit (ibid). Moreover, rescue of rtt107Δ and 
slx4Δ adaptation deficiency has been demonstrated to be rescuable by overexpression of Rad9 and is 
thought to prevent extensive resection of DNA at the break site (Dibitetto et al. 2016). This led us to 
generate and test the effects of rtt107Δ and slx4Δ mutations in combination with Rfa2 NT extensive 
mutations. Initially, Diagnostic spot assays revealed that rtt107Δ mutations were sensitive to DNA 
damaging agents and combining rtt107Δ with Rfa2 NT extensive mutations led to a significant synthetic 
genetic defect (Figures 4.8 and 4.9). A similar effect was observed for slx4Δ cells containing the Rfa2 NT 
extensive mutations (Figures 4.10 and 4.11). 
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Figure 4.4.  Rfa2 NT is dispensable for long-range resection of MAT locus. 
A. Schematic of qPCR assay used. R1, R4, and R6 SspI sites exist at 1.7 kbp, 5.9 kbp, 8.9 kpb distal to 
the MAT locus on the right arm of chromosome III. B. Relative fold enrichment of qPCR products at R1, 
R4, and R6 of rfa2 NT mutations in NMM104 cells. All mutations appear to exhibit a moderate defect in 
resection when compared to WT. rfa1-t11 does not exhibit a hyper-resection phenotype as previously 
reported. Cells were harvested at 4 hours from culture induced to express HO endonuclease using 
galactose to a final concentration of 2%. 10 OD600 of cells were harvested for genomic DNA isolation, and 
100 ng of template DNA was used in each qPCR experiment. qPCR was performed using appropriate 
primers described in section 4.3.F, and are identical to that used in Dibettito et al. 2017 and are listed in 
Appendix C. 
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Figure 4.5.  The Rfa2 NT is required for checkpoint adaptation in tel1Δ. 
Microscopic analysis of checkpoint adaptation in tel1Δ Rfa2 NT extensive mutations. Broadly, rfa2 NT 
phospho-mimetic or naturally phosphorylatable mutations promote adaptation rescue, whereas an 
unphosphorylatable NT leads to a reduction in adaptation and an NT truncation severely impedes 
adaptation. Cells were harvested at 8 hours from culture induced to express HO endonuclease using 
galactose to a final concentration of 2%. 0.05 OD600 of cells were spread on YPRG plates using 
microbeads and analyzed at 8, 24, and 48 hours post-HO induction. Averages are from three 
independent experiments. 
Table 4.2. Average Adaptation Percentages observed in NMM104 tel1Δ. 
Strain Percent of clusters  ≥3 Cells at 8 hours 
Average Percent  
Adaptation by 24 hours 
Average Percent 
Adaptation by 48 hours 
tel1Δ RFA2 13% 95% 96% 
tel1Δ + rfa2-DX 9% 83% 86% 
tel1Δ + rfa2-AX 9% 74% 79% 
tel1Δ + rfa2-ΔNX 7% 44% 48% 
tel1Δ + rfa2-h2NT 11% 87% 97% 
Average adaptation was calculated by subtracting the total number of cells greater than or equal to three 
cells at 8 hours from total observed adaptation at 24 and 48 hours. Averages are from three independent 
experiments. 
Microscopic analysis of rtt107Δ Rfa2 NT extensive mutations during checkpoint adaptation 
reveals that rtt107Δ recapitulates its known adaptation-deficient phenotype, and this adaptation deficiency 
is rescued by phospho-mimetic rfa2-DX or the naturally phosphorylatable rfa2-h2NT (Figure 4.12). 
Biochemical analysis of the Rad53 phospho-state during adaptation reveals that rtt107Δ cells containing 
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rfa2-DX or rfa2-h2NT activate the Rad53-dependent checkpoint with near-WT kinetics; however, hyper-
activation of Rad53 is not observed (Figure 4.13). Moreover, rtt107Δ rfa2-AX or rfa2-ΔNX mutations lead 
to the formation of hyper-phosphorylated Rad53 that persists through the observed time course (Figure 
4.13, panels 2A, 3A, 3B and 4B). This hyper-phosphorylated species is detected in WT cells at 
approximately 8 hours (Figure 4.13B, panel 1), but is not present at 12 hours or later in the time-course. 
This demonstrates that in rtt107Δ, phospho-mimetic or naturally phosphorylatable forms of Rfa2 prevent 
hyper-activation of Rad53. 
Microscopic analysis of slx4Δ Rfa2 NT extensive mutations during checkpoint adaptation reveals 
that not only does slx4Δ recapitulate its known adaptation-deficient phenotype, but that phospho-mimetic 
or naturally phosphorylated Rfa2 NT mutations promote checkpoint adaptation, similar to that observed 
for rtt107Δ cells (Figure 4.14). Biochemical analysis of Rad53 during adaptation in slx4Δ Rfa2 NT 
extensive mutations revealed that Rad53 phosphorylation and hyper activation occurs in a similar fashion 
to that observed for rtt107Δ mutations (Figure 4.15). While the biochemical data argues that these cells 
may not properly checkpoint, morphological observations of cells at 8 hours (Figure 4.12, Table 4.3; 
Figure 4.14, Table 4.4) reveal that approximately 80% of the cells display morphology that indicates 
proper checkpoint arrest. Consistently, the rfa2-DX or rfa2-h2NT mutations prevented hyper-activation of 
Rad53 in slx4Δ cells. Taken together, our data suggests that both Rtt107 and Slx4 are required for full 
checkpoint activation, and that phosphorylation of the Rfa2 NT can prevent full hyper-activation of Rad53 
during lesion processing and repair. 
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Figure 4.6.  Diagnostic spot assay of rtt107Δ mutations (rfa2-DX and rfa2-h2NT). 
rtt107Δ Rfa2 NT mutations were harvested and an OD600 for the exponentially growing culture was 
determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered water. 
200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was then 
spotted onto the plates using a multi-channel pipetman.  
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Figure 4.7.  Diagnostic spot assay of rtt107Δ mutations (rfa2-AX and rfa2-ΔNX). 
rtt107Δ Rfa2 NT mutations were harvested and an OD600 for the exponentially growing culture was 
determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered water. 
200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was then 
spotted onto the plates using a multi-channel pipetman.  
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Figure 4.8.  Diagnostic spot assay of slx4Δ mutations (rfa2-DX and rfa2-h2NT). 
slx4Δ Rfa2 NT mutations were harvested and an OD600 for the exponentially growing culture was 
determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered water. 
200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was then 
spotted onto the plates using a multi-channel pipetman.  
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Figure 4.9.  Diagnostic spot assay of slx4Δ mutations (rfa2-AX and rfa2-ΔNX). 
slx4Δ Rfa2 NT mutations were harvested and an OD600 for the exponentially growing culture was 
determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered water. 
200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was then 
spotted onto the plates using a multi-channel pipetman. 
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Figure 4.10. Rfa2 NT phosphorylation is required for checkpoint adaptation in rtt107Δ cells. 
Microscopic analysis of checkpoint adaptation in rtt107Δ Rfa2 NT extensive mutations. Broadly, Rfa2 NT 
phospho-mimetic or naturally phosphorylatable mutations promote adaptation rescue, whereas an 
unphosphorylatable NT leads to a reduction in adaptation and an NT truncation severely impedes 
adaptation. Cells were harvested at 8 hours from culture induced to express HO endonuclease using 
galactose to a final concentration of 2%. 0.05 OD600 of cells were spread on YPRG plates using 
microbeads and analyzed at 8, 24, and 48 hours post-HO induction. Averages are from three 
independent experiments. 
Table 4.3. Average Adaptation Percentages observed in NMM104 rtt107Δ cells. 
Strain Percent of clusters  ≥3 Cells at 8 Hours 
Average Percent  
Adaptation by 24 hours 
Average Percent  
Adaptation by 48 hours 
rtt107Δ RFA2 15% 25% 30% 
rtt107Δ rfa2-DX 11% 71% 77% 
rtt107Δ rfa2-AX 11% 24% 26% 
rtt107Δ rfa2-ΔNX 13% 20% 23% 
rtt107Δ rfa2-h2NT 15% 76% 78% 
Average adaptation was calculated by subtracting the total number of cells greater than or equal to three 
cells at 8 hours from total observed adaptation at 24 and 48 hours. Averages are from three independent 
experiments. 
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Figure 4.11. Rad53 inactivation during checkpoint adaptation requires Rfa2 NT phosphorylation in 
rtt107Δ. 
Rad53 immunoblots from rtt107Δ cells. A. rtt107Δ cells containing rfa2-DX or rfa2-h2NT display reduced 
Rad53 hyper-activation and faster deactivation during checkpoint adaptation, as observed in the 12-hour 
and 16-hour blots (panels 2 and 3, comparing rfa2-DX/rfa2-h2NT with rfa2-AX/rfa2-ΔNX). rfa2-AX and rfa2-
ΔNX maintain hyper-active Rad53 throughout the observed time course. 10 OD600 of cells were harvested 
at indicated time points and treated as described. 40 ug of whole cell lysate was used in SDS-PAGE. B. 
Rad53 immunoblots for each individual Rfa2 NT mutation in rtt107Δ mutant strain. Activation of Rad53 
occurs indistinguishably from WT cells, however, rtt107Δ mutants containing the rfa2-AX or rfa2-ΔNX 
mutation display more hyper-phosphorylated Rad53 throughout the observed time course. 
4.4.D. Effects of Rfa2 NT extensive mutations on sae2Δ adaptation-deficient mutations 
During initiation of LPR, MRX localization to the DSB leads to the phosphorylation and 
localization of Sae2 to the MRX complex at the DSB site, and promotes MRXS endonucleolytic cleavage 
of nucleotides proximal to the DSB to promote resection (Nicolette et al. 2010). Deletion of Sae2 has 
been demonstrated to lead to checkpoint adaptation deficiency through a resection-dependent 
mechanism (Gobbini et al. 2015), as sae2Δ cells are unable to properly initiate the endonucleolytic 
activity of the MRXS complex at break sites, inhibiting resection by STR-Dna2 (Sgs1-Top3-Rmi1-Dna2 
nuclease helicase complex). Because this mutation is reported to be resection-deficient, we tested 
whether Rfa2 NT phospho-mimetic or naturally phosphorylatable mutations could rescue the observed 
adaptation deficiency in sae2Δ. First, we assessed whether the generated sae2Δ and Rfa2 NT extensive 
mutation combinations recapitulated their known phenotypes via diagnostic spot assays (Figures 4.16 
and 4.17), which revealed that the sae2Δ mutations generated in this study are sensitive to genotoxic 
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agents and that this sensitivity is exacerbated when in combination with rfa2-DX, rfa2-h2NT, or rfa2-ΔNX. 
Cells containing the sae2Δ rfa2-AX mutation were no more sensitive to genotoxic agents than sae2Δ Rfa2 
cells, suggesting that an unphopshorylated Rfa2 NT is required for clastogen resistance, as previously 
observed (Ghospurkar et al. 2015). Microscopic analysis of sae2Δ Rfa2 NT extensive mutations reveals 
that our generated sae2Δ recapitulates its known adaptation-deficient phenotype and is rescued by rfa2-
DX or rfa2-h2NT mutations, similar to that observed for rtt107Δ and slx4Δ mutations. Moreover, rfa2-AX 
and rfa2-ΔNX mutations consistently prevented adaptation or reduced the number of cells proceeding 
from 2 ‘big buds’ to 3 or more cells (Figure 4.18, Table 4.5). Additionally, sae2Δ is dispensable for 
checkpoint activation, as previously described (Gobbini et al. 2015). Biochemical analysis of the Rad53 
phospho-state in sae2Δ Rfa2 NT extensive mutants revealed that Rad53 hyper-activation occurs in all 
Rfa2 NT extensive mutations and more extensively than wild-type cells (Figure 4.19A, panel 2). 
 
Figure 4.12. Rfa2 NT phosphorylation is required for checkpoint adaptation in slx4Δ cells. 
Microscopic analysis of checkpoint adaptation in slx4Δ Rfa2 NT extensive mutations. Broadly, Rfa2 NT 
phospho-mimetic or naturally phosphorylatable mutations promote adaptation rescue, whereas an 
unphosphorylatable NT leads to a reduction in adaptation and an NT truncation severely impedes 
adaptation. Cells were harvested at 8 hours from culture induced to express HO endonuclease using 
galactose to a final concentration of 2%. 0.05 OD600 of cells were spread on YPRG plates using 
microbeads and analyzed at 8, 24, and 48 hours post-HO induction. Averages are from three 
independent experiments. 
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Table 4.4. Average Adaptation Percentages observed in NMM104 slx4Δ. 
Strain Percent of clusters ≥3 Cells at 8 Hours 
Average Percent  
Adaptation by 24 hours 
Average Percent  
Adaptation by 48 hours 
slx4Δ RFA2 15% 19% 20% 
slx4Δ rfa2-DX 15% 69% 72% 
slx4Δ rfa2-AX 20% 19% 21% 
slx4Δ rfa2-ΔNX 13% 12% 12% 
slx4Δ rfa2-h2NT 16% 75% 73% 
Average adaptation was calculated by subtracting the total number of cells greater than or equal to three 
cells at 8 hours from total observed adaptation at 24 and 48 hours. Averages are from three independent 
experiments. 
 
Figure 4.13. Rad53 inactivation during checkpoint adaptation requires Rfa2 NT phosphorylation in 
slx4Δ. 
Rad53 immunoblots from slx4Δ cells. A. Persistent hyper-activation of Rad53 is observed in rfa2-AX or 
rfa2-ΔNX, but not rfa2-DX or rfa2-h2NT mutations, specifically focusing on the temporal window within 
which checkpoint adaptation occurs (12-16 hours, panels 2 and 3). B. Rad53 immunoblots for each 
individual Rfa2 NT mutation in slx4Δ mutant strain. Activation of Rad53 occurs indistinguishably from WT 
cells, however, slx4Δ mutants containing the rfa2-AX or rfa2-ΔNX mutation display more hyper-
phosphorylated Rad53 throughout the observed time course. 10 OD600 of cells were harvested at 
indicated time points and treated as described. 40 ug of whole cell lysate was used in SDS-PAGE. 
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Figure 4.14. Diagnostic spot assay of sae2Δ mutations (rfa2-DX and rfa2-h2NT). 
sae2Δ Rfa2 NT mutations were harvested and an OD600 for the exponentially growing culture was 
determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered water. 
200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was then 
spotted onto the plates using a multi-channel pipetman.  
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Figure 4.15. Diagnostic spot assay of sae2Δ mutations (rfa2-AX and rfa2-ΔNX). 
sae2Δ Rfa2 NT mutations were harvested and an OD600 for the exponentially growing culture was 
determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered water. 
200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was then 
spotted onto the plates using a multi-channel pipetman.  
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Figure 4.16. Rfa2 NT phosphorylation is required for checkpoint adaptation in sae2Δ cells. 
Microscopic analysis of checkpoint adaptation in sae2Δ Rfa2 NT extensive mutations. Broadly, rfa2 NT 
phospho-mimetic or naturally phosphorylatable mutations promote adaptation rescue, whereas an 
unphosphorylatable NT leads to a reduction in adaptation and an NT truncation severely impedes 
adaptation. Cells were harvested at 8 hours from culture induced to express HO endonuclease using 
galactose to a final concentration of 2%. 0.05 OD600 of cells were spread on YPRG plates using 
microbeads and analyzed at 8, 24, and 48 hours post-HO induction. Averages are from three 
independent experiments. 
Table 4.5. Average Adaptation Percentages observed in NMM104 sae2Δ. 
Strain Percent of clusters  ≥3 Cells at 8 Hours 
Average Percent  
Adaptation by 24 hours 
Average Percent  
Adaptation by 48 hours 
sae2Δ RFA2 11% 20% 23% 
sae2Δ rfa2-DX 11% 35% 57% 
sae2Δ rfa2-AX 11% 11% 8% 
sae2Δ rfa2-ΔNX 12% 7% 7% 
sae2Δ rfa2-h2NT 13% 56% 59% 
Average adaptation was calculated by subtracting the total number of cells greater than or equal to three 
cells at 8 hours from total observed adaptation at 24 and 48 hours. Averages are from three independent 
experiments. 
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Figure 4.17. Rad53 inactivation during checkpoint adaptation requires Rfa2 NT phosphorylation in 
sae2Δ. 
Rad53 immunoblots from sae2Δ cells. A. Rad53 hyper-activation is not impaired in sae2Δ cells but 
becomes more rapidly inactivated in rfa2-DX or rfa2-h2NT mutations by 16 hours, as observed in rtt107Δ 
mutations. B. Rad53 immunoblots for each individual Rfa2 NT mutation in the sae2Δ mutant strain. 
Activation of Rad53 occurs indistinguishably from WT cells, however, sae2Δ mutants containing the rfa2-
AX or rfa2-ΔNX mutation display more hyper-phosphorylated Rad53 throughout the observed time course. 
10 OD600 of cells were harvested at indicated time points and treated as described. 40 ug of whole cell 
lysate was used in SDS-PAGE. 
4.4.E. rfa2-DX and rfa2-h2NT promote adaptation rescue more efficiently than rfa1-t11 in ckIIΔ 
adaptation-deficient mutations 
In the late 1990’s, Toczyski and Hartwell demonstrated that mutation of Cdc5 and Ckb2 
(component of the CKII kinase complex) led to adaptation deficiency in yeast (Toczyski et al. 1997). 
Later, it was discovered that the rfa1-t11 mutation could rescue the adaptation deficiency in yku70Δ and 
rdh54Δ cells, but are unable to overcome the checkpoint adaptation deficiency conferred by the cdc5-AD 
mutation (Lee et al. 2001). Our success in relieving checkpoint adaptation deficiency with phospho-
mimetic or naturally phosphorylatable Rfa2 NT extensive mutations led us to test and compare the 
adaptation profiles of individual CKII complex-forming mutations cka1Δ, cka2Δ, ckb1Δ, and ckb2Δ in 
combination with the Rfa2 NT extensive mutations. Prior to analysis of adaptation, however, we sought to 
characterize the synthetic genetic interactions of individual ckIIΔ subunit deletions with the Rfa2 NT 
extensive mutations. Deletion mutations of Cka1 (Figures 4.20 and 4.21) or Cka2 (Figures 4.22 and 4.23) 
are not hyper-sensitive to MMS or CPT but are hyper-sensitive to HU and PHL treatment. In combination 
with rfa1-t11, cka1Δ and cka2Δ are hyper-sensitive to all clastogens tested similar to that observed for 
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CKA1/CKA2 rfa1-t11, suggesting that rfa1-t11 is the driver of this damage sensitive phenotype. Similar to 
that observed for the deletion mutations described in section 4.4.C and 4.4.D, combination of 
cka1Δ/cka2Δ with rfa2-DX, rfa2-h2NT, or rfa2-ΔNX increase sensitivity to genotoxic agents, suggesting 
that there is a synthetic genetic interaction between Cka1/Cka2 and Rfa2. Moreover, deletions of Ckb1 
and Ckb2 yield similar damage sensitive phenotypes to their cka1Δ or cka2Δ counterparts (Figures 4.24, 
4.25, 4.26 and 4.27, respectively), suggesting a synthetic genetic interaction between the CKII kinase 
complex and Rfa2. 
Microscopic analysis of individual ckIIΔ subunit mutations during checkpoint adaptation, and in 
combination with Rfa2 NT extensive mutations, reveals a surprising separation of function during 
adaptation. Deletions of Cka1 and Cka2 are rescuable by rfa2-DX, rfa2-h2NT and to a lesser extent rfa1-
t11 (Figure 4.28, Table 4.6; Figure 4.29, Table 4.7, respectively). Contrary to that observed in other 
deletion mutants tested in this study, the rfa2-AX mutation promotes a very minor adaptation proficiency in 
cka1Δ/cka2Δ (66% in cka1Δ versus 51% in cka1Δ rfa2-AX; 37% in cka2Δ versus 49% in cka2Δ rfa2-AX at 
48 hours), similar to that observed in NMM104 cells. The rfa2-ΔNX mutation reduces adaptation 
proficiency (cka1Δ rfa2-ΔNX adapts at 23%; cka2Δ rfa2-ΔNX adapts at 24% by 48 hours). Deletions of 
Ckb1 or Ckb2, however, produce slightly different adaptation phenotypes from their cka1 and cka2 
counterparts. In both ckb1Δ and ckb2Δ (Figure 4.30; Table 4.8; Figure 4.31, Table 4.9, respectively), rfa1-
t11 is unable to promote robust rescue of the adaptation deficiency (26% in ckb1Δ versus 35% in ckb1Δ 
rfa1-t11; 25% in ckb2Δ versus 25% in ckb2Δ rfa1-t11 at 48 hours). However, rfa2-DX and rfa2-h2NT are 
able to rescue the aforementioned adaptation deficiency to ~85% and 95%, respectively, in both ckb1Δ 
and ckb2Δ. Consistent with other adaptation-deficient mutations used in this study, the presence of either 
the rfa2-AX or rfa2-ΔNX mutation severely reduce the ability of ckb1Δ and ckb2Δ mutants to perform 
checkpoint adaptation. Biochemical analysis of the Rad53 phospho-state was not performed in these 
mutations, however, each individual ckIIΔ subunit mutation and each combination with Rfa2 NT extensive 
mutations appeared to have G2/M arrested morphology at 8 hours indicative of Rad53-damage-
dependent checkpoint arrest. Taken together, our data suggests that, while each of the individual ckIIΔ 
subunit deletions is adaptation-deficient, rescue of the observed adaptation deficiency is preferentially 
driven by the phospho-state of the Rfa2 NT and not the rfa1-t11 mutation.  
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Figure 4.18. Diagnostic spot assay of cka1Δ mutations (rfa2-DX and rfa2-h2NT). 
cka1Δ Rfa2 NT mutations were harvested and an OD600 for the exponentially growing culture was 
determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered water. 
200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was then 
spotted onto the plates using a multi-channel pipetman.  
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Figure 4.19. Diagnostic spot assay of cka1Δ mutations (rfa2-AX and rfa2-ΔNX). 
cka1Δ Rfa2 NT mutations were harvested and an OD600 for the exponentially growing culture was 
determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered water. 
200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was then 
spotted onto the plates using a multi-channel pipetman.  
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Figure 4.20. Diagnostic spot assay of cka2Δ mutations (rfa2-DX and rfa2-h2NT). 
cka2Δ Rfa2 NT mutations were harvested and an OD600 for the exponentially growing culture was 
determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered water. 
200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was then 
spotted onto the plates using a multi-channel pipetman.  
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Figure 4.21. Diagnostic spot assay of cka2Δ mutations (rfa2-AX and rfa2-ΔNX). 
cka2Δ Rfa2 NT mutations were harvested and an OD600 for the exponentially growing culture was 
determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered water. 
200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was then 
spotted onto the plates using a multi-channel pipetman.  
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Figure 4.22. Diagnostic spot assay of ckb1Δ mutations (rfa2-DX and rfa2-h2NT). 
ckb1Δ Rfa2 NT mutations were harvested and an OD600 for the exponentially growing culture was 
determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered water. 
200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was then 
spotted onto the plates using a multi-channel pipetman.  
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Figure 4.23. Diagnostic spot assay of ckb1Δ mutations (rfa2-AX and rfa2-ΔNX). 
ckb1Δ Rfa2 NT mutations were harvested and an OD600 for the exponentially growing culture was 
determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered water. 
200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was then 
spotted onto the plates using a multi-channel pipetman.  
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Figure 4.24. Diagnostic spot assay of ckb2Δ mutations (rfa2-DX and rfa2-h2NT). 
ckb2Δ ° mutations were harvested and an OD600 for the exponentially growing culture was determined. 
Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered water. 200 uL of 
the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was then spotted onto 
the plates using a multi-channel pipetman. 
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Figure 4.25. Diagnostic spot assay of ckb2Δ mutations (rfa2-AX and rfa2-ΔNX). 
ckb2Δ Rfa2 NT mutations were harvested and an OD600 for the exponentially growing culture was 
determined. Starting at an OD600 of 1.0, six ten-fold serial dilutions were performed in sterile filtered water. 
200 uL of the diluted culture was added to a 96-well microtiter plate and 5 uL of the dilution was then 
spotted onto the plates using a multi-channel pipetman. 
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Figure 4.26. Rfa2 NT phosphorylation is required for checkpoint adaptation in adaptation-deficient 
cka1Δ mutations. 
Microscopic analysis of checkpoint adaptation in cka1Δ Rfa2 NT extensive mutations. Similar to that 
observed for resection deficient mutations, rfa2 NT phospho-mimetic or naturally phosphorylatable 
mutations promote adaptation rescue in each resection deficient mutation, whereas an 
unphosphorylatable NT or NT truncation severely impedes adaptation. Adaptation rescue promoted by 
NT mutations exceeds that of rfa1-t11, a known checkpoint adaptation proficient mutation. Cells were 
harvested at 8 hours from culture induced to express HO endonuclease using galactose to a final 
concentration of 2%. 0.05 OD600 of cells were spread on YPRG plates using microbeads and analyzed at 
8, 24, and 48 hours post-HO induction. Averages are from three independent experiments. 
Table 4.6. Average Adaptation Percentages observed in NMM104 cka1Δ. 
Strain Percent of clusters  ≥3 Cells at 8 Hours 
Average Percent  
Adaptation by 24 hours 
Average Percent  
Adaptation by 48 hours 
cka1Δ 12% 41% 66% 
cka1Δ rfa1-t11 14% 60% 73% 
cka1Δ + rfa2-DX 12% 80% 81% 
cka1Δ + rfa2-AX 11% 37% 51% 
cka1Δ + rfa2-ΔNX 11% 22% 23% 
cka1Δ + rfa2-h2NT 12% 87% 89% 
Average adaptation was calculated by subtracting the total number of cells greater than or equal to three 
cells at 8 hours from total observed adaptation at 24 and 48 hours. Averages are from three independent 
experiments. 
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Figure 4.27. Rfa2 NT phosphorylation is required for checkpoint adaptation in adaptation-deficient 
cka2Δ mutations. 
Microscopic analysis of adaptation in cka2Δ Rfa2 NT extensive mutations. Similar to that observed for 
resection deficient mutations, rfa2 NT phospho-mimetic or naturally phosphorylatable mutations promote 
adaptation rescue in each resection deficient mutation, whereas an unphosphorylatable NT or NT 
truncation severely impedes adaptation. Adaptation rescue promoted by NT mutations exceeds that of 
rfa1-t11, a known checkpoint adaptation proficient mutation. Cells were harvested at 8 hours from culture 
induced to express HO endonuclease using galactose to a final concentration of 2%. 0.05 OD600 of cells 
were spread on YPRG plates using microbeads and analyzed at 8, 24, and 48 hours post-HO induction. 
Averages are from three independent experiments. 
Table 4.7. Average Adaptation Percentages observed in NMM104 cka2Δ. 
Strain Percent of clusters 
≥3 Cells at 8 Hours 
Average Percent 
Adaptation by 24 hours 
Average Percent 
Adaptation by 48 hours 
cka2Δ 12% 35% 37% 
cka2Δ rfa1-t11 13% 49% 60% 
cka2Δ + rfa2-DX 17% 80% 81% 
cka2Δ + rfa2-AX 12% 37% 49% 
cka2Δ + rfa2-ΔNX 10% 24% 24% 
cka2Δ + rfa2-h2NT 12% 86% 90% 
Average adaptation was calculated by subtracting the total number of cells greater than or equal to three 
cells at 8 hours from total observed adaptation at 24 and 48 hours. Averages are from three independent 
experiments. 
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Figure 4.28. Rfa2 NT phosphorylation is required for checkpoint adaptation in adaptation-deficient 
ckb1Δ mutations. 
Microscopic analysis of adaptation in ckb1Δ Rfa2 NT extensive mutations. Similar to that observed for 
resection deficient mutations, rfa2 NT phospho-mimetic or naturally phosphorylatable mutations promote 
adaptation rescue in each resection deficient mutation, whereas an unphosphorylatable NT or NT 
truncation severely impedes adaptation. Adaptation rescue promoted by NT mutations exceeds that of 
rfa1-t11, a known checkpoint adaptation proficient mutation. Cells were harvested at 8 hours from culture 
induced to express HO endonuclease using galactose to a final concentration of 2%. 0.05 OD600 of cells 
were spread on YPRG plates using microbeads and analyzed at 8, 24, and 48 hours post-HO induction. 
Averages are from three independent experiments. 
Table 4.8. Average Adaptation Percentages observed in NMM104 ckb1Δ. 
Strain Percent of clusters ≥3 Cells at 8 Hours 
Average Percent 
Adaptation by 24 hours 
Average Percent 
Adaptation by 48 hours 
ckb1Δ 12% 17% 26% 
ckb1Δ rfa1-t11 14% 35% 35% 
ckb1Δ + rfa2-DX 15% 84% 85% 
ckb1Δ + rfa2-AX 11% 27% 29% 
ckb1Δ + rfa2-ΔNX 11% 12% 13% 
ckb1Δ + rfa2-h2NT 12% 91% 95% 
Average adaptation was calculated by subtracting the total number of cells greater than or equal to three 
cells at 8 hours from total observed adaptation at 24 and 48 hours. Averages are from three independent 
experiments. 
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Figure 4.29. Rfa2 NT phosphorylation is required for checkpoint adaptation in adaptation-deficient 
ckb2Δ mutations. 
Microscopic analysis of adaptation in ckb2Δ Rfa2 NT extensive mutations. Similar to that observed for 
resection deficient mutations, rfa2 NT phospho-mimetic or naturally phosphorylatable mutations promote 
adaptation rescue in each resection deficient mutation, whereas an unphosphorylatable NT or NT 
truncation severely impedes adaptation. Adaptation rescue promoted by NT mutations exceeds that of 
rfa1-t11, a known checkpoint adaptation proficient mutation. Cells were harvested at 8 hours from culture 
induced to express HO endonuclease using galactose to a final concentration of 2%. 0.05 OD600 of cells 
were spread on YPRG plates using microbeads and analyzed at 8, 24, and 48 hours post-HO induction. 
Averages are from three independent experiments. 
Table 4.9. Average Adaptation Percentages observed in NMM104 ckb2Δ. 
Strain Percent of clusters 
≥3 Cells at 8 Hours 
Average Percent 
Adaptation by 24 hours 
Average Percent 
Adaptation by 48 hours 
ckb2Δ 12% 21% 25% 
ckb2Δ rfa1-t11 9% 24% 25% 
ckb2Δ + rfa2-DX 16% 81% 83% 
ckb2Δ + rfa2-AX 11% 30% 33% 
ckb2Δ + rfa2-ΔNX 12% 20% 22% 
ckb2Δ + rfa2-h2NT 10% 89% 95% 
Average adaptation was calculated by subtracting the total number of cells greater than or equal to three 
cells at 8 hours from total observed adaptation at 24 and 48 hours. Averages are from three independent 
experiments. 
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4.4.F. Rpa2 NT phosphorylation during checkpoint adaptation is distinct from phosphorylation 
during genotoxic stress 
As described in Chapter 2, phosphorylation of the Rfa2 NT is difficult to detect, at best, in 
response to genotoxic stressors. However, phosphorylation of the Rfa2 NT does occur and is observable 
via immunoblot. Figure 4.32 shows the Rfa2 phospho-state observed in response to global DSBs 
generated by phleomycin compared to that of cells that experience a single, controlled DSB at the MAT 
locus using HO endonuclease. In rfa1-t11 cells Rfa2 phosphorylation can still occur. This additional 
distinct species is observed in sae2Δ, rtt107Δ, and to a lesser extent slx4Δ in response to PHL treatment 
and appears more prevalently in the same deletion mutations in response to the HO-induced DSB (Figure 
4.32 A and B). Moreover, this distinct phosphorylation event that occurs in response to the HO-induced 
DSB is also observed in tel1Δ, chk1Δ, and dun1Δ mutants indicating that these DNA damage sensor or 
effector kinases are not responsible for the NT phosphorylation event observed. This distinct 
phosphorylation event is also observed in cka1Δ and cka2Δ mutant cells and is more abundant in the 
slower mobility species in ckb1Δ and ckb2Δ mutant cells in response to phleomycin (and possibly Gal-
HO), suggesting that CKII activity may regulate the extent of phosphorylation on the Rfa2 NT through a 
yet unidentified mechanism. 
4.5. Discussion 
4.5.A. Checkpoint adaptation promoted by Rfa2 NT phospho-mutations is not dependent on 
resection 
The results described in 4.4A revealed that each Rfa2 NT extensive mutations are proficient for 
both short- and long-range resection of the HO-induced DSB at the MAT locus. However, rfa2-AX or rfa2-
ΔNX are generally incapable of promoting checkpoint adaptation, whereas rfa2-DX and rfa2-h2NT are 
capable of rescuing all of the adaptation-deficient mutations tested in this study. Moreover, previous data 
has reported that resection of the DNA is not required for checkpoint adaptation (Eapen et al. 2012). 
Resection does provide cells with the ability to do alternative repair through single-strand annealing (SSA) 
(Helleday et al. 2007). If the DNA being resected on both ends of the break reaches a stretch of adequate 
homology between each, annealing between each of the generated overhangs occurs, followed by 
removal of non-homologous DNA ‘flaps’, DNA synthesis and completion of repair. However, this process 
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Figure 4.30. Rfa2 NT phosphorylation during checkpoint adaptation is distinct from that observed 
during genotoxic stress. 
A. Rfa2 immunoblots from NMM104, rfa1-t11 and sae2Δ cells treated with 5 ug/mL phleomycin or 
galactose-induced HO. B. Rfa2 immunoblots from rtt107Δ, sae2Δ, and tel1Δ cells. Phosphorylation in 
tel1Δ cells indicates that Tel1 is dispensable for Rfa2 NT phosphorylation during adaptation. C. Rfa2 
immunoblots from chk1Δ and dun1Δ cells, treated as described in A. Phosphorylation in chk1Δ and 
dun1Δ cells indicates both kinases are dispensable for Rfa2 NT phosphorylation during adaptation. D. 
Rfa2 immunoblots from cka1Δ and cka2Δ cells, treated as described in A. E. Rfa2 immunoblots from 
ckb1Δ and ckb2Δ cells, treated as described in A. Phosphorylation of Rfa2 in CKII mutations indicates 
that CKII regulatory or kinase activity is dispensable for Rfa2 NT phosphorylation during adaptation. 
ckb1Δ and ckb2Δ mutations display NT phosphorylation during phleomycin challenge, indicating these 
genes may be important for controlling or reducing Rfa2 NT phosphorylation during the DNA damage 
response through an indirect mechanism. 10 OD600 of cells were harvested at indicated time points and 
treated as described. 20 ug of whole cell lysate was used in SDS-PAGE. 
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is incredibly mutagenic, as any genetic information contained within the DNA flaps that are removed prior 
to synthesis is lost forever. It is entirely possible that our Rfa2 NT extensive mutations are promoting a 
type of SSA repair of chromosome III, which would allow for reversal of the DDC and mitotic exit; 
however, further study will be required to determine whether this phenomenon is what is driving 
adaptation Rfa2 NT extensive mutations. Moreover, this also alludes to the possibility that Rfa2 possess 
some signaling activity in cells that is independent of the RFA complex binding to DNA. 
4.5.B. Phospho-mimetic Rfa2 promotes adaptation rescue better than rfa1-t11 
It is somewhat interesting that despite an impaired checkpoint, cells containing the rfa1-t11 
mutation are also as resection-proficient as the Rfa2 NT extensive mutations, albeit reduced from WT, but 
do not support checkpoint adaptation-proficiency to the same degree as Rfa2 NT extensive mutations in 
the mutant strain backgrounds tested. Previously, the rfa1-t11 mutation was reported to lead to improper 
checkpoint maintenance through defective interactions with the 9-1-1 clamp loader complex Rad24-RFC, 
thus impairing 9-1-1 clamp loading (Kim et al. 2001, Majka et al. 2006). Cells containing the rfa1-t11 
mutation, however, still faithfully activate the Rad53-dependent checkpoint initially. Similarly, each of the 
Rfa2 NT extensive mutations tested herein all faithfully activate the Rad53-dependent checkpoint, 
however, preventing phosphorylation of the Rfa2 NT by alanine mutagenesis (rfa2-AX) or truncation of the 
Rfa2 NT (rfa2-ΔNX) lead to a more permanent arrest, whereas phospho-mimetic or naturally 
phosphorylatable forms of the Rfa2 NT (rfa2-DX and rfa2-h2NT, respectively) lead to more rapid 
deactivation of the Rad53 checkpoint and appear to promote entry into mitosis, despite the presence of 
persistent DNA breaks. This phenomenon may explain the differences observed in clastogen sensitivity 
for each of the Rfa2 NT extensive mutations as well. For example, if rfa2-DX is promoting aberrant 
checkpoint exit during LPR, these cells would divide continuously until their genomes were so unstable 
that the cells become inviable. Subsequently, rfa2-ΔNX may lead to permanent arrest, rather than a repair 
defect, where cells do not exit the Rad53-dependent checkpoint regardless of whether DNA repair has 
occurred. Taken together, our results indicate that phosphorylation of the Rfa2 NT is required for 
checkpoint exit and mitotic entry, in a mechanism similar to that observed in human cells (Anantha et al. 
2008). 
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Consistent with the hypothesis that Rfa2 NT phosphorylation promotes mitotic entry, regardless 
of the repair state of the DNA, is the observation that Rfa2 NT phosphorylation occurs in a distinct 
manner in cells experiencing an HO-induced DSB (Figure 4.24). Previously, it was demonstrated that 
CKII, the PP2 phosphatase complex, and Rad53 interact and this interaction is required for the 
dephosphorylation of Rad53 to alleviate checkpoint arrest and promote mitotic exit (Guillemain et al. 
2007). Additionally, Figure 2.6 (Chapter 2) shows that rfa2-h2NT is more robustly phosphorylated in a 
rad53Δ mutation. Moreover, it was demonstrated that in a set1Δ or mec3Δ that Rad53 phosphorylates the 
Rfa2 NT (Schramke et al. 2001). It is entirely possible then that upon substantial hyper-activation of 
Rad53 that Rad53 inevitably targets the Rfa2 NT for phosphorylation in order to promote mitotic exit. It is 
also plausible that the Clb2/Cdc28 cyclin-dependent kinase complex would also phosphorylate the Rfa2 
NT, similar to that observed in Candida albicans (Gao et al. 2014), as the Clb2/Cdc28-meiosis-specific 
homolog Ime2 phosphorylates Rfa2 at S27 during meiosis, prior to meiotic recombination (Clifford et al. 
2004). Ultimately, cells must commit to permanent arrest or continued growth in order to survive, and it is 
plausible to think about the DDR program in a temporal fashion where cells only provide the DDR 
program with a certain amount of time to complete DNA repair and resume cell growth before the cell 
overrides the DDC and enters mitosis. 
4.5.C. Potential therapeutic value in targeting Rpa2 phosphorylation during chemoradiation 
therapy in human disease 
If phosphorylation of the Rfa2 NT is the predominant driver of mitotic entry, then it is also possible 
to speculate on the potential therapeutic value of promoting or inhibiting Rfa2 NT phosphorylation. In a 
tel1Δ, we observed that adaptation could not be rescued when combined with rfa2-ΔNX to the same level 
as WT cells. Moreover, cells containing rfa2-ΔNX are proficient for DNA replication in unstressed cells, 
similar to rfa2-DX. Current therapeutic strategies for the treatment of cancer, a cellular disease caused by 
genetic mutations that cause dysregulation of cell growth, involve whole-organism exposure to genotoxic 
agents like MMS or CPT, in combination with radiation-induced DNA damage (chemoradiation therapy) 
with the idea that non-cancerous cells will be able to faithfully repair any lesions generated by the 
genotoxic agents, and cancer cells by virtue of their dysregulated growth cycle, will ultimately suffer 
enough genome-destabilizing mutations that the cancer cells will undergo apoptosis. While this is one of 
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the main therapeutic strategies used today, it still threatens the genomic fidelity of all cells within the 
affected host. A more effective treatment option may be a targeted therapy to inhibit Rpa2 
phosphorylation through targeted kinase inhibition, or through promoting Rpa2 phosphorylation by 
stimulating the kinases that directly phosphorylate Rpa2 during mitotic entry (CDK). Recently, it was 
shown that the Rpa2 phospho-state correlates with cancer progression, as phosphorylated Rpa2 at 
S4/S8 were shown to be observed in higher concentration in dysplasias (abnormal cells within a tissue 
that may indicate pre-cancerous development), moderate concentrations in early grade tumors, and low 
concentrations in late-stage tumors (Rector et al. 2017). Moreover, RPA inhibitors to the Rpa1 N-terminal 
oligonucleotide-binding-fold-like domain have been demonstrated to increase replication stress and 
suppress tumor development in squamous cell carcinoma lines (Glanzer et al. 2014). Taken altogether, 
the findings presented here in context with what is currently known about Rpa2 phosphorylation 
mediating mitotic exit support a model where preventing phosphorylation of the Rpa2 NT may be a 
requirement of proper, concerted DNA repair, whereas promoting phosphorylation may be the signal that 
tells the cell that DNA repair is complete and that the cell can divide, safely preserving the fidelity of the 
genome. It is also possible that phosphorylation of the Rpa2 NT may be the biochemical signal that tells 
the cell to divide, irrespective of whether DNA repair has occurred.   
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CHAPTER 5: FUNCTION OF THE RFA2 NT IN MEIOSIS AND OTHER UNSOLVED MYSTERIES 
5.1. Introduction 
The process of meiosis (Chapter 1, Figure 1.2), or the generation of haploid gametes from diploid 
cells, is essential for the propagation of all sexually reproducing life (Martini et al. 2002). During meiosis, 
180-200 programmed DSBs are generated by the recombination initiation complex (RIC) (described in 
Chapter 1, section 1.5) (Keeney et al. 1997). The role the RFA complex plays during meiosis remains 
poorly understood. Furthermore, the role Rfa2 NT phosphorylation plays during meiosis in 
Saccharomyces cerevisiae has not been examined. 
In budding yeast, Rfa2 is known to be phosphorylated at S27 by the meiosis-specific Cdc28-
homolog Ime2 (Clifford et al. 2004). This phosphorylation occurs independent of RFA complex binding to 
DNA, and occurs prior to meiotic recombination (ibid), however, the physiological relevance of this 
phosphorylation event remains unclear. Rfa2 is also known to be phosphorylated by the DNA damage 
sensor kinase Mec1 at S122 during meiosis, however, the role of this phosphorylation event appears 
mostly moot as cells expressing phospho-mutation forms of rfa2-S122A/D produce only a modest change 
in crossover frequency with no impact on sporulation or spore viability (Bartrand et al. 2006). 
In an effort to elucidate the function of the Rfa2 NT and its phospho-state during meiosis, a series 
of integrating vectors containing Rfa2 NT extensive mutations were generated. Using these Rfa2 NT 
extensive integrating vectors, chromosome replacements of the endogenous RFA2 locus were performed 
in two meiotic yeast strain backgrounds, and the effects of extensive Rfa2 NT mutation were examined. I 
determined that the yeast Rfa2 NT phosphorylation plays a role in mediating meiosis, as cells containing 
mutant forms of the Rfa2 NT are defective in sporulation and produce high numbers of inviable spores. 
Moreover, I discovered that the Rfa2 NT is dispensable for the process of meiotic recombination, as cells 
containing rfa2-ΔNX are able to recombine at diagnostic loci examined at the same frequency as cells 
containing RFA2. 
While Rfa2 interaction with Rfa1 and Rfa3 are essential for complex formation and RFA activity, it 
is currently unknown what other yeast proteins involved in the lesion processing and repair (LPR) 
program Rfa2 interacts with. In an effort to examine Rfa2 interactions during both mitosis and meiosis, a 
series of yeast two hybrid vectors was generated with the assistance of Dr. Haring’s Methods of 
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Recombinant DNA technology class during the spring semester in 2015. A list of the vectors generated 
can be found in Table 5.1. Unfortunately, however, the reporter vector used auto-activated on diagnostic 
media producing false-positive hits. As a result, the experiment was terminated until a new yeast two 
hybrid system could be obtained. 
Table 5.1. List of yeast two hybrid vectors generated. 
Gene Target Vector Sequence Verified? 
Mre11 pJG4-5-B42-MRE11 Yes 
Lge1 pJG4-5-B42-LGE1 Yes 
Ybr137 pJG4-5-B42-YBR137W Yes 
Xrs2 pJG4-5-B42-XRS2 Yes 
Sae2 pJG4-5-B42-SAE2 Yes 
Cmr1 pJG4-5-B42-CMR1 Yes 
Dmc1 pJG4-5-B42-DMC1 Yes 
Rad50 pJG4-5-B42-RAD50 Yes 
Rad51 pJG4-5-B42-RAD51 Yes 
Rad52 pJG4-5-B42-RAD52 Yes 
Rad54 pJG4-5-B42-RAD54 Yes 
Rad55 pJG4-5-B42-RAD55 Yes 
Rad57 pJG4-5-B42-RAD57 Yes 
Rad59 pJG4-5-B42-RAD59 Yes 
 
5.2. Materials and Methods 
5.2.A. Construction and In vitro site-directed mutagenesis of pRS315-Rfa2 NT extensive vectors 
Construction of pRS316-Rfa2 NT extensive mutant vectors was performed as follows. pRS315-
derivative plasmids containing each Rfa2 NT mutation were digested with PvuII in order to excise the 
Rfa2 NT mutant cassette from pRS315. Empty pRS316 plasmid was digested with EcoRV and PvuII to 
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linearize the vector and create two homologous ends for in vivo homologous recombination in budding 
yeast. Linearized pRS316 and PvuII digested pRS315-Rfa2 NT mutant DNA was then co-transformed 
into yeast. Transformants were plated on SD-Ura media in order to select for pRS316 vector 
recircularization. Following a four-day incubation, 1 mL of SD-Ura liquid media was used to flood the 
media plate, and total transformants were harvested by gently scrapping the plate and suspending the 
total cells into the liquid media. The resuspension was then added to 4 mL of SD-Ura media and grown 
overnight. Following yeast genomic DNA isolation, bacterial transformation into DH10B E. coli cells was 
performed and selection was done using LB-Amp plates. Bacterial transformants were then analyzed via 
colony cracking and restriction digest using diagnostic enzymes for each pRS316-Rfa2 NT extensive 
mutant (section 5.2.B.). Positive candidate plasmids were then sequenced by Eton Biosciences and used 
in in vitro site-directed mutagenesis.  
In vitro site-directed mutagenesis of pRS316-Rfa2 NT extensive mutation vectors (Appendix B) 
using a mutagenic primer (Appendix C) designed to remove the CEN6/ARS4 centromeric and 
autonomously replicating sequence was performed under standard PCR conditions. Following a DpnI 
digest, mutagenesis reactions were transformed into DH10B E. coli cells and plated on Luria Broth plates 
containing Ampicilin to select for transformants that had taken up in-tact vector. Candidate transformants 
were then harvested from the plate after 24 hours and manually screened via colony cracking, followed 
by a diagnostic digest (Figure 5.1). Vectors lacking the CEN6/ARS4 site were then mini-prepped using 
the Omega Biotech E.Z.N.A Plasmid mini-prep kit, transformed back into E. coli, and added to the Haring 
lab permanent collection. pRS316-Rfa2 NT extensive vectors were accidentally discarded. 
5.2.B. Integration of pRS306-Rfa2 NT extensive mutations into haploid yeast 
RM26-26C and K264-10D yeast (Appendix A) were made competent and transformed with 
SnaBI-linearized pRS306-Rfa2 NT extensive mutation vectors. The SnaBI digest linearized the vector 
near the rfa2 coding sequence and was necessary to target two-step gene replacement at the RFA2 
locus. Transformations were plated on SD-URA media. Positive transformants were struck to a master 
plate and tested via PCR to verify that the yeast were RFA2/rfa2 positive. Overnight cultures of verified 
integrants were grown in YPD to stimulate pop-out of one of the RFA2 sequences and were then spread 
out on 1.0 mg/mL 5’-FOA in order to select for cells that recombined out the pRS306 vector sequence. 
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Cells that grew on 5’-FOA were then analyzed via PCR for integration of the Rfa2 NT extensive mutation. 
Positive candidate PCR fragments were then sent to Eton Biosciences for sequencing, and positive 
candidate yeast were replicated to YP-Glycerol media to ensure functional mitochondria. Verified 
candidates were then added to the Haring lab yeast permanent collection. 
 
Figure 5.1.  Restriction digest verification of Rfa2 NT extensive mutations in pRS306 integrating 
vectors. 
pRS306-Rfa2 NT extensive mutation vectors were digested with AlwNI, AccI, and HpaI in order to verify 
that each Rfa2 NT extensive mutation was present. pRS316-Rfa2-cDNA was used as a vector control for 
pRS306 or pRS316. AlwNI restriction digest is diagnostic for the presence of rfa2-AX as the coding 
sequence for rfa2-AX contains an additional AlwNI site that produces two additional fragments at ~1300 
bp and ~650 bp from the 2 kbp fragment present in rfa2-DX and rfa2-ΔNX extensive mutation vectors. AccI 
restriction digest is diagnostic for the presence of rfa2-DX and produces distinct digestion products from 
the 2 kbp fragment produced in the other extensive mutation vectors. HpaI is diagnostic for rfa2-ΔNX, as 
insertion of the rfa2-ΔNX coding sequence eliminates an HpaI site present within the other Rfa2 NT 
extensive mutation vectors. PCR amplification was also used to verify 
5.2.C. Mating of haploid yeast to create diploid cells 
RM26-26C and K264-10D yeast integrants containing Rfa2 NT extensive mutations were mated 
by taking a patch of RM26-26C haploid cells and mashing them in with K264-10D haploid cells on SD-
Com media. The following day. A streak from the mash was then taken from the haploid mash and struck 
out for single colonies on SD-His media to screen for diploids. Diploid yeast were verified as such by 
diagnostic replica plating to SD-His, SD-Leu, SD-Lys, and SD-Trp media. 
5.2.D. Sporulation of diploid yeast and tetrad dissection 
Diploids containing Rfa2 NT extensive mutations were patched to SpoIII-Com media (minimal 
media) in order to induce sporulation via carbon/nitrogen starvation. Sporulation was monitored by 
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morphological analysis of cells following a three-minute zymolyase treatment using 3 uL of zylmolyase in 
300 uL of ddH2O on a hemocytometer. Zymolyase-treated tetrads were then spread finely on a YPD plate 
and dissected using a micro-dissection needle attached to an Olympus microscope. Spore viability was 
then quantitated from resulting spores after four days of growth. 
5.2.E. Diagnostic replica plating 
Diploid yeast patches from a master plate were replica plated onto diagnostic media (SD-His, SD-
Leu, SD-Trp) to rapidly analyze effects on heteroallelic recombination. Plates were monitored over four 
days and results were documented. 
5.2.F. Analysis of heteroallelic recombination 
Diploid yeast grown in liquid SpoII-Com media were harvested, treated with zymolyase to remove 
the ascal coat and spread on SD-Leu or SD-Trp plates in order to assess heteroallelic recombination. 
Colonies that grew (positive recombinants) were then counted on each plate and quantitated. 
5.2.G. qPCR of MAT locus during mating type switching 
K264-10D cells containing Rfa2 NT extensive mutations cells were transformed with pGAL-HO 
(URA3+) and selected for positive transformants on SD-Ura media. Positive transformants were then 
plated to a master plate, and overnight cultures were started. The following day, cells were subcultured 
into 50 mL of SA-Ura (Synthetic complete media using acetate as a carbon source without uracil) and 
grown to an OD600 of 1.0. 10mL of 20% galactose in sterile filtered ddH2O was then added to the media to 
a final concentration of 2% to induce expression of the HO endonuclease. Cells were harvested pre-HO 
induction (T=0) and at 30-minute intervals following HO induction for four hours. Genomic DNA was 
harvested from samples isolated via phenol:chloroform:isoamyl alcohol (P:C:I) extraction and quantitated 
via spectroscopy. 10ng of DNA was used for qPCR with appropriate primers (Appendix C) diagnostic to 
determine the frequency of mating type switching from ‘A’ to ‘α’. 
5.2.H. Generation of yeast two hybrid vectors 
With the assistance of the Spring 2015 BIOC 474/674 Methods of Recombinant DNA technology 
course, pJG4-5 yeast two hybrid prey vectors to various lesion and processing repair proteins were 
generated. Vectors were analyzed during the course via diagnostic digest for proper insertion of desired 
target-prey genes. Positive candidate vectors were then sent to Eton Biosciences for sequence 
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verification. Vectors with whole gene insertions were then added to the Haring lab plasmid collection, and 
transformed into yeast with pEG202, and pSH18-34. Candidate yeast were then screened via diagnostic 
replica plating to SD-His/Trp/Leu media containing X-Gal. Unfortunately, all of the yeast two hybrid 
vectors auto-activated, producing blue colonies. Results were documented, and plates were discarded 
without photo documentation. 
5.3. Results 
5.3.A. Examination of the effects of Rfa2 NT extensive mutations during meiosis 
Diploid yeast containing Rfa2 NT extensive mutations were pushed to undergo meiosis via 
carbon/nitrogen starvation as described above. Microscopic analysis of the cellular morphology of 
zymolyase treated yeast revealed that each Rfa2 NT extensive mutation was capable of facilitating 
meiosis in yeast. However, as Figure 5.2 shows, a severe meiotic deficiency was observed in 
homozygous diploids containing rfa2-ΔNX. The wild-type yeast tested in this study were able to undergo 
meiosis roughly 52% of the time, whereas cells containing rfa2-ΔNX displayed only sporulated at 46%. 
Moreover, rfa2-ΔNX led to an increase in the number of 2-cell, incomplete spores, much more frequently 
than wild-type (~20% for rfa2-ΔNX versus ~12% for RFA2). The phospho-state of the Rfa2 NT, however, 
did not appear to play a major role in the ability of cells to undergo meiosis, as cells containing the rfa2-DX 
or rfa2-AX mutations sporulated at roughly the same frequency (~63% for each).  
While each of the Rfa2 NT extensive mutations were able to promote and facilitate meiosis in 
budding yeast, their effects on tetrad formation (Figure 5.2, Tables 5.2 and 5.3) and spore viability was 
markedly different (Figure 5.3, Tables 5.4and 5.5). Analysis of the ability of Rfa2 NT extensive mutant 
diploids to form tetrads revealed that mutant cells containing rfa2-DX or rfa2-AX formed a tetrad containing 
four spores in approximately 50% of cells examined. Cells containing RFA2 were only able to form tetrads 
40% of the time, and the removal of the RFA2 intron (cDNA-WT) led to a 7% increase in the ability of 
these diploids to form tetrads after meiosis. Mutant cells containing the rfa2-ΔNX mutation were only able 
to form tetrads in 26% of cells examined. This is potentially suggestive of a role for the intron of RFA2 in 
regulating Rfa2 activity during meiosis and will require further study.  
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Further analysis of effects of Rfa2 NT extensive mutations during meiosis revealed markedly 
different spore survival phenotypes for each Rfa2 NT mutation. Cells containing RFA2, or the rfa2-cDNA-
WT or rfa2-AX mutations, produced 4 viable spores in at least 80% of tetrads dissected. Cells containing 
 
Figure 5.2.  Effect of Rfa2 NT extensive mutations on meiosis in budding yeast. 
Yeast diploids containing Rfa2 NT extensive mutations grown on YPD plates were replica plated to 
SpoIII-Com plates. After 4 days, a P-200 pipetman was used to harvest a small scrape of cells from the 
patch. Cells were then resuspended in 300 uL sterile ddH2O and 3 uL of zymolyase was added and cells 
were zymolyase treated for 3 minutes. 20 uL of the reaction was then added to a hemocytometer slide 
and sporulation was counted via microscopic analysis of cellular morphology and quantitated. Averages 
and error bars presented were calculated from three independent replica platings and microscopic 
counts. 
Table 5.2. Effect of Rfa2 NT extensive mutations on tetrad formation in budding yeast. 
RFA2 Allele 4 Spores 2 Spores Vegetative 
RFA2 40% 12% 49% 
cDNA-WT 47% 8% 44% 
rfa2-DX 51% 12% 37% 
rfa2-AX 53% 10% 37% 
rfa2-ΔNX 26% 20% 54% 
Tetrads that form four spores were counted against a total population of cells scraped from the 
sporulating yeast patches on solid media plates. Two spores indicate dyads, whereas vegetative cells are 
single unbudded yeast cells. 
Table 5.3. Effect of Rfa2 NT extensive mutations on meiosis in budding yeast. 
RFA2 Allele: RFA2 RFA2-cDNA rfa2-DX rfa2-AX rfa2-ΔNX 
% Sporulated 51 ± 8% 56 ± 8% 63 ± 11% 63 ± 9% 46 ± 11% 
Percent sporulation was calculated by adding the total of two and four spore meiotic products together.  
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the rfa2-DX mutation only produced viable tetrads in approximately 60% of tetrads dissected, suggesting 
that permanent phospho-mimetic mutation of the Rfa2 NT leads to a meiotic defect. Cells containing the 
rfa2-ΔNX were only able to produce four viable tetrads in 22% of tetrads dissected, demonstrating that the 
physical presence of the Rfa2 NT is a requirement for proper progression through meiosis in budding 
yeast.   
After tetrad dissection, 92% of the spores analyzed from WT cells were viable, as well as 97% of 
the spores examined from rfa2-cDNA diploids. Spores containing the rfa2-AX mutation were examined 
and determined to have a viability of 94%, in-line with wild-type cells. Examination of rfa2-DX and rfa2-
ΔNX revealed that only 85% and 66% of spores analyzed, respectively, were viable. This indicates that 
phospho-mimetic mutation of the Rfa2 NT or deletion of the Rfa2 NT has a detrimental effect on the 
meiotic program during meiosis. Moreover, this data also indicates that the Rfa2 NT is required for proper 
meiotic progression. 
 
Figure 5.3.  Effect of Rfa2 NT extensive mutations on spore viability in budding yeast. 
Diploid cells containing Rfa2 NT extensive mutations were harvested as described in Figure 5.3. 
Following zymolyase treatment, cells were spread thinly onto a YPD plate using a sterilized inoculating 
loop. Tetrads were then micro-dissected using a pulled glass needle attached to an Olympus microscope 
and each spore’s position on the plate was documented. Spore survival ratio was then calculated based 
on how many individual spores grew into single colonies at their respective positions. 4:0 indicates all four 
spores from the tetrad grew into colonies, 0:4 indicates none of the dissected tetrads grew into colonies. 
Viability percentages and error bars were calculated from a total of 160 (four independent experiments) 
dissected spores of each Rfa2 NT extensive mutation diploid. 
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Table 5.4. Effect of Rfa2 NT extensive mutations on spore survival ratio in budding yeast. 
RFA2 Allele 4:0 3:1 2:2 1:3 0:4 
RFA2 81% 9% 7% 3% 0% 
cDNA-WT 89% 11% 0% 0% 0% 
rfa2-DX 59% 25% 13% 3% 0% 
rfa2-AX 81% 15% 4% 0% 0% 
rfa2-ΔNX 22% 39% 25% 11% 3% 
Spore survival ratio was calculated by counting the number of live spores per row after tetrad dissection. 
A ratio of 4:0 indicates four live spores, zero dead spores, whereas 2:2 indicates two live cells, two dead 
spores. 
Table 5.5. Effect of Rfa2 NT extensive mutations on spore viability in budding yeast. 
RFA2 Allele: RFA2 RFA2-cDNA rfa2-DX rfa2-AX rfa2-ΔNX 
% Viability 92 ± 6% 97 ± 2% 85 ± 7% 94 ± 3% 66 ± 5% 
Percent viability is calculated as a ratio of total colonies that grew from individual spores divided by the 
total number of spores dissected, irrespective of their spore survival ratio 
5.3.B. Effects of Rfa2 NT extensive mutations on heteroallelic recombination 
To analyze the effects of Rfa2 NT extensive mutations during homologous recombination, 
heteroallelic recombination was assayed in mitotically growing and meiotic products from Rfa2 NT 
extensive mutant diploids via qualitative replica plating (Figure 5.4) as well as a quantitative spore 
recombination assay (Figure 5.5). For cells to produce micro-colonies on diagnostic media, a single 
homologous recombination event must occur between auxotrophic mutant alleles (e.g: lys2-2 and lys2-5) 
to produce a prototrophic colony. During meiosis, the process of homologous recombination occurs at a 
nearly 100-fold increased frequency from that of mitotic cells. During diagnostic replica plating we 
observed micro-colony formation on two different diagnostic media. This demonstrates that diploids 
containing Rfa2 NT extensive mutations are proficient for both mitotic recombination and meiotic 
recombination and suggests that the Rfa2 NT is dispensable for the processes of homologous 
recombination in both mitotic and meiotic cells.  
Further evidence of the dispensability for the Rfa2 NT during meiotic recombination was obtained 
through a quantitative assessment of heteroallelic recombination via random spore spreads. After treating 
tetrads with zymolyase, cells were spread on diagnostic media, allowed to grow, and then counted. Cells 
containing Rfa2 NT extensive mutations were able to perform heteroallelic recombination within 1-2-fold 
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total recombination frequency compared to wild-type Rfa2 or the rfa2-cDNA-WT mutation. If homologous 
recombination at any level were impacted by the state of the Rfa2 NT, then we would expect that less or 
no recombinants would be present. However, as indicated by both recombination assays the Rfa2 NT 
state does not play a major role in the ability of cells to perform homologous recombination during 
meiosis.  
  
Figure 5.4.  Effect of Rfa2 NT extensive mutations on heteroallelic recombination in budding yeast 
via diagnostic replica plating. 
Diploid yeast containing Rfa2 NT extensive mutations were replica plated to SpoIII-Com plates in order to 
induce meiosis. The YPD master plate containing diploids was replica plated to SD-His, SD-Leu, and SD-
Trp media to qualitatively analyze mitotic recombination frequency. After 4 days, SpoIII-Com replica plate 
was replica plated to SD-His, SD-Leu, and SD-Trp media to qualitatively analyze meiotic recombination 
frequency. 
5.3.C. Effects of Rfa2 NT extensive mutations on mating type switching 
Using qPCR analysis, I attempted to quantify the ability of cells to undergo a specialized type of 
recombination event that allows yeast to switch mating-type from A to α, and vice versa. During mating-
type switching, donor sequence from the HML-α and HMR-a loci on chromosome III are used to repair the 
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MAT locus to the opposite mating type. Initiation of mating-type switching occurs via expression of HO 
endonuclease, which cleaves the MAT locus. However, the DSB generated in cells that are HML+ and 
 
Figure 5.5.  Effect of Rfa2 NT extensive mutations on heteroallelic recombination in budding yeast. 
Diploid yeast containing Rfa2 NT extensive mutations were grown in YPD rich media overnight, 
harvested, washed in ddH2O and subcultured into YPA media. The following day, cells were harvested, 
washed once more, and subcultured into SpoII-Com liquid media and allowed to sporulate overnight. 
Presence of spores was examined microscopically. Cells were then harvested, treated with zymolyase, 
and equal numbers of cells were spread on SD-Leu or SD-Trp plates using microbeads. After four days of 
growth, colonies on each plate were calculated. Trial 1 and Trial 2 averages and error bars are from three 
independent platings following two independent liquid sporulation assays. 
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HMR+ does not lead to activation of Rad53-dependent checkpoint arrest and is repaired rapidly (Pellicioli 
et al. 2001). Because we had discovered a meiotic defect in diploids containing Rfa2 NT extensive 
mutations, we sought to understand if this defect was due to an inability to perform homologous 
recombination. However, results from heteroallelic recombination assays suggested that Rfa2 NT 
extensive mutations were proficient for recombination (section 5.3.B). Unfortunately, due to the 
experimental conditions we were using, I was unable to obtain a consistent result for the ability of the 
tested Rfa2 NT extensive mutations in K264-10D. Dr. Haring and I believe that this was largely due to the 
fact that we were doing glucose depletion in acetate media, rather than raffinose media. Induction or 
expression of HO was not measured. Furthermore, the cells we were using were expressing HO off of a 
plasmid that had a leaky promoter, and HO ended up being expressed at inopportune and unmeasurable 
times. As a result, the project was shelved. However, because yeast cells containing Rfa2 NT extensive 
mutations all progress through meiosis, albeit at differential rates and viabilities, and were successfully 
able to produce heteroallelic recombinants (Figure 5.5 and 5.6), we assessed that the defect in Rfa2 NT 
extensive mutation yeast was not due to an inability to perform homologous recombination. 
5.3.D. Auto-activation of pJG4-5 bait vector prevented identification of Rfa2 interacting partners 
Using the assistance of Dr. Haring’s Recombinant DNA technology course at NDSU, we were 
able to successfully generate a number of yeast two hybrid (Y2H) prey vectors (Table 5.1) that we tested 
in a yeast two hybrid assay. During the Y2H assay, a reporter vector containing LexA operator sites 
recruits the LexA-DBD-Bait protein, in this case LexA-DBD-Rfa1, to the operator sequence. In order for 
transcription of the reporter gene LacZ, the B42-AD-Prey construct must come within close enough 
proximity to interact with the LexA-DBD-Bait protein. Reporter activity can be assessed by blue-white 
screening using X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside), which when cleaved by LacZ 
leads to the formation of a blue pigment in the yeast. Yeast patches that turn blue after replica plating to 
X-Gal media are ‘positive’ hits indicative of a protein-protein interaction between bait and prey proteins, 
whereas white patches are indicative of a null interaction. During my attempts to perform the Y2H assay, 
it became apparent that the bait vector was auto-activating and producing blue colonies, even in the 
presence of empty pJG4-5 vector. When testing the prey vectors listed in Table 5.1, our reporter vector 
displayed auto-activation in the presence of an empty bait vector as recognized by blue tinted yeast, 
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suggesting that our Rfa1-prey vector was likely responsible for this auto-activation. As a result, the Y2H 
project was shelved, and it was determined that a new Y2H system with different reporter, bait, and prey 
vectors would be required. 
5.4. Discussion 
From the results above, it is clear that the Rfa2 NT is required for proper progression through the 
meiotic program but is dispensable for meiotic recombination during meiosis. It is fascinating to speculate 
as to why rfa2-ΔNX mutations were unable to promote proper meiotic progression, lead to an increase in 
the number of 2-cell spores, and also produced a much higher frequency of inviable haploids. Based on 
my research in previous chapters, I speculate that is likely caused by the lack of the Rfa2 NT, of which 
phosphorylation within this domain may be required during meiosis to promote both the reductional 
division during MI and the equational division during MII. However, it is possible that the lack of the Rfa2 
NT and phospho-sites therein leads to a cell cycle timing defect. MII is often referred to as a mitotic-like 
equational division and if Rfa2 NT phosphorylation is required for mitotic exit, the lack of phospho-sites 
caused by the NT truncation would cause cells to accumulate in MII as dyads (two-cell spores). This idea 
is supported by the observation that DSBs generated during late meiosis (e.g. MII) typically lead to mitotic 
LPR signaling, Rad53 activation and normal mitotic DDC establishment (Cartagena-Lirola et al. 2008). 
Therefore, phosphorylation of the Rfa2 NT during meiosis may be a requirement of proper temporal 
progression of the meiotic program. 
Moreover, defects in rfa2-DX allude to the idea that rapid modulation of the Rfa2 NT phospho-
state may be required to produce viable spores, as cells containing rfa2-DX sporulated with the same 
frequency as rfa2-AX but also produced many more inviable cells. It is plausible then that the phospho-
mimetic rfa2-DX mutation is promoting aberrant checkpoint exit during meiosis, as I have observed in 
mitotically growing cells. This aberrant exit from MII, for example, would cause missegregation of 
chromosomes and inviability due to progressing through the meiotic division faster than cells containing 
Rfa2 or Rfa2-AX.  While a disruption in the temporal meiotic program is enticing, analyzing which RFA-
protein interactions are important for promoting proper meiotic progression will be a key area of research 
in the future as well. For example, it has been demonstrated that RPA interacts with both Rad51 and 
Dmc1 during meiosis (Golub et al. 1998, Murayama et al. 2013)
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has been demonstrated to be weak but still occur and may be a result of the programmed nature of the 
DSBs during meiotic recombination. Dmc1 is utilized preferentially during presynaptic filament formation 
during meiosis over Rad51 because Dmc1 drives interhomolog exchange (Schwacha et al. 1997) 
whereas Rad51 drives intersister exchange (Nimonkar et al. 2012).  Understanding how these 
interactions are disrupted or impacted by the phospho-state of the Rfa2 NT may provide insight into the 
regulatory mechanisms utilized by cells during the MI and MII divisions. 
Unfortunately, my current experimental design did not allow for adequate testing of RFA-protein 
interactions via Y2H due to auto-activation of the reporter vector pSH18-34. In order for Y2H to function 
properly, the LexA binding domain fused to a bait protein (Rfa1 in this case; pEG202-LexA-BD-Rfa1) and 
the LexA BD localizes to the LexA operator sites present on pSH18-34. In order for transcription of the 
reporter to occur, the B42 activation domain fused to a prey protein must come within close enough 
proximity to the LexA BD to interact, driving transcription of the reporter gene. During my attempts to 
perform the Y2H, our reporter vector auto-activated in the presence of empty pEG202-LexA-BD. 
Moreover, reporter auto-activation also occurred in the presence of each of our pJG4-5-B42-AD-Prey 
vectors making it impossible to distinguish positive hits from false positive results. Dr. Haring and I 
recently discussed some ways around this. Our main problem appears to be with our bait vector, and our 
collaborator Dr. Andre Walther from Cedar Crest College has offered his Y2H vector system as a 
replacement for our own. Once obtained, simple in vivo homologous recombination reactions could re-
generate all of the vectors described in Table 5.1. Transformation and diagnostic replica plating would 
then yield strains ready to be tested via Y2H, hopefully with auto-activation free vectors. 
Dr. Haring and I also discussed ways to better the qPCR mating-type switch assay in order to get 
a final result on whether the Rfa2 NT extensive mutations do not have a major effect on homologous 
recombination. First, each of the strains utilized should be grown in or on YPR media in order to deplete 
glucose stores and provide a better starting point for galactose induction. Second, DNA isolated for qPCR 
should be isolated via the methods described in chapter 4.3.E, as this yields the cleanest, contaminant-
free DNA for qPCR. Third, our use of Applied Biological Materials (abm) EvaGreen qPCR mix has yielded 
exceptional results, where previously we had been using QuantaBioscience SYBR qPCR Fast mix. While 
it is unlikely that the age of the reagents used played a significant role in the failure of the aforementioned 
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qPCR experiments, care should be taken in the future to use the freshest reagents possible for optimal 
results. 
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CHAPTER 6: CONCLUDING DISCUSSION AND FINAL REMARKS 
Stable transfer of unadulterated genetic information during mitosis and meiosis is essential for the 
continued propagation of all life on Earth. Despite the wealth of information that is known about Rpa2 NT 
phosphorylation in human cells, the physiological consequences and impacts of phosphorylation of the 
Rpa2 NT remain elusive. The work described in Chapter 2 demonstrates a dispensability for 
phosphorylation of the Rfa2 NT in yeast and suggests that preventing cells from rapidly modulating the 
phospho-state of the Rfa2 NT may have negatively impact the ability of cells to perform stable genetic 
transfer. The work described in Chapters 3 and 4 contribute significantly to the understanding of the 
mechanisms of checkpoint adaptation in that phosphorylation of the Rfa2 NT appears to be the 
predominant driver of the molecular decisions to exit an established checkpoint in response to a 
permanent DNA lesion. Moreover, one question that remains unanswered is whether DSB resection is 
required for checkpoint adaptation. My results using a qPCR-based resection assay (Chapter 4, Figure 
4.4) demonstrate that resection is not impacted by the Rfa2 NT phospho-state and suggest that Rfa2 NT 
phosphorylation promotes checkpoint adaptation independent of DNA resection and rescues all of the 
tested adaptation-deficient phenotypes generated by deletion of several recombination/repair and 
checkpoint factors. The brief studies performed in meiotic cells in Chapter 5 also allude to a role in Rfa2 
NT phosphorylation in mediating successful meiotic progression and divisions. This chapter will focus on 
the results of my work and how they relate to previous and current work in the field of the DNA damage 
response (DDR), encompassing the processes of lesion processing and repair (LPR) and the DNA 
damage-dependent checkpoint (DDC), and provide a model for the role of Rfa2 NT phosphorylation in 
each process. 
6.1. The role of the Rpa2 NT in LPR 
Upon detection of a DNA lesion, the RPA complex localizes to the DSB and binds and protects 
the single-stranded DNA (ssDNA) generated during lesion processing, prior to DNA repair. Previous 
research in human cells has demonstrated that Rpa2 becomes phosphorylated by the damage sensor 
kinases DNA-PK, ATM, and ATR/ATRIP (Wang et al. 2001, Manthey et al. 2007, Liu et al. 2012). 
However, the physiological relevance of these phosphorylation events and their function in cells has 
remained elusive. Studies performed using permanent phospho-mimetic mutations has revealed that 
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preventing phosphorylation at damage-dependent phospho-sites leads to aberrant replication restart 
(Vassin et al. 2009) and deficiencies in homologous recombination repair (Liaw et al. 2011). Thus, rapid 
modulation of the Rpa2 NT phospho-state is a requirement for proper LPR, checkpoint maintenance, and 
mitotic exit. 
6.1.A. Phosphorylation of the Rfa2 NT appears to be dispensable for LPR 
As mentioned above, Rpa2 in human cells is robustly phosphorylated during the LPR program by 
DNA-PK, ATM, and ATR/ATRIP. In yeast, however, overt phosphorylation of the Rfa2 NT is not readily 
observable under short-term genotoxic conditions and only seems to appear during prolonged exposure 
to genotoxic agents. Phosphorylation of the yeast Rfa2 NT also appears to be dispensable for LPR, as 
the phospho-mimetic rfa2-DX mutation leads to an increased sensitivity to genotoxic agents in wild-type 
cells, as well as cells already sensitive to genotoxic agents. Moreover, the rfa2-AX mutation seems to 
confer clastogen resistance on par with wild-type cells, further suggestive that phosphorylation of the 
Rfa2 NT during LPR has negative consequences for the cell. 
Phosphorylation of the Rpa2 NT has been reported to reduce interaction with the MRN complex 
in vitro, specifically impeding interaction with Nbs1 and Mre11 (Oakley et al. 2009). Moreover, phospho-
mimetic Rpa2 displays impairs both interactions with DNA polymerase α and inhibits SV40 DNA 
replication (Oakley et al. 2003). The impaired interactions with the MRN complex and DNA polymerase α 
may explain the sensitivity to genotoxic agents conferred by rfa2-DX in yeast, as well as repair 
deficiencies observed in human cells. While phospho-mimetic forms of Rpa2 have been demonstrated to 
be proficient during checkpoint activation, impairing an interaction with MRN could potentially lead to 
aberrant resection phenotypes that cause loss of genetic information or lead to mutation. Furthermore, 
impaired interactions with DNA polymerase α during repair synthesis at the D-loop pseudo-replication 
bubble would prevent adequate DNA synthesis from occurring, inhibiting repair and leading to the 
recombination deficient phenotypes observed in human cells. Moreover, the phospho-state of the Rpa2 
NT does not appear to be required for localization of the RPA complex to DSB sites, as cells expressing 
the phospho-mimetic mutations of Rpa2 were still proficient for repair foci formation (Binz et al. 2003, 
Vassin et al. 2004). In the studies performed in Chapter 2, all of the Rfa2 NT extensive mutations were 
capable of activating the Rad53-dependent checkpoint indistinguishably from WT cells, demonstrating 
  171 
that the phospho-state of Rfa2 or the physical presence of the Rfa2 NT is not a requirement for proper 
initiation of checkpoint signaling during the initial LPR events. 
6.1.B. The Rfa2 NT is physically required for LPR 
Previous research has demonstrated that the Rfa2 NT is physically required in order for cells to 
tolerate genotoxic stress by a number of clastogens (Ghospurkar et al. 2015). Similar results were 
observed in experiments carried out in Chapter 2. Together, these results demonstrate that the physical 
presence of the Rfa2 NT is required for proper genome maintenance during lesion processing and repair, 
but as mentioned above its phospho-state may be completely dispensable. Previous research by Anantha 
et al. (2009) indicated that Rpa2 NT phosphorylation is a requirement of proper mitotic exit, and 
prematurely stimulating phosphorylation of the Rpa2 NT via phospho-mimetic mutation leads to aberrant 
checkpoint exit despite the presence of lesions. Thus, being unable to modulate the phospho-state of the 
Rpa2 NT is detrimental to cells and genomic stability. Furthermore, if phosphorylation of the Rpa2 NT 
impairs interaction with DNA polymerase α, as reported, preventing phosphorylation during DNA 
synthesis would be essential for ensuring that DNA replication can initiate properly. 
Additional evidence in human cells has demonstrated that phosphorylation of the Rpa2 NT is 
required for an interaction with the Prp19 ubiquitin ligase (Dubois et al. 2017). Ubiquitination of proteins 
involved in LPR have been described as a requirement for proper repair and checkpoint activation, 
however, this data is somewhat inconsistent with other evidence demonstrating that ubiquitin ligases are 
also required for inactivation of the DNA damage-dependent checkpoint (Zhang et al. 2005).  
I propose a model (Figure 6.1) that involves dephosphorylated RPA recruiting in the initial repair 
machinery, which then would lead to phosphorylation of the Rpa2 NT driving an interaction with the Prp19 
ligase. RPA would then sumoylated by the Pias1/Pias4 E3 sumo-ligases (Galanty et al. 2009), protecting 
it from ubiquitination and promoting DNA repair (Galanty et al. 2012). Upon initiation of repair, Senp6 
desumoylase (Dou et al. 2010) would push RPA back into a hyposumoylated state which would allow 
RPA to be ubiquitinated. In this model, ubiquitination of RPA might then promote removal of RPA bound 
to the ssDNA at the DSB, facilitating Rad51 exchange. RPA-Prp19 could then ubiquitinate repair 
components to ensure proper strand invasion and repair synthesis (the D-loop would be bound by 
dephosphorylated RPA to promote proper association with DNA polymerase α). As repair synthesis 
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occurs, RPA bound in the D-loop would then be phosphorylated, bound by Prp19, and removed from the 
D-loop, tipping the balance of the number of inactive to active ubiquitin ligases attached to RPA which 
would drive ubiquitin-targeted degradation of repair components in a timely fashion, allowing the cells to 
spend a minimal amount of time arrested due to a DNA lesion.  
 
Figure 6.1.  Model for Rfa2 NT phospho-regulation of ubiquitin and sumo ligase activity during 
LPR and adaptation 
In this theoretical model, Rfa2 NT phosphorylation is achieved through an unknown kinase after S122 
phosphorylation by Mec1/Ddc2. Phosphorylation of the Rfa2 NT leads to removal of RPA from ssDNA, 
allowing formation of the Rad51-presynaptic filament. Phospho-RPA then interacts with a ubiquitin ligase 
(‘Ubi ligase’), simulating the ubiquitination of Rad53, targeting it for destruction by the proteasome. 
Targeted degradation of Rad53 leads to the inactivation of the DDC and promotes mitotic exit in cells that 
have either repaired the DNA lesion or are experiencing checkpoint adaptation due to the presence of a 
persistent DNA lesion. 
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It is also plausible that association of RPA with other ubiquitin ligases like Rfwd3 or the sumo-
targeted ubiquitin ligase Rnf4 might drive the formation of ubiquitin super-complex that preferentially 
targets lesion processing and repair proteins for degradation through the ubiquitin-dependent 
proteasome. Another fascinating possibility would be that the phospho-state of Rpa2 preferentially inhibits 
checkpoint kinase activity through upregulation of phosphatase activity required to reverse checkpoint 
signaling and promote mitotic entry and will be discussed in 6.2.C. 
6.1.C. Role for the Rfa2 NT in genome maintenance at telomeres 
Telomere length has long been implicated in the life-span of a cell in that once a single cell has 
divided to the point where the telomeres are eroded as a result of shortening, the cells apoptose (Zhang 
et al. 1999). Telomere maintenance is somewhat similar to lesion processing and repair in that an ssDNA 
template, in the absence of the proteinaceous telomeric binding complex shelterin, can be bound by RPA 
and elicit a checkpoint response (Denchi et al. 2007, Guo et al. 2007). RPA at the telomeres is then 
displaced by the TERRA complex, leading to RPAs replacement at telomeres by the Pot1-Tpp1, which 
prevents RPA re-loading onto the telomeric ssDNA (Flynn et al. 2011, Flynn et al. 2012). In budding 
yeast, cells expressing the rfa2-ΔNX mutation were deficient for Est1 recruitment to telomeres, leading to 
severely shortened telomeres (Schramke et al. 2004, Luciano et al. 2012). This demonstrates that the 
physical presence of the Rfa2 NT is required for adequate maintenance of telomeres and fidelity of the 
genome.  
Moreover, the interaction between Est1 and RFA during S-phase may be a requirement during 
DNA replication when the shelterin complex is removed from telomeres. As discussed in 1.4, phospho-
mimetic mutation of the Rpa2 NT has been reported to inhibit homologous recombination; however, the 
data presented in Chapter 5 demonstrates that homologous recombination is not impacted during meiosis 
where homologous recombination occurs at 100-fold higher frequency than in mitotic cells. Moreover, 
other members of the Haring lab have demonstrated that it is possible to integrate constructs into the 
genome in all of the yeast Rfa2 NT mutants. As such, in yeast, phosphorylation of the Rfa2 NT during S-
phase or during mitotic exit may be required to prevent homologous recombination at telomeric DNA 
sequences that are preferentially kept in an ssDNA state when bound by shelterin. 
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6.2. Defining the role of Rfa2 NT phosphorylation during mitotic exit 
It is abundantly clear from the studies in Chapters 3 and 4 that phospho-mimetic or naturally 
phosphorylatable Rfa2 NT mutations promote aberrant mitotic exit in response to a single, controlled, 
irreparable DSB. Moreover, Rfa2 NT phospho-mutations appear to rescue checkpoint adaptation 
deficiencies more often and more efficiently than that of rfa1-t11, as Rfa2 NT phospho-mutations were 
able to rescue every adaptation-deficient phenotype tested in the aforementioned studies and rfa1-t11 
was not. The idea that the Rpa2 NT phospho-state regulates mitotic exit is not entirely novel; however, it 
is currently unknown how and why Rpa2 NT phosphorylation promotes mitotic exit. Previous research has 
demonstrated that phospho-mimetic mutation of Rpa2 in human cells promotes mitotic exit despite the 
persistence of DNA lesions within the genome (Anantha et al. 2008). Furthermore, preventing 
phosphorylation at CDK-dependent phospho-sites on the Rpa2 NT has been reported to lead to 
accumulation of cells in S- and G2/M phases of the cell cycle (Anantha et al. 2007, Anantha et al. 2008, 
Shi et al. 2010). Taken in context, the studies described in Chapters 3 and 4 reinforce the hypothesis that 
Rpa2 NT phosphorylation mediates mitotic exit, and may do so in the presence or absence of DNA 
lesions 
6.2.A. Rfa2 NT phosphorylation causes aberrant checkpoint exit in the presence of a persistent 
lesion 
In response to a persistent DNA lesion, Rfa2 in yeast becomes robustly phosphorylated as 
indicated by the studies done in Chapter 3. While certain factors may be required to stimulate the repair 
of DNA, such as those tested in Chapters 3 and 4, this phosphorylation even correlates well with the 
phospho-state of Rad53 returning to an inactive state. Moreover, phosphorylation of the Rfa2 NT is 
impaired in recombination deficient rdh54Δ cells, suggesting that these cells may not adapt on their own 
because Rfa2 NT phosphorylation is impaired. The phosphorylation events observed during checkpoint 
adaptation are distinct from those observed during mitotic genotoxic stress, highlighting a difference for 
Rfa2 NT phosphorylation in each process. During DNA repair, phosphorylation of the Rpa2 NT in human 
cells has been reported to inhibit homologous recombination. In yeast that cannot undergo homologous 
recombination at the MAT locus (due to the deletion of HML and HMR), Rfa2 phosphorylation occurs 12 
hours after an HO-induced DSB is formed, and these cells readily adapt, starting at the 12-hour mark. 
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Furthermore, the addition of phospho-mimetic rfa2-DX or the naturally phosphorylatable rfa2-h2NT rescue 
checkpoint adaptation in nearly every case examined. Thus, phosphorylation of the Rfa2 NT promotes 
checkpoint exit in the presence of a persistent lesion. 
The studies described in Chapters 3 and 4 also provide some impetus for studying how 
promoting or inhibiting Rpa2 phosphorylation in human cells would contribute to diseases like cancer, 
which are driven by both mutation of the genome and dysregulated cell cycle pathways. Promoting Rpa2 
phosphorylation, in combination with chemo/radiation therapy for example, may promote to a more 
effective response in cancer cells that would divide more rapidly than normal cells, and would be unable 
to tolerate additional DSBs generated by chemotherapeutic agents. Driving Rpa2 phosphorylation may 
allow cancerous cells to divide in the presence of significant DNA damage which would ultimately lead to 
severe genotoxic instability and potentially apoptosis. Alternatively, controlling the malignant growth of a 
tumor may be possible by developing ways to replace the endogenous Rpa2 with an N-terminal 
truncation. As described above in section 6.1.C, the rfa2-ΔNX mutation prevents stable association of 
Est1 with telomeres and leads to severe telomere shortening. Cancer cells can survive severe genomic 
insult by performing genome rearrangements that elongate the telomeres artificially. Therapeutic use of 
rpa2-ΔNX may lead to telomere shortening in cancer cells, sensitizing them to genotoxic agents or 
potentially returning them to a more tolerable growth level for treatment. Moreover, since cells containing 
N-terminal truncations of Rpa2 have been demonstrated to be sensitive to clastogens, finding a way to 
stably express the truncation mutation in human cancer cells may be an effective way to enhance 
treatment strategies and limit the negative impact chemo/radiation therapy has on the host. 
6.2.B. A simple model for Rfa2 NT phosphorylation promoting checkpoint exit 
In Chapter 2, I discovered that Rfa2 phosphorylation at S122 is impaired in tel1Δ mutants. S122 
is a common marker for Mec1 activity on the RFA complex at DSB sites and reduced phosphorylation at 
S122 in tel1Δ mutant cells indicates that Mec1 activity is indicative of impaired Mec1 signaling. Moreover, 
in Chapters 3 and 4, the phospho-mimetic or naturally phosphorylatable Rfa2 NT mutants used during 
checkpoint adaptation studies (rfa2-DX and rfa2-h2NT, respectively) were able to successfully promote 
mitotic exit in the presence of persistent DNA lesions in all adaptation-deficient mutants tested. Together, 
this data allows for the proposal of a simple model (Figure 6.2) where Rfa2 NT phosphorylation leads to 
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indirect inhibition of Mec1 checkpoint signaling and checkpoint exit through direct inhibition of hyper-
phosphorylation of Rad53. Mec1 is the primary sensor kinase the phosphorylates Rad53 during LPR and 
the establishment of the DDC. The rfa1-t11 mutation has been demonstrated to checkpoint initially as 
observed by Rad53 hyper-phosphorylation but leads to impaired checkpoint maintenance and aberrant 
checkpoint exit (Lee et al. 2001, Pellicioli et al. 2001, Ghospurkar et al. 2015). However, mutant forms of 
RFA containing the rfa1-t11 mutation are still able to interact with Ddc2, as observed through 
crystallographic analysis (Deshpande et al. 2017), suggesting that the checkpoint maintenance defect 
conferred by rfa1-t11 are not due to impaired interaction with Ddc2. Additional crystallographic studies 
using human RPA peptides have determined that NT phosphorylated Rpa2 interacts with a proteolyzed 
portion of Rpa2, specifically DBD-B (Liu et al. 2005). However, in vivo it is unlikely that the Rpa2 NT 
interacts with DBD-B while RPA is on ssDNA, as DBD-A and DBD-B of Rpa1 contain the strongest affinity 
for ssDNA compared to the other DBDs within RPA. Thus, it is plausible that NT phosphorylated Rpa2 
may interact with the basic cleft of DBD-F, which is attached to Rpa2 via a highly-flexible linker region and 
has an OB-fold structure that does not bind ssDNA or contribute to RPA’s ability to bind ssDNA. If NT 
phosphorylated Rfa2 in yeast is the negatively charged substrate that DBD-F interacts with during LPR, 
then the relocation of this flexibly linked interaction domain may cause reduced interaction with Ddc2, 
leading to reduced Mec1 activation through reduced interaction with RFA, Dbp11 and Ddc1. Moreover, 
the interaction between DBD-F of Rfa1 and the phosphorylated Rfa2 NT may be highly dynamic, 
providing rational for why cells containing the rfa2-DX mutation are still able to activate the DDC with 
kinetics similar to wild-type cells. Preventing Mec1 activation would then inhibit Rad53 hyper-
phosphorylation and lead directly to checkpoint exit. Further studies will be required to better analyze the 
effects of the phospho-state of Rfa2 and its impact on conformational changes of the RFA/RPA 
complexes when bound to ssDNA.  
6.2.C. Phospho-mimetic Rfa2 NT mutations promote adaptation more efficiently than rfa1-t11 
Previously, it was demonstrated that rfa1-t11 promotes checkpoint adaptation in yeast cells 
(Pellicioli et al. 2001), however, the adaptation proficiency promoted by rfa1-t11 is overshadowed by that 
of the phospho-mimetic Rfa2 mutations. The rfa1-t11 mutation is thought to reduce interaction with  
  177 
 
Figure 6.2.  Rfa2 NT phosphorylation inhibits Mec1 potentiation of Rad53 phosphorylation leading 
to aberrant checkpoint exit 
During initial LPR events, Mec1 recruitment to the DSB leads to phosphorylation of Rfa2 at S122. An 
unknown kinase then phosphorylates the Rfa2 NT allowing DBD-F of Rfa1 to interact with the 
phosphorylated Rfa2 NT. This attenuates and inhibits Mec1 signaling by destabilizing the interaction 
between Rfa1 and Ddc2 (Mec1 chaperone). Reduced Mec1 signaling at the DSB site leads reduced 
potentiation and maintenance of Rad53 hyper-phosphorylation and signaling, promoting exit from the 
established DNA damage-dependent checkpoint.   
  178 
Rad24-RFC and by extension inhibit loading of the 9-1-1 clamp required for repair synthesis (Majka et al. 
2006). While cells containing rfa1-t11 are proficient for the initial activation of the damage-dependent 
checkpoint, they appear to have a deficiency in maintaining the required checkpoint signal so that faithful 
repair of a lesion can take place. Checkpoint initiation deficiencies were not observed for any of the Rfa2 
NT extensive mutations, however, rfa2-DX and rfa2-h2NT were able to rescue every adaptation deficiency 
tested in Chapters 3 and 4. It is likely then that these mutations and their effects on checkpoint 
maintenance are different. If rfa1-t11 is preventing adequate loading of the 9-1-1 clamp, leading to an 
impaired checkpoint, how then do phospho-mimetic or naturally phosphorylatable Rfa2 NT mutations 
subvert the established checkpoint to promote mitotic exit in the presence of a persistent lesion?  
A few enticing but complex hypotheses emerge. First, as described in 6.1.B, a model (Figure 6.1) 
surrounding the sumo and ubiquitin ligase complexes involved in DNA repair centered around RPA would 
lead to targeted degradation of checkpoint components, preferentially driven by phospho-Rpa2. Second, 
since the number of known interactors of the RPA complex continues to grow annually, it is possible that 
phospho-Rpa2 forms a complex with a yet unidentified interacting partner to drive mitotic exit. 
Phosphorylation of Rpa2 has been reported to cause disassembly of the RPA heterotrimer (Treuner et al. 
1999), however, if this were true phospho-mimetic RPA mutations would be unable to support DNA 
replication or DNA repair in any capacity. However, this logic does not preclude the existence of a 
phospho-Rpa2 complex which has the sole purpose of promoting mitotic exit that also does not include 
Rpa1 or Rpa3, and forms after disassembly of the heterotrimer during the later stages of DNA repair. The 
third potential possibility is that Rpa2 NT phosphorylation is a signal that somehow intentionally 
suppresses kinase activity both at the DSB site and intracellularly to promote checkpoint exit and will be 
discussed below in 6.2.C. It is also plausible, that the entire mechanism governing the function of Rpa2 
NT phosphorylation during mitotic exit, in the presence of absence of DNA lesions, is a complex 
combination of all three of the aforementioned hypotheses. 
6.2.D. Rfa2 NT phosphorylation may drive signaling away from kinases and towards phosphatases 
In Chapters 3 and 4, I demonstrated that the Rfa2 NT phospho-state impacts the phospho-state 
of the yeast master checkpoint regulator Rad53. Preventing phosphorylation of the Rfa2 NT leads to 
extensive Rad53 activation, whereas phospho-mimetic or naturally phosphorylatable forms lead to 
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noticeable dephosphorylation of Rad53 within the temporal window with which checkpoint adaptation 
occurs. The kinase activity of Rad53 during LPR, checkpoint maintenance, and checkpoint exit is not only 
modulated by ubiquitination, as described in section 6.1.B, but also on the activity of several kinases and 
phosphatases. As described in Chapter 1, phospho-activation of Rad53 is achieved by both sensor 
kinases Mec1 and Tel1, in a chaperone Rad9- or Mrc1- dependent fashion. This phospho-activation leads 
to the establishment of the DDC in yeast, leads to the activation of Chk1 through Tel1 activity, and 
prevents anaphase entry by Chk1 and Rad53 dependent phosphorylation of Pds1. During checkpoint 
exit, however, dephosphorylation and inactivation of Rad53 is achieved through a concerted network of 
phosphatases including the Ptc2, Ptc3, and Pph3 phosphatases (Guillemain et al. 2007, O'Neill et al. 
2007, Kim et al. 2011). Deletions of the aforementioned phosphatases display checkpoint adaptation-
deficient phenotypes in-line with that observed for other adaptation deficiencies (Leroy et al. 2003, 
Guillemain et al. 2007). Thus, phosphatase activity on proteins involved in the DDC and lesion processing 
and repair rare required for checkpoint recovery and mitotic exit once a break has been processed and 
repaired. Moreover, as described previously, Ptc2, Ckb1, and Rad53 interact in vitro and in vivo 
suggesting that CK2 phosphorylation of the PP2C phosphatase complex is required for checkpoint exit 
(Guillemain et al. 2007). It is currently unknown whether RFA and the CK2 kinase complex interact, or 
how the phospho-state of the Rfa2 NT would affect interaction with phosphatase complexes involved in 
the deactivation of the established DDC. 
Large scale genetic-interaction screens have identified a negative genetic interaction (Costanzo 
et al. 2016) between Rfa2 and Ckb1 (catalytic subunit of CKII; Ackermann et al.2001), Cdc20 (Activator of 
the anaphase-promoting complex/cyclosome APC/CCDC20; Charles et al. 1998, Cohen-Fix and Koshland 
1999), and several components of the LPR program (Slx4, Dna2, Sgs1, Top3, Rmi1, Rad51, Rad52, 
Rad54, Rad55, Rad57; Costanzo et al. 2016). Moreover, negative synthetic genetic interactions have 
also been identified between CK2 components and Psy2 and Pph3 components of the PP4 phosphatase 
complex (ibid). Together with the studies performed in Chapters 3 and 4, as well as previous research 
using rfa2 or rpa2-NT phospho-mutations, these negative genetic interactions suggest that mutations that 
loss of function or impaired regulation of RPA lead to synthetically sick or lethal phenotypes that impair a 
cell’s ability to maintain its genome and provide a framework for RPA regulating kinase and phosphatase 
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activity during LPR and the DDC. Furthermore, work performed by Trevor Baumgartner in the Haring lab 
has demonstrated that phospho-mimetic or naturally phosphorylatable extensive mutation of the Rfa2 NT 
promotes checkpoint adaptation rescue in cells containing deletions of phosphatases Ptc2, Ptc3, and 
Pph3. Moreover, these phospho-forms of Rfa2 are also able to rescue the adaptation deficient ptc2Δ 
ptc3Δ double mutant, suggesting that dephosphorylation of Rad53 is not the only requirement of 
checkpoint exit. 
Thus, a potential kinase-phosphatase regulatory model (Figure 6.3) that depends on the 
phospho-state of the Rpa2 NT can be proposed. Phosphorylation of the Rpa2 NT during HR is thought to 
be inhibitory towards homologous recombination (Liaw et al. 2011). Therefore, during LPR, the Rpa2 NT 
would be preferentially maintained in a dephosphorylated state prior to Rad51 exchange during 
presynaptic filament formation. Phosphorylation of the Rpa2 NT has been shown in human cells to be 
important for Rad52-Rad51 recruitment (Shi et al. 2010); however, in vitro studies have demonstrated 
that Rad51 can displace RPA from ssDNA independent of kinase activity (Ma et al. 2017, Ma et al. 2017). 
This data, combined with my studies, suggests a novel signaling function for the phospho-state of the 
Rfa2 NT. However, in the nuclear environment phosphorylation of Rpa2 may promote removal of the RPA 
complex from the ssDNA overhang, and RPA containing a dephosphorylated Rpa2 NT would be localized 
to the D-loop to promote DNA polymerase α recruitment. Phosphorylation of the Rpa2 NT would then 
remove RPA from the D-loop during repair synthesis. RPA containing phosphorylated Rpa2 NT could 
then drive interaction between a phosphatase complex (PP2C; Ptc2/Ptc3), and/or PP4; Pph3/Psy2) that 
would then begin dephosphorylation of multiple components involved in LPR once repair synthesis 
begins. Moreover, the formation of these phosphatase-RPA complexes may be directly responsible for 
the dephosphorylation of Rad53, promoting checkpoint recovery and mitotic exit. Direct interactions 
between Rpa2/Rfa2 and the aforementioned phosphatase complexes and their subunits has not been 
identified, and future research may better define a role for Rpa2/Rfa2 signaling activity outside of the RPA 
complexes main biochemical purpose of binding ssDNA and repair-scaffold formation. However, my 
research combined with what is known in the field clearly dictates that dysregulation of the Rpa2 NT 
phospho-state leads to mitotic exit in the presence of DNA lesions, and this process may be a direct 
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mechanism that leads to the accumulation of mutations within the genome that lead to cellular diseases 
like cancer in humans. 
6.3. Role of the Rfa2 NT during meiosis unclear 
Attempts to study the function of the Rfa2 NT during meiosis in yeast performed in Chapter 5 
have provided the framework for additional study of the Rfa2 NT phospho-state during this critical cellular 
process. It is currently unknown that the cellular consequences of Rfa2 NT phosphorylation are during 
each stage of meiosis, however, it is clear that permanent phospho-mimetic mutation or truncation of the 
Rfa2 NT lead to the formation of inviable gametes in budding yeast. Further studies will be required to 
better define the role of the Rfa2 NT during meiosis. 
6.3.A. Rfa2 NT extensive mutations lead to different meiotic phenotypes 
During meiosis, yeast containing Rfa2 NT extensive mutations were all able to perform meiotic 
divisions leading to the formation of four spores, with truncation of the Rfa2 NT leading to a severe 
reduction in the ability of cells to generate gametes compared to wild-type cells. Cells containing either 
rfa2-DX or rfa2-AX mutations were able to produce tetrads at a higher frequency than wild-type cells, 
suggesting that the Rfa2 NT phospho-state are dispensable during meiosis. Fascinatingly, the wild-type, 
cDNA-less Rfa2 mutant (Rfa2-cDNA-WT) was also able to produce spores at a higher frequency than 
cells containing RFA2 with an intron, suggestive of a role for the RFA2 intron in meiosis. Further research 
will be required to analyze what role, if any, the intron of RFA2 plays during the meiotic process.  
However, the physical presence of the Rfa2 NT is a requirement of meiosis, as cells containing 
the rfa2-ΔNX mutation produced fewer viable spores following meiosis. Moreover, cells containing the 
rfa2-ΔNX mutation produce significantly more dyads (two-cell spores) than any of the other Rfa2 mutants 
tested, suggesting a defect in the ability of these cells to adequately complete the required meiotic 
divisions. The Rfa2 NT is known to be phosphorylated prior to meiotic recombination by Ime2 (Clifford et 
al. 2004). However, the physiological relevance of the Ime2-driven phosphorylation event remains 
elusive. It is plausible that this phosphorylation event is required to drive the MII division, which is often 
referred to as a mitotic-like equational division. However, if this event were required for proper meiotic 
progression, eliminating the S27 phosphorylation through mutagenesis should lead to MII arrest. My work 
in Chapter 5 using rfa2-DX and rfa2-AX extensive mutations suggest that this phosphorylation event does 
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not play a role in mediating the meiotic divisions during MI and MII, suggesting that this phosphorylation 
event is not required to promote entry or exit from both MI and MII. Moreover, this evidence also suggests 
that the physical presence of the NT is much more important during meiosis than the NT phospho-state. 
During meiotic recombination, it has also been reported that phosphorylation of Rfa2 outside of the NT at 
S122 controls meiotic crossover frequency (Bartrand et al. 2006). This further suggests that Rfa2 
phosphorylation, generally, has no clear role during entry and exit from MI and MII. Future work by 
Angela Adsero in the Haring lab will better define a role for the Rfa2 NT during meiosis. 
However, phosphorylation of Rfa2 during meiosis may play a role in mediating the signaling 
activity of the protein-interaction domain DBD-F of Rfa1. DBD-F is required for a number of protein-
protein interactions during LPR and DDC establishment. During meiosis, phosphorylation of the Rfa2 NT 
may be required to prevent these interactions by driving an interaction between the positively charged 
cleft within the OB-fold of DBD-F and the negatively charged Rfa2 phospho-NT. In human cells, RPA 
interacts with MeioB and Spata22. MeioB is referred to as a meiosis-specific paralog to Rpa1 but lacks 
DBD-F (Ribeiro et al. 2016). MeioB and Spata22 may therefore take the place of Rpa1 and Rpa3 during 
meiosis, leading to the formation of a meiosis-specific MeioB-Rpa2-Spata22 ssDNA binding complex.  
However, yeast lack a functional homolog to MeioB or Spata22. Moreover, Rfa1 is subjected to 
significant proteolysis during the meiotic program (Clifford et al. 2004), suggestive that DBD-F may be 
proteolytically removed from Rfa1 in order to prevent DDC signaling and Rad53 activation during meiotic 
recombination. In order to promote this conversion of mitotic-RPA (containing DBD-F) to meiotic-RPA 
(lacking DBD-F), Rfa2 NT phosphorylation may be required. Providing the positively charged DBD-F cleft 
with a negatively charged binding substrate would expose the flexible linker region to protease activity in 
cells, allowing this conversion to occur. However, more complex organisms may avoid this irreversible 
change to the RPA complex by utilizing alternative ssDNA binding complexes containing one or more of 
the individual RPA subunits. Moreover, identification of alternative RPA subunit-dependent complexes 
may further elucidate the multifunctional and dynamic roles these proteins have in mitotic and meiotic 
processes.  
  183 
 
Figure 6.3.  Model for Rfa2 NT phospho-regulation of kinase activity during LPR and adaptation 
In this theoretical model for Rfa2 NT phospho-regulation of kinase activity during LPR and adaptation, 
Rfa2 NT phosphorylation leads to its dissociation from ssDNA and the formation of the Rad51-
presynaptic filament, as described in Figure 6.1 and Figure 1.6. Phospho-RPA then, by an unknown 
mechanism, directly inhibits Mec1/Ddc2 activity at the break. Mec1 activity at the DSB attenuates Tel1 
signaling (Clerici et al. 2014). Reduction in Mec1/Tel1 activity at the DSB further reduces Rad53 
activation, and skews signaling towards PP2C and PP4 phosphatase complexes, leading to a further 
reduction in active, hyper-phosphorylated Rad53 and Chk1. Pds1 dephosphorylation leads to its 
destruction by the APC/CCDC20 complex, promoting mitotic entry. This is likely to occur once repair has 
completed during the LPR. During adaptation, the presence of phospho-RPA promotes mitotic exit 
irrespective of whether repair has occurred or not.  
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6.3.B. Timing of meiotic divisions may be affected by Rfa2 NT phosphorylation 
While the ability of cells to form gametes during meiosis is not impacted in rfa2-DX or rfa2-AX 
extensive mutations, the viability of gametes produced by these two extensive mutations differs greatly. 
As described in Chapter 5, rfa2-DX extensive mutation leads to a reduction in spore viability, whereas 
rfa2-AX extensive mutations seem to promote spore viability in-line with that of wild-type cells. Not only 
does this reinforce the argument that Rfa2 NT phosphorylation is dispensable for the meiotic program, but 
it clearly argues that irreversible phosphorylation or phospho-mimetic mutation of the Rfa2 NT during 
meiosis leads to increased gamete inviability. However, the Rfa2 NT is required for meiosis as cells 
containing the rfa2-ΔNX extensive mutation led to a significant decrease in four spore viability (WT cells 
92%, rfa2-ΔNX cells 67%) measured in my assays. Furthermore, the ability of cells to perform meiotic 
recombination, as measured by heteroallelic recombination, is unaffected in any of the Rfa2 NT extensive 
mutations, suggesting that the Rfa2 NT and the phospho-state of the Rfa2 NT are dispensable during 
recombination. 
Since phosphorylation of the Rpa2 NT has been demonstrated in mitotic cells to regulate 
checkpoint exit (Anantha et al. 2008), and phospho-mimetic or naturally phosphorylatable mutation of the 
Rfa2 NT promotes checkpoint exit in response to irreparable lesions in yeast (Chapters 3 and 4; Wilson 
2018b, Wilson et al. 2018c) , it is entirely plausible to speculate that the Rfa2 NT phospho-state may be 
impacting the timing of the meiotic divisions during MI and MII. If the phospho-state of Rfa2 NT is 
important for timely progression of divisions during MI and MII, I would hypothesize that preventing 
phosphorylation of this domain would lead to an arrest somewhere between MI and MII, leading to the 
formation of two-cell products. While this was not observed for rfa2-AX extensive mutations, it was indeed 
the case for cells containing the NT truncation rfa2-ΔNX. This suggests that the NT is required for timely 
progression during meiotic divisions. The reduction in viability exhibited by rfa2-DX may be caused by a 
more rapid progression through the meiotic divisions, leading to inviability in some of the gametes formed 
during meiotic divisions. Thus, timely and well controlled phosphorylation and dephosphorylation of the 
Rfa2 NT may be required for proper progression through meiosis. 
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6.4. Final Remarks 
Recent studies examining the effects of the Rpa2 NT phospho-state on cellular processes like 
apoptosis (controlled cell death) have reported that phosphorylation of the Rpa2 NT during replication 
leads to apoptosis in Chk1-inhibited cells using Gö6976 (Zuazua-Villar et al. 2015). Gö6976 is a known 
checkpoint inhibitor that inhibits protein kinase C (PKC), Chk1, and Chk2 activity leading to defective 
checkpoint signaling (Kohn et al. 2003). Normally, inhibition of Chk1 during DNA replication should also 
prevent adequate checkpoint maintenance, and thus lead to cellular division despite the presence of 
broken DNA or regressed/unstable replication forks and incomplete DNA replication. Anantha et al. 2008 
reported that inhibition of Chk1 using UCN-01 (Chk1 inhibitor, synthetic derivative of staurosporine) 
prevented mitotic entry (Anantha et al. 2008). UCN-01 inhibits Chk1 function, but also induces cell cycle 
arrest and increases the effectiveness of DSB inducers like cisplatin, camptothecin, and ionizing radiation 
(Zhao et al. 2002). Conversely, Zuazua-Villar et al. also report that mutation forms of Rpa2 (rpa2-
S23/S29/S33A) or depletion of Rpa2 through RNAi knockdown prevented apoptosis in their assays. S23 
and S29 are known CDK phosphorylation sites and have been demonstrated by others to promote mitotic 
exit in the presence of DNA damage (Anantha et al. 2008).  
It is possible then that direct inhibition of checkpoint function by inhibiting Chk1 and/or Chk2 
activity directly leads to more robust phosphorylation of the Rpa2 NT, which would then drive mitotic exit 
as the DNA damage-dependent checkpoint is not properly maintained. Additionally, it may be possible 
that fragmented DNA that is unable to be repaired leads to the formation of a pseudo-telomeric structure 
at the break-site still attached to the centromere causing an aberrant checkpoint exit. Another intriguing 
possibility is that Rpa2 phosphorylation may drive apoptosis, or that irreversible apoptotic signaling may 
lead to Rpa2 phosphorylation. Previous research has demonstrated that Rpa2 phosphorylation is 
observed during the apoptotic process in cells (Zuazua-Villar et al. 2015); however, it is unknown whether 
increased fragmentation of DNA leads to increased phosphorylation of Rpa2 or if increased Rpa2 
phosphorylation leads to increased DNA fragmentation. Future studies may better clarify whether Rpa2 
phosphorylation causes or is a byproduct of DNA fragmentation. Moreover, if Rpa2 phosphorylation leads 
to increased DNA fragmentation, then a more effective treatment option for cancer may be to drive Rpa2 
phosphorylation thus driving apoptosis in these cells.  However, it is abundantly clear that, preventing 
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proper checkpoint maintenance leads directly to more robust Rpa2 NT phosphorylation, promoting 
aberrant mitotic exit and leading directly to genome instability and should be pursued from a therapeutic 
perspective. 
My work done in Chapter 2 demonstrates that in yeast the Rfa2 NT is not overtly phosphorylated 
during LPR. Additionally, mimicking phosphorylation or the addition of a readily phosphorylatable Rfa2 NT 
leads to an increased sensitivity to genotoxic agents, likely due to the ability of the phospho-Rfa2 NT to 
promote checkpoint exit in the presence of unrepaired DNA lesions. This argument is reinforced by the 
work performed in Chapters 3 and 4, which demonstrate that phospho-mimetic or naturally 
phosphorylatable mutation of the Rfa2 NT leads to checkpoint exit in the presence of a persistent DNA 
lesion. The above combined with the work performed in Chapter 5 allude to a defined role for Rfa2 NT 
phosphorylation in the proper progression of the cell cycle during both mitosis and meiosis, and alteration 
of Rfa2 NT phospho-states has direct negative effects on each process, the ability of cells to maintain 
their genome, and viability when challenged with genotoxic stress. 
There may be therapeutic value in preventing or promoting Rpa2 NT phosphorylation during 
genotoxic stress in human disease. Dysregulation of the cell cycle is a hallmark of cancer cells in 
humans, underscored by mass genome rearrangements that prevent telomere destruction that is critical 
for the aging process. Currently, inhibitors to checkpoint kinases like those mentioned above, are being 
used in combination with genotoxic DSB inducers to combat the dysregulated cell growth within tumors. 
However, the broader effects on the host caused by these inhibitors and genotoxic agents can directly 
lead to the formation of other cancers in different tissues. Rather than inhibiting checkpoint function in the 
presence of genotoxic agents through reductions in kinase activity, a more efficacious but more difficult 
approach may be to directly inhibit the phosphorylation of the Rpa2 NT or develop a novel strategy to 
remove the Rpa2 NT from malignant cells via a viral transfection or CRISPR-Cas9-like systems. Not only 
should this lead to permanent arrest in malignant cells and prevent Rpa2 NT phosphorylation-dependent 
mitotic exit, it would potentially lead to a restoration of telomere-dependent aging in these cells and also 
prevent the host from being exposed to any dose of genotoxic agent that would lead to the formation of 
malignancy in other tissues. As described above, yeast cells expressing the rfa2-ΔNX mutation were 
defective for recruitment of Est1 to telomeres leading to severely shortened telomeres (Schramke et al. 
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2004). While the effects of NT truncations in humans has not been examined, there has already been 
some research done suggesting that regulating RPA function at telomeres, through association with 
TERRA and exchange for Pot1/Tpp1 (Flynn et al. 2011, Flynn et al. 2012), is important for proper 
regulation of telomeric DNA. Moreover, DNA-PK activity on hnRNP-A1 is thought to assist in mediating 
the switch from RPA to Pot1/Tpp1 at telomeres (Sui et al. 2015), and DNA-PK is also known to 
phosphorylate RPA on the Rpa2 NT when RPA is bound to ssDNA (Cruet-Hennequart et al. 2008, Liaw 
et al. 2011, Liu et al. 2012, Ashley et al. 2014). Taken together, the aforementioned studies in 
combination with what I have demonstrated in Chapters 3 and 4 regarding Rfa2 NT function during 
aberrant checkpoint release and mitotic exit, suggest that preventing phosphorylation or truncation of the 
Rpa2 NT in human cells may have significant therapeutic value in restoring malignant cells to a more 
normal growth state, or preventing cancer prior to the development of cellular dysregulation. 
The work presented in this thesis makes one thing abundantly clear – dysregulation of the Rfa2 
NT phospho-state in yeast has severe phenotypic consequences in both mitotic and meiotic cells, and 
alleviates checkpoint signaling in the face of DNA lesions. This may be the base mechanism by which 
malignancy or inherited cellular diseases, like Down and Turner syndromes caused by missegregation of 
chromosomes, forms in human cells and should be investigated further from a therapeutic angle. The 
core focus of the Haring lab is unraveling the molecular mechanisms by which cells prevent mutations 
within their genome, and this work performed and described within this thesis implicates the phospho-
state of the Rfa2 NT as being a direct contributor to genomic instability in cells during genotoxic stress. 
While mutation of the genome is a requirement of evolution and population diversity within a species, too 
many mutations lead to cellular disease and genomic instability. In the future, more vigorous study of how 
the phospho-state of the Rpa2 NT regulates and promotes mitotic exit in the presence of DNA lesions will 
be critical in our understanding of how to combat cancer prior to the formation of malignancy, rather than 
treating cancer after the fidelity of a cell or organism’s genome is compromised beyond the point of repair. 
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APPENDIX A. YEAST STRAINS  
Strain Genotype Source 
B9B-A MAT-A ade3 his5-2 leu1-c trp5-20 ura1 cyhr SJH 
B9B-α MAT-α ade3 his5-2 leu1-c trp5-20 ura1 cyhr SJH 
AWY 111 JKM179 cdc5-AD Andre Walther 
AWY 112 JKM179 mec1Δ::natMX sml1Δ::G418 Andre Walther 
AWY 113 JKM179 sml1Δ::G418 Andre Walther 
AWY 115 JKM179 tel1Δ::URA3 Andre Walther 
AWY 134 JKM179 rad53Δ::natMX sml1Δ::G418 Andre Walther 
AWY 182 JKM179 chk1Δ::G418 Andre Walther 
AWY 190 JKM179 dun1Δ::G418 Andre Walther 
JKM 179A MAT-A ura3-52 lys5 trp1::hisG leu2-3 112 ade1-100 ade3::GAL-HO ho Δ hmr1 Δ::ADE1 hml Δ::ADE1 (Lee et al. 1998) 
JKM 179α MAT-α ura3-52 lys5 trp1::hisG leu2-3 112 ade1-100 ade3::GAL-HO ho Δ hmr1 Δ::ADE1 hml Δ::ADE1 (Lee et al. 1998) 
AWY 292 JKM179 rfa2-AX Andre Walther 
AWY 295 JKM179 rfa2-DX ku70 Δ::G418 Andre Walther 
AWY 296 JKM179 rdh54Δ::URA3 Andre Walther 
AWY 298 JKM179 rfa2-DX rdh54Δ::URA3 Andre Walther 
AWY 301 JKM179 rfa2-AX rdh54Δ::URA3 Andre Walther 
AWY 308 JKM179 rfa2-DX cdc5-AD Andre Walther 
AWY 309 JKM179 rfa2-AX cdc5-AD Andre Walther 
AWY 32 JKM179 ku70::KAN Andre Walther 
AWY 38 JKM179 rfa1-t11 Andre Walther 
AWY 39 JKM179 ku70::KAN rfa-t11 Andre Walther 
AWY 556 JKM179 tel1Δ::TRP1 Andre Walther 
AWY 92 JKM179 rfa2-AX Andre Walther 
AWY 96 JKM179 rfa2-DX Andre Walther 
AWY 97 JKM179 rfa2-ΔNX Andre Walther 
AWY 99 JKM179 rfa1-t11 rfa2-DX Andre Walther 
  211 
Strain Genotype Source 
BLS 106 NMM104 pRS315-rfa2-RX This Study 
BLS 107 NMM104 pRS315-rfa2-RX This Study 
EMR 001 NMM104 pRS315-rfa2-ΔNX-S122D-I This Study 
EMR 002 NMM104 pRS315-rfa2-ΔNX-S122D-II This Study 
EMR 003 NMM104 pRS315-rfa2-ΔNX-S122A-I This Study 
EMR 004 NMM104 pRS315-rfa2-ΔNX-S122A-II This Study 
EMR 006 TMW150 pRS315-rfa2-DX-S122A This Study 
EMR 007 TMW150 pRS315-rfa2-DX-S122D This Study 
EMR 008 TMW150 pRS315-rfa2-ΔNX-S122A This Study 
EMR 009 TMW150 pRS315-rfa2-ΔNX-S122D This Study 
EMR 010 TMW163 pRS315-rfa2-DX-S122A This Study 
EMR 011 TMW163 pRS315-rfa2-DX-S122A This Study 
EMR 012 TMW163 pRS315-rfa2-DX-S122D This Study 
EMR 013 TMW163 pRS315-rfa2-DX-S122D This Study 
NMM 101 JKM179 rfa1Δ::G418 pJM132 This Study 
NMM 102 JKM179 rfa1Δ::G418 pJM132 This Study 
NMM 103 JKM179 rfa1Δ::G418 pJM132 This Study 
NMM 104 JKM179 rfa2Δ::G418 pJM132 This Study 
NMM 105 JKM179 rfa2Δ::G418 pJM132 This Study 
NMM 106 JKM179 rfa2Δ::G418 pJM132 This Study 
TAB 113 NMM104 pRS315-rfa2-DX-S122A This Study 
TAB 114 NMM104 pRS315-rfa2-DX-S122D This Study 
TAB 115 NMM104 pRS315-rfa2-AX-S122A This Study 
TAB 116 NMM104 pRS315-rfa2-AX-S122D This Study 
TAB 117 NMM104 pRS315-rfa2-S122A This Study 
TAB 118 NMM104 pRS315-rfa2-S122D This Study 
TAB 123 JKM179 yku70∆::G418 This Study 
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Strain Genotype Source 
TMW 101 RMY122A pRS313-RFA1 pRS315-rfa2-h2NT (Ghospurkar et al. 2015) 
TMW 102 RMY122A pRS313-RFA1 pRS315-rfa2-h2DX (Ghospurkar et al. 2015) 
TMW 103 RMY122A pRS313-RFA1 pRS315-rfa2-h2AX (Ghospurkar et al. 2015) 
TMW 104 RMY122A pRS313-RFA1 pRS315-rfa2-h2ΔNX (Ghospurkar et al. 2015) 
TMW 105 RMY122A pRS313-RFA1 pRS315-rfa2-h24PD (Ghospurkar et al. 2015) 
TMW 106 RMY122A pRS313-RFA1 pRS315-rfa2-h2L34 (Ghospurkar et al. 2015) 
TMW 107 RMY122A pRS313-RFA1 pRS315-rfa2-h4L34 (Ghospurkar et al. 2015) 
TMW 108 RMY122A pRS313-rfa1-S178A pRS315-rfa2-S122A (Ghospurkar et al. 2015) 
TMW 109 RMY122A pRS313-rfa1-S178A pRS315-rfa2-S122D (Ghospurkar et al. 2015) 
TMW 110 RMY122A pRS313-rfa1-S178D pRS315-rfa2-S122A (Ghospurkar et al. 2015) 
TMW 111 RMY122A pRS313-rfa1-S178D pRS315-rfa2-S122D (Ghospurkar et al. 2015) 
TMW 112 RMY122A pRS313-rfa1-S178A pRS315-RFA2 (Ghospurkar et al. 2015) 
TMW 113 RMY122A pRS313-rfa1-S178D pRS315-RFA2 (Ghospurkar et al. 2015) 
TMW 114 RMY122A pRS313-RFA1 pRS315-rfa2-S122A (Ghospurkar et al. 2015) 
TMW 115 RMY122A pRS313-RFA1 pRS315-rfa2-S122D (Ghospurkar et al. 2015) 
TMW 116 RMY122A pRS313-rfa1-LexA-S178A pRS315-RFA2 (Ghospurkar et al. 2015) 
TMW 117 RMY122A pRS313-rfa1-LexA-S178D pRS315-RFA2 (Ghospurkar et al. 2015) 
TMW 118 JKM139 rfa1Δ::G418 pJM132 This Study 
TMW 119 JKM139 rfa2Δ::G418 pJM132 This Study 
TMW 130 NMM101 cka1Δ::natMX This Study 
TMW 131 NMM101 cka1Δ::natMX This Study 
TMW 132 NMM101 cka2Δ::natMX This Study 
TMW 133 NMM101 cka2Δ.::natMX This Study 
TMW 134 NMM101 ckb1Δ::natMX This Study 
TMW 135 NMM101 ckb1Δ::natMX This Study 
TMW 136 NMM101 ckb2Δ::natMX This Study 
TMW 137 NMM101 ckb2Δ::natMX This Study 
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Strain Genotype Source 
TMW 138 NMM104 cka1Δ::natMX This Study 
TMW 139 NMM104 cka2Δ::natMX This Study 
TMW 140 NMM104 ckb1Δ::natMX This Study 
TMW 141 NMM104 ckb2Δ::natMX This Study 
TMW 142 JKM179 cdc5-AD rfa2-DX This Study 
TMW 143 JKM179 cdc5-AD rfa2-DX This Study 
TMW 144 JKM179 cdc5-AD rfa2-AX This Study 
TMW 145 JKM179 cdc5-AD rfa2-AX This Study 
TMW 146 JKM179 cdc5-AD rfa2-ΔNX This Study 
TMW 147 JKM179 cdc5-AD rfa2-ΔNX This Study 
TMW 148 NMM104 dun1Δ::natMX This Study 
TMW 149 NMM104 chk1Δ::natMX This Study 
TMW 150 NMM104 tel1Δ::natMX This Study 
TMW 151 NMM104 sml1Δ::hphNX This Study 
TMW 152 NMM104 rtt107Δ::hphNX This Study 
TMW 153 NMM104 rtt107Δ::hphNX This Study 
TMW 154 NMM104 slx4Δ::hphNX This Study 
TMW 155 NMM104 slx4Δ::hphNX This Study 
TMW 156 NMM104 sae2Δ::hphNX This Study 
TMW 157 NMM104 sae2Δ::hphNX This Study 
TMW 158 NMM104 sae2::hphNX This Study 
TMW 159 NMM104 rdh54Δ::natMX This Study 
TMW 160 NMM104 rdh54Δ::natMX This Study 
TMW 161 NMM104 rdh54Δ::natMX This Study 
TMW 162 NMM104 rdh54Δ::natMX This Study 
TMW 163 TMW151 mec1Δ::natMX This Study 
TMW 164 NMM104 cdc5-AD rfa1-t11 pRS315-RFA2 This Study 
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Strain Genotype Source 
TMW 165 NMM104 cdc5-AD rfa1-t11 pRS315-RFA2 This Study 
TMW 166 NMM104 rfa1-t11 pRS315-RFA2  This Study 
TMW 167 NMM104 rfa1-t11 pRS315-RFA2  This Study 
TMW 168 TMW154 pRS315-RFA2 This Study 
TMW 169 TMW154 pRS315-rfa2-DX This Study 
TMW 170 TMW154 pRS315-rfa2-AX This Study 
TMW 171 TMW154 pRS315-rfa2-ΔNX This Study 
TMW 172 TMW154 pRS315-rfa2-h2NT This Study 
TMW 173 TMW159 pRS315-RFA2 This Study 
TMW 174 TMW159 pRS315-DX This Study 
TMW 175 TMW159 pRS315-AX This Study 
TMW 176 TMW159 pRS315-ΔNX This Study 
TMW 177 TMW159 pRS315-h2NT This Study 
TMW 178 NMM104 pRS315-AM1 This Study 
TMW 179 NMM104 pRS315-AM2 This Study 
TMW 180 NMM104 pRS315-AM3 This Study 
TMW 181 NMM104 pRS315-rfa2-ΔN1 This Study 
TMW 182 NMM104 pRS315-rfa2-ΔN2 This Study 
TMW 183 NMM104 pRS315-rfa2-ΔN3 This Study 
TMW 184 TMW184 rfa1-t11 This Study 
TMW 185 TMW184 cka1::natMX pRS315-rfa1-t11 This Study 
TMW 186 TMW184 cka2::natMX pRS315-rfa1-t11 This Study 
TMW 187 TMW184 ckb1::natMX pRS315-rfa1-t11 This Study 
TMW 188 TMW184 ckb2::natMX pRS315-rfa1-t11 This Study 
TMW 189 NMM104 pRS315-RFA2 This Study 
TMW 190 NMM104 pRS315-rfa2-DX This Study 
TMW 191 NMM104 pRS315-rfa2-AX This Study 
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Strain Genotype Source 
TMW 193 TMW156 pRS315-RFA2 This Study 
TMW 194 TMW156 pRS315-rfa2-DX This Study 
TMW 195 TMW156 pRS315-rfa2-AX This Study 
TMW 196 TMW156 pRS315-rfa2-ΔNX This Study 
TMW 197 TMW156 pRS315-rfa2-h2NT This Study 
TMW 198 TMW152 pRS315-RFA2 This Study 
TMW 199 TMW152 pRS315-rfa2-DX This Study 
TMW 200 TMW152 pRS315-rfa2-AX This Study 
TMW 201 TMW152 pRS315-rfa2-ΔNX This Study 
TMW 202 TMW152 pRS315-rfa2-h2NT This Study 
TMW 203 NMM104 pRS315-rfa2-h2NT This Study 
TMW 204 NMM104 pRS315-rfa2-AM2+3 This Study 
TMW 205 NMM104 pRS315-rfa2-AM1+3 This Study 
TMW 206 NMM104 pRS315-rfa2-AM1+2 This Study 
TMW 207 TMW159 pRS315-rfa2-DM1 This Study 
TMW 208 TMW159 pRS315-rfa2-DM2 This Study 
TMW 209 TMW159 pRS315-rfa2-DM3 This Study 
TMW 210 TMW159 pRS315-rfa2-DM1+2 This Study 
TMW 211 TMW159 pRS315-rfa2-DM1+3 This Study 
TMW 212 TMW159 pRS315-rfa2-DM2+3 This Study 
TMW 213 TMW159 pRS315-rfa2-DI3 This Study 
TMW 214 TMW159 pRS315-rfa2-DI11 This Study 
TMW 215 TMW159 pRS315-rfa2-DI12 This Study 
TMW 216 TMW159 pRS315-rfa2-DI14 This Study 
TMW 217 TMW159 pRS315-rfa2-DI21 This Study 
TMW 218 TMW159 pRS315-rfa2-DI27 This Study 
TMW 219 TMW159 pRS315-rfa2-DI30 This Study 
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Strain Genotype Source 
TMW 220 TMW159 pRS315-rfa2-DI32 This Study 
TMW 221 TMW159 pRS315-rfa2-DI34 This Study 
TMW 222 TMW159 pRS315-rfa2-DI38 This Study 
TMW 223 TMW151 pRS315-rfa2-h2NT This Study 
TMW 224 TMW150 pRS315-rfa2-h2NT This Study 
TMW 225 TMW148 pRS315-rfa2-h2NT This Study 
TMW 226 TMW156 pRS315-rfa2-h2NT This Study 
TMW 227 TMW163 pRS315-rfa2-h2NT This Study 
TMW 228 TMW149 pRS315-rfa2-h2NT This Study 
TMW 229 TMW152 pRS315-rfa2-h2NT This Study 
TMW 230 TMW154 pRS315-rfa2-h2NT This Study 
TMW 231 TMW159 pRS315-rfa2-h2NT This Study 
TMW 232 TMW156 pRS315-RFA2 This Study 
TMW 233 TMW156 pRS315-rfa2-DX This Study 
TMW 234 TMW156 pRS315-rfa2-AX This Study 
TMW 235 TMW156 pRS315-rfa2-ΔNX This Study 
TMW 236 TMW156 pRS315-rfa2-h2NT This Study 
TMW 237 TMW152 pRS315-RFA2 This Study 
TMW 238 TMW152 pRS315-rfa2-DX This Study 
TMW 239 TMW152 pRS315-rfa2-AX This Study 
TMW 240 TMW152 pRS315-rfa2-ΔNX This Study 
TMW 241 TMW152 pRS315-rfa2-h2NT This Study 
TMW 242 TMW154 pRS315-RFA2 This Study 
TMW 243 TMW154 pRS315-rfa2-DX This Study 
TMW 244 TMW154 pRS315-rfa2-AX This Study 
TMW 245 TMW154 pRS315-rfa2-ΔNX This Study 
TMW 246 TMW154 pRS315-rfa2-h2NT This Study 
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Strain Genotype Source 
TMW 247 TMW159 pRS315-RFA2 This Study 
TMW 248 TMW159 pRS315-rfa2-DX This Study 
TMW 249 TMW159 pRS315-rfa2-AX This Study 
TMW 250 TMW159 pRS315-rfa2-ΔNX This Study 
TMW 251 TMW159 pRS315-rfa2-h2NT This Study 
TMW 252 TMW150 pRS315-RFA2 This Study 
TMW 253 TMW150 pRS315-rfa2-DX This Study 
TMW 254 TMW150 pRS315-rfa2-AX This Study 
TMW 255 TMW150 pRS315-rfa2-ΔNX This Study 
TMW 256 TMW150 pRS315-rfa2-h2NT This Study 
TMW 257 TMW163 pRS315-RFA2 This Study 
TMW 258 TMW163 pRS315-rfa2-DX This Study 
TMW 259 TMW163 pRS315-rfa2-AX This Study 
TMW 260 TMW163 pRS315-rfa2-ΔNX This Study 
TMW 261 TMW163 pRS315-rfa2-h2NT This Study 
TMW 262 TMW149 pRS315-RFA2 This Study 
TMW 263 TMW149 pRS315-rfa2-DX This Study 
TMW 264 TMW149 pRS315-rfa2-AX This Study 
TMW 265 TMW149 pRS315-rfa2-ΔNX This Study 
TMW 266 TMW149 pRS315-rfa2-h2NT This Study 
TMW 267 TMW148 pRS315-RFA2 This Study 
TMW 268 TMW148 pRS315-rfa2-DX This Study 
TMW 269 TMW148 pRS315-rfa2-AX This Study 
TMW 270 TMW148 pRS315-rfa2-ΔNX This Study 
TMW 271 TMW148 pRS315-rfa2-h2NT This Study 
TMW 272 TMW151 pRS315-RFA2 This Study 
TMW 273 TMW151 pRS315-rfa2-DX This Study 
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Strain Genotype Source 
TMW 274 TMW151 pRS315-rfa2-AX This Study 
TMW 275 TMW151 pRS315-rfa2-ΔNX This Study 
TMW 276 TMW151 pRS315-rfa2-h2NT This Study 
TMW 277 TMW138 pRS315-RFA2 This Study 
TMW 278 TMW138 pRS315-rfa2-DX This Study 
TMW 279 TMW138 pRS315-rfa2-AX This Study 
TMW 280 TMW138 pRS315-rfa2-ΔNX This Study 
TMW 281 TMW138 pRS315-rfa2-h2NT This Study 
TMW 282 TMW130 pRS315-rfa1-t11 This Study 
TMW 283 TMW139 pRS315-RFA2 This Study 
TMW 284 TMW139 pRS315-rfa2-DX This Study 
TMW 285 TMW139 pRS315-rfa2-AX This Study 
TMW 286 TMW139 pRS315-rfa2-ΔNX This Study 
TMW 287 TMW139 pRS315-rfa2-h2NT This Study 
TMW 288 TMW132 pRS315-rfa1-t11 This Study 
TMW 289 TMW140 pRS315-RFA2 This Study 
TMW 290 TMW140 pRS315-rfa2-DX This Study 
TMW 291 TMW140 pRS315-rfa2-AX This Study 
TMW 292 TMW140 pRS315-rfa2-ΔNX This Study 
TMW 293 TMW140 pRS315-rfa2-h2NT This Study 
TMW 294 TMW134 pRS315-rfa1-t11 This Study 
TMW 295 TMW141 pRS315-RFA2 This Study 
TMW 296 TMW141 pRS315-rfa2-DX This Study 
TMW 297 TMW141 pRS315-rfa2-AX This Study 
TMW 298 TMW141 pRS315-rfa2-ΔNX This Study 
TMW 299 TMW141 pRS315-rfa2-h2NT This Study 
TMW 300 TMW136 pRS315-rfa1-t11 This Study 
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TMW 301 RM26-26C: MATα ade2-1, ade5, can
r, CYHs, his1, HIS7, 
leu1-12, lys2-1, trp5-2, ura3-1, RFA2 This Study 
TMW 302 Isogenic to RM26-26C, rfa2-AX This Study 
TMW 303 Isogenic to RM26-26C, rfa2-DX This Study 
TMW 304 Isogenic to RM26-26C, rfa2-ΔNX This Study 
TMW 305 Isogenic to RM26-26C, rfa2-cDNA-WT This Study 
TMW 306 K264-10D: MATa, ade2-1 cyh
r, HIS1, leu1-c, lys2-2, 
met13-c, trp5-c, tyr1-2, ura3-1 This Study 
TMW 307 Isogenic to K264-10D, rfa2-AX This Study 
TMW 308 Isogenic to K264-10D, rfa2-DX This Study 
TMW 309 Isogenic to K264-10D, rfa2-ΔNX This Study 
TMW 310 Isogenic to K264-10D, rfa2-cDNA-WT This Study 
TMW 311 RMY122A pRS313-RFA1 pRS315-RFA2 (Ghospurkar et al. 2015) 
TMW 312 RMY122A pRS313-rfa1-t11 pRS315-RFA2 (Ghospurkar et al. 2015) 
TMW 313 RMY122A pRS313-RFA1 pRS315-rfa2-DX (Ghospurkar et al. 2015) 
TMW 314 RMY122A pRS313-RFA1 pRS315-rfa2-AX (Ghospurkar et al. 2015) 
TMW 315 RMY122A pRS313-RFA1 pRS315-rfa2-ΔNX (Ghospurkar et al. 2015) 
TMW 316 TMW159 pRS315-rfa2-DM1 This Study 
TMW 317 TMW159 pRS315-rfa2-DM2 This Study 
TMW 318 TMW159 pRS315-rfa2-DM3 This Study 
TMW 319 TMW159 pRS315-rfa2-DM1+2 This Study 
TMW 320 TMW159 pRS315-rfa2-DM1+3 This Study 
TMW 321 TMW159 pRS315-rfa2-DM2+3 This Study 
TMW 322 TMW159 pRS315-RFA2 This Study 
TMW 323 TMW159 pRS315-rfa2-DX This Study 
TMW 324 TMW159 pRS315-rfa2-AX This Study 
TMW 325 TMW159 pRS315-rfa2-ΔNX This Study 
TMW 326 TMW159 pRS315-rfa2-h2NT This Study 
TMW 327 TMW159 pRS315-rfa2-DI3 This Study 
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TMW 328 TMW159 pRS315-rfa2-DI11 This Study 
TMW 329 TMW159 pRS315-rfa2-DI12 This Study 
TMW 330 TMW159 pRS315-rfa2-DI14 This Study 
TMW 331 TMW159 pRS315-rfa2-DI21 This Study 
TMW 332 TMW159 pRS315-rfa2-DI23 This Study 
TMW 333 TMW159 pRS315-rfa2-DI27 This Study 
TMW 334 TMW159 pRS315-rfa2-DI30 This Study 
TMW 335 TMW159 pRS315-rfa2-DI32 This Study 
TMW 336 TMW159 pRS315-rfa2-DI34 This Study 
TMW 337 TMW159 pRS315-rfa2-DI38 This Study 
TMW 338 TMW159 pRS315-rfa2-E-Q This Study 
TMW 339 NMM104 pRS315-rfa2-AM1 This Study 
TMW 340 NMM104 pRS315-rfa2-AM2 This Study 
TMW 341 NMM104 pRS315-rfa2-AM3 This Study 
TMW 342 NMM104 pRS315-rfa2-ΔN1 This Study 
TMW 343 NMM104 pRS315-rfa2-ΔN2 This Study 
TMW 344 NMM104 pRS315-rfa2-ΔN3 This Study 
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 APPENDIX B. PLASMIDS 
Name Plasmid Genotype/Description 
pRS313-rfa1-t11 pRS313-rfa1-t11 Derivative pRS313-RFA1 on HIS3+ vector 
pRS313-RFA1 pRS313-RFA1 Derivative pRS313-RFA1 on HIS3+ vector 
pAW07 pRS315-RFA2 Derivative pRS315-RFA2 on LEU2+ vector 
pAW08 pRS315-rfa2-DX Derivative pRS315-rfa2-DX on LEU2+ vector 
pAW09 pRS315-rfa2-AX Derivative pRS315-rfa2-AX on LEU2+ vector 
pAW10 pRS315-rfa2-ΔNX Derivative pRS315-rfa2-ΔNX on LEU2+ vector 
pPLG1 pRS315-rfa2-S3D Derivative pRS315-rfa2-S3D 
pPLG2 pRS315-rfa2-S11D Derivative pRS315-rfa2-S11D 
pPLG3 pRS315-rfa2-S12D Derivative pRS315-rfa2-S12D 
pPLG4 pRS315-rfa2-T14D Derivative pRS315-rfa2-T14D 
pPLG5 pRS315-rfa2-S21D Derivative pRS315-rfa2-S21D 
pPLG6 pRS315-rfa2-S23D Derivative pRS315-rfa2-S23D 
pPLG7 pRS315-rfa2-S27D Derivative pRS315-rfa2-S27D 
pPLG8 pRS315-rfa2-S30D Derivative pRS315-rfa2-S30D 
pPLG9 pRS315-rfa2-T32D Derivative pRS315-rfa2-T32D 
pPLG10 pRS315-rfa2-T34D Derivative pRS315-rfa2-T34D 
pPLG11 pRS315-rfa2-T38D Derivative pRS315-rfa2-T38D 
pPLG12 pRS315-rfa2-S3A Derivative pRS315-rfa2-S3A 
pPLG13 pRS315-rfa2-S11A Derivative pRS315-rfa2-S11A 
pPLG14 pRS315-rfa2-S12A Derivative pRS315-rfa2-S12A 
pPLG15 pRS315-rfa2-T14A Derivative pRS315-rfa2-T14A 
pPLG16 pRS315-rfa2-S21A Derivative pRS315-rfa2-S21A 
pPLG17 pRS315-rfa2-S23A Derivative pRS315-rfa2-S23A 
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pPLG18 pRS315-rfa2-S27A Derivative pRS315-rfa2-S27A 
pPLG19 pRS315-rfa2-S30A Derivative pRS315-rfa2-S30A 
pPLG20 pRS315-rfa2-T32A Derivative pRS315-rfa2-T32A 
pPLG21 pRS315-rfa2-T34A Derivative pRS315-rfa2-T34A 
pPLG22 pRS315-rfa2-T38A Derivative pRS315-rfa2-T38A 
pPLG23 pRS315-rfa2-Am1 Derivative pRS315-rfa2-Am1 
pPLG24 pRS315-rfa2-Am2+3 Derivative pRS315-rfa2-Am2+3 
pPLG25 pRS315-rfa2-Am2 Derivative pRS315-rfa2-Am2 
pPLG26 pRS315-rfa2-Am3 Derivative pRS315-rfa2-Am3 
pPLG27 pRS315-rfa2-Am1+2 Derivative pRS315-rfa2-Am1+3 
pPLG28 pRS315-rfa2-Am1+3 Derivative pRS315-rfa2-Am1+3 
pPLG29 pRS315-rfa2-Dm1 Derivative pRS315-rfa2-Dm1 
pPLG30 pRS315-rfa2-Dm2+3 Derivative pRS315-rfa2-Dm2+3 
pPLG31 pRS315-rfa2-Dm2 Derivative pRS315-rfa2-Dm2 
pPLG32 pRS315-rfa2-Dm3 Derivative pRS315-rfa2-Dm3 
pPLG33 pRS315-rfa2-Dm1+2 Derivative pRS315-rfa2-Dm1+3 
pPLG34 pRS315-rfa2-Dm1+3 Derivative pRS315-rfa2-Dm1+3 
pFA6-hphNT1 P30347 pFA6 empty vector, hphNX resistance cassette 
pFA6-natNT2 P30346 pFA6 empty vector, natMX resistance cassette 
pAMH1 pRS315-rfa2-Hs2PD pRS315-rfa2-h2NT 
pAMH2 pRS315-rfa2-Hs2PD pRS315-rfa2-h2NT 
pAMH3 pRS315-rfa2-Hs2Asp9 pRS315-rfa2-h2DX 
pAMH4 pRS315-rfa2-Hs2Ala10 pRS315-rfa2-h2AX 
pAMH5 pRS315-rfa2-Hs2Ala10 pRS315-rfa2-h2AX 
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pAMH6 pRS315-rfa2-Hs2ΔN33 pRS315-rfa2-h2ΔN33 
pAMH7 pRS315-rfa2-Hs4PD pRS315-rfa2-h4NT 
pENM10 pJG4-5-B42-HA-RFA1 pJG4-5-B42-HA-RFA1 
pENM11 pJG4-5-B42-HA-RFA2 pJG4-5-B42-HA-RFA2 
pENM12 pJG4-5-B42-HA-RFA3 pJG4-5-B42-HA-RFA3 
pEG202 pEG202 Y2H Vector 
pSH18-34 pSH18-34 Y2H vector 
pEG202K pEG202KAN pEG202 amp marker replaced by KanMX 
pJG4-5 pJG4-5 pJG4-5 empty vector, HA tag, B42 activation domain 
pBLS1 pHs2S4A pHs2S4A 
pBLS2 pHs2S8A-6 pHs2S8A-6 
pBLS2 pHs2S8A-7 pHs2S8A-7 
pBLS3 pHs2S11A-4 pHs2S11A-4 
pBLS3 pHs2S11A-5 pHs2S11A-5 
pBLS4 pHs2S12A pHs2S12A 
pBLS5 pHs2S13A pHs2S13A 
pBLS6 pHs2T21A pHs2T21A 
pBLS7 pHs2S23A pHs2S23A 
pBLS8 pHs2S29A pHs2S29A 
pBLS9 pHs2S33A pHs2S33A 
pPLG61 pEG202K pEG202 amp marker replaced by kan 
pPLG62 pSH18-34K pSH18-34 amp marker replaced by kan 
LexA-S178A pRS313-LexA-rfa1-S178A Y2H construct, S178A rfa1 mutation 
LexA-S178D pRS313-LexA-rfa1-S178D Y2H construct, S178D rfa1 mutation 
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S178A pRS313-rfa1-S178A Derivative pRS313-rfa1-S178A 
S178D pRS313-rfa1-S178D Derivative pRS313-rfa1-S178D 
S122A pRS315-rfa2-S122A Derivative pRS315-rfa2-S122A 
S122D pRS315-rfa2-S122D Derivative pRS315-rfa2-S122D 
pTMW01 pRS306-rfa2-WT(cDNA) pRS305-rfa2-cDNA-WT, integrating vector 
pTMW02 pRS306-rfa2-DX pRS306-rfa2-DX, integrating vector 
pTMW03 pRS306-rfa2-AX pRS306-rfa2-AX, integrating vector 
pTMW04 pRS306-rfa2-ΔNX pRS306-rfa2-ΔNX, integrating vector 
pTMW10 pJG4-5-B42-MRE11 pJG4-5 Prey - MRE11  
pTMW11 pJG4-5-B42-LGE1 pJG4-5 Prey - LGE1  
pTMW12 pJG4-5-B42-YBR137W pJG4-5 Prey - YBR137W  
pTMW13 pJG4-5-B42-XRS2 pJG4-5 Prey - XRS2 
pTMW14 pJG4-5-B42-SAE2 pJG4-5 Prey - SAE2  
pTMW15 pJG4-5-B42-CMR1 pJG4-5 Prey - CMR1  
pTMW16 pJG4-5-B42-DMC1 pJG4-5 Prey - DMC1  
pTMW17 pJG4-5-B42-DMC1 pJG4-5 Prey - DMC1  
pTMW18 pJG4-5-B42-DMC1 pJG4-5 Prey - DMC1  
pTMW19 pJG4-5-B42-DMC1 pJG4-5 Prey - DMC1  
pTMW20 pJG4-5-B42-RAD50 pJG4-5 Prey - RAD50  
pTMW21 pJG4-5-B42-RAD50 pJG4-5 Prey - RAD50  
pTMW22 pJG4-5-B42-RAD51 pJG4-5 Prey - RAD51  
pTMW23 pJG4-5-B42-RAD52 pJG4-5 Prey - RAD52  
pTMW24 pJG4-5-B42-RAD54 pJG4-5 Prey - RAD54  
pTMW25 pJG4-5-B42-RAD55 pJG4-5 Prey - RAD55 
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pTMW26 pJG4-5-B42-RAD57 pJG4-5 Prey - RAD57  
pTMW27 pJG4-5-B42-RAD59 pJG4-5 Prey - RAD59 
pPLG13 pRS315-Rfa2-S11A Identical to B708, Sequenced 
pPLG14 pRS315-Rfa2-S12A Identical to B709, Sequenced 
pPLG15 pRS315-Rfa2-T14A Identical to B710, Sequenced 
pPLG16 pRS315-Rfa2-S21A Identical to B711, Sequenced 
pPLG17 pRS315-Rfa2-S23A Identical to B712, Sequenced 
pPLG18 pRS315-Rfa2-S27A Identical to B713, Sequenced 
pPLG19 pRS315-Rfa2-SS30A Identical to B714, Sequenced 
pPLG20 pRS315-Rfa2-T32A Identical to B715, Sequenced 
pPLG21 pRS315-Rfa2-T34A Identical to B716, Sequenced 
pPLG22 pRS315-Rfa2-T38A Identical to B717, sequenced 
pTMW28 pKU2-Rfa1-T11-BsaHI-1 rfa1-T11 integrating vector BsaHI site 
pTMW29 pKU2-Rfa1-T11-BsaHI-2 rfa1-T11 integrating vector BsaHI site 
pTMW30 pKU2-Rfa1-T11-BsaHI-3 rfa1-T11 integrating vector BsaHI site 
pPLG12 pRS315-Rfa2-S3A Identical to B707, Sequenced 
pBLS1-1 B109/O-284-3 Derivative pRS315-rfa2-DX-S122D 
pBLS1-2 B109/O-284-4 Derivative pRS315-rfa2-DX-S122D 
pBLS1-3 B109/O-284-7 Derivative pRS315-rfa2-DX-S122D 
pBLS2-1 B109/O-285-2 Derivative pRS315-rfa2-DX-S122A 
pBLS2-2 B109/O-285-4 Derivative pRS315-rfa2-DX-S122A 
pBLS2-3 B109/O-285-8 Derivative pRS315-rfa2-DX-S122A 
pBLS3-1 B110/O-284-2 Derivative pRS315-rfa2-AX-S122D 
pBLS3-2 B110/O-284-8 Derivative pRS315-rfa2-AX-S122D 
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pBLS3-3 B110/O-284-10 Derivative pRS315-rfa2-AX-S122D 
pBLS4-1 B110/O-285-3 Derivative pRS315-rfa2-AX-S122A 
pBLS4-2 B110/O-285-5 Derivative pRS315-rfa2-AX-S122A 
pBLS4-3 B110/O-285-7 Derivative pRS315-rfa2-AX-S122A 
pNPT1 pRS316-RFA1 RFA1 full length into pRS316 
pNPT2 pRS316-rfa-t11 rfa1-t11 in vivo cloned into pRS316 
pSA39 pSA39 pSA empty vector, Lys5(MX) cassette 
pPLG1 pRS315-Rfa2-DI3 Derivative pRS315-rfa2-DI3 
pPLG2 pRS315-Rfa2-DI11 Derivative pRS315-rfa2-DI11 
pPLG3 pRS315-Rfa2-DI12 Derivative pRS315-rfa2-DI12 
pPLG4 pRS315-Rfa2-DI14 Derivative pRS315-rfa2-DI14 
pPLG5 pRS315-Rfa2-DI21 Derivative pRS315-rfa2-DI21 
pPLG7 pRS315-Rfa2-DI27 Derivative pRS315-rfa2-DI27 
pPLG8 pRS315-Rfa2-DI30 Derivative pRS315-rfa2-DI30 
pPLG9 pRS315-Rfa2-DI32 Derivative pRS315-rfa2-DI32 
pPLG10 pRS315-Rfa2-DI34 Derivative pRS315-rfa2-DI34 
pPLG11 pRS315-Rfa2-DI38 Derivative pRS315-rfa2-DI38 
pPLG29 pRS315-Rfa2-Dm1 Derivative pRS315-rfa2-DM1 
pPLG31 pRS315-Rfa2-Dm2 Derivative pRS315-rfa2-DM2 
pPLG32 pRS315-Rfa2-Dm3 Derivative pRS315-rfa2-DM3 
pPLG33 pRS315-Rfa2-DM1+2 Derivative pRS315-rfa2-DM1+2 
pPLG34 pRS315-Rfa2-DM1+3 Derivative pRS315-rfa2-DM1+3 
pPLG31 pRS315-Rfa2-DM2+3 Derivative pRS315-rfa2-DM2+3 
pEMR001 B111 / O284 - 4c Derivative pRS315-rfa2-ΔNX-S122D  
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pEMR002 B111 / O284 - 4d Derivative pRS315-rfa2-ΔNX-S122D  
pEMR003 B111 / O285 - 5e Derivative pRS315-rfa2-ΔNX-S122A  
pEMR004 B111 / O285 - 5g Derivative pRS315-rfa2-ΔNX-S122A 
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APPENDIX C. PRIMERS  
Name Sequence Purpose 
RFA2-UP-NEW TAGCAATTCCTTTGGCCTCGATGAGCTTCC Upstream RFA2 primer 
RFA2-DOWN-NEW GATAAAACCCTGGTCAGTCAAGGTCGTAC Downstream RFA2 primer 
pJG4-5-UP-Sequence GATCCAGCCTGACTGGCTGAAATCGAATGG pJG4-5 sequencing primer 
pJG4-5-UP-Recover TGGCGGATCAGGCGATTAACGTGGTGCCGG pJG4-5 sequencing primer 
pJG4-5-DOWN-Recover TCAACAACGTATCTACCAACGATTTGACCC pJG4-5 sequencing primer 
RFA2-UP-NEW-O-338 TAGCAATTCCTTTGGCCTCGATGAGCTTCC Upstream RFA2 primer 
RFA2-DOWN-NEW-O-339 GATAAAACCCTGGTCAGTCAAGGTCGTAC Downstream RFA2 primer 
MATα-HO-UP-Proximal TGCAGCAGCGAATATGGGACTACTTC HO qPCR primer 
MATα-HO-DOWN-Proximal CAAGATCGTTTATGGTTAAGATAAGAACAAAGAATGATGC HO qPCR primer 
MATα-HO-UP-Distal CACGCGGACAAAATGCAGCAC HO qPCR primer 





rfa1-t11 mutagenic primer w/ 
BsaHI diagnostic site 
HIS4-qPCR-REV GTTAAGGATGCCACCTCTTCC His4 qPCR control 
HIS4-qPCR-FOR TGATAGGTATGAAGCCACAATACAA His4 qPCR control 
HO-BglII-Distal-REV GCACTTTGCATGAGATGAAGTT HO qPCR primer 
HO-BglII-Distal-FOR GGATCAACGGAATGATTATTATAGTAGC HO qPCR primer 
HO-Xho1-REV GAAGGCACCGATGATACTACAC HO qPCR primer 
HO-Xho1-FOR TCGGTAAATCACCAGACATAGC HO qPCR primer 
HO-HindIII-REV CGGAATTGACAGGAATGATAATG HO qPCR primer 
HO-HindIII-FOR ACAAGGGCATCCTTGTTT HO qPCR primer 
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HO-StyI-Proximal-REV GCAAATACATGATCTTGTTAGGG HO qPCR primer 
HO-StyI-Proximal-FOR CCTTCTTCATTACTATTCATCTTCG HO qPCR primer 
ARE1-qPCR-REV CGACCAGAGTGCAGCATATC ARE1 qPCR control 
ARE1-qPCR-FOR GGTAGAACTGGGCCACAAAT ARE1 qPCR control 
MATa-HO-UP-Distal ATCCTATACTAACAATTTGTAGTTCATAAATAAACGTATGAGATC HO qPCR primer 
MATa-HO-UP-Proximal TCGTTTTCAATGATTAAAATAGCATAGTCGGGTTT HO qPCR primer 
MATa-FOR ACTTCAAGTAAGAGTTTGGGTATGT HO qPCR primer 
MATα-FOR GCACGGAATATGGGACTACTTC HO qPCR primer 
MAT-REV GTCACATCAAGATCGTTTATGGTTAAG HO qPCR primer 
pJG4-5-CMR1-FOR ATTATGCCTCTCCCGAATTCATGCCGGAATTAACAGAATT 
CMR1 Forward primer - Y2H 
project pJG4-5 homology 
pJG4-5-CMR1-REV GAAGTCCAAAGCTTCTCGAGTCATTCTTCCTGCTTTATGG 
CMR1 Reverse primer - Y2H 
project pJG4-5 homology 
pJG4-5-CSM3-FOR ATTATGCCTCTCCCGAATTCATGGATCAAGATTTTGACAG 
CSM3 Forward primer - Y2H 
project pJG4-5 homology 
pJG4-5-CSM-REV GAAGTCCAAAGCTTCTCGAGCTAAAAGCCCATTTCCTTCA 
CSM3 Reverse primer - Y2H 
project pJG4-5 homology 
pJG4-5-MRC1-FOR ATTATGCCTCTCCCGAATTCATGGATGATGCCTTGCATGC 
MRC1 Forward primer - Y2H 
project pJG4-5 homology 
pJG4-5-MRC1-REV GAAGTCCAAAGCTTCTCGAGCTAATTATCAAAGCTATCTT 
MRC1 Reverse primer - Y2H 
project pJG4-5 homology 
pJG4-5-TOF1-FOR ATTATGCCTCTCCCGAATTCATGTCTGCTGATTTGCAACA 
TOF1 Forward primer - Y2H 
project pJG4-5 homology 
pJG4-5-TOF1-REV GAAGTCCAAAGCTTCTCGAGTCAATCATCACTATCACCTT 
TOF1 Reverse primer - Y2H 
project pJG4-5 homology 
pJG4-5-MRE11-FOR ATTATGCCTCTCCCGAATTCATGGACTATCCTGATCCAGA 
MRE11 Forward primer - Y2H 
project pJG4-5 homology 
pJG4-5-MRE11-REV GAAGTCCAAAGCTTCTCGAGCTATTTTCTTTTCTTAGCAA 
MRE11 Reverse primer - Y2H 
project pJG4-5 homology  
pJG4-5-RAD50-FOR ATTATGCCTCTCCGGAATTCATGAGCGCTATCTATAAATT 
RAD50 Forward primer - Y2H 
project pJG4-5 homology 
pJG4-5-RAD50-REV GAAGTCCAAAGCTTCTCGAGTCAATAAGTGACTCTGTTAA 
RAD50 Reverse primer - Y2H 
project pJG4-5 homology 
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pJG4-5-XRS2-FOR ATTATGCCTCTCCCGAATTCATGTGGGTAGTACGATACCA 
XRS2 Forward primer - Y2H 
project pJG4-5 homology 
pJG4-5-XRS2-REV GAAGTCCAAAGCTTCTCGAGTTATCCTTTTCTTCTTTTGA 
XRS2 Reverse primer - Y2H 
project pJG4-5 homology  
pJG4-5-SAE2-FOR ATTATGCCTCTCCCGAATTCATGGTGACTGGTGAAGAAAA 
SAE2 Forward primer - Y2H 
project pJG4-5 homology 
pJG4-5-SAE2-REV GAAGTCCAAAGCTTCTCGAGTTAACATCTAGCATATATCT 
SAE2 Reverse primer - Y2H 
project pJG4-5 homology 
pJG4-5-DMC1-FOR ATTATGCCTCTCCCGAATTCATGTCTGTTACAGGAACTGA 
DMC1 Forward primer - Y2H 
project pJG4-5 homology 
pJG4-5-DMC1-REV GAAGRCCAAAGCTTCTCGAGCTAGTCACTTGAATCGGTAA 
DMC1 Reverse primer - Y2H 
project pJG4-5 homology 
pJG4-5-RAD51-FOR ATTATGCCTCTCCCGAATTCATGTCTCAAGTTCAAGAACA 
RAD51 Forward primer - Y2H 
project pJG4-5 homology 
pJG4-5-RAD51-REV GAAGTCCAAAGCTTCTCGAGCTACTCGTCTTCTTCTCTGG 
RAD51 Reverse primer - Y2H 
project pJG4-5 homology 
pJG4-5-RAD52-FOR ATTATGCCTCTCCCGAATTCATGAATGAAATTATGGATAT 
RAD52 Forward primer - Y2H 
project pJG4-5 homology 
pJG4-5-RAD52-REV GAAGTCCAAAGCTTCTCGAGTCAAGTAGGCTTGCGTGCAT 
RAD52 Reverse primer - Y2H 
project pJG4-5 homology 
pJG4-5-RAD54-FOR ATTATGCCTCTCCCGAATTCATGGCAAGACGCAGATTACC 
RAD54 Forward primer - Y2H 
project pJG4-5 homology 
pJG4-5-RAD54-REV GAAGTCCAAAGCTTCTCGAGTCAATGTGAAATATATTGAA 
RAD54 Reverse primer - Y2H 
project pJG4-5 homology 
pJG4-5-RAD55-FOR ATTATGCCTCTCCCGAATTCATGTCGCTTGGTATACCACT 
RAD55 Forward primer - Y2H 
project pJG4-5 homology 
pJG4-5-RAD55-REV GAAGTCCAAAGCTTCTCGAGTTAACCCTCACTATCATAAA 
RAD55 Reverse primer - Y2H 
project pJG4-5 homology 
pJG4-5-RAD57-FOR ATTATGCCTCTCCCGAATTCATGCCTAGGGCCTTATCAAT 
RAD57 Forward primer - Y2H 
project pJG4-5 homology 
pJG4-5-RAD57-REV GAAGTCCAAAGCTTCTCGAGTCAGGCTGTTTCTATTCCTC 
RAD57 Reverse primer - Y2H 
project pJG4-5 homology 
pJG4-5-RAD59-FOR ATTATGCCTCTCCCGAATTCATGACGATACAAGCGAAGCC 
RAD59 Forward primer - Y2H 
project pJG4-5 homology 
pJG4-5-RAD59-REV GAAGTCCAAAGCTTCTCGAGTTATTTGATATGCGTGCCTT 
RAD59 Reverse primer - Y2H 
project pJG4-5 homology 
pJG4-5-RDH54-FOR ATTATGCCTCTCCCGAATTCATGGCGGTAATAAGCGTTAA 
RDH54 Forward primer - Y2H 
project pJG4-5 homology 
pJG4-5-RDH54-REV GAAGTCCAAAGCTTCTCGAGTCATTGTTCTCTGAGACATA 
RDH54 Reverse primer - Y2H 
project pJG4-5 homology 
pJG4-5-LGE1-FOR ATTATGCCTCTCCCGAATTCATGAGCGGATACACGGGAAA 
LGE1 Forward primer - Y2H 
project pJG4-5 homology 
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pJG4-5-LGE1-REV GAAGTCCAAAGCTTCTCGAGCTACTGCATTAATAACAATG 
LGE1 Reverse primer - Y2H 
project pJG4-5 homology 
rfa1-del-for CTGCAGTAGGCAAAGTTCCAGATAACACACCAC 
Rfa1 deletion diagnostic 
primer (Forward) 
rfa1-del-rev GGTAATAACTTGCTTGTAGAACGGTTCACAATCCC 
Rfa1 deletion diagnostic 
primer (Reverse) 
rfa2-del-for GCTGTACTAGCTGGTATGATTCACCACTGATG 
Rfa2 deletion diagnostic 
primer (Forward) 
rfa2-del-rev CAGTAATGAGCCCTGAATCAGACATTCACCACAC 
Rfa2 deletion diagnostic 
primer (Reverse) 
pJG4-5-UP-Sequence GATCCAGCCTGACTGGCTGAAATCGAATGG pJG4-5 sequencing primer 
pJG4-5-DOWN-Recover TCAACAACGTATCTACCAACGATTTGACCC pJG4-5 sequencing primer 
UBC6-FOR AACCACCGGCTATCAGAATG For detection of Rfa1 expression via qPCR 
UBC6-REV TTCCAAGTATCAGGGTGGTAATC For detection of Rfa1 expression via qPCR 
cdc5-ad-FOR TCCAAATTAAGGACGATTCAGGCG Used to amplify cdc5-AD for in vivo cloning 
cdc5-ad-REV GTCAAAGAGGGCCTTTCTATTGG Used to amplify cdc5-AD for in vivo cloning 
MEC1-UP-FOR CAAGGCTCCATAACTATATGGAGC Upstream MEC1 Forward primer 
MEC1-DOWN-REV TAACTTATATGGTGTCAACATCCC Downstream MEC1 Reverse primer 
RAD53-UP-FOR TGGCAGAAAAATCATCACCGTGGG Upstream RAD53 Forward primer 
RAD53-DOWN-REV CCACATCAAGCAGGATTATGTTTT Downstream RAD53 Reverse primer 
SML1-UP-FOR AGCCCAAACGGGCTCCACTACCCG Upstream SML1 Forward primer 
SML1-DOWN-REV GGCGCTAGCGATATCTAGCTGTAT Downstream SML1 Reverse primer 
TEL1-UP-FOR GATATTATGAGCGTGATAGGAGGG Upstream TEL1 Forward primer 
TEL1-DOWN-REV CCCTTTGTATCTTACTGTTCTCAT Downstream TEL1 Reverse primer 
CHK1-UP-FOR TTCAACATTACTACGAGGCCTGCC Upstream CHK1 Forward primer 
CHK1-DOWN-REV GGCTCGAATATTACTCAAACAGGG Downstream CHK1 Reverse primer 
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DUN1-UP-FOR TAGTAATACGATGGTATGTGTGTG Upstream DUN1 Forward primer 
DUN1-DOWN-REV ACTGTGACATTTTTTATATGCGGG Downstream DUN1 Reverse primer 
RDH54-UP-FOR ATCTTCAACAACGCGCTGTTGGAG Upstream RDH54 Forward primer 















































natmx based deletion primer 
for ckb2 
CKA1-UP-FOR ACATACAGCAGCACTAAGTGGTAG Forward primer to amplify CKA1 
CKA1-DOWN-REV TATGAAATTTGCTCGTGTCAACCC Reverse primer to amplify CKA1 
CKA2-UP-FOR CCTTGCGTAGCCCGCTTTTCGCCC Forward primer to amplify CKA2 
CKA2-DOWN-REV GTAGACATCGCTACCGTCGGCAGG Reverse primer to amplify CKA2 
CKB1-UP-FOR AGAATATCGCTACCGCTGCTGCCC Forward primer to amplify CKB1 
CKB1-DOWN-REV GACGACGAAGCTGGTGTGAAGCTG Reverse primer to amplify CKB1 
CKB2-UP-FOR AGCGAATAAATGGAGGTGTATTGG Forward primer to amplify CKB2 
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CKB2-DOWN-REV ATATATAACAGGCTAACTTCGGAG Reverse primer to amplify CKB2 
RFA2-UP-FOR-NEW-O-338 TAGCAATTCCTTTGGCCTCGATGAGCTTCC Upstream RFA2 primer 
RFA2-UP-REV-NEW-O-339 GATAAAACCCTGGTCAGTCAAGGTCGTAC Downstream RFA2 primer 
natMX-DOWN-FOR CCCTGTACGACGGCACCGCCTCGG natMX amplicon - Forward 













































































natMX based deletion primers 
for dun1 
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extension primer for mec1 





extension primer for mec1 





extension primer for rad53 





extension primer for rad53 



























































hphNX based deletion primer 
for slx4 
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hphNX based deletion primer 
for ura3 





C-terminal Forward primer for 





N-terminal Reverse primer for 





C-terminal Forward primer for 





N-terminal Reverse primer for 



























































Upstream primer for sae2 (-
500bp) 
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extension primer for rdh54 
deletion cassettes 
LysMX-Mid-For TATCGCTTCTCCGTGCAATT LysMX diagnostic primer. Forward primer 
LysMX-Mid-REV TTTACGAGGAACATAGCTAC LysMX diagnostic primer., Reverse primer 
cka1-up-for ATGAGAAATCTATTGGAAAC CKA1 external Forward primer 
cka2-up-for GTCGATTGCTCCAAAGTTGG cka2 external Forward primer 
ckb1-up-for ATAGAGTTGTTGAATTCTTT ckb1 external Forward primer 
ckb2-up-for CCAATATGATATAGGGACCA ckb2 external Forward primer 
cka1-down-rev TAGAAGGTGGTAAGGATCCA cka1 external Reverse primer 
cka2-down-rev CTTCTTCATTGCTGAAAAAA cka2 external Reverse primer 
ckb1-down-rev GCCCAACAAGGTAGTGAACA ckb1 external Reverse primer 
ckb2-down-rev GCCGAAAGAAATTTGCTGCA ckb2 external Reverse primer 
TRP1-up-rev CAAGTATTTCGGAGTGCCTG internal gene primer for confirmation of knockout 
TRP1-down-for CGATTTCTGACTGGGTTGGA internal gene primer for confirmation of knockout 
RAD53-UP-NEW-FOR ATGGACTGTTCTTTCTGCACAGGCGACTAA 
Upstream RAD53 Forward 
primer 
RAD53-DOWN-NEW-REV GGTTGGCGCTGACCAACAACAAGGCCAATGG 
Downstream RAD53 Reverse 
primer 
MEC1-UP-NEW-FOR GCGGTACTCAGACGATAACTATGAGTACAGG 
Upstream MEC1 Forward 
primer 
MEC1-DOWN-NEW-REV CAATCCACTTATAGTTAAGCAGGCATAGGGG 
Downstream MEC1 Reverse 
primer 
RFA1-SEQ TCACGCTAAAAATTAGACGAGGCG Rfa1 sequencing primer 
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RFA2-UP-F TAGCAATTCCTTTGGCCTCGATGAGCTTCC Rfa2 upstream Forward primer 
rad53-gblock-FOR CATCACCGTGGGTAGACTTGGAAATGAAAACATTTATAGA 
Amplification of G-42 for rad53 
knockouts 
rad53-gblock-REV CTTTTTCTGATTCAAAAATTCATTAAGCATAACTAAAACT 
Amplification of G-42 for rad53 
knockouts 
cka1-up-new-FOR AGATGTTATTTTCACATCACATGTCGCTAATTTG Upstream CKA1 primer 
cka1-down-new-REV GTTTTGGTGAGCACAACGGTGTTTCATTCAAGAA Downstream CKA1 primer 
cka2-up-new-FOR CAACTCTGAAGTTGATTTACTTGCTGTAGGTCGA Upstream CKA2 primer 
cka2-down-new-REV ATTTTACTCAAAAGGTAAATGGCTCTCTCAGCGT Downstream CKA2 primer 
ckb1-up-new-FOR TGAAGATGGGCCTGAAAGGCTTTATTTTCTGATT Upstream CKB1 primer 
ckb1-down-new-REV CAATCCAGATTAAGGAAGGAGTATAGGCAATTAC Downstream CKB1 primer 
ckb2-up-new-FOR GAGATCACCTGTTATGAAAAAAATATCACCGGTA Upstream CKB2 primer 
ckb2-down-new-REV GTAAATAACTATAATTGACACCACCTGTCAACCA Downstream CKB2 primer 
QMAT2.F ATTGCGACAAGGCTTCACCC MAT qPCR (Rsa1 -5kbp) 
QMAT2.R CACATCACAGGTTTATTGGTTCC MAT qPCR (Rsa1 -5kbp) 
QMAT3.1.F GGTTCAACAACTGCCACCTTTG MAT qPCR (Rsa1 -10kbp) 
QMAT3.1.R GGTGATGGAGATGGAGTAGGAACG MAT qPCR (Rsa1 -10kbp) 
QPRE1.F CCCACAAGTCCTCTGATTTACATTCG Pre1 control qPCR primers 
QPRE1.R ATTCGATTGACAGGTGCTCCCTTTTC Pre1 control qPCR primers 
QARO1.F GAGTCGTTACAAGGTGATGCCAG Aro1 control qPCR primers 
QARO1.R AATAGCGGCAACAACACATGC Aro1 control qPCR primers 
MAT-HO-F AATGGCACGCGGACAAA PCR @ Mat locus during resection (+break control) 
MAT-HO-R CATCTTCCCAATATCCGTCACC PCR @ Mat locus during resection (+break control) 
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MAT-Ssp1-r1.1-F ACCATTCTCATTATAAACAAGAATATCCAG R1 Forward 
MAT-Ssp1-r1.1-R TACTGCCGGTGTTAAGCATTTA R1 Reverse 
MAT-Ssp1-r2.1-F AGCCACAGGATTAATTATCTGAAATATG R2 Forward 
MAT-Ssp1-r2.1-R AAGAAGAAGAGGAAGGCGAAAG R2 Reverse 
MAT-Ssp1-r3.1-F AGTATTTAAGTGTTACCCGGTTACTT R3 Forward 
MAT-Ssp1-r3.1-R ATTCTTGCGGATATCGTGCTAC R3 Reverse 
MAT-Ssp1-r4.1-F GTTCTCTCAATAAGGAAGCATCAAG R4 Forward 
MAT-Ssp1-r4.1-R CGCTCTTTCTGTATGTATAGAACTAAAT R4 Reverse 
MAT-Ssp1-r5.2-F CAGTGAACGCTTGTGCTATCTT R5 Forward 
MAT-Ssp1-r5.2-R CGGTCTTTCACTGTCGTGATTT R5 Reverse 
MAT-Ssp1-r6.1-F GTTAGAGGATGTCTAGCACTTGAG R6 Forward 
MAT-Ssp1-r6.1-R CGTAGTGATGACGTACGTGTATAG R6 Reverse 
MAT-Ssp1-r7.1-F AGAGTCATTACAACGAGGAAATAGAA R7 Forward 
MAT-Ssp1-r7.1-F CGTGGATCTGGTAGATCTGTAAAC R7 Reverse 
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APPENDIX D. APPENDIX FIGURES 
 
Figure D.1. Distribution of cells in Rfa2 NT extensive mutations during adaptation time course. 
NMM104 cells containing Rfa2 NT mutations were harvested from HO-induced culture at 8 hours, diluted, 
spread on YPRG plates using glass beads, and then analyzed microscopically and quantitated at 8, 24, 
and 48 hours post-HO induction. Cells were categorized based on morphology of 1 unbudded cell, 2 cells 
or bilobal ‘big’ buds, 3 cells, 4 cells, or 5 or more cells per cluster at 8 hours. At 24 and 48 hours, cells 
were categorized as 1-2 ‘arrested’ cells, 3-4 cells, 5-6 cells, 7-8 cells, or 9 or more cells per cluster. 
Averages are from three independent replicate data sets. Errors bars represent standard deviation from 
averages obtained in replicate data sets. HO expression was induced in exponentially growing cells by 
adding 2% galactose to the media.   
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Figure D.2. Distribution of cells in rdh54Δ rfa2 NT extensive mutations during adaptation time 
course. 
rdh54Δ cells containing Rfa2 NT mutations were harvested from HO-induced culture at 8 hours, diluted, 
spread on YPRG plates using glass beads, and then analyzed microscopically and quantitated at 8, 24, 
and 48 hours post-HO induction. Cells were categorized based on morphology of 1 unbudded cell, 2 cells 
or bilobal ‘big’ buds, 3 cells, 4 cells, or 5 or more cells per cluster at 8 hours. At 24 and 48 hours, cells 
were categorized as 1-2 ‘arrested’ cells, 3-4 cells, 5-6 cells, 7-8 cells, or 9 or more cells per cluster. 
Averages are from three independent replicate data sets. Errors bars represent standard deviation from 
averages obtained in replicate data sets. HO expression was induced in exponentially growing cells by 
adding 2% galactose to the media.   
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Figure D.3. Distribution of cells in rdh54Δ rfa2-h2NT mutations during adaptation time course. 
NMM104 or rdh54Δ cells containing rfa2-h2NT were harvested from HO-induced culture at 8 hours, 
diluted, spread on YPRG plates using glass beads, and then analyzed microscopically and quantitated at 
8, 24, and 48 hours post-HO induction. Cells were categorized based on morphology of 1 unbudded cell, 
2 cells or bilobal ‘big’ buds, 3 cells, 4 cells, or 5 or more cells per cluster at 8 hours. At 24 and 48 hours, 
cells were categorized as 1-2 ‘arrested’ cells, 3-4 cells, 5-6 cells, 7-8 cells, or 9 or more cells per cluster. 
Averages are from three independent replicate data sets. Errors bars represent standard deviation from 
averages obtained in replicate data sets. HO expression was induced in exponentially growing cells by 
adding 2% galactose to the media.   
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Figure D.4. Distribution of cells in rfa2-S122D/A mutations during adaptation time course. 
NMM104 containing rfa2-S122D or rfa2-S122A were harvested from HO-induced culture at 8 hours, 
diluted, spread on YPRG plates using glass beads, and then analyzed microscopically and quantitated at 
8, 24, and 48 hours post-HO induction. Cells were categorized based on morphology of 1 unbudded cell, 
2 cells or bilobal ‘big’ buds, 3 cells, 4 cells, or 5 or more cells per cluster at 8 hours. At 24 and 48 hours, 
cells were categorized as 1-2 ‘arrested’ cells, 3-4 cells, 5-6 cells, 7-8 cells, or 9 or more cells per cluster. 
Averages are from three independent replicate data sets. Errors bars represent standard deviation from 
averages obtained in replicate data sets. HO expression was induced in exponentially growing cells by 
adding 2% galactose to the media.  
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Figure D.5. Distribution of cells in rfa2-DX-S122D/A mutations during adaptation time course. 
NMM104 containing rfa2-DX-S122D or rfa2-DX-S122A were harvested from HO-induced culture at 8 
hours, diluted, spread on YPRG plates using glass beads, and then analyzed microscopically and 
quantitated at 8, 24, and 48 hours post-HO induction. Cells were categorized based on morphology of 1 
unbudded cell, 2 cells or bilobal ‘big’ buds, 3 cells, 4 cells, or 5 or more cells per cluster at 8 hours. At 24 
and 48 hours, cells were categorized as 1-2 ‘arrested’ cells, 3-4 cells, 5-6 cells, 7-8 cells, or 9 or more 
cells per cluster. Averages are from three independent replicate data sets. Errors bars represent standard 
deviation from averages obtained in replicate data sets. HO expression was induced in exponentially 
growing cells by adding 2% galactose to the media. 
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Figure D.6. Distribution of cells in rfa2-ΔNX-S122D/A mutations during adaptation time course. 
NMM104 containing rfa2-ΔNX-S122D or rfa2-ΔNX-S122A were harvested from HO-induced culture at 8 
hours, diluted, spread on YPRG plates using glass beads, and then analyzed microscopically and 
quantitated at 8, 24, and 48 hours post-HO induction. Cells were categorized based on morphology of 1 
unbudded cell, 2 cells or bilobal ‘big’ buds, 3 cells, 4 cells, or 5 or more cells per cluster at 8 hours. At 24 
and 48 hours, cells were categorized as 1-2 ‘arrested’ cells, 3-4 cells, 5-6 cells, 7-8 cells, or 9 or more 
cells per cluster. Averages are from three independent replicate data sets. Errors bars represent standard 
deviation from averages obtained in replicate data sets. HO expression was induced in exponentially 
growing cells by adding 2% galactose to the media. 
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Figure D.7. Distribution of cells in rfa2-DM mutations during adaptation time course. 
NMM104 or rdh54Δ cells containing rfa2-DM1, rfa2-DM2, or rfa2-DM3, were harvested from HO-induced 
culture at 8 hours, diluted, spread on YPRG plates using glass beads, and then analyzed microscopically 
and quantitated at 8, 24, and 48 hours post-HO induction. Cells were categorized based on morphology 
of 1 unbudded cell, 2 cells or bilobal ‘big’ buds, 3 cells, 4 cells, or 5 or more cells per cluster at 8 hours. At 
24 and 48 hours, cells were categorized as 1-2 ‘arrested’ cells, 3-4 cells, 5-6 cells, 7-8 cells, or 9 or more 
cells per cluster. Averages are from three independent replicate data sets. Errors bars represent standard 
deviation from averages obtained in replicate data sets. HO expression was induced in exponentially 
growing cells by adding 2% galactose to the media.  
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Figure D.8. Distribution of cells in rfa2-AM mutations during adaptation time course. 
NMM104 or rdh54Δ cells containing rfa2-AM1, rfa2-AM2, or rfa2-AM3, were harvested from HO-induced 
culture at 8 hours, diluted, spread on YPRG plates using glass beads, and then analyzed microscopically 
and quantitated at 8, 24, and 48 hours post-HO induction. Cells were categorized based on morphology 
of 1 unbudded cell, 2 cells or bilobal ‘big’ buds, 3 cells, 4 cells, or 5 or more cells per cluster at 8 hours. At 
24 and 48 hours, cells were categorized as 1-2 ‘arrested’ cells, 3-4 cells, 5-6 cells, 7-8 cells, or 9 or more 
cells per cluster. Averages are from three independent replicate data sets. Errors bars represent standard 
deviation from averages obtained in replicate data sets. HO expression was induced in exponentially 
growing cells by adding 2% galactose to the media. 
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Figure D.9. Distribution of cells in NMM104 Rfa2 NT extensive mutations during adaptation time 
course. 
NMM104 cells containing Rfa2 NT mutations were harvested from HO-induced culture at 8 hours, diluted, 
spread on YPRG plates using glass beads, and then analyzed microscopically and quantitated at 8, 24, 
and 48 hours post-HO induction. Averages are from three independent replicate data sets. HO 
expression was induced in exponentially growing cells by adding 2% galactose to the media. rfa2-AX or 
rfa2-ΔNX display reduced average adaptation compared to RFA2 cells. rfa2-DX adapts indistinguishably 
from RFA2 cells. 
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Figure D.10. Distribution of cells in tel1Δ Rfa2 NT extensive mutations during adaptation time 
course. 
tel1Δ cells containing Rfa2 NT mutations were harvested from HO-induced culture at 8 hours, diluted, 
spread on YPRG plates using glass beads, and then analyzed microscopically and quantitated at 8, 24, 
and 48 hours post-HO induction. Averages are from three independent replicate data sets. HO 
expression was induced in exponentially growing cells by adding 2% galactose to the media. rfa2-AX or 
rfa2-ΔNX display reduced average adaptation compared to RFA2 cells. rfa2-DX adapts indistinguishably 
from RFA2 cells. 
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Figure D.11. Distribution of cells in sae2Δ Rfa2 NT extensive mutations during adaptation time 
course. 
sae2Δ cells containing Rfa2 NT mutations were harvested from HO-induced culture at 8 hours, diluted, 
spread on YPRG plates using glass beads, and then analyzed microscopically and quantitated at 8, 24, 
and 48 hours post-HO induction. Averages are from three independent replicate data sets. HO 
expression was induced in exponentially growing cells by adding 2% galactose to the media.  
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Figure D.12. Distribution of cells in rtt107Δ Rfa2 NT extensive mutations during adaptation time 
course. 
rtt107Δ cells containing Rfa2 NT mutations were harvested from HO-induced culture at 8 hours, diluted, 
spread on YPRG plates using glass beads, and then analyzed microscopically and quantitated at 8, 24, 
and 48 hours post-HO induction. Averages are from three independent replicate data sets. HO 
expression was induced in exponentially growing cells by adding 2% galactose to the media. 
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Figure D.13. Distribution of cells in slx4Δ Rfa2 NT extensive mutations during adaptation time 
course. 
slx4Δ cells containing Rfa2 NT mutations were harvested from HO-induced culture at 8 hours, diluted, 
spread on YPRG plates using glass beads, and then analyzed microscopically and quantitated at 8, 24, 
and 48 hours post-HO induction. Averages are from three independent replicate data sets. HO 
expression was induced in exponentially growing cells by adding 2% galactose to the media. 
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Figure D.14. Distribution of cells in cka1Δ Rfa2 NT extensive mutations during adaptation time 
course. 
cka1Δ cells containing Rfa2 NT mutations were harvested from HO-induced culture at 8 hours, diluted, 
spread on YPRG plates using glass beads, and then analyzed microscopically and quantitated at 8, 24, 
and 48 hours post-HO induction. Averages are from three independent replicate data sets. HO 
expression was induced in exponentially growing cells by adding 2% galactose to the media.  
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Figure D.15. Distribution of cells in cka2Δ Rfa2 NT extensive mutations during adaptation time 
course. 
cka2Δ cells containing Rfa2 NT mutations were harvested from HO-induced culture at 8 hours, diluted, 
spread on YPRG plates using glass beads, and then analyzed microscopically and quantitated at 8, 24, 
and 48 hours post-HO induction. Averages are from three independent replicate data sets. HO 
expression was induced in exponentially growing cells by adding 2% galactose to the media. 
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Figure D.16. Distribution of cells in ckb1Δ Rfa2 NT extensive mutations during adaptation time 
course. 
ckb1Δ cells containing Rfa2 NT mutations were harvested from HO-induced culture at 8 hours, diluted, 
spread on YPRG plates using glass beads, and then analyzed microscopically and quantitated at 8, 24, 
and 48 hours post-HO induction. Averages are from three independent replicate data sets. HO 
expression was induced in exponentially growing cells by adding 2% galactose to the media. 
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Figure D.17. Distribution of cells in ckb2Δ Rfa2 NT extensive mutations during adaptation time 
course. 
ckb2Δ cells containing Rfa2 NT mutations were harvested from HO-induced culture at 8 hours, diluted, 
spread on YPRG plates using glass beads, and then analyzed microscopically and quantitated at 8, 24, 
and 48 hours post-HO induction. Averages are from three independent replicate data sets. HO 
expression was induced in exponentially growing cells by adding 2% galactose to the media. 
